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ABSTRACT 
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Part I. The first asymmetric synthesis of α-allyl-α-aryl α-amino acids by means 
of a three component coupling of α-iminoesters, Grignard reagents, and cinnamyl acetate 
is reported.  Notably, the enolate from the tandem process provides a much higher level 
of reactivity and selectivity than the same enolate generated via direct deprotonation, 
presumably due to differences in the solvation/aggregation state.  
 
A novel method for removal of a homoallylic amine protecting group delivers the 
free amine congeners.  The α-allyl moiety offers a means to generate further valuable α-
amino acid structures. Cross-metathesis of the tandem product provided allylic diversity 
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not afforded in the parent reaction. Cyclic α-amino acid derivatives could be accessed by 
ring closing metathesis presenting a viable strategy to higher ring homologues of 
enantioenriched α-substituted proline. The 8-member proline analog was successfully 
converted to the pyrrolizidine natural product backbone.  
Part II. The asymmetric spirocyclization of allenyl ketones is reported. High-
throughput experimentation by means of a chiral Lewis acid library enabled the 
determination of a suitable catalyst system. Protecting group manipulation provides an 
orthogonal route to enantioenriched para-quinone and ortho-quinone spirocycles. This 
novel technology provides access to the spirocyclic core that is prevalent in many natural 
products. 
 
Part III. Palladium has been identified as a suitable catalyst for the 
chemoselective activation of C(sp3)−H bond over C(sp2)−H bond of toluene and tolyl 
analogs. This technology has been combined with the C(sp3)−H activation of acidic C−H 
bonds to form new C−C bonds. High-throughput experimentation was used for 
identifying conditions that reduced toluene loading and engendered catalyst turnover via 
a suitable oxidant.  
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The parent reaction has been extended to include the Pd catalyzed alkylation of 
phenylglycine azlactones with ethylbenzene, 2-ethylnaphthalene, propylbenzene and 
butylbenzene. Mechanistic studies were initiated to determine whether the process occurs 
via free radicals or via Pd mediated C(sp3)−H activation. Our studies support a Pd 
mediated process in which the C(sp3)−H activation of the tolyl analog is the rate 
determining step. This finding represents a paradigm shift in our understanding of Pd and 
its selectivity for arene activation vs benzylic activation. 
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1 
1. ASYMMETRIC SYNTHEISS OF α-ALLYL-α-ARYL α-AMINO ACIDS BY 
TANDEM ALKYLATION/π-ALLYLATION OF α-IMINOESTERS 
1.1. BACKGROUND 
1.1.1. Significance of α,α-Disubstituted α-Amino Acids 
Enantiomerically pure α,α-disubstituted α-amino acids and their derivatives are 
vital synthetic building blocks in organic synthesis and play an integral role in 
pharmaceutical research. The α,α-disubstituted α-amino acid structural motif is found in 
many natural products.1 Fumimycin, a natural product related to sorbicillactiones A and 
B, was discovered in 2007; it is a peptide deformylase inhibitor with antibacterial activity 
(Figure 1.1).2 The pharmaceutical industry has demonstrated in numerous examples that 
incorporation of α,α-disubstituted α-amino acids into biologically active molecules can 
improve drug properties (Figure 1.1).3 
 
Figure 1.1 Examples of biologically active α-alkyl-α-aryl α-amino acids. 
                                                
1) (a) Kan, T.; Kawamoto, Y.; Asakawa, T.; Furuta, T.; Fukuyama, T. “Synthetic Studies on Altemicidin: 
Stereocontrolled Construction of the Core Framework” Org. Lett. 2008, 10, 169-171. (b) Kobayashi, 
S.; Furuta, T.; Hayashi, T.; Nishijima, M.; Hanada, K. “Catalytic Asmmetric Syntheses of Antifungal 
Sphingofungins and Their Biological Activity as Potent Inhibitors of Serine Palmitoyltransferase 
(SPT)” J. Am. Chem. Soc. 1998, 120, 908-919.  
2) Kwon, Y. –J.; Sohn, M. –J.; Zheng, C. –J.; Kim, W. –G. “Fumimycin: A Peptide Deformylase 
Inhibitor with an Unusual Skeleton Produced by Aspergillus fumisynnematus” Org. Lett. 2007, 9, 
2449-2451.  
3) (a) Savage, S.A.; Waltermire, R.E.; Campagna, S.; Bordawekar, S.; Toma, J.D.R. “Development and 
Large-Scale Preparation of an Oral TACE Inhibitor” Org. Process Res. Dev. 2009, 13, 510 (b) 
Washburn, W.N. et al., “BMS-201620: a selective beta 3 agonist” Bioorg. Med. Chem. Lett. 2004, 14, 
3525-3529.  
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2 
Perhaps most notable is the use of α,α-disubstituted α-amino acids for 
peptidomimetics (Figure 1.2, top).4 Peptidomimetics are small molecules that exhibit 
similar properties to peptides and are useful for the study of protein-protein interactions. 
α-Methyl alanine and α-alkyl alanine are the most well studied modifications to peptides. 
The incorporation of an alkyl group on the α-position of alanine in a peptide chain 
restricts the number of potential conformations for higher-order structures and typically 
induces helical formation with proteins that have >5 and <50 amino acid units.  
 
Figure 1.2 Peptidomimetics: side chain modification. 
A less studied system is a sterically bulky groups with alanine, (αMe)Phg, or α,α-
disubstituted α-amino acids with two bulky substituents (Figure 1.2, bottom). These 
types of amino acids are incorporated into peptides to limit the number of potential 
tertiary structures and typically induce a fully extended backbone conformation.5 
 
                                                
4) (a) Fernandez-Tejada, A.; Corzana, F.; Busto, J. H.; Avenoza, A.; Peregrina, J. M. “Conformational 
Effects of the Non-natural α-Methylserine on Small Peptides and Glycopeptides” J. Org. Chem. 2009, 
74, 9305-9313. (b) Grauer, A.; Konig, B. “Peptidomimetics − A Versatile Route to Biologically Active 
Compounds” Eur. J. Org. Chem. 2009, 5099-5111. (c) Venkatraman, J.; Shankaramma, S. C.; 
Belaram, P. “Design of Folded Peptides” Chem. Rev. 2001, 101, 3131-3152.  
5) Toniolo, C.; Crisma, M.; Formaggio, F.; Peggion, C. “Control of Peptide Conformation by the Thorpe-
Ingold Effect (Cα-Tetrasubstituion)” Biopolymers 2001, 60, 396-419. 
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1.1.2.  Previous Synthetic Access to α,α-Disubstituted α-Amino Acids 
Due to the considerable importance of enantioenriched α,α-disubstituted α-amino 
acids, several methods have been developed for their synthesis.6 The synthesis of α,α-
disubstituted α-amino acids can be accomplished by nucleophilic (Scheme  1.1, left) or 
electrophilic functionalization (Scheme  1.1, right).  
Scheme  1.1 General enantioselective methods for the synthesis of acyclic α,α-
disubstituted α-amino acids. 
 
The Strecker reaction as well as C-alkylation of α-iminoesters have been 
catalyzed by chiral Lewis acids, chiral Brønsted acids and hydrogen bond catalysts. The 
range of α,α-disubstituted α-amino acids that can be synthesized by the Strecker reaction 
is limited by the unreactive nature of the ketimine combined with the need for 
substituents to differ in size.7 Alternatively, C-alkylation of α-iminoesters is limited to 
                                                
6) (a) Liu, Z.; Mehta, S. J.; Hruby, V. J. “Strategies for Asymmetric Synthesis of Amino Acids with γ,δ-
Unsaturation” Organic Preparations and Procedures International: The New Journal for Organic 
Synthesis 2012, 44, 222-255. (b) Cativiela, C.; Diaz-De-Villegas, M. D. “Recent progress on the 
stereoselective synthesis of acyclic quaternary α-amino acids” Tetrahedron: Asymm. 2007, 18, 569-
623. (c) Vogt, H.; Brase, S. “Recent approaches towards the asymmetric synthesis of α,α-disubstituted 
α-amino acids” Org. Biomol. Chem. 2007, 5, 406-430. 
7) Wang, J.; Liu, X.; Feng, X. “Asymmetric Strecker Reactions” Chem. Rev. 2011, 111, 6947-6983. 
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unhindered nucleophiles.8 Electrophilic functionalization of activated α-amino acids by 
phase transfer catalysis (PTC) with alkyl halides or α,β-unsaturated carbonyls leads to 
α,α-disubstituted α-amino acids.9 Conversely, a disubstituted enolate can undergo α-
amination.4 
A thorough investigation of the methods for synthesizing α,α-disubstituted α-
amino acids revealed less common methods such as sigmatropic rearrangements, 
cycloadditions, aldol type reactions and allylic alkylation.4 However, a class of 
compounds that has no general enantioselective synthesis is α-allyl-α-aryl α-amino acids 
(Figure 1.3).  
 
Figure 1.3 Underexplored class of α,α-disubstituted α-amino acids. 
 
                                                
8) (a) Wieland, L. C.; Vieira, E. M.; Snapper, M. L.; Hoveyda, A. H. “Ag-Catalyzed Diastereo- and 
Enantioselective Vinylogous Mannich Reactions of α-Ketoimine Esters. Development of a Method 
and Investigation of its Mechanism” J. Am. Chem. Soc. 2009, 131, 570-576. (b) Fu, P.; Snapper, M. L.; 
Hoveyda, A. H. “Catalytic Asymmetric Alkylations of Ketoimines. Enantioselective Synthesis of N-
Substituted Quaternary Carbon Stereogenic Centers by Zr-Catalyzed Additions of Dialkylzinc 
Reagents to Aryl-, Alkyl-, and Trifluoroalkyl-Substituted Ketoimines” J. Am. Chem. Soc. 2008, 130, 
5530-5541. (c) Basra, S.; Fennie, M. W.; Kozlowski, M. C. “Catalytic Asymmetric Addition of 
Dialkylzinc Reagents to α-Aldiminoesters” Org. Lett. 2006, 8, 2659-2662. (d) Zhuang, W.; Saaby, S.; 
Jorgensen, K. A. “Direct Organocatalytic Enantioselective Mannich Reactions of Ketimines: An 
Approach to Optically Active Quaternary α-Amino Acid Derivatives” Angew. Chem., Int. Ed. 2004, 
43, 4476-4478. 
9) Maruoka, K.; Ooi, T. “Enantioselective Amino Acid Synthesis by Chiral Phase-Transfer Catalysis” 
Chem. Rev. 2003, 103, 3013-3028. 
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1.1.3.  Synthesis of Enantioenriched α-Allyl-α-Aryl α-Amino Acids 
To date, synthetic access to enantioenriched α-allyl-α-aryl α-amino acids has 
remained elusive. The phenylglycine racemate can readily undergo allylation in high 
yield when the amine is pre-activated as the aldimine. Upon hydrolysis of the aldimine, 
each enantiomer of α-allylphenylglycine can be kinetically resolved via preferential 
interaction with a chiral agent (Scheme  1.2). Tourwe and co-workers demonstrated this 
strategy utilizing pig liver esterase (PLE) to deliver the (R)-enantiomer and 
Ochrobactrum anthropic NCIMB 40321 to provide the (S)-enantiomer.10 In 2005, Maeda 
and co-workers at Merck found that D-(-)-tartaric acid and Bacillus stearomorphilus 
(BS3) could also be used.11 Kinetic resolutions deliver very high enantioenriched product 
but a drawback is the theoretical maximum yield of 50%. Tourwe and Maeda each 
desired the enantioenriched α-allylphenylglycine to deliver novel chemical space through 
functionalization of the allyl moiety.  
Scheme  1.2 Kinetic resolution of α-allylphenylglycine. 
 
Diastereoselective processes can be powerful tools to deliver enantioenriched 
product with high yields. Chiral auxiliaries, when low cost and easily accessible, have 
been utilized successfully to deliver important natural products and active pharmaceutical 
                                                
10) Van Betsbrugge, J.; Tourwe, D.; Kaptein, B.; Kierkels, H.; Broxterman, R. “A Convenient Synthesis of 
Protected (R)-α-Phenylproline Derivatives Using the Mitsunobu Reaction” Tetrahedron 1997, 53, 
9233-9240.  
11) Maeda, K.; Miller, R. A.; Szumigala, R. H., Jr.; Shafiee, A.; Karady, S.; Armstrong, J. D., III 
“Stereoselective synthesis of 4-hydroxy-2-phenylproline framework” Tetrahedron Lett. 2005, 46, 
1545-1549.  
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ingredients (API).12 The synthesis of α-allyl-α-aryl α-amino acids by diastereoselective 
processes is rare. Tayama and co-workers developed a novel Stevens rearrangement of N-
allylic α-aryl amino acid derived ammonium salts with good yields and dr (Scheme  1.3, 
a).13 The chiral auxiliary chosen was derived from menthol, but the necessary salt for 
reactivity provides the N-alkyl α-allylphenylglycine α-amino acid. Xu and co-workers 
followed up this work by incorporating the chiral auxiliary on the nitrogen, which allows 
the synthesis of enantioenriched α-allylphenylglycine (Scheme  1.3, b).14 The pincer-like 
chiral auxiliary is not readily available, involves three steps to incorporate into the α-
phenylglycine starting material, and requires harsh conditions to be removed.  
Scheme  1.3 Diastereoselective synthesis of α-allyl-α-aryl α-amino acids by the Stevens 
rearrangement.  
 
Barrett and co-workers have developed an elegant route to α-allyl-α-aryl α-amino 
acids with Schollkopf’s bislactim ether in good yield and diastereoselectivities (Scheme  
                                                
12) Evans, D. A.; Helmchen, G.; Ruping, M. “Chiral Auxiliaries in Asymmetric Synthesis” In Asymmetric 
Synthesis − The Essentials; Christman, M.; Brase, S., Eds.; Wiley: Weinheim, 2007, 2nd Edition, 3-9.   
13) Tayama, E.; Orihara, K.; Kimura, H. “New synthetic routes to optically active α-quaternary α-aryl 
amino acid derivatives via the diastereoselective Stevens and Sommelet−Hauser rearrangements” Org. 
Biomol. Chem. 2008, 6, 3673-3680. 
14) Zhu, T. –S.; Xu, M. –H. "Efficient synthesis of optically active α-quaternary amino acids by highly 
diastereoselective [2,3]-rearrangement of allylic ammonium ylides" Chem. Commun. 2012, 48, 7274-
7276.  
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1.4).15 The initial step involves the nucleophilic addition of the bislactim ether on a 
benzyne. The benzyne can only be formed in situ when the aromatic ring is substituted 
with electron-donating substituents. The Schollkopf adduct can be transformed to the α-
allyl-α-aryl amino acid by treatment with acid.  
Scheme  1.4 Diastereoselective synthesis of α-allyl-α-aryl α-amino acids with 
Schollkopf’s bislactim. 
 
 The synthesis of large quantities of enantioenriched compounds from pro-chiral 
starting materials via a relatively small quantity of chiral catalysts has enormous 
potential. Ooi and Maruoka have demonstrated that PTC can be used to synthesize 
enantioenriched α,α-disubstituted α-amino acids.16a,b PTC applied to the synthesis of α-
allyl-α-aryl α-amino acids has been successful in the synthesis of α-allylphenylglycine 
(Scheme  1.5, a).16b,c In 2011, Cossy and co-workers utilized Ooi and Maruoka’s method 
for the synthesis of an analog of α-allylphenylglycine but encountered challenges 
resulting in low yield and ee (Scheme  1.5, b).16d 
                                                
15) Jones, E. P; Jones, P.; White, A. J. P.; Barrett, A. G. M. "Asymmetric synthesis of quaternary aryl 
amino acid derivatives via a three-component aryne coupling reaction" Beilstein J. Org. Chem. 2011, 
7, 1570-1576.  
16) (a) Ooi, T.; Takeuchi, M.; Kameda, M.; Maruoka, K. "Practical Catalytic Enantioselective Synthesis of 
α,α-Dialkyl-α-amino Acids by Chiral Phase-Transfer Catalysis" J. Am. Chem. Soc. 2000, 122, 5228-
5229. (b) Ooi, T.; Takeuchi, M.; Ohara, D.; Maruoka, K. "Advantage of Anaerobic Conditions in the 
Highly Enatioselective Synthesis of α,α-Dialkyl-α-amino Acids by Chiral Phase-Transfer Catalysis" 
Synlett 2001, 7, 1185-1187. (c) Belokon, Y. N.; Bhave, D.; D'Addario, D.; Groaz, E.; North, M.; 
Tagliazucca, V. "Copper(II)salen catalysed, asymmetric synthesis of α,α-disubstituted amino acids" 
Tetrahedron Lett. 2004, 60, 1849-1861. (d) Metro, T. -X.; Cochi, A.; Pardo, D. G.; Cossy, J. 
"Asymmetric Synthesis of an Antagonist of Neurokinin Receptors: SSR 241586" J. Org. Chem. 2011, 
76, 2594-2602.  
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Scheme  1.5 PTC for the synthesis of α-allyl-α-aryl α-amino acids. 
 
Nucleophilic functionalization of α-iminoesters by C-alkylation has seen 
significant progress over the last 15 years for the synthesis of α,α-disubstituted α-amino 
acids.8 Leighton and co-workers have utilized a benzoylhydrazone with a chiral 
allylsilane reagent to produce α-allylphenylglycine (Scheme  1.6).17 Similar work has 
been conducted with chiral sulfoxides and allylation of cyclic imines via rhodium, but in 
each example, yields and ee were moderate (30-70%, 21-76% ee).18  
 
 
 
                                                
17) Berger, R.; Duff, K.; Leighton, J. L. "Enantioselective Allylation of Ketone-Derived 
Benzoylhydrazones: Practical Synthesis of Tertiary Carbinamines" J. Am. Chem. Soc. 2004, 126, 5686-
5687.  
18) (a) Reyes-Rangel, G.; Bandala, Y.; Garcia-Flores, F.; Juaristi, E. "Asymmetric Allylation of α-
Ketoester-Derived N-Benzoylhydrazones Promoted by Chiral Sulfoxides/N-Oxides Lewis Bases: 
Highly Enantioselective Synthesis of Quaternary α-Substituted α-Allyl-α-Amino Acids" Chirality 
2013, 25, 529-540. (b) Hepburn, H. B.; Chotsaeng, N.; Luo, Y.; Lam, H. W. "Enantioselective 
Rhodium-Catalyzed Allylation of Cyclic Imines with Potassium Allyltrifluoroborates" Synthesis 2013, 
45, 2649-2661.  
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Scheme  1.6 C-Allylation of α-iminoesters to generate α-allyl-α-aryl α-amino acids. 
 
 
1.1.4.  N-Alkylation of α-Iminoesters with Organometallic Nucleophiles 
α-Iminoesters have played an important role in the synthesis of α-amino acid 
derivatives. The presence of the adjacent electron-withdrawing ester enhances the 
electrophilicity of the imine carbon. α-Iminoesters display the expected positive charge 
buildup at the carbonyl carbons; however, three potential modes of reactivity can be 
observed (Figure 1.4).19 Addition to the polarized carbonyl of the imine is the most 
common mode of reactivity (Figure 1.4, path a). Electron-donating or -withdrawing 
groups on the nitrogen protecting group typically promote C-alkylation. Both hard and 
soft nucleophiles have shown selectivity for the imine carbon. C-Alkylation of the ester is 
viable but less frequent because of the lower electrophilicity of esters compared to 
imines; however, in some cases organolithiums preferentially add to the ester (Figure 1.4, 
path b).19  
                                                
19) Dickstein, J. S.; Kozlowski, M. C. “Organometal additions to α-iminoesters: N-alkylation via 
umpolung” Chem. Soc. Rev. 2008, 37, 1166-1173.  
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Figure 1.4 Charge calculations of α-iminoesters and modes of reactivity. 
Synthesis of N-substituted α-amino acids is an important field of research in 
chemistry and biology. N-Alkylation of α-iminoesters requires a reversal of polarity of 
the imine group (Figure 1.4, path c). Umpolung is any process by which the donor and 
acceptor reactivity of an atom are interchanged.20 Nitrogen as an electrophile has been 
well developed with diazoesters and nitroso compounds but in each case the double bond 
is composed of two heteroatoms and there is no clear acceptor or donor for addition. N-
Alkylation of α-iminoesters is proposed to occur by bidentate coordination of the metal 
species between the nitrogen of the imine and the oxygen of the ester (Figure 1.5). 
Ostensibly, chelation locks the imine carbon in a more sterically hindered conformation, 
thus favoring N-alkylation.19  
 
                                                
20) Seebach, D. “Methods of Reactivity Umpolung” Angew. Chem. Int. Ed. Engl. 1979, 18, 239-258.  
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Figure 1.5 Proposed mechanism for N-alkylation. 
Magnesium, aluminum, and zinc reagents have been shown to undergo the N-
alkylation mode with α-iminoesters. N-Alkylation was first observed by Kagan and Fiaud 
in 1970, wherein an α-aldiminoester was reacted with various Grignard reagents (Scheme  
1.7, a).21 Kagan observed differing reactivity when primary, secondary and tertiary 
Grignard reagents were examined. Primary Grignard reagents preferentially produced the 
N-alkylated product. Secondary Grignard reagents produced a 60:40 mixture of N-
alkylated product to C-alkylated product. tert-Butylmagnesium bromide provided only C-
alkylated product at rt but a 55:45 mixture of N-alkylated product to C-alkylated product 
at −78 °C. Interestingly, methyl Grignard and allyl Grignard provide exclusively the C-
alkylated product. Shimizu and co-workers studied the addition of Grignard reagents to 
iminomalonates (Scheme  1.7, b).22 In contrast to Kagan’s observation, secondary, 
tertiary, methyl and allyl Grignard reagents provided exclusively the N-alkylated product; 
the addition of the second electron-withdrawing group on the imine carbon enhances the 
electrophilicity of the imine nitrogen.   
 
                                                
21) Fiaud, J. C.; Kagan, H. B. “Une nouvelle synthese D’α amino-acides. Synthese asymetrique de 
l’alaine” Tetrahedron Lett. 1970, 11, 1813-1816.   
22) Niwa, Y.; Takayama, K.; Shimizu, M. “Electrophilic amination with iminomalonate” Tetrahedron 
Lett. 2001, 42, 5473-5476.  
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Scheme  1.7 Examples of umpolung N-alkylation of α-iminoesters with organometals. 
 
Yamamoto and co-workers explored various organometal reagents with α-
aldiminoester utilizing benzyl Grignard and transmetallating reagents (Scheme  1.7, c).23 
Organo-copper, titanium and boron reagents produced the N-alkylated product but were 
inferior when compared with the selectivity observed by Kagan with Grignard reagents. 
Shimizu and co-workers discovered that a mixture of organoaluminum reagents 
could preferentially produce the N-alkylated enolate, which could be oxidized to the 
imininum and then subjected to nucleophilic addition with allyltin (Scheme  1.7, d).24  
In 2008, our research group demonstrated the first three component coupling of 
α-iminoesters with alkyl Grignards and electrophiles (Figure 1.6).25,26 Dickstein and co-
                                                
23) Yamamoto, Y.; Ito, W. “Studies on the Reaction of α-Imino Esters with Organometallic Compounds” 
Tetrahedron 1988, 44, 5415-5423.  
24) Niwa, Y.; Shimizu, M. “Tandem N-Alkylation−C-Allylation Reaction of α-Imino Esters with 
Organoaluminums and Allyltributyltin” J. Am. Chem. Soc. 2003, 125, 3720-3721.  
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workers were able to demonstrate that the enolate generated in situ from the initial N-
alkylation could be trapped with electrophiles. This novel technology provided access to 
a library of racemic α,α-disubstituted α-amino acids. The diversity of functional groups 
from the various electrophiles allows the synthesis of other novel compounds.   
 
Figure 1.6 Three component coupling of α-iminoesters via umpolung addition of alkyl 
Grignards providing α,α-disubstituted α-amino acids. 
Dr. Dickstein demonstrated that Grignard reagents could preferentially undergo 
N-alkylation with hindered α-iminoesters. Previously, only unhindered (aldimine)21 and 
doubly activated (iminomalonates)22 were shown to be successful. This work also 
provided insight about the activating group on the imine nitrogen (Table 1.1). An 
electron-withdrawing activating group such as tosyl or phosphoryl promotes C-alkylation 
                                                                                                                                            
25) Dickstein, J. S.; Fennie, M. W.; Norman, A. L.; Paulose, B. J.; Kozlowski, M. C. “Three Component 
Coupling of α-Iminoesters via Umpolung Addition of Organometals: Synthesis of α,α-Disubstituted 
α-Amino Acids” J. Am. Chem. Soc. 2008, 130, 15794-15795. 
26) For tandem reactions of α-iminoesters that followed ref. 25, see: (a) Mizota, I.; Matsuda, Y.; 
Kamimura, S.; Tanaka, H.; Shimizu, M. “Regioselective Tandem N-Alkylation/C-Acylation of β,γ-
Alkynyl α-Imino Esters” Org. Lett. 2013, 15, 4206-4209. (b) Shimizu, M.; Kurita, D.; Mizota, I. 
“Highly Diastereoselective Tandem N-Alkylation-Mannich Reaction of α-Imino Esters” Asian J. Org. 
Chem. 2013, 2, 208-211. (c) Shimizu, M.; Takao, Y.; Katsurayama, H.; Mizota, I. “Synthesis of 
Indolin-3-ones and Tetrahydro-4-quinolones from α-Imino Esters” Asian J. Org. Chem. 2013, 2, 130-
134. (d) Mizota, I.; Tanaka, K.; Shimizu, M. “Synthesis of γ,δ–unsaturated quaternary α-alkylamino 
acids using umpolung reaction and Claisen rearrangement” Tetrahedron Lett. 2012, 53, 1847-1850.  
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or reduction via β-hydride elimination. However, hindered α-iminoesters with phenyl or 
para-methoxy phenyl (PMP) activating groups provide entry to the tetra-substituted 
enolate via N-alkylation.    
Table 1.1 Regioselectivity of organometals with α-iminoester with various activating 
groups on the imine nitrogen. 
 
 
1.1.5.  Asymmetric Allylic Alkylation for the Synthesis of α,α-Disubstituted α-Amino 
Acids 
Transition metal-catalyzed allylic substitution with carbon nucleophiles is a 
powerful tool for the controlled formation of carbon-carbon bonds. Asymmetric allylic 
alkylation (AAA) has seen considerable progress since Tsuji’s seminal work in 1965.27 
However, AAA with α-amino acids is rare. The unreactive nature of α-amino acids as 
                                                
27) (a) Tsuji, J.; Takahashi, H.; Morikawa, M. “Organic syntheses by means of noble metal and 
compounds. XVII. Reaction of π-allylpalladium chloride with nucleophiles” Tetrahedron Lett. 1965, 
4387-4388. (b) Trost, B. M. “Pd asymmetric allylic alkylation (AAA). A powerful synthetic tool” 
Chem. Pharm. Bull. 2002, 50, 1-14. (c) Lu, Z.; Ma, S. “Metal-Catalyzed Enantioselective Allylation in 
Asymmetric Synthesis” Angew. Chem., Int. Ed. 2008, 47, 258-297. (d) Rios, I. G.; Rosas-Hernandez, 
A.; Martin, E. “Recent Advances in the Application of Chiral Phosphine Ligands in Pd-Catalyzed 
Asymmetric Allylic Alkylation” Molecules 2011, 16, 970-1010.  
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well as the sterically hindered α-carbon requires pre-activation and limits the types of α-
amino acid nucleophiles.  
Trost and Ariza in 1997 revealed the first AAA for the synthesis of α,α-
disubstituted α-amino acids.28a Previous work for the synthesis of such compounds was 
accomplished by the use of a chiral auxiliary or self-reproduction of chirality.29 AAA is 
difficult because the attacking nucleophile is very remote from the chiral inducing unit. 
However, this challenge was overcome by the use of the [(R,R)-DACH phenyl Trost 
ligand], which provides conformational chirality, creating chiral space around the allyl 
moiety, similar to an enzyme active site. Trost and Lee applied this novel technology for 
the asymmetric synthesis of Sphingofungin F, a natural product that inhibits the 
biosynthesis of sphingolipids; all stereochemistry in the final product emanated from the 
initial AAA (Scheme  1.8).28b  
 
 
 
 
                                                
28) (a) Trost, B. M.; Ariza, X. “Catalytic Asymmetric Alkylation of Nucleophiles: Asymmetric Synthesis 
of α-Alkylated Amino Acids” Angew. Chem., Int. Ed. 1997, 36, 2635-2637. (b) Trost, B. M.; Lee, C. 
B. “A New Strategy for the Synthesis of Sphingosine Analogues. Sphingofungin F” J. Am. Chem. Soc. 
1998, 120, 6818-6819. (c) Trost, B. M.; Ariza, X. “Enantioselective Allylations of Azlactones with 
Unsymmetrical Acyclic Allyl Esters” J. Am. Chem. Soc. 1999, 121, 10727-10737.  
29) (a) Seyden-Penne, J. Chiral Auxiliaries and Ligands in Asymmetric Synthesis, Wiley, New York, 1995. 
(b) Seebach, D.; Sting A. R.; Hoffmann, M. “Self-Regeneration of Stereocenters (SRS)−Applications, 
Limitations, and Abandonment of a Synthetic Principle” Angew. Chem. Int. Ed. Engl. 1996, 35, 2708-
2748.    
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Scheme  1.8 Pd-catalyzed AAA for the synthesis of α,α-disubstituted α-amino acids and 
related natural product, Sphingofungin F. 
 
Trost and Dogra, and subsequently Hartwig and Chen, demonstrated that the 
branched allyl product could be accessed with molybdenum or iridium catalyst with high 
diastereo- and enantioselectivity (Scheme  1.9).30,31 The α-amino acid must be converted 
to the azlactone derivative for reactivity to be observed. Ito and Kuwano have found that 
acyclic α-amino acids can be utilized when the α-carbon is substituted with an electron-
withdrawing group.32b  
 
 
 
 
                                                
30) Trost, B. M.; Dogra, K. “Synthesis of Novel Quaternary Amino Acids Using Molybdenum-Catalyzed 
Asymmetric Allylic Alkylation” J. Am. Chem. Soc. 2002, 124, 7256-7257.  
31) Chen, W.; Hartwig, J. F. “Control of Diastereoselectivity for Iridium-Catalyzed Allylation of a 
Prochiral Nucleophile with a Phosphate Counterion” J. Am. Chem. Soc. 2013, 135, 2068-2071.  
32) For other examples of palladium catalyzed AAA to synthesize α,α-disubstituted α-amino acids, see: 
(a) Fang, P.; Chaulagain, M. R.; Aron, Z. D. “Catalytic α-Allylation of Unprotected Amino Acid 
Esters” Org. Lett. 2012, 14, 2130-2133. (b) Kuwano, R.; Ito, Y. “Catalytic Asymmetric Allylation of 
Prochiral Nucleophiles, α-Acetamido-β-ketoesters” J. Am. Chem. Soc. 1999, 121, 3236-3237. 
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Scheme  1.9 Mo- or Ir-catalyzed AAA for the synthesis of α,α-disubstituted α-amino 
acids. 
 
 
1.1.6.  Proposed Asymmetric N-Alkylation/π-Allylation of α-Iminoesters to Synthesize α-
Allyl-a-Aryl α-Amino Acids 
The previous work by our group with the three component coupling of α-
iminoesters inspired our interest in the asymmetric synthesis of α,α-disubstitued α-amino 
acids. A thorough investigation of the literature revealed there is no general method for 
the synthesis of enantioenriched α-allyl-α-aryl α-amino acids. Considering the previous 
work of Trost and Hartwig, we proposed the enolate generated in situ from N-alkylation 
of α-iminoesters when treated with a Grignard reagent could undergo AAA (Figure 1.7). 
If this hypothesis proved correct then this novel method would provide access to 
previously inaccessible α-allyl-α-aryl α-amino acids. This class of compounds is 
important because of their unknown peptidomimetic properties. Also, the allyl moiety 
present would allow further reactivity to produce other compounds of interest.  
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Figure 1.7 Synthesis of α-allyl-α-aryl α-amino acids and project goals. 
 
1.2. RESULTS 
1.2.1.  Initial Studies on the Asymmetric Allylic Alkylation of α-Iminoesters 
 Initial studies on the asymmetric three component coupling reaction were 
conducted by a former group member, Dr. Joshua Dickstein.33 The proposed trapping of 
the enolate (1.02) generated from N-alkylation with an allylmetal complex was 
investigated. [η3-C3H5PdCl]2 with PPh3 provided the linear product (1.03a) in over 90% 
conversion, while the branched product (1.03b) was not observed (Scheme  1.10).   
Scheme  1.10 N-Alkylation/π-allylation with Pd and PPh3. 
 
                                                
33) Dickstein, J. S. Part I: Palladium-Mediated Aromatic Decarboxylation. Part II: Formation of α,α-
Disubstituted α-Amino Acids via Three Component Coupling of α-Iminoesters. Ph.D. Thesis, 
University of Pennsylvania, Philadelphia, PA, 2009.   
 Access to previously inaccessible  α-allyl-α-aryl α-amino acids
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Dr. Dickstein investigated chiral, enantioenriched ligands with allyl acetate 
(Scheme  1.11). The [(R,R)-DACH phenyl Trost ligand] (1.04a) was superior to (R)-
BINAP (1.05a) in selectivity but inferior in conversion. Pd2dba3•CHCl3 was also tested 
with each ligand and provided 10% and 90% conversion to product, respectively; the 
selectivity for (R)-BINAP with Pd2dba3•CHCl3 was 8% ee.  
Scheme  1.11 Asymmtric N-alkylation/π-allylation with allyl acetate. 
 
In an effort to improve the enantioselectivity of the reaction, cinnamyl acetate was 
substituted for allyl acetate. The mono-substitution of cinnamyl acetate creates an allyl-
palladium complex with enhanced definition of termini. Dr. Dickstein found that when 
cinnamyl acetate was substituted for allyl acetate with (R)-BINAP, an increase from 20% 
to 75% ee was observed without loss of conversion (Scheme  1.12). The Trost ligand was 
unsuccessful in catalyzing the formation of the tandem product when cinnamyl acetate 
was substituted for allyl acetate.  
Scheme  1.12 Asymmtric N-alkylation/π-allylation with cinnamyl acetate. 
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1.2.2.  Optimization of the Asymmetric Allylic Alkylation of α-Iminoesters 
Reaction optimization (solvent, temperature, concentration, stoichiometry) was 
investigated with 1.01a, EtMgBr, cinnamyl acetate, [η3-C3H5PdCl]2, and (R)-BINAP 
(Figure 1.8).  A solvent screen revealed that non-ethereal solvents such as CH2Cl2, 
chlorobenzene, trifluorotoluene and toluene all provided lower selectivity than THF; 2-
MeTHF and CPME provided the tandem product with comparable selectivity (Et2O 
provided lower selectivity). Temperature studies were conducted (-90 °C, -50 °C, -20 °C, 
0 °C and rt) and it was found that a temperature profile of -78 °C to 0 °C for each step is 
optimal. Reaction time was explored, the minimal time for N-alkylation was 30 minutes, 
but similar enantioselectivity was observed when the enolate was aged between 1-3 h. 
The second step was complete after reaching rt. Concentration has a minimal effect on 
the reaction. With 1.1 equiv of EtMgBr conversion was reduced to 64% and 24% ee. 
With 5 equiv of EtMgBr conversion was less than 10%; presumably, the allyl electrophile 
was consumed by the excess Grignard.  
 
Figure 1.8 Reaction optimization of 1.01a with EtMgBr and cinnamyl acetate. 
In 2010, our research group began collaborating with Dr. Spencer Dreher of 
Merck & Co Inc., utilizing the high-throughput experimentation center in Rahway, NJ. 
Parallel microscale experimentation (PME), a valuable tool for rapidly screening 
conditions and drawing out trends, was used to optimize the tandem N-alkylation/π-
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allylation of 1.01a (Table 1.2).34 Greater than 190 chiral, enantioenriched ligands were 
explored with the optimal conditions established with the exception that -50 °C was 
employed instead of -78 °C due to the limitation with the PME workflow.35 Nearly all 
ligands gave minimal conversion and selectivity but axial chiral bisphosphines, such as 
1.05a-c, 1.06a-c and 1.09-1.12 were most effective in generating 1.03a as confirmed in 
larger scale reactions at -78 °C (Table 1.2, right). The Trost ligand (1.04a-b) possessing 
central chirality and the Pfaltz ligand (1.13) with planar chirality were unsuccessful, 
showing both poor reactivity and poor selectivity. 
Table 1.2 Select results from parallel microscale experimentation and scale up reactions. 
                                                
34) Dreher, S. D.; Dormer, P. G.; Sandrock, D. L.; Molander, G. A. “Efficient Cross-Coupling of 
Secondary Alkyltrifluoroborates with Aryl Chlorides−Reaction Discovery Using Parallel Microscale 
Experimentation” J. Am. Chem. Soc. 2008, 130, 9257-9259.   
35) Ir and Mo were explored with cinnamyl acetate. Mo provided the linear product (<30% conv) and the 
branch product was not observed.  
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(R)-DIFLUORPHOS (1.06c) was chosen as the lead ligand after the HTE screen 
(8.6 µmol) was explored at bench top scale (0.372 mmol). Ethereal solvents (CPME, 2-
MeTHF) were investigated but did not improve the reaction. The success of 
DIFLUORPHOS (1.06c) vs SEGPHOS (1.06a) suggested that increased π-acidity was 
important for selectivity.  (R)-BINAPO (1.15a) was investigated along with modification 
at the C3,C3’ position (1.15b) but neither showed significant enantioselectivity (Scheme  
1.13). Modification of (R)-DIFLUORPHOS was not explored because of the multiple 
synthetic steps required.  
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Scheme  1.13 Asymmtric N-alkylation/π-allylation with π-acidic ligands. 
 
With optimal conditions established for solvent, temperature, allylating agent, 
ligand and metal source, the activating agent on the α-iminoester was explored (Table 
1.3). Dr. Dickstein and co-workers established that electron donating activating agents 
were superior to electron withdrawing (phenyl vs tosyl/POPh2, see Table 1.1) for the 
initial addition of alkyl Grignard reagents to α-iminoesters. Electron-donating phenyl 
activating agents improved conversion and selectivity (Table 1.3, 1.03a, 1.03e-1.03f). 
para-Chlorophenyl (1.03h) reduced yield and selectivity. To our surprise, when benzyl 
(1.03i) was substituted for phenyl, the tandem product was not formed. This activating 
group had been successful with less sterically hindered α-iminoesters in past reports (see 
Scheme  1.7).21,23 
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Table 1.3 Exploration of activating agent on the α-iminoester for the asymmtric N-
alkylation/π-allylation.a 
 
Substitution at the carbonyl was explored once the PMP activating group was 
determined to be optimal (Table 1.4). As the size of the alkyl ester was increased from 
ethyl to tert-butyl ester, the selectivity of the reaction was reduced. The production of the 
tandem product was still efficient. Presumably, as the alkyl ester becomes larger, the 
solvated bridge dimer enolate is less likely to form, and the distinction between the pro-
chiral nucleophilic faces is reduced (see Figure 1.10). Compound 1.03m prevents 
bidentate coordination of the α-iminoeser with the Grignard reagent (see Figure 1.5) and 
does not provide the N-alkylated product.  
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aReaction conditions: α-Iminoester (0.37 mmol), 1.5 equiv EtMgBr, THF (2.0 mL), 1.0 equiv cinnamyl acetate in THF (2.0 mL). 
bIsolated yield unless labeled conversion. cConv. is determined by amount of product to N-alkylated intermediate.   
dee determined by CSP HPLC.
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Table 1.4 Exploration of the alkyl ester on the α-iminoester for the asymmtric N-
alkylation/π-allylation.a 
 
Reasoning that the same product 1.03a ought to be available from racemic α-
phenylgylcine, the enolate was generated via deprotonation (Table 1.5). A wide range of 
bases provided good conversion (>85%), but poor enantioselectivity (ee = 18-34%) 
compared to the tandem reaction (80% ee) (Table 1.5, entries 1-3). Notably, treatment of 
1.16 with EtMgBr should generate the exact same enolate (1.02) as in the tandem 
reaction. However, this enolate provided low conversion and significantly lower 
selectivity (Table 1.5, entry 4). Enolate aggregation has been shown to play an important 
role in the asymmetric alkylation of various carbonyls.36 It was concluded that the exact 
structural form of the enolate is critical to the outcome. Specifically, the aggregate of 
1.21a-c obtained from 1.01a differs from that obtained from 1.16 (see Figure 1.10). 
                                                
36) (a) Kawabata, T.; Kawakami, S. P.; Shimada, S.; Fuji, K. “Control of the Enantioselectivity of 
Alkylation of Phenylalanine Derivatives by Regulation of the Aggregate Structure of Chiral Enolate 
Intermediates” Tetrahedron 2003, 59, 965-974. (b) Kawabata, T.; Kawakami, S.; Fuji, K. 
“Enantioselective Alpha-Allylation of a Phenylalanine Derivative under the Control of Aggregation of 
a Chiral Nonracemic Enolate” Tetrahedron Lett. 2002, 43, 1465-1467. 
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1.03k 1.03le
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1.03n
aReaction conditions: α-iminoester (0.37 mmol), 1.5 equiv EtMgBr, THF (2.0 mL), 1.0 equiv cinnamyl acetate in THF (2.0 mL). 
bIsolated yield unless labeled conversion. cConv. is determined by amount of product to N-alkylated intermediate.
dee determined by CSP HPLC. eReaction performed by Joshua Dickstein.
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Table 1.5 Allylation of the N-alkylation product.a 
 
Entry Base Conversion (%)b ee (%)c 
1 NaHMDS ~90 19d 
2 KHMDS ~85 23d 
3 LiHMDS ~90 18d 
4 EtMgBr ~50 34 
5 NaH No Product nd 
aReaction conditions: [1.16] = 0.19 M, 2.0 equiv base, THF (1.0 mL), rt for 10 min, then cool to -78 °C and add solution of 
2.5 mol% [η3-C3H5PdCl]2, 5.0 mol% (R)-BINAP, 1.0 equiv cinnamyl acetate in THF (1.0 mL) and warm to rt. b Determined 
By 1H NMR spectroscopy. cDetermined by CSP HPLC. dOpposite major enantiomer observed.  
In order to determine if the enolate aggregate was organizing more than one 
palladium complex or was selecting for a 2:1 ligand:palladium catalyst, a non-linear 
effect study was undertaken (Figure 1.9). The observation of a linear trend suggests that 
1:1 ligand:palladium complexes are reacting independent of each other with the enolate 
aggregate.  
 
Figure 1.9 Non-linear effects with BINAP (Scheme  1.14). 
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A number of different types of additives have been shown to affect the selectivity 
in AAA.37 Tertiary amines and silver salts should break-up aggregates from enolate 
formation with magnesium, but each additive explored either had no effect or reduced 
selectivity (Table 1.6, entry 1-5). It was postulated that transmetallation of the enolate 
from magnesium to zinc could improve selectivity, but instead it was reduced to 4% ee 
(Table 1.6, entry 6). Lloyd-Jones and co-workers have proposed ion-pair partitioning on 
the allyl-Pd complex can improve reaction selectivity.38 However, treatment of cinnamyl 
acetate, [η3-C3H5PdCl]2, and (R)-BINAP with NaBAr’F did not improve ee (Table 1.6, 
entry 8)  
Table 1.6 The addition of additives after enolate formation.a 
 
Entry Additive Conversion (%)b ee (%)c 
1 NPh3 ~90 79 
2 NEt3 ~90 34 
3 DIPA ~90 34 
4 AgBr  ~90 30 
5 Ag2O ~90 28 
6 ZnCl2 ~50 4 
7 Me3SnCl ~80 21 
                                                
37) (a) Yan, X. X.; Liang, C. G.; Zhang, Y.; Hong, W.; Cao, B. X.; Dai, L. X.; Hou, X. L. “Highly 
Enantioselective Pd-Catalyzed Allylic Alkylations of Acyclic Ketones” Angew. Chem., Int. Ed. 2005, 
44, 6544-6546. (b) Negishi, E. I.; John, R. A. “Selective Carbon Carbon Bond Formation Via 
Transition-Metal Catalysis. 34. Counterion Effects on the Palladium-Catalyzed Allylation of Enolates” 
J. Org. Chem. 1983, 48, 4098-4102.  
38) Evans, L. A.; Fey, N.; Harvey, J. N.; Hose, D.; Lloyd-Jones, G. C.; Murray, P.; Orpen, A. G.; Osborne, 
R.; Owen-Smith, G. J. J.; Purdie, M. “Counterintuitive Kinetics in Tsuji-Trost Allylation: Ion-Pair 
Partitioning and Implications for Asymmetric Catalysis” J. Am. Chem. Soc. 2008, 130, 14471-14473.   
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8 NaBAr’Fd ~90 28 
aReaction conditions: 1-2 equiv of additive was added after step 1. bDetermined by 1H NMR spectroscopy with respect to 
N-alkylated intermediate. cDetermined by CSP HPLC. d5 mol % ligand, 2.5 mol % Pd, 5 mol % additive.  
In summary, the best activating agent, ester substitution, solvent, ligand and metal 
source provided the tandem product in 87% yield and 88% ee (Scheme  1.14). This new 
technology was the first asymmetric three component coupling of α-iminoesters. The 
next goal was to expand the substrate scope so previously inaccessible enantioenriched 
α-allyl-α-aryl α-amino acids could be obtained.  
Scheme  1.14 Optimal conditions with 1.01a and cinnamyl acetate. 
 
 
1.2.3.  Substrate Scope for the Asymmetric Allylic Alkylation of α-Iminoesters 
With the optimal conditions, a range of α-iminoesters reacted with satisfactory 
yields and enantioselectivity (Table 1.7). Notably, the reaction was equally effective with 
imine substituents (R1) containing electron-donating and electron-withdrawing aryl 
groups, while ortho-substituted aryl (2-OMe) resulted in lower formation of the desired 
product. Thiophene could also be employed to good effect but the indole tandem product 
was not stable. Compound 1.03t is the only tandem product that is a crystalline solid. 
Trituration provided >99% ee material and allowed the absolute configuration of the 
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asymmetric N-alkylation/π-allylation products to be determined by X−ray 
crystallography.    
Table 1.7 Variation of the α-iminoester in the asymmetric N-alkylation/π-allylation.a 
 
In contrast to most other reports of N-alkylation of α-iminoesters, a range of 
Grignard reagents could be employed to provide unique N-alkyl α-allyl-α-aryl α-amino 
acid derivatives (Table 1.8). Notably, more functional Grignards provided terminal silyl 
and alkenyl derivatives (1.03y−1.03bb).  For alkenyl substrates, the alkene must be distal 
to the reacting center as allyl, benzyl, phenyl and vinyl Grignard reagents were not 
successful. Methyl Grignard would not undergo N-alkylation; to date, methyl Grignard 
has only been successful with the doubly-activated α-iminomalonate (see Scheme  1.7).22    
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Table 1.8 Exploration of Grignard Reagents in the asymmetric N-alkylation/π-allylation.a 
 
 The leaving group on cinnamyl alcohol was explored (Scheme  1.15). The 
cinnamyl carbonate (1.17a) and phosphate (1.17b) are better leaving groups than acetate 
and should form a more reactive allylpalladium-ligand complex. However, cinnamyl 
acetate gave higher selectivity than cinnamyl carbonate and phosphate. When the π-
allylation step was allowed to run at lower temperature for prolonged reaction time with 
cinnamyl phosphate, no improvement in selectivity was seen.  
Scheme  1.15 Leaving group on cinnamyl alcohol in the asymmetric N-alkylation/π-
allylation. 
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Replacing the phenyl ring of cinnamyl acetate with hydrogen reduced selectivity 
(Table 1.9). This result is in line with phenyl differentiating the termini of the allyl-
palladium complex, which is expected to increase selectivity. However, modification of 
the phenyl group in cinnamyl acetate with either electron-donating or -withdrawing 
groups did not increase selectivity (1.03dd and 1.03ee). Driven by a desire to generate 
aspartic/glutamic acid analogs, the corresponding furyl allyl acetate (1.18) was surveyed, 
but no product was observed. Lastly, 1,3-disubstituted allylating agents generated no 
tandem product (1.19 and 1.20). 
Table 1.9 Allylating agents in the asymmetric N-alkylation/π-allylation.a 
 
 
1.2.4.  Stereochemical Model for the Asymmetric Allylic Alkylation of α-Iminoesters 
Recently, Trost has proposed a stereochemical model for the attack of β-
ketoesters onto allyl chloroformate and suggested that lithium aggregates are responsible 
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for changing the predominant enantiomer obtained.39 Magnesium enolates, like that 
generated here, of all but the most hindered ketones are reported to be dimeric in 
solution.40 In the development of this technology, a strong solvent dependence was 
observed, with ethereal solvents being far superior.  Depending on the exact structure of 
the Grignard reagent, subtle differences were seen among the ethereal solvents THF, 2-
MeTHF, Et2O, and CPME. On the other hand, non-solvating solvents such as toluene or 
dichloromethane resulted in minimal addition to the allyl-Pd complex and low selectivity. 
Amine base additives also reduced the selectivity to less than 30% ee (see Table 1.6). 
Together, these results suggest a delicate balance where the most selective species is a 
solvated dimer, such as 1.21a, that lies in between poorly selective forms including a 
deaggregated form, such as monomer 1.21c, and a less solvated form, such as a tetramer 
or dimer 1.21b (Figure 1.10). 
 
 
                                                
39) Trost, B. M.; Schaffner, B.; Osipov, M.; Wilton, D. A. A. “Palladium-Catalyzed Decarboxylative 
Asymmetric Allylic Alkylation of β-ketoesters: An Unusual Counterion Effect” Angew. Chem., Int. 
Ed. 2011, 50, 3548-3551.  
40) For X-ray crystal structure and 13C NMR studies of halomagnesium ketone enolates, see: (a) Williard, 
P. G.; Salvino, J. M. “X-Ray Crystal Structure Determination of a Bromomagnesium Ketone Enolate” 
J. Chem. Soc., Chem. Commun. 1986, 153-154. (b) Fellman, P.; Dubois, J.−E. “Metal Enolates: 
Carbon −13 Magnetic Resonance Spectra” Tetrahedron Lett. 1977, 18, 247-250. (c) Pinkus, A. G.; 
Lindberg, J. G.; Wu, A.−B. “Structure of Grignard Compound Derived from Mesityl Methyl Ketone” 
Chem. Commun. 1969, 1350-1351.  
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Figure 1.10 Possible enolate forms of N-alkylated intermediate in solution (sol = 
solvent). 
Hypothesizing that a dimeric enolate (1.21a) plays a major role in the 
stereoselectivity of the Pd-catalyzed AAA, a model for the stereochemical outcome can 
be proposed. Newman projections predict that the enolate dimer should attack via an 
outer-sphere mechanism with the five-membered enolate chelate ring furthest from the 
carbon substituent of the allyl (Figure 1.11). 
 
Figure 1.11 Newman projections of dimeric enolate attack on allyl. 
PME revealed that the more common Trost or Pfaltz ligands for AAA, which 
have central or planar chirality, failed to produce the allylated product (see Table 1.2). 
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(1.04a) has a flap, wall, flap, wall motif.41 Helmchen has shown that substituted allyls 
align their largest group syn to the phosphorus terminus of the Pfaltz ligand (1.13), thus 
creating a pocket from the amine terminus in which nucleophiles can approach.42 Based 
on our results, we propose that because of the steric bulk of our α-aryl α-amino acid 
nucleophile, a pocket type ligand-Pd-allyl reaction site cannot afford nucleophilic 
addition; this accounts for the poor reactivity observed with these types of ligands. On the 
other hand, axially chiral ligands gave acceptable enantioselectivity and conversion (see 
Scheme  1.14).  
Ito and Ogasawara have both crystallized and studied BINAP-Pd-allyl 
complexes.32b,43 Their X-ray crystal structures show that the largest interaction between a 
BINAP backbone and a nucleophile undergoing outer sphere attack is through the 
pseudo-axial phenyl ring on phosphorus near the allyl termini. Inspection of the steric 
interactions with three-dimensional models reveals sterically unfavorable interactions in 
the pro-(R) approach of the dimeric enolate and the pseudo-axial aryl of (R)-BINAP 
(Figure 1.12, left). On the other hand, the pro-(S) approach can minimize interactions 
with the (R)-BINAP phosphorus phenyl rings (Figure 1.12, right). The observed product 
corresponds to that from this more favorable pro-(S) enolate approach. Also, the model 
predicts that a solvated-monomer enolate with a counterion such as sodium, lithium or 
                                                
41) Trost, B. M.; Toste, F. D. “Regio- and Enantioselective Allylic Alkylation of an Unsymmetrical 
Substrate: A Working Model” J. Am. Chem. Soc. 1999, 121, 4545-4554. 
42) Kollmar, M.; Steinhagen, H.; Janssen, J. P.; Goldfuss, B.; Malinovskaya, S. A.; Vazquez, J.; 
Rominger, F.; Helmchen, G. “(η3-Phenylallyl)(phosphanyloxazoline)palladium Complexes: X-Ray 
Crystallographic Studies, NMR Investigations, and Ab Initio/DFT Calculations” Chem.−Eur. J. 2002, 
8, 3103-3114. 
43) Ogasawara, M.; Ngo, H. L.; Sakamoto, T.; Takahashi, T.; Lin, W. “Applications of 4,4’-(Me3Si)2-
BINAP in Transition-Metal-Catalyzed Asymmetric Carbon-Carbon Bond-Forming Reactions” Org. 
Lett. 2005, 7, 2881-2884.   
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potassium would favor the opposite enantiomer, in accord with observed results (see 
Table 1.5). 
 
Figure 1.12 Stereochemical model favoring addition of the pro-(S) dimer. 
 
1.3. CONCLUSIONS 
In summary, we have disclosed the first asymmetric tandem N-alkylation/π-
allylation of α-iminoesters, which gives rise to complex enantioenriched α-allyl-α-aryl α-
amino acids in one step from three commercially available components. This report 
represents the first enantioselective synthesis of this class of compounds beyond α-allyl-
α-phenylglycine. PME was an important element in optimizing this technology, and it 
showed that the best chiral, enantioenriched ligand was (R)-DIFLUORPHOS. The 
activating group on the imine nitrogen and substitution on the ester were optimized by 
examining electronic and steric variables. Optimized conditions of ligand, substrate 
substitution, and solvent allowed the synthesis of >15 α-allyl-α-aryl α-amino acids in 
good yield and selectivity. The dramatic effect of enolate aggregation demonstrated the 
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importance of the tandem protocol and provides a cautionary tale for other systems. A 
stereochemical model was outlined that explains the observed major enantiomer and the 
importance of ligand screening.   
 
1.4. EXPERIMENTAL SECTION 
General Considerations 
 Unless otherwise stated, all non-aqueous reactions were carried out under an 
atmosphere of dry argon in dry glassware. All glassware used in three component 
coupling reactions was base-washed (KOH/i-PrOH) prior to use. When necessary, 
solvents and reagents were dried prior to use. Tetrahydrofuran, diethyl ether, 2-
methyltetrahydrofuran, cyclopentyl methyl ether and toluene were distilled from 
Na/benzophenone prior to use. Organometallic reagents (EtMgBr, n-PentylMgBr) were 
purchased from Aldrich, or made from magnesium turnings/ribbon. Analytical thin layer 
chromatography (TLC) was performed on Silicycle 250 µm silica-gel F-254 plates. 
1H NMR and 13C NMR spectra were recorded on a AM-500 Fourier transform 
NMR spectrometer at 500 MHz and 125 MHz, respectively.  Chemical shifts are reported 
relative to the solvent resonance peak δ 7.26 (CDCl3) for 1H and δ 77.16 (CDCl3) for 13C.  
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, b = broad singlet, m = multiplet), coupling constants, and number of 
protons.  High resolution mass spectra were obtained using a VG autospec with an 
ionization mode of either ESI or CI.  Infrared spectra are reported in cm-1. Melting points 
were obtained and are uncorrected. Unless otherwise noted, yields refer to isolated 
 
 
37 
material on the basis of product purity ≥95% by 1H NMR following silica gel 
chromatography with Silica-P flash silica gel (50-63 µm mesh particle size). 
Enantiomeric excess was determined utilizing chiral stationary phase (CSP) HPLC or 
SFC on OD [cellulose tris(3,5-dimethylphenylcarbamate) coated on silica gel] 0.46cm x 
25 cm or IA [amylose tris(3,5-dimethylphenylcarbamate) immobilized on silica gel] 0.46 
cm x 25 cm columns. 
General Procedure A −  Synthesis of α-Iminoesters 
 
To a solution of aniline (20 mmol) in toluene (29 mL), tosic acid monohydrate 
(350 mg, 2.0 mmol) was added. To this solution was added alkyl arylester (20 mmol). 
The solution was then heated at reflux with azeotropic removal of water under N2 (Dean-
Stark conditions) for 20 h. The mixture was then cooled, passed through SiO2 with 30% 
EtOAc/Hexanes, and concentrated. The resulting solid was recrystallized from hexanes to 
afford x.x.x (5.0 g) as a mixture of Z:E isomers.  
α-Iminoesters 1.01a44, 1.01b45, 1.01e8b, 1.01f46, 1.01g47, 1.01h24, 1.01i48, 1.01j48, 
1.01k49, 1.01m44, 1.01n44, 1.01o44, 1.01p44, 1.01q44, 1.01r44, 1.01s25, and 1.01t50 are 
                                                
44) Shang, G.; Yang, Q.; Zhang, X. “Rh-Catalyzed Asymmetric Hydrogenation of αAryl Imino Esters: An 
Efficient Enantioselective Synthesis of Aryl Glycine Derivatives” Angew. Chem., Int. Ed. 2006, 45, 
6360-6362. 
45) Huang, H.; Wang, Y.; Chen, Z.; Hu, W. “Rhodium-Catalyzed, Three-Component Reaction of Diazo 
Compounds with Amines and Azodicarboxylates” Adv. Synth. Catal. 2005, 347, 531-534. 
46) Zhu, C.; Akiyama, T. “Enantioselective Organocatalytic Transfer Hydrogenation of α-Imino Esters by 
Utilization of Benzothiazoline as Highly Efficient Reducing Agent” Adv. Synth. Catal. 2010, 352, 
1846-1850. 
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known compounds and their physical and spectroscopic data were in agreement with the 
reported ones.  
 
Figure 1.13 α-Iminoesters explored in N-alkylation/π-allylation. 
 
(Z)-Methyl 2-(4-dimethylaminophenylimino)-2-phenylacetate (1.01c). Following the 
                                                                                                                                            
47) Guizzetti, S.; Benaglia, M.; Rossi, S. “Highly Stereoselective Metal-Free Catalytic Reduction of 
Imines: An Easy Entry to Enantiomerically Pure Amines and Natural and Unnatural α-Amino Esters” 
Org. Lett. 2009, 11, 2928-2931.  
48) Kang, Q.; Zhao, Z.−A.; You, S.−Li “Highly Enantioselective Transfer Hydrogenation of α-Imino 
Esters by a Phosphoric Acid” Adv. Synth. Catal. 2007, 349, 1657-1660. 
49) Miyabe, H.; Yamaoka, Y.; Takemoto, Y. “Reactive Ketimino Radical Acceptors: Intermolecular Alkyl 
Radical Addition to Imines with a Phenolic Hydroxyl Group” J. Org. Chem. 2006, 71, 2099-2106.  
50) Jovanovic, B. Z.; Misic-Vukovic, M.; Marinkovic, A. D.; Vajs, V. “Effect of substitution on the 13C 
chemical shifts of the azomethine carbon atom of N-(phenyl substituted) pyridine-4-aldimines” J. Mol. 
Structure 1999, 482-483, 375-378.  
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general procedure A, N,N-Dimethyl-p-phenylenediamine (1.0 g, 7.3 mmol) was reacted 
with methyl benzoylformate (1.2 g, 7.3 mmol) and tosic acid monohydrate (260 mg, 1.5 
mmol) in toluene (10.4 mL) for 20 h under Dean-Stark conditions. After filtration, 
concentration and column chromatography (7.5% EtOAc/hexanes) to afford 1.01c (568 
mg) in 28% yield as a 8:1 mixture of Z:E isomers in the form of a brown crystalline solid: 
mp 66-68 °C; 1H NMR (500 MHz, CDCl3) δ 7.84 (dd, J = 7.8, 1.4 Hz, 2H), 7.49-7.43 (m, 
3H), 7.00 (d, J = 8.9 Hz, 2H), 6.71 (d, J = 7.9 Hz, 2H), 3.74 (s, 3H), 2.97 (s, 6H); 13C 
NMR (125 MHz, CDCl3) δ 170.0, 156.8, 148.9, 139.3, 134.8, 131.1, 128.7, 127.7, 121.9, 
112.8, 52.0, 40.7 (minor rotamer peaks: 128.9, 128.5, 125.2, 111.8, 53.1, 40.4).   
 
(Z)-Methyl 2-(3,4-dimethylphenylimino)-2-phenylacetate (1.01d). Following the 
general procedure A, 3,4-dimethylaniline (1.0 g, 8.2 mmol) was reacted with methyl 
benzoylformate (1.35 g, 8.2 mmol) and tosic acid monohydrate (282 mg, 1.5 mmol) in 
toluene (12 mL) for 20 h under Dean-Stark conditions. After filtration, concentration and 
column chromatography (7% EtOAc/hexanes) to afford 1.01d (1.56 g) in 71% yield as a 
12:1 mixture of Z:E isomers in the form of a yellow amorphous solid; 1H NMR (500 
MHz, CDCl3) δ 7.86 (dd, J = 8.0, 1.7 Hz, 1H), 7.52-7.44 (m, 3H), 7.08 (d, J = 7.9 Hz, 
1H), 6.81 (d, J = 1.8 Hz, 1H), 6.72 (dd, J = 7.9, 1.8 Hz, 1H), 3.69 (s, 3H), 2.25 (s, 3H), 
2.24 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 166.0, 159.3, 147.9, 137.3, 134.3, 133.6, 
131.7, 130.1, 128.8, 128.0, 121.3, 116.8, 52.0, 20.0, 19.4.  
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(Z)-Methyl 2-(4-methoxyphenylimino)-2-(thiophen-2-yl)acetate (1.01s). Following the 
general procedure A, p-anisidine (362 mg, 2.94 mmol) was reacted with methyl (2-
thiophene)formate (417 mg, 2.45 mmol)  and TsOH (42 mg, 0.245 mmol) in toluene (5 
mL) for 20 h under Dean-Stark conditions. After filtration, concentration and column 
chromatography (10% EtOAc/hexanes) product 1.01s (350 mg) was obtained in 52% 
yield as a 15:1 mixture of Z:E isomers in the form of a dark yellow solid: mp 92-94 °C; 
1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 5.0 Hz, 1H), 7.39 (d, J = 3.8 Hz, 1H), 7.10 (t, 
J = 4.2 Hz, 1H), 6.96 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 3.81 (s, 3H), 3.71 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ 165.2, 157.7, 153.1, 142.7, 141.1, 131.2, 131.2, 
128.0, 121.7, 114.3, 55.5, 52.4; IR (film) 2952, 1734, 1607, 1500, 1246 cm-1; HRMS 
(ESI) calcd for C14H13NO3S [M+H]+ m/z = 276.0694; found 276.0692. 
Parallel Microscale Experimentation ( 
Table 1.2) 
 
 
The following procedure is representative of the high-throughput experimentation 
reactions.  The ligands (0.86 µmol) were dosed into the 96-well reactor 1-mL vials as 
solutions (50 µL of a 0.017 M solution in THF).  Plates of these ligands may be plated in 
advance of the screen; the solvent is removed by evacuation on a Genevac, and the plates 
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are stored in a glovebox. A solution of [η3-C3H5PdCl]2  (0.86 µmol Pd, 50 µL of a 0.017 
M solution in THF) was then added to the reaction vials and was evacuated to dryness on 
a Genevac. A parylene stir-bar was added to each vial. In a separate 20 dram vial, α-
iminoester 1.01a (914 µmol, 246 mg) was dissolved in 4.9 mL THF. The vial was cooled 
to -50 °C on a Mecour Coolingbox combined with a Julabo temperature controller and 
3.0 M EtMgBr in Et2O (1500 µmol, 0.50 ml) was added. The reaction mixture was 
warmed to ambient temperature and allowed to react for 45 min and subsequently cooled 
back to -50 °C. Cinnamyl acetate (8.5 µmol) was dosed into the 96 well reactor 1-mL 
vials with ligand/catalyst mixture at  -50 °C as solutions (50 µL of a 0.17 M solution in 
THF). The substrate and Grignard mixture was then dosed to the reaction vials at -50 °C 
(50 µL of a 0.18M solution in THF). The vials were then sealed and allowed to warm to 
ambient temperature. After stirring for 45 min the residues were diluted with 500 µL of a 
5% solution of glacial acetic acid in isopropyl alcohol and the contents were stirred for 30 
min.  Into a separate 96-well plate LC block was added 750 µL of MeCN per well 
followed by 20 µL of the diluted reaction mixtures. The 96-well plate LC block was then 
sealed with a polypropylene 1 mL cap mat.  The reactions were analyzed using a CSP 
SFC (OD-H 250x4.6mm, 5 um, MeOH/CO2, 3 mL/min, 35 C, 200 bar, 215nm, 4% 
MeOH for 4 min then to 40% at 6 min hold for 5 min, Peak 1 at 6.9 min and Peak 2 at 7.5 
min).  
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Structures of ligands in Table 1.2 
   
 
General Procedure B −  Three Component Coupling of α-Iminoesters 
 
Rigorously anhydrous and air-free conditions are required for optimal results due 
to the reactivity of the intermediate enolate (see General Considerations). α-Iminoester 
(0.372 mmol) was added to a flamed dried Schlenk flask that had been charged with a stir 
bar and was then vacuum-purged three times under argon. The α-iminoester was 
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dissolved in THF (2.0 mL) and cooled to -78 °C. To this solution was added EtMgBr (3.0 
M in Et2O, 198 µL, 0.595 mmol) under argon. The mixture was slowly warmed to room 
temperature and allowed to stir for an additional 30 min at room temperature. A flame 
dried round bottom flask equipped with a stir bar was charged with [η3-C3H5PdCl]2 (5.1 
mg, 0.0140 mmol) and (R)-DIFLUORPHOS (12.7 mg, 0.0186 mmol) and vacuum-
purged three times under argon. The mixture was dissolved with THF (2.0 mL) and 
cinnamyl acetate (66 µL, 0.372 mmol) was added. The second solution was stirred for 5 
minutes at ambient temperature under argon, cooled to -78 °C, and added to the cooled  (-
78 °C) first solution via syringe. The combined mixture was allowed to warm to room 
temperature and stirred for 45 min. The resultant reaction mixture was quenched with 
satd NH4Cl (10 mL) and extracted with EtOAc (3 x 15 mL). The combined organic layers 
were washed with brine, dried over Na2SO4, filtered and concentrated in vacuo. The 
resulting residue was purified by chromatography to afford pure α-allyl-α-aryl α-amino 
acids.  
Notes: Typical color after the first step is a translucent yellow and red to orange after the 
second step. An indicator of the first step not working is when the reaction color turns 
green or black. Grignard source was important. More than 1 equiv of cinnamyl acetate, or 
a ligand to palladium ratio greater than 1:1 was detrimental to the enantioselectivity of 
second step.   
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(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-2-phenylpent-4-enoate (1.03c). 
Following the general procedure B, 3.0 M EtMgBr (50 µL, 0.15 mmol) was added to 
1.01a (25 mg, 0.093 mmol) in THF (0.5 mL), allowed to react for 45 min and subjected 
to a solution of [η3-C3H5PdCl]2 (0.85 mg, 0.0023 mmol), (R)-DIFLUORPHOS (3.1 mg, 
0.0045 mmol) and allyl acetate (11 µL, 0.10 mmol) in THF (0.5 mL) for 45 min. After 
work-up, concentration and column chromatography (pre-wash SiO2 with 5% 
NEt3/hexanes, eluent 3% EtOAc/hexanes) product 1.03c (26 mg) was obtained in 82% 
yield as a yellow oil: 1H NMR (500 MHz, CDCl3) δ 7.43 (d, J = 8.1 Hz, 2H), 7.34 (t, J = 
7.5 Hz, 2H), 7.28-7.25 (m, 1H), 7.10 (d, J = 8.9 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 5.43-
5.35 (m, 1H), 4.72 (d, J = 10.3 Hz, 1H), 4.59 (d, J = 17.2 Hz, 1H), 3.85 (s, 3H), 3.82 (s, 
3H), 3.02-2.88 (m, 2H), 2.48 (dd, J = 13.9, 6.8 Hz, 1H), 2.28 (dd, J = 13.9, 7.3 Hz, 1H), 
0.79 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 173.3, 157.9, 141.5, 139.2, 
134.2, 131.2, 128.0, 127.8, 127.3, 117.7, 113.8, 74.8, 55.5, 51.4, 46.6, 45.3, 14.7; IR 
(film) 2962, 2929, 1726, 1605, 1507, 1243 cm-1; HRMS (ESI) calcd for C21H26NO3 
[M+H]+ m/z = 340.1913; found 340.1900; [α]25D = +58.6 (c 0.08, 54% ee, CH2Cl2); chiral 
HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 1.03c: 4.8 min (major) 
and 5.2 min (minor). 
 
(S,E)-Methyl 2-(ethyl(4-methoxyphenyl)amino)-2,5-diphenylpent-4-enoate (1.03a). 
Following the general procedure B, 3.0 M EtMgBr (198 µL, 0.595 mmol) was added to 
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1.01a (100 mg, 0.372 mmol) in THF (2 mL), allowed to react for 45 min and subjected to 
a solution of [η3-C3H5PdCl]2 (5.1 mg, 0.0140 mmol), R-DIFLUORPHOS (12.8 mg, 
0.0186 mmol) and cinnamyl acetate (65 mg, 0.372 mmol) in THF (2 mL) for 45 min. 
After work-up, concentration and column chromatography (pre-wash SiO2 with 5% 
NEt3/hexanes, eluent 3% EtOAc/hexanes) product 1.03a (134 mg) was obtained in 87% 
yield as a yellow oil: 1H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 7.7 Hz, 2H), 7.36 (t, J = 
7.7 Hz, 2H), 7.30-7.27 (m, 1H), 7.21 (t, J = 7.4 Hz, 2H), 7.17-7.12 (m, 3H), 7.09 (d, J = 
7.2 Hz, 2H), 6.89 (d, J = 9.0 Hz, 2H), 5.89 (d, J = 16.0 Hz, 1H), 5.73 (dt, J = 15.9, 7.5 
Hz, 1H), 3.88 (s, 3H), 3.83 (s, 3H), 3.09-3.02 (m, 1H), 2.99-2.92 (m, 1H), 2.63 (ddd, J = 
13.9, 7.2, 0.5 Hz, 1H), 2.44 (ddd, J = 14.0, 7.4, 0.5 Hz, 1H), 0.83 (t, J = 7.0 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 173.3, 157.8, 141.6, 139.1, 138.0, 133.0, 131.3, 128.4, 127.8 
(2), 127.3, 127.0, 126.1 (2), 113.8, 75.1, 55.5, 51.4, 46.7, 44.4, 14.7; IR (film) 3026, 
2694, 2836, 1724, 1603, 1507, 1244 cm-1; HRMS (ESI) calcd for C27H30NO3 [M+H]+ m/z 
= 416.2226; found 416.2229; [α]24D = +145.3 (c 0.28, 88% ee, CH2Cl2); chiral HPLC (IA, 
97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 1.03a: 6.6 min (major) and 8.0 min 
(minor).  
Ethylmagnesium bromide from Aldrich was batch dependent and was only successful in 
general procedure A when it was colorless; EtMgBr from Acros was never colorless. 
Ethylmagnesium Bromide. Magnesium turnings (1.4 g, 58.3 mmol) were stirred in 2.0 
M HCl (~15 mL) for ten minutes, filtered, washed with ethanol (~100 mL), Et2O (~150 
mL), collected and dried under vacuum in a 50 °C oil bath for 2 h, and then added to a 
flame dried 50 mL Schlenk flask charged with a stir bar equipped with a reflux condenser 
under argon. Et2O (~3 mL) was added to magnesium. Bromoethane (4.58 mL, 61.4 
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mmol) and Et2O (6.14 mL) were added to a second flamed dried round bottom flask 
under argon. 500 µL of the bromoethane solution was added to magnesium to initiate 
reflux. Et2O (5.5 mL) was added to the refluxing magnesium solution, followed by 
bromoethane solution (500 µL), then Et2O (5.5 mL). The bromoethane solution was 
added dropwise while maintaining reflux (~20 min). After addition was complete, the 
mixture was heated to reflux for 30 min, allowed to cool to rt, and transferred via 
cannulation into a sealed flask under argon. The 3.0 M ethylmagnesium bromide solution 
in Et2O was colorless and would be stored in a refrigerator for up to two weeks with 
continuous use. 
 
(S,E)-Methyl 2-(N-ethyl-N-phenylamino)-2,5-diphenylpent-4-enoate (1.03d). 
Following the general procedure B, 3.0 M EtMgBr (177 µL, 0.532 mmol) was added to 
1.01b (64 mg, 0.266 mmol) in THF (1.5 mL), allowed to react for 45 min and subjected 
to a solution of [η3-C3H5PdCl]2 (3.64 mg, 0.0098 mmol), (R)-DIFLUORPHOS (9.1 mg, 
0.013 mmol) and cinnamyl acetate (46.8 mg, 0.266 mmol) in THF (1.5 mL) for 45 min. 
After work-up, concentration and column chromatography (pre-wash SiO2 with 5% 
NEt3/hexanes, eluent 3% EtOAc/hexanes) product 1.03d (80 mg) was obtained in 78% 
yield as a yellow oil:  1H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 8.0 Hz, 2H), 7.38-7.34 
(m, 4H), 7.29 (dt, J = 7.3 Hz, 0.4 Hz, 1H), 7.25-7.20 (m, 5H), 7.15 (t, J = 7.3 Hz, 1H), 
7.10 (d, J = 7.7 Hz, 2H), 5.91 (d, J = 15.8 Hz, 1H), 5.75 (dt, J = 15.8, 7.2 Hz, 1H), 3.87 
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(s, 3H), 3.16-3.03 (m, 2H), 2.68 (dd, J = 13.8, 7.1 Hz, 1H), 2.51 (dd, J = 13.7, 7.5 Hz, 
1H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 173.2, 146.6, 141.5, 137.9, 
133.1, 129.9, 128.7, 128.4, 127.9, 127.9, 127.4, 126.9, 126.1, 125.9, 125.9, 75.0, 51.5, 
46.4, 44.2, 14.7; IR (film) 3025, 2867, 1725, 1595, 1493, 1215 cm-1; HRMS (ESI) calcd 
for C26H28NO2 [M+H]+ m/z = 386.2120; found 386.2132; [α]25D = +162.9 (c 0.47, 82% 
ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 1.03d: 
4.8 min (minor) and 5.1 min (major). 
 
(S,E)-Methyl 2-((4-(dimethylamino)phenyl)(ethyl)amino)-2,5-diphenylpent-4-enoate 
(1.03e). Following the general procedure B, 3.0 M EtMgBr (100 µL, 0.298 mmol) was 
added to 1.01c (53 mg, 0.186 mmol) in THF (1 mL), allowed to react for 45 min and 
subjected to a solution of [η3-C3H5PdCl]2 (3.7 mg, 0.0093 mmol), (R)-BINAP (11.6 mg, 
0.0186 mmol) and cinnamyl acetate (34 mg, 0.195 mmol) in THF (1 mL) for 45 min. 
After work-up, concentration and column chromatography (eluent 7% EtOAc/hexanes) 
product 1.03e (62 mg) was obtained in 74% yield as a yellow oil: 1H NMR (500 MHz, 
(CD3)2CO) δ 7.50 (d, J = 7.9 Hz, 2H), 7.33 (t, J = 7.6 Hz, 2H), 7.24 (t, J = 7.4 Hz, 1H), 
7.18 (t, J = 7.4 Hz, 2H), 7.14-7.07 (m, 5H), 6.73 (d, J = 8.9 Hz, 2H), 5.88-5.79 (m, 2H), 
3.87 (s, 3H), 3.02-2.93 (m, 8H), 2.61 (dd, J = 14.2, 6.1 Hz, 1H), 2.43 (dd, J = 14.2, 6.1 
Hz, 1H), 0.79 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, (CD3)2CO) δ 173.6, 150.2, 143.0, 
138.8, 135.9, 133.2, 131.6, 129.1, 128.6, 128.4, 127.9, 127.6, 127.2, 126.6, 113.2, 75.9, 
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51.5, 47.2, 45.3, 40.7, 15.0; chiral HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 
nm): tR of 1.03e: 5.7 min (minor) and 6.4 min (major).  
 
(S,E)-Methyl 2-((3,4-dimethylphenyl)(ethyl)amino)-2,5-diphenylpent-4-enoate 
(1.03f). Following the general procedure B, 3.0 M EtMgBr (100 µL, 0.298 mmol) was 
added to 1.01d (50 mg, 0.186 mmol) in THF (1.3 mL), allowed to react for 45 min and 
subjected to a solution of [η3-C3H5PdCl]2 (1.72 mg, 0.005 mmol), (R)-BINAP (5.9 mg, 
0.009 mmol) and cinnamyl acetate (36 mg, 0.195 mmol) in THF (1 mL) for 45 min. After 
work-up, concentration and column chromatography (eluent 10% acetone/hexanes) 
product 1.03f (65 mg) was obtained in 84% yield as a yellow oil: 1H NMR (500 MHz, 
(CDCl3) δ 7.48 (d, J = 7.4 Hz, 2H), 7.35 (t, J = 7.7 Hz, 2H), 7.28 (d, J = 7.3 Hz, 1H), 
7.20 (t, J = 7.5 Hz, 2H), 7.14-7.06 (m, 4H), 6.99 (s, 1H), 6.94 (d, J = 7.9 Hz, 1H), 5.88 
(d, J = 15.8 Hz, 1H), 5.72 (dt, J = 15.8 Hz, 7.3 Hz, 1H), 3.87 (s, 3H), 3.08-2.95 (m, 2H), 
2.63 (dd, J = 13.7, 7.0 Hz, 1H), 2.45 (dd, J = 13.7, 7.4 Hz, 1H), 2.27 (s, 3H), 2.26 (s, 3H), 
0.83 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, (CDCl3) δ 173.2, 144.1, 141.7, 138.0, 
136.7, 134.5, 132.9, 131.5, 129.8, 128.4, 127.9, 127.8, 127.3, 127.2, 126.9, 126.2, 126.1, 
75.1, 51.4, 46.4, 44.4, 20.1, 19.5, 14.8; chiral HPLC (IA, 99:1 hexanes:i-PrOH, 0.5 
mL/min, 254 nm): tR of 1.03f: 8.5 min (minor) and 8.9 min (major).  
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(S,E)-Ethyl 2-(ethyl(4-methoxyphenyl)amino)-2,5-diphenylpent-4-enoate (1.03j) 
Following the general procedure B, 3.0 M EtMgBr (85 µL, 0.282 mmol) was added to 
1.01h (50 mg, 0.177 mmol) in THF (1.3 mL), allowed to react for 45 min and subjected 
to a solution of [η3-C3H5PdCl]2 (1.63 mg, 0.005 mmol), (R)-BINAP (5.5 mg, 0.009 
mmol) and cinnamyl acetate (34 mg, 0.195 mmol) in THF (1 mL) for 45 min. After work-
up, concentration and column chromatography (pre-wash SiO2 with 5% NEt3/hexanes, 
eluent 7% EtOAc/hexanes) product 1.03j (62 mg) was obtained in 77% yield as a yellow 
oil: 1H NMR (500 MHz, (CDCl3) δ 7.49 (d, J = 7.5 Hz, 2H), 7.35 (t, J = 7.7 Hz, 2H), 
7.28 (d, J = 7.3 Hz, 1H), 7.22-7.16 (m, 4H), 7.13 (t, J = 7.4 Hz, 1H), 7.08 (d, J = 7.3 Hz, 
2H), 6.87 (d, J = 8.6 Hz, 2H), 5.89 (d, J = 15.8 Hz, 1H), 5.72 (dt, J = 15.9, 7.2 Hz, 1H), 
4.42-4.31 (m, 2H), 3.83 (s, 3H), 3.08-2.96 (m, 2H), 2.62 (dd, J = 13.9, 7.1 Hz, 1H), 2.42 
(dd, J = 13.9, 7.2 Hz, 1H), 1.36 (t, J = 7.2 Hz, 3H), 0.83 (t, J = 6.9 Hz, 3H); 13C NMR 
(125 MHz, (CDCl3) δ 172.7, 157.8, 141.8, 139.2, 138.0, 132.9, 131.4, 128.4, 127.9, 
127.8, 127.2, 126.9, 126.2, 126.0, 113.8, 74.9, 60.7, 55.5, 46.7, 44.4, 14.7, 14.5; chiral 
HPLC (OD, 97.5:2.5 hexanes:i-PrOH, 1.0 mL/min, 254 nm): tR of 1.03j: 4.5 min (major) 
and 8.3 min (minor). 
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(S,E)-Benzyl 2-(ethyl(4-methoxyphenyl)amino)-2,5-diphenylpent-4-enoate (1.03k) 
Following the general procedure B, 3.0 M EtMgBr (193 µL, 0.579 mmol) was added to 
1.01i (100 mg, 0.290 mmol) in THF (2.5 mL), allowed to react for 45 min and subjected 
to a solution of [η3-C3H5PdCl]2 (3.30 mg, 0.009 mmol), (R)-BINAP (11.6 mg, 0.019 
mmol) and cinnamyl acetate (56 mg, 0.318 mmol) in THF (2.0 mL) for 45 min. After 
work-up, concentration and column chromatography (eluent 7% EtOAc/hexanes) product 
1.03k (139 mg) was obtained in 76% yield as a yellow oil: 1H NMR (500 MHz, (CDCl3) 
δ 7.47 (d, J = 8.2 Hz, 2H), 7.40 (dd, J = 7.5, 4.3 Hz, 2H), 7.37-7.31 (m, 5H), 7.28-7.26 
(m, 1H), 7.19 (t, J = 7.3 Hz, 2H), 7.14-7.10 (m, 1H), 7.05 (d, J = 8.8 Hz, 2H), 7.00 (d, J = 
7.5 Hz, 2H), 6.77 (d, J = 8.9 Hz, 2H), 5.83 (d, J = 15.9 Hz, 1H), 5.68 (dt, J = 15.9, 7.2 
Hz, 1H), 5.34 (d, J = 12.1 Hz, 1H), 5.29 (d, J = 12.1 Hz, 1H), 3.80 (s, 3H), 3.08-3.01 (m, 
1H), 2.97-2.91 (m, 1H), 2.62 (dd, J = 13.8, 7.2 Hz, 1H), 2.41 (dd, J = 13.5, 7.2 Hz, 1H), 
0.79 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, (CDCl3) δ 172.5, 157.8, 141.7, 139.1, 
138.0, 135.8, 133.0, 131.4, 129.1, 128.7, 128.5, 128.4, 127.9, 127.8, 127.3, 126.9, 126.1, 
126.0, 113.8, 75.1, 66.7, 55.5, 46.7, 44.4, 14.7; chiral HPLC (OD, 97.5:2.5 hexanes:i-
PrOH, 1.0 mL/min, 254 nm): tR of 1.03k: 5.8 min (major) and 9.5 min (minor).  
 
(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-2-(4-fluorophenyl)-5-
phenylpent-4-enoate (1.03o). Following the general procedure B, 3.0 M EtMgBr (177 
µL, 0.532 mmol) was added to 1.01m (76.3 mg, 0.266 mmol) in THF (1.5 mL), allowed 
to react for 45 min and subjected to a solution of [η3-C3H5PdCl]2 (3.64 mg, 0.0098 
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mmol), (R)-DIFLUORPHOS (9.1 mg, 0.013 mmol) and cinnamyl acetate (46.8 mg, 0.266 
mmol) in THF (1.5 mL) for 45 min. After work-up, concentration and chromatography 
(pre-wash SiO2 with 5% NEt3/hexanes, eluent 3% EtOAc/hexanes) product 1.03o (99 
mg) was obtained in 86% yield as a yellow oil:  1H NMR (500 MHz, CDCl3) δ 7.48-7.45 
(m, 2H), 7.22 (t, J = 7.4 Hz, 2H), 7.17-7.13 (m, 3H), 7.10 (d, J = 7.3 Hz, 2H), 7.05 (t, J = 
8.7 Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 5.90 (d, J = 15.7 Hz, 1H), 5.71 (dt, J = 15.7, 7.6 
Hz, 1H), 3.87 (s, 3H), 3.83 (s, 3H), 3.03-2.89 (m, 2H), 2.62 (dd, J = 13.7, 7.2 Hz, 1H), 
2.39 (dd, J = 13.7, 7.6 Hz, 1H), 0.82 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
172.9, 162.9 (d, J = 246 Hz), 157.9, 138.8, 137.8, 137.3 (d, J = 3.2 Hz), 133.4, 131.2, 
129.6 (d, J = 7.6 Hz), 128.5, 127.1, 126.0, 125.6, 114.6 (d, J = 21.2 Hz), 113.9, 74.6, 
55.5, 51.5, 46.4, 44.4, 14.6; IR (film) 3036, 2965, 2837, 1727, 1606, 1505, 1244 cm-1; 
HRMS (ESI) calcd for C27H29FNO3 [M+H]+ m/z =434.2131; found 434.2133; [α]25D = 
+128.4 (c 0.48, 86% ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 mL/min, 
254 nm): tR of 1.03o: 6.6 min (major) and 11.7 min (minor). 
 
(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-2-(4-chlorophenyl)-5-
phenylpent-4-enoate (1.03p). Following the general procedure B, 3.0 M EtMgBr (219 
µL, 0.658 mmol) was added to 1.01n (100 mg, 0.329 mmol) in 2-MeTHF (2 mL), 
allowed to react for 45 min and subjected to a solution of [η3-C3H5PdCl]2 (4.49 mg, 
0.0123 mmol), (R)-DIFLUORPHOS (11.26 mg, 0.0165 mmol) and cinnamyl acetate (58 
mg, 0.329 mmol) in 2-MeTHF (2 mL) for 45 min. After work-up, concentration and 
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chromatography (pre-wash SiO2 with 5% NEt3/hexanes, eluent 5% EtOAc/hexanes) 
product 1.03p (124 mg) was obtained in 84% yield as a yellow oil:  1H NMR (500 MHz, 
CDCl3) δ 7.42 (d, J = 8.6 Hz, 2H), 7.32 (d, J = 8.6 Hz, 2H), 7.22 (t, J = 7.4 Hz, 2H), 
7.16-7.08 (m, 5H), 6.87 (d, J = 8.7 Hz, 2H), 5.90 (d, J = 15.8 Hz, 1H), 5.68 (dt, J = 15.6, 
7.3 Hz, 1H), 3.86 (s, 3H), 3.82 (s, 3H), 2.98-2.87 (m, 2H), 2.60 (dd, J = 14.0, 7.0 Hz, 
1H), 2.37 (dd, J = 14.0, 7.3 Hz, 1H), 0.80 (t, J = 7.0 Hz, 3H) ; 13C NMR (125 MHz, 
CDCl3) δ 172.7, 158.0, 140.3, 138.7, 137.8, 133.5, 133.0, 131.2, 129.4, 128.5, 128.0, 
127.1, 126.1, 125.4, 113.9, 74.7, 55.5, 51.6, 46.5, 44.3, 14.6; IR (film) 2958, 2855, 1725, 
1604, 1507, 1244 cm-1; HRMS (ESI) calcd for C27H29ClNO3 [M+H]+ m/z = 450.1836; 
found 450.1835; [α]25D = +117.2 (c 0.37, 92% ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 
hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 1.03p: 7.2 min (major) and 12.8 min (minor). 
 
(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-2-(4-methylphenyl)-5-
phenylpent-4-enoate (1.03q). Following the general procedure B, 3.0 M EtMgBr (177 
µL, 0.532 mmol) was added to 1.01o (75.4 mg, 0.266 mmol) in THF (1.5 mL), allowed to 
react for 45 min and subjected to a solution of [η3-C3H5PdCl]2 (3.64 mg, 0.0010 mmol), 
(R)-DIFLUORPHOS (9.1 mg, 0.013 mmol) and cinnamyl acetate (46.8 mg, 0.266 mmol) 
in THF (1.5 mL) for 45 min. After work-up, concentration and chromatography (pre-
wash SiO2 with 5% NEt3/hexanes, eluent 3% EtOAc/hexanes) product 1.03q (99 mg) was 
obtained in 87% yield as a yellow oil:  1H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 8.1 Hz, 
2H), 7.22 (t, J = 7.6 Hz, 2H), 7.18- 7.13 (m, 5H), 7.11 (d, J = 7.9 Hz, 2H), 6.88 (d, J = 
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8.8 Hz, 2H), 5.93 (d, J = 15.7 Hz, 1H), 5.75 (dt, J = 15.8, 7.2 Hz, 1H), 3.87 (s, 3H), 3.83 
(s, 3H), 3.09-3.02 (m, 1H), 2.98-2.91 (m, 1H), 2.62 (dd, J = 13.9, 7.0 Hz, 1H), 2.44 (dd, J 
= 13.9, 7.3 Hz, 1H), 2.37 (s, 3H), 0.83 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
173.4, 157.8, 139.2, 138.5, 138.1, 136.9, 132.8, 131.3, 128.6, 128.4, 127.7, 126.9, 126.2 
126.0, 113.8, 74.8, 55.5, 51.4, 46.6, 44.2, 21.2, 14.7; IR (film) 3026, 2963, 2865, 1724, 
1605, 1508, 1244, 1036 cm-1; HRMS (ESI) calcd for C28H32NO3 [M+H]+ m/z = 
430.2382; found 430.2369; [α]25D = +123.1 (c 0.47, 80% ee, CH2Cl2); chiral HPLC (IA, 
97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 1.03q: 7.0 min (major) and 8.1 min 
(minor). 
 
(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-2-(4-methoxyphenyl)-5-
phenylpent-4-enoate (1.03r). Following the general procedure B, 3.0 M EtMgBr (124 
µL, 0.372 mmol) was added to 1.01p (56 mg, 0.186 mmol) in THF (1 mL), allowed to 
react for 45 min and subjected to a solution of [η3-C3H5PdCl]2 (1.70 mg, 0.0047 mmol), 
R-BINAP (5.67 mg, 0.0091 mmol) and cinnamyl acetate (32 mg, 0.186 mmol) in THF (1 
mL) for 45 min. After work-up, concentration and chromatography (pre-wash SiO2 with 
5% NEt3/hexanes, eluent 5% EtOAc/hexanes) product 1.03r (65 mg) was obtained in 
79% yield as a yellow oil:  1H NMR (500 MHz, CDCl3) δ 7.39 (d, J = 8.7 Hz, 2H), 7.21 
(t, J = 7.5 Hz, 2H), 7.15-7.10 (m, 5H), 6.90-6.88 (m, 4H), 5.93 (d, J = 15.9 Hz, 1H), 5.73 
(dt, J = 15.8, 7.3 Hz, 1H), 3.86 (s, 3H), 3.83 (s, 3H), 3.82 (s, 3H), 3.07-3.00 (m, 1H), 
2.95-2.89 (m, 1H), 2.61 (dd, J = 13.9, 7.2 Hz, 1H), 2.41 (dd, J = 13.8, 7.3 Hz, 1H), 0.81 
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(t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 173.4, 158.7, 157.8, 139.2, 138.0, 
133.6, 132.9, 131.3, 129.0, 128.4, 126.9, 126.2, 126.1, 113.8, 113.2, 75.5, 55.5, 55.4, 
51.4, 46.4, 44.3, 14.7 ; IR (film) 3035, 2960, 2836, 1724, 1609, 1508, 1245, 1036 cm-1; 
HRMS (ESI) calcd for C28H32NO4 [M+H]+ m/z = 446.2331; found 446.2325; [α]25D = 
+126.1 (c 0.32, 74% ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 mL/min, 
254 nm): tR of 1.03r: 10.4 min (major) and 12.4 min (minor). 
 
(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-2-(napthalen-2-yl)-5-
phenylpent-4-enoate (1.03t). Following the general procedure B, 3.0 M EtMgBr (177 
µL, 0.532 mmol) was added to 1.01r (85 mg, 0.266 mmol) in THF (1.5 mL), allowed to 
react for 45 min and subjected to a solution of [η3-C3H5PdCl]2 (3.64 mg, 0.0010 mmol), 
(R)-DIFLUORPHOS (9.1 mg, 0.013 mmol) and cinnamyl acetate (46.8 mg, 0.266 mmol) 
in THF (1.5 mL) for 45 min. After work-up, concentration and chromatography (pre-
wash SiO2 with 5% NEt3/hexanes, eluent 3% acetone/hexanes) product 1.03t (89 mg) 
was obtained in 72% yield as a yellow oil. Absolute configuration was determined by the 
x-ray structure obtained from >99% ee material by stirring the 84% ee solid in hexanes 
and then removing the liquid three times, the enhanced ee solid was recrystallized from 
Et2O over 24 h of slow evaporation. mp (>99% ee material) = 104 °C. 1H NMR (500 
MHz, CDCl3) δ 7.91-7.85 (m, 4H), 7.73 (d, J = 8.7 Hz, 1H), 7.51-7.49 (m, 2H), 7.23 (d, J 
= 8.7 Hz, 2H), 7.18 (t, J = 7.3 Hz, 2H), 7.12 (t, J = 6.9 Hz, 1H), 7.04 (d, J = 7.8 Hz, 2H), 
6.92 (d, J = 8.5 Hz, 2H), 5.95 (d, J = 15.8 Hz, 1H), 5.75 (dt, J = 15.8 Hz, 7.1 Hz, 1H), 
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3.93 (s, 3H), 3.85 (s, 3H), 3.12-2.98 (m, 2H), 2.75 (dd, J = 13.8, 7.2 Hz, 1H), 2.59 (dd, J 
= 13.6, 7.3 Hz, 1H), 0.87 (t, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 173.2, 
157.9, 139.2, 139.1, 137.9, 133.1, 133.0, 132.9, 131.4, 128.5, 128.4 (2), 127.6, 127.4, 
127.0, 126.9, 126.1 (3), 126.0, 113.9, 75.2, 55.5, 51.5, 46.7, 44.1, 14.7; IR (film) 3056, 
2964, 2835, 1724, 1600, 1242, 1036 cm-1; HRMS (ESI) calcd for C31H32NO3 [M+H]+ m/z 
= 466.2382; found 466.2371; [α]25D = +137.5 (c 0.43, 86% ee, CH2Cl2); chiral HPLC (IA, 
97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 1.03t: 9.9 min (minor) and 10.7 min 
(major). 
 
(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-2-(thiophen-2-yl)-5-
phenylpent-4-enoate (1.03u). Following the general procedure B, 3.0 M EtMgBr (177 
µL, 0.532 mmol) was added to 1.01s (73.2 mg, 0.266 mmol) in THF (1.5 mL), allowed to 
react for 45 min and subjected to a solution of [η3-C3H5PdCl]2 (3.64 mg, 0.0098 mmol), 
(R)-DIFLUORPHOS (9.1 mg, 0.013 mmol) and cinnamyl acetate (46.8 mg, 0.266 mmol) 
in THF (1.5 mL) for 45 min. After work-up, concentration and column chromatography 
(pre-wash SiO2 with 5% NEt3/hexanes, eluent 5% EtOAc/hexanes) product 1.03u (96 
mg) was obtained in 86% yield as a yellow oil:  1H NMR (500 MHz, CDCl3) δ 7.27-7.26 
(m, 1H), 7.24-7.19 (m, 4H), 7.17-7.14 (m, 3H), 7.07 (d, J = 3.7 Hz, 1H), 6.97-6.95 (m, 
1H), 6.87 (d, J = 8.5 Hz, 2H), 6.07 (d, J = 15.9 Hz, 1H), 5.75 (dt, J = 15.9, 7.3 Hz, 1H), 
3.85 (s, 3H), 3.82 (s, 3H), 3.17-3.10 (m, 1H), 3.04-2.98 (m, 1H), 2.63 (dd, J = 13.4, 7.7 
Hz, 1 H), 2.47 (dd, J = 13.4, 7.1 Hz, 1H), 0.85 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, 
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CDCl3) δ 172.3, 157.9, 148.1, 138.4, 137.7, 133.4, 131.3, 128.5, 127.2, 126.9, 126.4, 
126.2, 125.2, 124.6, 113.7, 72.9, 55.5, 51.8, 46.2, 45.6 14.3; IR (film) 3027, 2970, 2835, 
1729, 1605, 1507, 1243 cm-1; HRMS (ESI) calcd for C25H28NO3 [M+H]+ m/z = 
422.1750; found 422.1807; [α]25D = +120.2 (c 0.34, 76% ee, CH2Cl2); chiral HPLC (IA, 
97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 1.03u: 7.2 min (minor) and 7.8 min 
(major). 
 
(S,E)-Methyl 2-(N-pentyl-N-(4-methoxyphenyl)amino)-2,5-diphenylpent-4-enoate 
(1.03x). Following the general procedure B, 2.0 M pentylMgBr (300 µL, 0.600 mmol) 
was added to 1.01a (81 mg, 0.300 mmol) in THF (1.9 mL), allowed to react for 45 min 
and subjected to a solution of [η3-C3H5PdCl]2 (4.12 mg, 0.0113 mmol), (R)-
DIFLUORPHOS (10.25 mg, 0.0150 mmol) and cinnamyl acetate (53 mg, 0.300 mmol) in 
THF (1.9 mL) for 45 min. After work-up, concentration and chromatography (pre-wash 
SiO2 with 5% NEt3/hexanes, eluent 3% EtOAc/hexanes) product 1.03x (112 mg) was 
obtained in 82% yield as a yellow oil:  1H NMR (500 MHz, CDCl3) δ 7.47 (d, J = 7.6 Hz, 
2H), 7.35 (t, J = 7.6 Hz, 2H), 7.28 (d, J = 7.3 Hz, 1H), 7.20 (t, J = 7.5 Hz, 2H), 7.16-7.13 
(m, 3H), 7.07 (d, J = 7.1 Hz, 2H), 6.87 (d, J = 8.9 Hz, 2H), 5.89 (d, J = 15.9 Hz, 1H), 
5.70 (dt, J = 15.7, 7.3 Hz, 1H), 3.86 (s, 3H), 3.82 (s, 3H), 2.97-2.87 (m, 2H), 2.62 (dd, J = 
13.4, 7.2 Hz, 1H), 2.43 (dd, J = 13.4, 7.2 Hz, 1H), 1.17-1.04 (m, 6H), 0.77 (t, J = 6.9 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 173.1, 157.8, 141.5, 139.6, 138.0, 132.9, 131.1, 
128.4, 128.0, 127.8, 127.3, 126.9, 126.2, 126.1, 113.8, 75.1, 55.5, 52.2, 51.4, 44.5, 29.3, 
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29.0, 22.6, 14.1; IR (film) 3025, 2857, 1725, 1603, 1508, 1245 cm-1; HRMS (ESI) calcd 
for C30H36NO3 [M+H]+ m/z = 458.2695; found 458.2704; [α]25D = +129.1 (c 0.30, 92% 
ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 1.03x: 
5.8 min (major) and 7.0 min (minor). 
 
(S,E)-Methyl 2-(N-(2-(trimethylsilyl)ethyl)-N-(4-methoxyphenyl)amino)-2,5-
diphenylpent-4-enoate (1.03y). Following the general procedure B, 1.38 M 2-
(trimethylsilyl)ethylMgBr (269 µL, 0.372 mmol) was added to 1.01a (50 mg, 0.186 
mmol) in THF (1.0 mL), allowed to react for 45 min providing a yellow mixture, which 
was subjected to a solution of [η3-C3H5PdCl]2 (1.70 mg, 0.00465 mmol), (R)-BINAP ( 
5.67 mg, 0.00911 mmol) and cinnamyl acetate (32 mg, 0.182 mmol) in THF (1.0 mL) for 
45 min, providing an orange mixture. After work-up, concentration and chromatography 
(pre-wash SiO2 with 5% NEt3/hexanes, eluent 5% EtOAc/hexanes) product 1.03y (75 
mg) was obtained in 83% yield as a yellow oil:  1H NMR (500 MHz, CDCl3) δ 7.45 (d, J 
= 7.9 Hz, 2H), 7.34 (t, J = 7.6 Hz, 2H), 7.29-7.26 (m, 1H), 7.21 (t, J = 7.6 Hz, 2H), 7.15-
7.13 (m, 3H), 7.08 (d, J = 7.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 5.89 (d, J = 15.9 Hz, 
1H), 5.75 (dt, J = 15.7, 7.4 Hz, 1H), 3.87 (s, 3H), 3.83 (s, 3H), 3.06-2.99 (m, 1H), 2.96-
2.90 (m, 1H), 2.64 (dd, J = 13.8, 7.0 Hz, 1H), 2.46 (dd, J = 13.8, 7.5 Hz, 1H), 0.57-0.47 
(m, 2H), -0.18 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 173.3, 157.8, 141.5, 139.3, 138.0, 
132.9, 131.4, 128.4, 127.9, 127.8, 127.3, 126.9, 126.2, 126.1, 113.8, 75.2, 55.5, 51.4, 
47.9, 44.3, 17.8, -1.6; IR (film) 3026, 2951, 1725, 1602, 1507, 1246 cm-1; HRMS (ESI) 
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calcd for C30H38NO3Si [M+H]+ m/z = 488.2621; found 488.2617; [α]25D = +118.7 (c 0.25, 
82% ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 
1.03y: 4.9 min (major) and 6.4 min (minor). 
2-(Trimethylsilyl)ethylmagnesium bromide was prepared by modification of a known 
procedure51: Magnesium ribbon (255 mg, 8.85 mmol) that was scored until shiny was 
added to a flame dried 10 mL Schlenk flask charged with a stir bar equipped with a reflux 
condenser under argon. Et2O (2.95 mL) was added to magnesium. Freshly prepared 2-
(trimethylsilyl)ethyl bromide52 is added dropwise to magnesium at a rate to sustain a slow 
reflux. After addition is complete, the mixture is heated to reflux for 2 h, allowed to cool 
to rt and used in preparation of 1.03y.  
 
(S,E)-Methyl 2-(N-(but-3-en-1-yl)-N-(4-methoxyphenyl)amino)-2,5-diphenylpent-4-
enoate (1.03z). Following the general procedure B, 2.7 M butenylmagnesium bromide 
(222 µL, 0.600 mmol) was added to 1.01a (81 mg, 0.300 mmol) in THF (1.9 mL), 
allowed to react for 45 min, providing a yellow/orange mixture, which was subjected to a 
solution of [η3-C3H5PdCl]2 (4.12 mg, 0.0113 mmol), (R)-DIFLUORPHOS (10.25 mg, 
0.0150 mmol) and cinnamyl acetate (53 mg, 0.300 mmol) in THF (1.9 mL) for 45 min, 
providing an orange mixture. After work-up, concentration and chromatography (pre-
                                                
51) Wilson, S. R.; Shedrinsky, A. “[β-(Trimethylsilyl)ethyl]lithium: A New Reagent for Carbonyl 
Reductive Vinylation” J. Org. Chem. 1982, 47, 1983-1984. 
52) Sommer, L.H.; Bailey, D.L.; Goldberg, G.M.; Buck, C.E.; Bye, T.S.; Evans, F.J.; Whitmore, F.C. 
“Vinylsilanes, Chlorovinylsilanes and β-Styryltrimethylsilane. Further Studies on the α-Silicon Effect 
and β-Eliminations Involving Silicon” J. Am. Chem. Soc. 1954, 76, 1613-1618. 
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wash SiO2 with 5% NEt3/hexanes, eluent 2% acetone/hexanes) product 1.03z (109 mg) 
was obtained in 82% yield as a yellow oil:  1H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 7.6 
Hz, 2H), 7.36-7.33 (m, 2H), 7.28 (d, J = 7.2 Hz, 1H), 7.22-7.13 (m, 5H), 7.07 (d, J = 7.6 
Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 5.89 (d, J = 15.8 Hz, 1H), 5.72-5.60 (m, 2H), 4.89-4.83 
(m, 2H), 3.87 (s, 3H), 3.83 (s, 3H), 3.06-2.98 (m, 2H), 2.62 (dd, J = 13.9, 7.2 Hz, 1H), 
2.43 (dd, J = 13.9, 7.6 Hz, 1H), 2.05-1.92 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 173.1, 
158.0, 141.3, 139.2, 138.0, 136.8, 133.0, 131.2, 128.4, 128.0, 127.9, 127.8, 127.4, 126.9, 
126.1, 115.5, 113.9, 75.1, 55.5 51.8, 51.5, 44.5, 33.9; IR (film) 3025, 2836, 1724, 1604, 
1507, 1245 cm-1; HRMS (ESI) calcd for C29H32NO3 [M+H]+ m/z = 442.2382; found 
442.2400; [α]25D = +137.8 (c 0.42, 90% ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 
hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 1.03z: 7.3 min (major) and 10.9 min (minor). 
Butenylmagnesium Bromide. Magnesium ribbon (255 mg, 8.85 mmol) that was scored 
until shiny was added to a flame dried 10 mL Schlenk flask charged with a stir bar 
equipped with a reflux condenser under argon. Et2O (2.95 mL) was added to the 
magnesium. Freshly distilled (98 °C, 760 torr) butenyl bromide was added dropwise to 
the magnesium at a rate to sustain a slow reflux. After addition was complete, the mixture 
was heated to reflux for 2 h, allowed to cool to rt, and used in preparation of 1.03z.  
 
(S,E)-Methyl 2-(N-(pent-4-en-1-yl)-N-(4-methoxyphenyl)amino)-2,5-diphenylpent-4-
enoate (1.03aa). Following the general procedure B, 2.8 M pentenylmagnesium bromide 
(213 µL, 0.595 mmol) was added to 1.01a (80 mg, 0.297 mmol) in CPME (1.6 mL), 
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allowed to react for 45 min providing a yellow/orange mixture, which was subjected to a 
solution of [η3-C3H5PdCl]2 (4.1 mg, 0.0112 mmol), (R)-DIFLUORPHOS (10.2 mg, 
0.0149 mmol) and cinnamyl acetate (52 mg, 0.299 mmol) in CPME (1.6 mL) for 45 min, 
providing an orange/red mixture. After work-up, concentration and column 
chromatography (pre-wash SiO2 with 5% NEt3/hexanes, eluent 3% acetone/hexanes) 
product 1.03aa (115 mg) was obtained in 85% yield as a yellow oil:  1H NMR (500 MHz, 
CDCl3) δ 7.47 (d, J = 7.9 Hz, 2H), 7.38-7.06 (m, 10H), 6.88 (d, J = 8.9 Hz, 2H), 5.91 (d, 
J = 15.7 Hz, 1H), 5.75-5.58 (m, 2H), 4.90-4.81 (m, 2H), 3.87 (s, 3H), 3.83 (s, 3H), 2.96 
(t, J = 7.7 Hz, 2H), 2.64 (dd, J = 13.5, 6.9 Hz, 1H), 2.44 (dd, J = 13.7, 7.1 Hz, 1H), 1.97-
1.78 (m, 2H), 1.42-1.22 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 173.0, 157.9, 141.4, 
139.4, 138.8, 138.0, 133.0, 131.1, 128.4, 128.0, 127.9, 127.4, 126.9, 126.1, 126.0, 114.2, 
113.9, 75.1, 55.5, 51.9, 51.4, 44.4, 31.3, 28.6; IR (film) 3026, 2856, 1725, 1604, 1508, 
1245  cm-1; HRMS (ESI) calcd for C30H34NO3 [M+H]+ m/z = 456.2539; found 456.2536; 
[α]24D = +130.4 (c 0.29, 86% ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 
mL/min, 254 nm): tR of 1.03aa: 6.2 min (major) and 7.6 min (minor). 
Pentenylmagnesium bromide. Cut magnesium ribbon (261 mg, 10.9 mmol) that was 
scored until shiny was added to a flame dried 10 mL Schlenk flask charged with a stir bar 
equipped with a reflux condenser under argon. Et2O (3.02 mL) was added to the 
magnesium. Freshly distilled (124-126 °C, 760 torr) pentenyl bromide was added 
dropwise to the magnesium at a rate to sustain a slow reflux. After addition was 
complete, the mixture was heated to reflux for 2 h, allowed to cool to rt, and used in 
preparation of 1.03aa. 
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(S,E)-Methyl 2-(N-(hex-5-en-1-yl)-N-(4-methoxyphenyl)amino)-2,5-diphenylpent-4-
enoate (1.03bb). Following the general procedure B, 1.5 M hexenylmagnesium bromide 
(355 µL, 0.532 mmol) was added to 1.01a (72 mg, 0.266 mmol) in 2-MeTHF (1.5 mL), 
allowed to react for 45 min providing a yellow mixture, which was subjected to a solution 
of [η3-C3H5PdCl]2 (3.58 mg, 0.0098 mmol), R-DIFLUORPHOS (8.09 mg, 0.013 mmol) 
and cinnamyl acetate (46.8 mg, 0.266 mmol) in 2-MeTHF (1.5 mL) for 45 min, providing 
an orange mixture. After work-up, concentration and chromatography (pre-wash SiO2 
with 5% NEt3/hexanes, eluent 3% EtOAc/hexanes) product 1.03bb (105 mg) was 
obtained in 84% yield as a yellow oil:  1H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 7.6 Hz, 
2H), 7.36 (t, J = 7.6 Hz, 2H), 7.30-7.27 (m, 1H), 7.21 (t, J = 7.3 Hz, 2H), 7.17-7.13 (m, 
3H), 7.08 (d, J = 7.9 Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 5.90 (d, J = 16 Hz, 1H), 5.74-5.65 
(m, 2H), 4.91-4.86 (m, 2H), 3.87 (s, 3H), 3.83 (s, 3H), 2.99-2.90 (m, 2H), 2.63 (dd, J = 
13.8, 7.1 Hz, 1H), 2.44 (dd, J = 13.5, 7.1 Hz, 1H), 1.89-1.85 (m, 2H), 1.27-1.18 (m, 4H); 
13C NMR (125 MHz, CDCl3) δ 173.0, 157.9, 141.5, 139.5, 139.0, 138.0, 132.9, 131.1, 
128.4, 128.0, 127.8, 127.4, 126.9, 126.1, 126.1, 114.3, 113.8, 75.1, 55.5, 52.1, 51.4, 44.5, 
33.7, 28.8, 26.3; IR (film) 3025, 2856, 1725, 1604, 1508, 1245, 1036 cm-1; HRMS (ESI) 
calcd for C31H36NO3 [M+H]+ m/z = 470.2695; found 470.2693; [α]25D = +129.0 (c 0.41, 
80% ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 
1.03bb: 6.0 min (major) and 7.5 min (minor). 
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Hexenylmagnesium bromide. Magnesium ribbon (144 mg, 6 mmol) that was scored 
until shiny was added to a flame dried 10 mL Schlenk flask charged with a stir bar 
equipped with a reflux condenser under argon. THF (3.33 mL) was added to the 
magnesium. Freshly distilled (25 °C, 0.01 torr) hexenyl bromide was added dropwise to 
the magnesium at a rate to sustain a slow reflux. After addition was complete, the mixture 
was heated to reflux for 2 h, allowed to cool to rt, and used in preparation of 1.03bb. 
 
(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-2-phenyloct-4-enoate (1.03cc). 
Following the general procedure B using 1.01a (50 mg, 0.19 mmol) in THF (1.0 mL), 3.0 
M EtMgBr (100 µL, 0.30 mmol), [η3-C3H5PdCl]2 (1.7 mg, 0.0047 mmol), (R)-BINAP 
(5.7 mg, 0.0091 mmol) and hex-2-enyl acetate (31 µL, 0.20 mmol) in THF (1.0 mL). 
Purification by column chromatography (8% EtOAc/hexanes) provided product 1.03cc 
(49 mg) in 70% yield as a yellow oil: 1H NMR (500 MHz, CDCl3) δ 7.43 (d, J = 7.5 Hz, 
2H), 7.32 (t, J = 7.6 Hz, 2H), 7.27-7.22 (m, 1H), 7.10 (d, J = 8.8 Hz, 2H), 6.84 (d, J = 9 
Hz, 2H), 5.03-4.88 (m, 2H), 3.84 (s, 3H), 3.81 (s, 3H), 3.03-2.86 (m, 2H), 2.42 (dd, J = 
14, 6.3 Hz, 1H), 2.19 (dd, J = 14, 7.0 Hz, 1H), 1.71 (dt, J = 7.6, 6.9 Hz, 2H), 1.16-1.09 
(m, 2H), 0.79 (t, J = 7.0 Hz, 3H), 0.71 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
173.2, 157.8, 141.7, 139.2, 134.1, 131.2, 128.1, 127.6, 127.0, 125.2, 113.7; IR (film) 
2959, 1726, 1508, 1244 cm-1; HRMS (ESI) calcd for C24H32NO3 [M+H]+ m/z = 382.2382 
; found 382.2388; [α]25D = +128.75 (c 0.32, 58% ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 
hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 1.03cc: 4.8 min (major) and 6.8 min (minor). 
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(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-5-(4-methoxyphenyl)-2-
phenylpent-4-enoate (1.03dd). Following general procedure B using 1.01a (40 mg, 0.15 
mmol) in THF (1.0 mL), 3.0 M EtMgBr (80 µL, 0.24 mmol), [η3-C3H5PdCl]2 (1.36 mg, 
0.0037 mmol), (R)-BINAP (4.6 mg, 0.0073 mmol) and (4-methoxy)cinnamyl acetate (32 
mg, 0.16 mmol) in THF (1.0 mL). Purification by column chromatography (pre-wash 
SiO2 with 5% NEt3/hexanes, eluent 8% EtOAc/hexanes) provided 1.03dd (48 mg) in 
72% yield as a yellow oil:  1H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 8.4 Hz, 2H), 7.34 
(t, J = 7.3 Hz, 2H), 7.28-7.27 (m, 1H), 7.14 (d, J = 8.8 Hz, 2H), 7.01 (m, J = 8.6 Hz, 2H), 
6.86 (d, J = 8.9 Hz, 2H), 6.74 (d, J = 8.7 Hz, 2H), 5.82 (d, J = 15.8 Hz, 1H), 5.26 (dt, J = 
15.8, 7.4 Hz, 1H), 3.86 (s, 3H), 3.82 (s, 3H), 3.76 (s, 3H), 3.06-2.99 (m, 1H), 2.97-2.90 
(m, 1H), 2.59 (ddd, J = 13.7, 7.0, 1.3 Hz, 1H), 2.39 (ddd, J = 13.8, 7.5, 1.1 Hz, 1H), 0.81 
(t, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 173.3, 158.7, 157.8, 141.7, 139.2, 
132.4, 131.3, 130.9, 127.9, 127.8, 127.3, 127.1, 123.8, 113.9, 113.8, 75.2, 55.5, 55.4, 
51.4, 46.6, 44.3, 14.7; IR (film) 2960, 2931, 1724, 1607, 1509, 1246 cm-1; HRMS (ESI) 
calcd for C28H32NO4 [M+H]+ m/z = 446.2331; found 446.2322; [α]25D = +95.3 (c 0.21, 
60% ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 
1.03dd: 9.9 min (major) and 11.8 min (minor). 
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(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-5-(3-(3-
trifluoromethyl)phenyl)-2-phenylpent-4-enoate (1.03ee). Following general procedure 
B using 1.01a (40 mg, 0.149 mmol) in THF (1.0 mL), 3.0 M EtMgBr (80 µL, 0.240 
mmol), [η3-C3H5PdCl]2 (1.36 mg, 0.0037 mmol), (R)-DIFLUORPHOS (4.98 mg, 0.0073 
mmol) and (3-trifluromethyl)cinnamyl acetate (38 mg, 0.156 mmol) in THF (1.0 mL). 
Purification by column chromatography (pre-wash SiO2 with 5% NEt3/hexanes, eluent 
8% EtOAc/hexanes) provided 1.03ee (55 mg) in 76% yield as a yellow oil:  1H NMR 
(500 MHz, CDCl3) δ 7.45 (d, J = 7.9 Hz, 2H), 7.38-7.34 (m, 3H), 7.30 (t, J = 7.9 Hz, 2 
H), 7.22 (d, J = 7.9, 1H), 7.14 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 5.87 (d, J = 
15.8 Hz, 1H), 5.80-5.74 (dt, J = 15.6, 7.0 Hz, 1H), 3.89 (s, 3H), 3.82 (s, 3H), 3.08-3.01 
(m, 1H), 2.98-2.92 (m, 1H), 2.63 (dd, J = 13.7, 6.8 Hz, 1H), 2.43 (dd, J = 13.7, 7.3 Hz, 1 
H), 0.82 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 173.3, 158.0, 141.5, 139.1, 
138.7, 131.6, 131.3, 130.8 (q, J = 32 Hz), 129.0, 128.8, 128.4, 128.0, 127.7, 127.5, 124.4 
(q, J = 254 Hz), 123.5-123.4 (m), 122.8-122.7 (m), 113.9, 75.1, 55.5, 51.6, 46.8, 44.5, 
14.7; IR (film) 3036, 2837, 1725, 1606, 1508, 1328, 1245, 1124 cm-1; HRMS (ESI) calcd 
for C28H29F3NO3 [M+H]+ m/z = 484.2100; found 484.2099; [α]25D = +99.5 (c 0.26, 64% 
ee, CH2Cl2); chiral HPLC (IA, 97.5:2.5 hexanes:i-PrOH, 1 mL/min, 254 nm): tR of 
1.03ee: 6.0 min (major) and 5.6 min (minor). 
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(3-Trifluoromethyl)cinnamyl acetate. Following the modified procedure previously 
reported.53 Reaction conditions: 3-iodobenzotrifluoride (577 µL, 4.0 mmol), allyl acetate 
(1.6 g, 16.0 mmol), Pd(OAc)2 (45 mg, 0.20 mmol), Ag2CO3 (662 mg, 2.4 mmol), toluene 
(24 mL). (3-Trifluoromethyl)cinnamyl acetate (315 mg) was obtained in 32% yield as 
a colorless liquid. Spectral data agreed with those reported previously.54  
 
 
Studies on Allylation of N-Alkylated Intermediate (Table 1.5) 
 
α-Amino ester 1.16 was dissolved in THF in a flame dried 10 mL round bottom 
flask charged with a stir bar and put under argon. The reaction mixture was cooled to -78 
°C and a solution of base in THF was added dropwise. The reaction mixture was warmed 
to ambient temperature and allowed to react for 10 min and then cooled to -78 °C. A 
second 10 mL round bottom flask charged with a stir bar was flamed dried under argon, 
Pd/(R)-BINAP/cinnamyl acetate was added, dissolved in THF and cooled to -78 °C. The 
Pd/(R)-BINAP/cinnamyl acetate slurry was added to the reaction mixture, which was 
allowed to warm to ambient temperature. The resultant reaction mixture was cooled to 0 
°C after 45 minutes, quenched with satd NH4Cl (10 mL) and extracted with EtOAc (3 x 
15 mL). The combined organic layers were washed with brine, dried over Na2SO4, 
                                                
53) Pan, D.; Chen, A.; Su, Y.; Zhou, W.; Li, S.; Jia, W.; Xiao, J.; Liu, Q.; Zhang, L.; Jiao, N. “Ligand-Free 
Pd-Catalyzed Highly Selective Arylation of Allylic Esters with Retention of the Traditional Leaving 
Group” Angew. Chem., Int. Ed. 2008, 47, 4729-4732 
54) Fleming, S. A.; Renault, L.; Grundy, E. C.; Pincook, J. A. “The Photochemistry of ring-substituted 
cinnamyl acetates” Can. J. Chem. 2006, 84, 1146-1154. 
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filtered and concentrated in vacuo. The resulting residue was purified by chromatography 
to afford pure α-allyl-α-aryl α-amino acid 1.03a. 
The Addition of Additives after Enolate Formation (Table 1.6) 
 
1.01a (40 mg, 0.15 mmol) was added to a flamed dried round bottom flask that 
had been charged with a stir bar and was put under an argon atmosphere. THF (1.0 mL) 
was added and the reaction was cooled to -78 °C. To this solution was added EtMgBr 
(3.0 M in Et2O, 80 µL, 0.24 mmol) under argon. The mixture was slowly warmed to 
ambient temperature, 1 equiv of respective additive was added (in the case of NaBAr’F, 5 
mol % was added to the Pd/L/cinnamyl acetate solution) and allowed to stir for an 
additional 30 minutes. A flame dried round bottom flask equipped with a stir bar was 
charged with [η3-C3H5PdCl]2 (1.4 mg, 0.0037 mmol) and (R)-BINAP (4.6 mg, 0.0.0073 
mmol) and put under an argon atmosphere. The mixture was dissolved with THF (1.0 
mL) and cinnamyl acetate (26 µL, 0.15 mmol) was added. The second solution was 
stirred for 5 minutes at ambient temperature under argon, cooled to -78 °C, and added to 
the cooled  (-78 °C) first solution via syringe. The combined mixture was allowed to 
warm to ambient temperature and stirred for 45 min. The workup for general procedure A 
was then followed providing 1.03a.   
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2. α-ALLYL-α-ARYL α-AMINO ESTERS IN THE ASYMMETRIC 
SYNTHESIS OF ACYCLIC AND CYCLIC AMINO ACID DERIVATIVES  
2.1. BACKGROUND 
2.1.1.  Synthesis of α-Allyl-α-Aryl α-Amino Esters 
Recently, we developed an asymmetric method for synthesizing α-allyl-α-aryl α-
amino acids, which relies on the formation of a chelated magnesium enolate that is 
generated in situ (Figure 2.1).55  This was the first example of α-phenylglycine used in 
asymmetric allylic alkylation (AAA) and represents the only asymmetric method for 
generating α-allyl-α-aryl α-amino acids that is general for the aryl substituent.16  
 
Figure 2.1 Asymmetric synthesis of α-allyl-α-aryl α-amino acids by N-alkylation/π-
allylation.  
α-Allyl-α-aryl α-amino acids are an interesting class of compounds. The 
structural properties and biological activities are relatively unknown. The allyl moiety as 
a side-chain substituent is very attractive. During the course of developing this novel 
technology for the synthesis of α-allyl-α-aryl α-amino acids, we envisioned that the allyl 
                                                
55) Curto, J. M.; Dickstein, J. S.; Berritt, S.; Kozlowski, M. C. “Asymmetric Synthesis of α-Allyl-α-Aryl 
α-Amino Acids by Tandem Alkylation/π-Allylation of α-Iminoesters” Org. Lett. 2014, 16, 1948-1951.  
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moiety would undergo various metathesis type reactions, providing access to other new 
compounds (Figure 2.2).  
 
Figure 2.2 Enantioenriched acyclic and cyclic amino acid derivatives from α-allyl-α-aryl 
α-amino esters. 
In contrast to most other reports on the N-alkylation of α-iminoesters, a range of 
Grignard reagents could be successfully combined with the AAA conditions (Scheme  
2.1). Notably, more functional Grignards provided terminal silyl and alkenyl derivatives. 
These substances proved to be important for generation of other novel α,α-disubstituted 
α-amino acids.   
Scheme  2.1 Our previous work on the tandem N-alkylation/π-allylation of α-iminoesters. 
 
 
NH
Ar O
MeO
2
35
6
7 8
N
Ar
IH
1
O
OMe
Higher Ring Order 
Proline Derivatives
 Pyrrolizidine
Analog
N H
O
OMe
R1/H
Ar
Ph
N PMP
O
OMe
R1
Ar
Ph
N H
O
OMe
R1
Ar
R2
1° or 2° N-α-Allyl-α-Aryl
 α-Amino Ester
Allylic Diversity
α-Allyl-α-Aryl
 α-Amino Ester
n
N
Ph
PMP
O
OMe
N PMP
O
OMe
R1
Ph
1) R1MgBr, THF
    -78 °C →  rt, 45 min
2) (R)-DIFLUORPHOS (4.9 mol %)
     [η3-C3H5PdCl]2 (3.8 mol %)
Ph OAc Ph-78 °C → rt, 30 min
2.01 2.02
MgBr
MgBr
R1MgBr =
2.02c: 85%, 86% ee
2.02b: 82%, 90% ee
MgBrTMS 2.02a: 83%, 82% ee
 
 
69 
2.2. RESULTS 
2.2.1.  Synthesis of Secondary and Primary N-α-Allyl-α-Aryl α-Amino Esters 
 The tandem N-alkylation/π-allylation method developed readily provides access 
to N-alkyl α-allyl-α-aryl α-amino acids including a number of N-alkyl substitutions that 
would be difficult to generate via reductive amination (see Scheme  2.1). The para-
methoxyphenyl (PMP) activating group on nitrogen was found to be very important for 
attaining the best yield and selectivity in this novel technology. We envisioned that the 
labile PMP group would provide access to secondary N-α-allyl-α-aryl α-amino acids 
(2.04) (Figure 2.3, known). The primary N-α-allyl-α-aryl α-amino acid (2.05) was also 
desired, but removal of the alkyl group (R1) would be much more challenging (Figure 
2.3, unknown).   
 
Figure 2.3 Synthesis of secondary and primary N-α-allyl-α-aryl α-amino acids from N-
alkylation/π-allylation product.  
Access to the secondary N-α,α-disubstituted α-amino acid was thus pursued with 
2.02a (Scheme  2.2). The PMP group can be removed with strong oxidative conditions.56  
Direct removal of the PMP group on 2.02a was unsuccessful with ceric ammonium 
nitrate (CAN), periodic acid or trichloroisocyanuric acid. PMP removal on tertiary amines 
                                                
56) Verkade, J. M. M.; van Hemert, J. C.; Quaedflieg, P. J. L. M.; Alsters, P. L.; van Delft, F. L.; Rutjes, P. 
J. T. “Mild and efficient deprotection of the amine protecting p-methoxyphenyl (PMP) group” 
Tetrahedron Lett. 2006, 47, 8109-8113.   
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is sluggish, and with 2.02a, the allyl moiety underwent undesired side reactions before 
PMP removal. The troublesome olefin was removed by subjecting 2.02a to H2 and Pd/C. 
Treatment of the saturated 2.06 with CAN led to the successful removal of the PMP 
group, providing the desired secondary N-α,α-disubstituted α-amino acid (Scheme  2.2, 
2.07).  
Scheme  2.2 Synthesis of secondary N-α,α-disubstituted α-amino acid (2.07). 
 
We demonstrated in our development of the asymmetric N-alkylation/π-allylation 
of α-iminoesters that the tandem reaction was necessary to achieve high 
enantioselectivity. This requirement, however, presented an N-alkylated α,α-
disubstituted α-amino acid that had no known method for C−N bond cleavage (phenyl, 
benzyl and allyl Grignards were unsuccessful in the N-alkylation step). 2-
(Trimethylsilyl)ethylmagnesium bromide was a competent nucleophile for the tandem 
process and precedent in the literature suggested it could be removed (Figure 2.4).  
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Figure 2.4 C−N Bond cleavage of 2-(trimethylsilyl)ethyl amine protecting group. 
An important protecting group for amines is trimethylsilylethyl carbamate (Teoc). 
The Teoc protecting group can be used orthogonally with acid labile protecting groups 
(e.g., Boc and acyl) because it is easily removed with fluoride sources (Figure 2.4, a).57  
A variation of the Teoc protecting group is trimethylsilylethyl, which has been shown to 
be removed with CsF when used to protect para-methoxyphenol (Figure 2.4, b).58 
Trimethylsilylethyl has been used with moderate success to protect N,N-dialkylated 
amines (Figure 2.4 ,c).59 These examples in the literature prompted us to propose that 2-
(trimethylsilyl)ethylamine on 2.14 could be removed with high yields (Figure 2.4, d). 
Putatively, the PMP group and α-CO2Me would increase the leaving group ability of the 
nitrogen on 2.14 compared to that in 2.12, which undergoes cleavage in low yield.  
                                                
57) Barrett, A. G. M.; Pilipauskas, D. “Electrochemical Oxidation of Proline Derivatives: Total Syntheses 
of Bulgecinine and Bulgecin C” J. Org. Chem. 1991, 56, 2787-2800.  
58) Dibakar, M.; Prakash, A.; Selvakuma, K.; Ruckmani, K.; Sivakuma, M. “2-(Trimethylsilyl)ethanol as a 
new alcohol equivalent for copper-catalyzed coupling of aryl iodides” Tetrahedron Lett. 2011, 52, 
5338-5341.  
59) Baldwin, J. J. et al. Preparation of phenyl[((amino)phenyl)methoxy]ethylcarbamate derivatives and 
analogs as renin inhibitors. WO 2008-US7662, Dec 24, 2008.   
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We initiated the investigation of C−N bond cleavage of 2-(trimethylsilyl)ethyl 
amine on 2.02a (Scheme  2.3) using TBAF, CsF, HF, KF/18-crown-6, LiBF4 or 
LiF/BF3•Et2O. At ambient temperature, as well at elevated temperatures (60−120 °C), for 
2−24 h starting material was recovered or decomposition was observed.  
Scheme  2.3 C−N bond cleavage of 2-(trimethylsilyl)ethyl amine (2.02a). 
 
 In previous studies, the tandem products from the N-alkylation/π-allylation 
method had been subjected to concentrated hydrochloric acid but did not form the 
ammonium salt. This finding led us to believe that 2.02a was too sterically hindered for 
nitrogen to be protonated or to coordinate with a Lewis acid additive to enhance its 
leaving group potential. The PMP group was removed to investigate the less hindered and 
more basic amine 2.07a. The secondary amine was subjected to TBAF, TBAF/BF3•Et2O, 
TsOH, TFA, HCl, HF or TFA/BF3•Et2O at elevated temperatures (65 °C) and prolonged 
reaction times (24 h) (Scheme  2.4). In each reaction, only unreacted starting material or 
unidentified side-products were isolated with no evidence of product (2.17b).   
Scheme  2.4 C−N bond cleavage of 2-(trimethylsilyl)ethyl amine (2.07a). 
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 The challenges incurred with the C−N bond cleavage of 2-(trimethylsilyl)ethyl 
amine inspired our investigation of homoallyic amine 2.18. A survey of the literature 
suggested that tertiary allylic amines could be reduced to the secondary amines.61,62,63,64,65 
If N-butenyl substrate (2.18) could be isomerized to the allylic amine (2.19), then 
conditions to either remove the allyl group (path a) or generate the enamine, which 
would undergo subsequent hydrolysis (path b), should be achievable (Figure 2.5).  
 
Figure 2.5 Proposed C−N bond cleavage of allylic amine.  
 The investigation of the C−N bond cleavage of the allylic amine commenced with 
2.01b. The terminal olefin was isomerized to the internal olefin with conditions 
developed by Nishida using a ruthenium hydride generated from second generation 
Grubbs catalyst (G-II) and vinyloxytrimethylsilane at elevated temperatures (Scheme  
2.5, left).60 Previous work by Cossy suggests that similar conditions could also generate 
the enamine from the allyl in situ, but even at elevated temperatures (140 °C) 
isomerization was not observed.61 Various conditions for C−N bond cleavage of the 
allylic amine were investigated (Scheme  2.5, right). Generation of the allylpalladium 
                                                
60) Arisawa, M.; Terada, Y.; Takahashi, K.; Nakagawa, M.; Nishida, A. “Ruthenium Hydride with N-
Heterocyclic Carbene and Its Application to the Synthesis of Heterocycles” J. Org. Chem. 2006, 71, 
4255-4261.   
61) Cadot, C.; Dalko, P. I.; Cossy, J. “Olefin isomerization by a ruthenium carbenoid complex. Cleavage 
of allyl and homoallyl groups” Tetrahedron Lett. 2002, 43, 1839-1841.    
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complex was unsuccessful.62 Strong bases including n-BuLi, t-BuLi, KOt-Bu or NaH 
were explored to form the enamine but in all cases the starting material was recovered 
unreacted.63 C−N bond cleavage of allylic amines has been shown to be successful with 
“Cp2Zr” but when applied to 2.22a, only unreacted starting material was recovered.64 
BF3•Et2O can promote C−N bond cleavage via an aza-Cope rearrangement but 
decomposition of 2.22a occurred instead.65   
Scheme  2.5 Isomerization of homoallylic amine to allylic amine and subsequent studies 
on the C−N bond cleavage. 
 
Redox isomerizations are examples of atom-economical processes in which one 
site in an organic substrate is oxidized with concomitant reduction of another site.66 After 
the challenges met with C−N bond cleavage of the 2-(trimethylsilyl)ethylamine and 
                                                
62) (a) Zhao, X.; Liu, D.; Guo, H.; Liu, Y.; Zhang, W. “C−N Bond Cleavage of Allylic Amines via 
Hydrogen Bond Activation with Alcohol Solvents in Pd-Catalyzed Allylic Alkylation of Carbonyl 
Compounds” J. Am. Chem. Soc. 2011, 133, 19354-19357. (b) Garro-Helion, F.: Merzouk, A.; Guibe, 
F. “Mild and Selective Palladium (0)-Catalyzed Deallylation of Allylic Amines. Allylamine and 
Diallylamine as Very Convenient Ammonia Equivalents for the Synthesis of Primary Amines” J. Org. 
Chem. 1993, 58, 6109-6113.     
63) Weisenburger, G. A.; Beak, P. “α-Lithiation of N-(tert-Butoxycarbonyl)-N(p-
methoxyphenyl)allylamines Mediated by (−)-Sparteine: Enantioselective Syntheses of Either 
Enantiomer of 3-Substituted Enecarbamates” J. Am. Chem. Soc. 1996, 118, 12218-12219.  
64) Ito, H.; Taguchi, T.; Hanzawa, Y. “Practical Zirconium-Mediated Deprotective Method of Allyl 
Groups” J. Org. Chem. 1993, 58, 774-775.  
65) Beholz, L. G.; Stille, J. R. “Lewis Acid-Promoted 3-Aza-Cope Rearrangement of N-Alkyl-N-
allylanilines” J. Org. Chem. 1993, 58, 5095-5100.  
66) Trost, B. M. “On Inventing Reactions for Atom Economy” Acc. Chem. Res. 2002, 35, 695-705.   
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allylic amines, we began investigating the literature for the isomerization of terminal 
alkenes to internal alkenes. Ir67, Fe68, Zr69 and Ru70 have all been shown to be active 
metals for zipper (>1 carbon) alkene isomerization.  
Douglas Grotjahn has published a series of papers detailing the efforts of his 
research group on redox isomerizations.71 Grotjahn generously provided us with his 
catalyst (~50 mg), which was investigated with terminal olefin 2.02b (Scheme  2.6). 
When 2.02b was treated with the Grotjahn catalyst in acetone at rt for 24 h, the mono-
isomerized allyl 2.22a was produced cleanly. Heating 2.02b to 70 °C for 24 h produced 
the hydrolyzed product (2.23) in 40% yield. Grotjahn and co-workers had demonstrated 
that the catalyst could be used in combination with D2O to deuterate allylic C−H bonds 
selectively.71b H2O and trifluoroacetic acid were thus applied to 2.02b, which led to 
exclusive formation of 2.23 resulting from in situ hydrolysis of the enamine (Scheme  
2.6).  
 
                                                
67) Lim, H. J.; Smith, C. R.; RajanBabu, T. V. “Facile Pd(II)- and Ni(II)-Catalyzed Isomerization of 
Terminal Alkenes into 2-Alkenes” J. Org. Chem. 2009, 74, 4565-4572.    
68) Iranpoor, N.; Mottaghinejad, E. “Dodecacarbonyl triiron, an efficient catalyst for photochemical 
isomerization of unsaturated alcohols, ethers and ester to their carbonyl compounds, enol ethers and 
esters” J. Organomet. Chem. 1992, 423, 399-404.  
69) Gibson, T.; Tulich, L. “Novel Synthesis of Long-Chain Primary Alkyl Compounds” J. Org. Chem. 
1981, 46, 1821-1823.  
70) Ruba, E.; Simanko, W.; Mauthner, K.; Soldouzi, K. M.; Slugovc, C.; Mereiter, K.; Schmid, R.; 
Kirchner, K. “[RuCp(PR3)(CH3CN)2]PF6 (R = Ph, Me, Cy). Convenient Precursors for Mixed 
Ruthenium(II) and Ruthenium(IV) Half-Sandwich Complexes” Organometallics 1999, 18, 3843-3850.   
71) (a) Larsen, C. R.; Grotjahn, D. B. “Stereoselective Alkene Isomerization over One Position” J. Am. 
Chem. Soc. 2012, 134, 10357-10360. (b) Erdogan, G.; Grotjahn, D. B. “Mild and Selective Deuteration 
and Isomerization of Alkenes by a Bifunctional Catalyst and Deuterium Oxide” J. Am. Chem. Soc. 
2009, 131, 10354-10355. (c) Grotjahn, D. B.; Larsen, C. R.; Gustafson, J. L.; Nair, R.; Sharma, A. 
“Extensive Isomerization of Alkenes Using a Bifunctional Catalyst: An Alkene Zipper” J. Am. Chem. 
Soc. 2007, 129, 9592-9593.  
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Scheme  2.6 C−N bond cleavage by alkene isomerization to enamine followed by in situ 
hydrolysis.  
  
The PMP group was removed from 2.23 with CAN to provide the primary N-α-
allyl-α-aryl α-amino acid 2.17a (Scheme  2.7). The successful removal of the PMP group 
on the secondary amine in the presence of the allylic moiety contrasted our previous 
efforts with tertiary amines (see Scheme  2.2). Putatively, the secondary amine more 
effectively coordinates Ce, thus becoming a better leaving group than the corresponding 
tertiary amine, and side-reactions of the allyl with CAN are minimized.  
Scheme  2.7 Synthesis of the primary N-α-allyl-α-aryl α-amino acid 2.17a by removal of 
the PMP protecting group.  
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2.2.2.  Asymmetric Synthesis of Acyclic Amino Acid Derivatives by Alkene Metathesis 
 α-Aryl homologs of tyrosine and glutamate have been shown to be biologically 
active.72 Yet, the inability to use other allylating agents with our previously developed N-
alkylation/π-allylation of α-iminoesters hindered access to such compounds (Scheme  
2.8).  
Scheme  2.8 Our previous work on exploration of allylating agent in N-alkylation/π-
allylation of α-iminoester.   
 
 Olefin cross metathesis (CM) is a convenient route to functionalized olefins from 
simple alkene precursors. The availability of catalysts with varied activities has increased 
the prominence of CM, but it is not utilized as often as ring opening metathesis 
polymerization (ROMP) or ring closing metathesis (RCM). Catalyst activity in CM is 
low because it has neither a strong enthalpic driving force (ring-strain release in ROMP) 
nor the entropic advantage of intramolecular reactions (RCM). Also, poor selectivity for 
the CM product is common because of the many alkylidene intermediates. A seminal 
paper by Grubbs and co-workers ranked olefins in CM by their ability to homodimerize 
                                                
72) Wehbe, J.; Rolland, V.; Fruchier, A.; Roumestant, M.; Martinez, J. “Enantioselective synthesis of new 
4-substituted glutamic acid derivatives” Tetrahedron: Asymmetry 2004, 15, 851-858. 
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(Figure 2.6).73 Selectivity could be predicted and statistical product distributions could be 
avoided if two different olefin types were reacted with the correct catalyst.  
 
Figure 2.6 Olefin reactivity in CM (taken from ref 73). 
 α-Amino acids have been investigated extensively in CM because of their role in 
biology and myriad applications.74 α,α-Disubstituted α-amino acids compared to their α-
H counterparts when incorporated into peptides typically enhance metabolic stability and 
possess different folding behavior. On the other hand, CM for the synthesis of α,α-
disubstituted α-amino acids is quite rare. Indeed, there are limited methods for the 
synthesis of enantioenriched α,α-disubstituted α-amino acids with an olefin present. The 
olefin near a quaternary center is sterically hindered, giving rise to the potential for 
selective CM.75 Rutjes and co-workers demonstrated the first example of CM with α,α-
disubstituted α-amino acids in the synthesis of α-allyl-α-methyl α-amino acids by 2nd 
generation, Grubbs catalyst (G-II) (Figure 2.7, a).76 Cordero followed this work by 
                                                
73) Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. “A General Model for Selectivity in 
Olefin Cross Metathesis” J. Am. Chem. Soc. 2003, 125, 11360-11370. 
74) (a) Brik, A. “Metathesis in Peptides and Peptidomimetics” Adv. Synth. Catal. 2008, 350, 1661-1675. 
(b) Connon, S. J.; Blechert, S. “Recent Developments in Olefin Cross-Metathesis” Angew. Chem., Int. 
Ed. 2003, 42, 1900-1923.   
75) Stewart, I. C.; Douglas, C. J.; Grubbs, R. H. “Increased Efficiency in Cross-Metathesis Reactions of 
Sterically Hindered Olefins” Org. Lett. 2008, 10, 441-444.  
76) Storcken, R. P. M.; Panella, L.; van Delft, F. L.; Kaptein, B.; Broxterman, Q. B.; Schoemaker, H. E.; 
Rutjes, F. P. J. T. “A Cross-Metathesis Route to Functionalized α-Methyl α-Substituted Amino Acids” 
Adv. Synth. Catal. 2007, 349, 161-164. 
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synthesizing several α-substituted N-Boc-protected prolines by CM of N-Boc-allylproline 
(Figure 2.7 ,b).77  
 
Figure 2.7 CM of α,α-disubstituted α-amino acids. 
 We envisioned that the tandem product from N-alkylation/π-allylation of α-
iminoesters could be utilized in CM to increase allylic diversity. The tandem product, 
specifically 2.02d with high ee (88%), would be a single intermediate that could be 
combined with a broad range of allyl adducts. A potential limitation to this approach is 
that tertiary amines need to be deactivated with an electron-withdrawing group (e.g., Boc, 
Cbz) to prevent catalyst poisoning. However, the tertiary N-α-allyl-α-aryl α-amino acids 
from the tandem chemistry do not behave as expected; ostensibly, the sterics of the α-
carbon prevent nitrogen coordination to Brønsted or Lewis acids.  
 The CM of α-allyl-α-aryl α-amino acids was explored with the tandem product 
(2.02d) and 2-vinylnaphthalene (2.28) with various metathesis catalysts (Scheme  2.9). 1st 
Generation (G-I) and 2nd generation (G-II), Grubbs catalyst provided zero or minimal 
CM product, respectively.78 To our satisfaction, the more active 2nd generation, Hoveyda-
Grubbs catalyst (HG-II) did successfully generate product in 68% yield. DCM and 
                                                
77) Lumini, M. Cordero, F. M.; Pisaneschi, F.; Brandi, A. “Straightforward Synthesis of α-Substituted 
Prolines by Cross-Metathesis” Eur. J. Org. Chem. 2008, 2817-2824. 
78) 1st Generation, Hoveyda-Grubbs catalyst also provided minimal CM product.  
G-II (5 mol %)
toluene 
95 °C, 6 h
84%
OMe
N
O
CbzH
Me
2.24 2.25
OMe
N
O
CbzH
Me
O
O
O
O
(5 equiv)
a. Rutjes
N CO2H
Boc
N CO2H
Boc
Me
G-II (5 mol %)
DCM
(4 equiv)
Me
4
4
µW (150 W, 
80 °C, 40 min)
92%
b. Cordero
2.26 2.27
 
 
80 
toluene were also tested but were not as efficient as 1,2-dichloroethane (DCE). 
Microwave conditions have been shown to increase the efficiency of CM, especially 
reactions with extended reaction times, but microwave conditions applied to Scheme  2.9 
did not improve yield or reaction time.79   
Scheme  2.9 Screen of metathesis catalysts in the CM of α-allyl-α-aryl α-amino acid. 
 
The optimized conditions were successfully applied with the tandem product with 
high enantioselectivity and 4-tert-butoxystyrene, as well as methyl acrylate (Table 2.1). 
In contrast to 2-vinylnaphthalene, increased temperature did improve yields with these 
substrates. Sequential addition of catalyst to 4-tert-butoxystyrene did not improve the 
reaction. Ethylene proved recalcitrant, but did afford product 2.02f with high 
enantioselectivity, in contrast to direct allylation (see Scheme  2.8), and with high yield 
based on recovered starting material.   
 
 
 
 
                                                
79) Coquerel, Y.; Rodriguez, J. “Microwave-Assisted Olefin Metathesis” Eur. J. Org. Chem. 2008, 1125-
1132.  
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Table 2.1 CM of high ee tandem product with various type I olefins. 
 
 A range of olefins was explored with the optimized conditions (see Table 2.1) but 
in nearly all cases only unreacted tandem product and homodimerized type I olefin were 
isolated (Figure 2.8). Three olefins did provide some product but with a considerable 
amount of starting material still unreacted; optimization of these compounds was not 
pursued (Figure 2.8, left). 
 
Figure 2.8 Type I olefins explored that did not provide significant product with 2.02d. 
To further our objective of generating α-amino acid homologs, hydrogenation and 
PMP-removal was performed on 2.02i to provide the α-aryl tyrosine homolog 2.30 
(Scheme  2.10). Notably, N-ethyl amino acids can be difficult to generate due to the 
difficulty of reductive amination with acetaldehyde.   
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Scheme  2.10 Generation of α-aryl tyrosine homolog. 
 
 
2.2.3.  Asymmetric Synthesis of Cyclic Amino Acid Derivatives by Alkene Metathesis 
Cyclic α-amino acid derivatives are of great synthetic and pharmaceutical 
interest. 80  Further, α-substituted prolines have been shown to be important as 
organocatalysts and privileged ligands. Seebach pioneered the asymmetric synthesis of α-
substituted prolines in 1983,81 yet the development of asymmetric methods for the 
synthesis of higher ring homologues of proline has received little attention.82   
Ring closing metathesis (RCM) has become pervasive in organic synthesis. Even 
though metathesis originated in polymer chemistry,83 and the catalysts were developed 
extensively by organometallic chemists,84 it has become an important tool for natural 
                                                
80) Park, K. H.; Kurth, M. J. “Cyclic amino acid derivatives” Tetrahedron 2002, 58, 8629-8659. 
81) Seebach, D.; Boes, M.; Naef, R.; Schweizer, W. B. “Alkylation of Amino Acids without Loss of the 
Optical Activity: Preparation of α-substituted Proline Derivatives. A Case of Self-Reproduction of 
Chirality” J. Am. Chem. Soc. 1983, 105, 5390-5398. 
82) For reviews on the asymmetric synthesis of cyclic α,α-disubstituted α-amino acid, see: (a) Cativiela, 
C.; Ordonez, M. “Recent progress on the stereoselective synthesis of cyclic quaternary α-amino acids” 
Tetrahedron: Asymmetry 2009, 20, 1-63. (b) Cativiela, C.; Diaz-De-Villegas, M. D. “Stereoselective 
synthesis of quaternary α-amino acids. Part 2: Cyclic compounds” Tetrahedron: Asymmetry 2000, 11, 
645-732. 
83) Chauvin, Y. “Olefin Metathesis: The Early Days (Nobel Lecture)” Angew. Chem., Int. Ed. 2006, 45, 
3740-3765.   
84) Vougioukalakis, G. C.; Grubbs, R. H. “Ruthenium-Based Heterocyclic Carbene-Coordinated Olefin 
Metathesis Catalysts” Chem. Rev. 2010, 110, 1746-1787.  
 H2
10% Pd/C (10 mol %)
EtOAc, rt, 45 min
85%
OMe
N
O
PMPEt
Ph
t-BuO
OMe
N
O
HEt
Ph
t-BuO
2.02i 2.29
OMe
N
O
PMPEt
Ph
t-BuO
CAN (3 equiv)
MeCN/H2O
0 °C, 45 min
64% 2.30
 
 
83 
product chemists.85 RCM is driven by entropic forces and is general for 5-membered 
rings and larger. It has been studied extensively for the formation of α-prolines,86 
spirocyclic α-amino acids87 and macrocyclization of peptides,88 but its use for higher-ring 
order α-substituted prolines is rare.  
The N-substituents and the α-alkene functional unit present in the α-iminoester 
addition product described in Scheme  2.1 provide effective precursors for RCM to cyclic 
analogs. This hypothesis was explored by surveying the various ruthenium based 
metathesis catalysts (G-I, G-II, HG-I, HG-II) with 2.02b. HG-II was found to form the 
azepine (2.31) effectively in 93% yield (Scheme  2.11, left). The catalyst loading and 
reaction time were relatively high, and microwave conditions were explored (Scheme  
2.11, right). Microwave conditions reduced the necessary catalyst loading (10 vs 5 mol 
%) and shortened reaction time (24 vs 1 h).  
Scheme  2.11 Synthesis of a higher ring homologue of α-substituted proline.  
 
                                                
85) Furstner, A. “Metathesis in total synthesis” Chem. Commun. 2011, 47, 6505-6511.  
86) Calaza, M. I.; Cativiela, C. “Stereoselective Synthesis of Quaternary Proline Analogues” Eur. J. Org. 
Chem. 2008, 3427-3448.   
87) Ple, K.; Haudrechy, A.; Probst, N. P. “Use of the Claisen/metathesis reaction sequence for the 
synthesis of enantiomerically pure 1-aminocycloalkene-1-carboxylic acids” Tetrahedron Lett. 2010, 
66, 5030-5035.  
88) Miller, S. J.; Grubbs, R. H. “Synthesis of Conformationally Restricted Amino Acids and Peptides 
Employing Olefin Metathesis” J. Am. Chem. Soc. 1995, 117, 5855-5856.    
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The azepine from RCM was subjected to hydrogenation to generate the higher 
ring order α-aryl proline 2.32 in 81% yield (Scheme  2.12). This compound was 
crystalline and could be triturated to produce >95% ee material. X-Ray crystallography 
was used to determine the absolute configuration of the tandem products from 2.32.   
Scheme  2.12 Establishing the absolute configuration of tandem products from N-
alkylation/π-allylation. 
 
 The azocine was also desired and formed readily from HG-II and microwave 
conditions (Scheme  2.13).89 The PMP group could be removed in the presence of the 
alkene, in contrast with the acyclic tertiary N-α-allyl-α-aryl α-amino acids (see Scheme  
2.2). Furthermore, azocine 2.34, with the alkene moiety, presents an expeditious entry to 
substituted pyrrolizidines via transannular cyclization. 
Scheme  2.13 RCM to generate azocine. 
 
 The naturally occurring pyrrolizidine structural motif exists in over 370 natural 
products, and some molecules in this class have been shown to have toxicity against 
                                                
89) The corresponding 9-member ring did not form readily.   
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livestock, wildlife and humans.90 Secondary amine 2.34 is poised to undergo an iodine-
induced transannular cyclization,91 and treatment with NIS led exclusively to cis-iodide 
2.35 (Scheme  2.14). Since most naturally occurring pyrrolizidines are substituted at C1, 
this route offers a labile functional group for further manipulation.90  
Scheme  2.14 Transannular cyclization of azocine to α-arly-α-ester pyrrolizidine 
analogue. 
 
The relative stereochemistry of 2.35 was assigned as (S,S,S) by comparing the 
calculated bond distances and coupling constants of the four potential diasteromers 
(Figure 2.9) with the NOESY of 2.35 (Figure 2.10). The protons on 2.35 were assigned 
utilizing the 1H NMR and 2D NMR (COSY). Splitting of the C1-H (ddd, J = 14, 7.5, 6.5 
Hz) matches the predicted cis-iodination products (S,S,S) and (R,S,R) predicted from our 
computational studies (Figure 2.9). The NOESY of 2.35 shows that the ortho-H of the 
phenyl ring couples with the C2-Ha, C2-Hb and C5-Ha (Figure 2.10, right). The limit for 
coupling through space is ~3 Å. Comparing (S,S,S) and (R,S,R) reveals that the observed 
coupling in the NOESY matches the predicted bond distances for (S,S,S). If (R,S,R) was 
produced the ortho-H would be expected to couple with C2-Hb and C8-H, which is not 
observed.  
                                                
90) Pelletier, S. W. “Alkaloids: Chemical & Biological Perspectives”, Vol 9, pp 155-233, Pergamon, New 
York, 1995. 
91) Wilson, S. R.; Sawicki, R. A. J. Org. Chem. 1979, 44, 287-291. 
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Figure 2.9 Calculated bond distances and coupling constants of 2.35. 
 
Figure 2.10 1H NMR and NOESY of 2.35. 
The expected trans-iodide product from formation of the iodonium and 
transannular cyclization of the amine was not observed (Figure 2.11, path A). The cis-
iodide is potentially formed from a double inversion type mechanism (path B and path 
C), or via a formal syn-addition to the alkene (path D).  
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Figure 2.11 Potential mechanistic pathways for formation of cis-iodide adduct. 
The relative stereochemistry of iodine to the β-ester is trans, this configuration is 
assumed to occur because of steric factors, but the ester could open the iodonium 
followed by amine displacement (path C). The most pragmatic mechanistic proposal is 
that the azocine undergoes N-iodination, followed by a syn addition across the double 
bond (path D).   
Carreira and co-workers found that when they treated oxabicyclonorbornene with 
NIS to form the tricyclic azabicyclononane, the endo-iodide was formed exclusively 
(Figure 2.12). 92  NMR studies of the reaction suggest the oxabicyclonorbornene is 
transformed immediately to an intermediate with the alkene still present; a tentative 
assignment of this structure was the N-iodo intermediate. It should be noted that the 
Carreira molecule also has a nearby ester functional group similar to that in our 
compound (2.35).  
                                                
92) Schindler, C. S.; Stephenson, C. R. J.; Carreira, E. M. “Enantioselective Synthesis of the Core of 
Banyaside, Suomilide, and Spumigin HKVV” Angew. Chem., Int. Ed. 2008, 47, 8852-8855.  
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Figure 2.12 Previous work by Carreira forming endo-iodide tricyclic azabicyclononane. 
 
2.3. CONCLUSIONS 
 We demonstrated the tandem α-allyl-α-aryl α-amino acid product from N-
alkylation/π-allyation could be used to access enantioenriched secondary and primary N-
α,α-disubstituted α-amino acids. C−N bond cleavage was explored with 2-
(trimethylsilyl)ethylamine, allylic amine and homoallylic amine. A novel method for 
C−N bond cleavage of the homoallyic amine was developed utilizing the Grotjahn 
catalyst, an alkene zipper, combined with water and acid.  
Entry to enantioenriched acylic and cyclic α,α-disubstituted amino acid 
derivatives by means of cross-metathesis or ring-closing metathesis of the previously 
disclosed products from asymmetric tandem N-alkylation/π-allylation of α-iminoesters 
was developed. This approach provided rapid entry to homologs of tyrosine and 
glutamate as well as to higher ring homologues of proline. The eight-membered cyclic α-
amino acid was further transformed to the pyrrolizidine natural product backbone in three 
steps. It was discovered in the synthesis of the pyrrolizidine analog that the transannular 
cyclization catalyzed by NIS provided a unique cis-iodide product.  
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2.4. EXPERIMENTAL SECTION 
General Considerations 
Unless otherwise stated, all non-aqueous reactions were carried out under an 
atmosphere of dry argon in dry glassware. All glassware used in three component 
coupling reactions was base-washed (KOH/i-PrOH) prior to use. When necessary, 
solvents and reagents were dried prior to use. Tetrahydrofuran, cyclopentyl methyl ether 
and toluene were distilled from Na/benzophenone prior to use. Organometallic reagents 
(EtMgBr) were purchased from Aldrich, or made from magnesium turnings/ribbon. 
Analytical thin layer chromatography (TLC) was performed on Silicycle 250 µm silica-
gel F-254 plates. 
1H NMR and 13C NMR spectra were recorded on a AM-500 Fourier transform 
NMR spectrometer at 500 MHz and 125 MHz, respectively.  Chemical shifts are reported 
relative to the solvent resonance peak δ 7.26 (CDCl3) for 1H and δ 77.16 (CDCl3) for 13C.  
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, b = broad singlet, m = multiplet), coupling constants, and number of 
protons.  Time of flight (TOF) high resolution mass spectra were obtained with an 
ionization mode of either ESI or CI.  Infrared spectra are reported in cm-1. Melting points 
were obtained and are uncorrected. Unless otherwise noted, yields refer to isolated 
material on the basis of product purity ≥95% by 1H NMR following silica gel 
chromatography with Silica-P flash silica gel (50-63 µm mesh particle size). 
Enantiomeric excess was determined utilizing chiral stationary phase (CSP) HPLC or 
SFC on OD [cellulose tris(3,5-dimethylphenylcarbamate) coated on silica gel] or IA 
[amylose tris(3,5-dimethylphenylcarbamate) immobilized on silica gel] columns.  
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Starting materials 2.01 and 2.02a-2.02d were synthesized following our previous 
report.55 
 
 
(S)-Methyl 2-((4-methoxyphenyl)(2-(trimethylsilyl)ethyl)amino)-2,5-
diphenylpentanoate (2.06). General Procedure A: A 10 mL round bottom flask was 
charged with a stir bar and flame dried under vacuum. To the reaction flask was added 
2.02a (50 mg, 0.113 mmol), EtOAc (3.4 mL) and 10% Pd/C (2.4 mg, 0.023 mmol). At 
ambient temperature the flask was purged with one hydrogen balloon and then subjected 
to a hydrogen atmosphere with a new hydrogen balloon for 45 min. The flask was opened 
to air, passed through SiO2 with 30% EtOAc in Hexanes, concentrated in vacuo and 
chromatographed (5% EtOAc in Hexanes) providing 2.06 (46 mg) in 92% yield as an oil: 
1H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 7.4 Hz, 2H), 7.32 (t, J = 7.6 Hz, 2H), 7.28-
7.23 (m, 1H), 7.17 (t, J = 7.4 Hz, 2H), 7.11 (d, J  = 7.3 Hz, 1H), 7.07 (d, J = 8.9 Hz, 2H), 
6.92 (d, J = 7.1 Hz, 2H), 6.85 (d, J = 8.9 Hz, 2H), 3.83 (s, 3H), 3.83 (s, 3H), 2.94 (dt, J = 
12.6, 5.4 Hz, 1H), 2.85 (dt, J = 12.5, 5.8 Hz, 1H), 2.31-2.23 (m, 1H), 2.21-2.13 (m, 1H), 
1.74 (dt, J = 12.4, 4.8 Hz, 1H), 1.59 (dt, J = 12.2, 4.6 Hz, 1H),  1.29-1.18 (m, 2H), 0.54-
0.41 (m, 2H), 0.21 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 173.7, 157.7, 142.6, 141.7, 
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139.4, 131.1, 128.4,128.2, 127.8, 127.8, 127.1, 125.6, 113.7, 74.8, 55.5, 51.3, 47.7, 40.1, 
36.3, 26.7, 17.9, -1.6; IR (film) 2951, 2925, 1725, 1507, 1246 cm-1; HRMS (ESI) calcd 
for C30H40NO3Si [M+H]+ m/z = 490.2777; found 490.2777; [α]25D = +103.2 (c 0.25, 82% 
ee, CH2Cl2). 
 
(S)-Methyl 2,5-diphenyl-2-((2-(trimethylsilyl)ethyl)amino)pentanoate (2.07). General 
Procedure B: A solution of 2.06 (23 mg, 0.047 mmol) in MeCN (949 µL) was cooled to 
0 °C. To this mixture was added a solution of ceric ammonium nitrate (78 mg, 0.141 
mmol) in H2O (475 µL). The mixture went from yellow to purple initially and then brown 
upon addition. After stirring for 60 min, the mixture was quenched with 5% NaHCO3 
until a pH of 9 was obtained (~2 mL). The mixture was diluted with 20% Na2SO3 (20 
mL) and extracted with EtOAc (3 x 25 mL). The combined organic phases were washed 
with brine (2 x 20 mL), dried over Na2SO4, and concentrated in vacuo. The resulting 
residue was chromatographed (15% EtOAc in Hexanes). The fractions that stained with 
KMnO4 (Rf = 0.3) in 20% EtOAc in Hexanes were concentrated to afford product 2.07 
(12.5 mg) in 69% yield as an oil: 1H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 7.6 Hz, 2H), 
7.31 (t, J = 7.4 Hz, 2H), 7.28-7.20 (m, 3H), 7.15 (t, J = 7.4 Hz, 1H), 7.10 (d, J  = 7.2 Hz, 
2H), 3.66 (s, 3H), 2.55 (t, J = 7.6, 2H), 2.41-2.25 (m, 2H), 2.13 (dt, J = 13.3, 4.5 Hz 1H), 
2.00 (dt, J = 13.3, 4.5 Hz 1H), 1.72 (b, 1H), 1.59-1.47 (m, 1H), 1.45-1.33 (m, 1H), 0.83-
0.68 (m, 2H), -0.013 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 176.0, 142.3, 142.1, 128.5, 
128.4, 128.3, 127.4, 126.2, 125.8, 68.6, 52.2, 39.3, 36.0, 34.7, 24.9, 18.8, -1.2; IR (film) 
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3332, 2951, 1733, 1248 cm-1; HRMS (ESI) calcd for C22H34NO2Si [M+H]+ m/z = 
384.2359; found 384.2363; [α]25D = -6.2 (c 0.13, 82% ee, CH2Cl2). 
 
(S,E)-Methyl 2-(((E)-but-2-en-1-yl)(4-methoxyphenyl)amino)-2,5-diphenylpent-4-
enoate (2.22a). 2nd Generation, Grubbs catalyst (G-II) (6.3 mg, 0.0074 mmol) was added 
to a flame dried 10 mL round bottom flask equipped with a stir bar and reflux condenser 
under an argon atmosphere, followed by the addition of vinyloxytrimethylsilane in 
toluene (0.25 M, 0.742 mmol). After 1 h at 50 °C, 2.02b in toluene (0.025 M, 0.074 
mmol) was added to the reaction mixture. After 15 h at 115 °C, the mixture was cooled, 
passed through SiO2 with 30% EtOAc in Hexanes, and concentrated in vacuo. 
Purification by column chromatography (pre-wash SiO2 with 5% NEt3 in Hexanes, eluent 
5% EtOAc in Hexanes) provided 2.22a. 
 
(S,E)-Methyl 2-((4-methoxyphenyl)amino)-2,5-diphenylpent-4-enoate (2.23). 
Following the modified procedure previously reported by the Grotjahn group for alkene 
isomerization71: An NMR tube equipped with a J Young valve that was kept in an 120 °C 
oven overnight was brought into the glovebox. 2.02b (40 mg, 0.09 mmol, 70% ee) was 
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added to the tube via a d6-acetone solution (0.3 M). The Grotjahn catalyst93 (3 mg, 0.005 
mmol) was added via a d6-acetone solution (0.02 M). The NMR tube was sealed and 
brought out of the glovebox and put under argon via a three-way adapter, allowing for 
addition of a TFA/D2O solution in d6-acetone (0.01 mmol of TFA, 0.51 mmol of D2O in 
100 µL d6-acetone, sparged after preparation). The NMR tube was sealed, removed from 
argon and put in a 70 °C oil bath. The reaction was monitored by 1H NMR every 4-5 h. 
After 24 h no more product was formed, the reaction was transferred with EtOAc, 
concentrated, passed through Celite with EtOAc and concentrated in vacuo. The resultant 
residue was subjected to chromatography (7% EtOAc in Hexanes) affording 2.23 (26 mg) 
in 74% yield: 1H NMR (500 MHz, CDCl3) δ 7.65 (d, J = 8.0 Hz, 2H), 7.39 (t, J = 7.5 Hz, 
2H), 7.34-7.20 (m, 6H), 6.65 (d, J = 9 Hz, 2H), 6.38 (d, J = 9 Hz, 2H), 6.32 (d, J = 15.9 
Hz, 1H), 6.02 (dt, J = 15.8, 7.2 Hz, 1H), 5.00 (b, 1H), 3.70 (s, 3H), 3.69 (s, 3H), 3.36 (d, 
J = 7.4 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 174.0, 152.5, 140.9, 138.5, 137.3, 134.3, 
134.5, 128.8, 128.6, 127.8, 127.5, 127.2, 126.4, 123.9, 117.2, 114.6, 67.2, 55.7, 53.1, 
37.6; IR (film) 3403, 1733, 1513, 1447, 1239 cm-1; HRMS (ESI) calcd for C25H26NO3 
[M+H]+ m/z = 388.1913; found 388.1911; [α]24D = -61.0 (c 0.67, 70% ee, CH2Cl2); 
 
(S,E)-Methyl 2-amino-2,5-diphenylpent-4-enoate (2.17a). General procedure B was 
followed using 2.23 (22 mg, 0.056 mmol) in MeCN (6.3 mL) and ceric ammonium 
nitrate (94 mg, 0.17 mmol) in H2O (3.1 mL). The mixture was allowed to warm to 
                                                
93) The Grotjahn Catalyst, CAS: 930601-66-4, is available from Strem Chemicals, Inc., but was 
generously provided by the Grotjahn group.  
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ambient temperature; it went from yellow to blue then purple at rt. The reaction was 
stirred for 30 min at rt then cooled to 0 °C and quenched. The resulting residue was 
purified by chromatography (pre-washed SiO2 with 3% NEt3 in Hexanes, eluent 40% 
EtOAc in Hexanes) providing product 2.17a (8.7 mg) in 55% yield. 1H NMR (500 MHz, 
CDCl3) δ 7.56 (d, J = 8 Hz, 2H), 7.38 (t, J = 7.6 Hz, 2H), 7.33-7.27 (m, 5H), 7.24-7.20 
(m, 1H), 6.54 (d, J = 15.9 Hz), 6.12-6.06 (m, 1H), 3.75 (s, 3H), 3.14 (dd, J = 13.6, 6.8 
Hz, 1H), 2.79 (dd, J = 13.8, 8.1 Hz, 1H), 2.00 (b, 2H); 13C NMR (125 MHz, CDCl3) δ 
175.8, 142.9, 137.1, 135.1, 128.7, 128.7, 127.8, 127.6, 126.4, 125.5, 124.4, 63.8, 52.8, 
44.2; IR (film) 3387, 3323, 3026, 2951, 1731, 1447, 1435, 1214 cm-1; HRMS (ESI) calcd 
for C18H20NO2 [M+H]+ m/z = 282.1494; found 282.1493; [α]25D = -31.3 (c 0.44, 70% ee, 
CH2Cl2). 
 
(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-5-(naphthalene-2-yl)-2-
phenylpent-4-enoate (2.02h). General Procedure C: 2nd Generation, Hoveyda-Grubbs 
catalyst (HG-II) (6.0 mg, 0.0096 mmol) was added to a flame dried 8 mL microwave vial 
equipped with stir bar in the glove box. 2-Vinylnaphthalene (22 mg, 0.15 mmol) was 
added followed by 2.02d (20 mg, 0.048 mmol) in 1,2-dichloroethane (482 µL). The vial 
was sealed with a Teflon cap, taken out of the glovebox, placed in a 70 °C oil bath and 
stirred for 20 h. The mixture was cooled, passed through SiO2 with 30% EtOAc in 
Hexanes, and concentrated in vacuo. Purification by column chromatography (pre-wash 
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SiO2 with 5% NEt3 in hexanes, eluent 7% EtOAc in hexanes) provided 2.02h (15 mg) in 
68% yield as a yellow oil: 1H NMR (500 MHz, CDCl3) δ 7.72 (dd, J = 12.0, 4.0 Hz, 2H), 
7.66 (d, J = 8.6 Hz, 1H), 7.48 (d, J = 7.7 Hz, 2H), 7.42-7.33 (m, 5H), 7.29 (t, J = 8.0 Hz, 
2H), 7.16 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 6.02 (d, J = 16.0 Hz, 1H), 5.84 
(dt, J = 16.0, 7.1 Hz, 1H), 3.88 (s, 3H), 3.83 (s, 3H), 3.08-3.01 (m, 1H), 2.98-2.92 (m, 
1H), 2.66 (dd, J = 14.0, 7.2 Hz, 1H), 2.47 (dd, J = 13.6, 7.5 Hz, 1H), 0.82 (t, J = 7.0 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 173.4, 157.9, 141.6, 139.2, 135.4, 133.7, 133.1, 
132.7, 131.3, 128.0, 127.9 (3), 127.7, 127.4, 126.6, 126.2, 125.6, 125.5, 123.7, 113.9, 
75.2, 55.5, 51.5, 46.7, 44.6, 14.7; IR (film) 2924, 2853, 1725, 1507 cm-1; HRMS (ESI) 
calcd for C31H32NO3 [M+H]+ m/z = 466.2382; found 466.2399; [α]25D = +125.5 (c 0.21, 
81% ee, CH2Cl2). 
 
(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-5-(4-(tert-butoxy)phenyl)-2-
phenylpent-4-enoate (2.02i). General procedure C was followed using 2.02d (20 mg, 
0.048 mmol, 88% ee), 4-tert-butoxystyrene (85 mg, 0.48 mmol) and HG-II (6.0 mg, 
0.0096 mmol) in toluene (482 µL) at 90 °C for 20 h. Purification by column 
chromatography (pre-wash SiO2 with 5% NEt3 in hexanes, eluent 3% acetone in hexanes) 
provided 2.02i (17 mg) in 74% yield as a yellow oil: 1H NMR (500 MHz, CDCl3) δ 7.47 
(d, J = 7.4 Hz, 2H), 7.35 (t, J = 7.1 Hz, 2H), 7.29 (d, J = 7.0 Hz, 1H), 7.14 (d, J = 8.8 Hz, 
2H), 6.97 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.8 Hz, 2H), 6.82 (d, J = 8.4 Hz, 2H), 5.86 (d, 
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J = 15.7 Hz, 1H), 5.58 (dt, J = 15.9, 7.3 Hz, 1H), 3.86 (s, 3H), 3.82 (s, 3H), 3.06-2.99 (m, 
1H), 2.96-2.91 (m, 1H), 2.60 (dd, J = 13.9, 7.4 Hz, 1H), 2.41 (dd, J = 13.9, 7.4 Hz, 1H), 
1.31 (s, 9H), 0.81 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 173.2, 157.8, 154.5, 
141.6, 139.1, 133.2, 132.4, 131.3, 127.9, 127.8, 127.3, 126.5, 124.7, 124.1, 113.8, 78.6, 
75.1, 55.5, 51.5, 46.6, 44.3, 29.0, 14.7; IR (film) 2975, 2855, 1725, 1604, 1507, 1241, 
1162 cm-1; HRMS (ESI) calcd for C31H38NO4 [M+H]+ m/z = 488.2801; found 488.2811; 
[α]25D = +170.1 (c 0.13, 88% ee, CH2Cl2). 
 
(S,E)-Dimethyl 5-(N-ethyl-N-(4-methoxyphenyl)amino)-5-phenylhex-2-enedioate 
(2.02j). General procedure C was followed using 2.02d (20 mg, 0.048 mmol), methyl 
acrylate (42 mg, 0.48 mmol) and HG-II (6.0 mg, 0.0096 mmol) in toluene (482 µL) at 90 
°C for 20 h. Purification by column chromatography (pre-wash SiO2 with 5% NEt3 in 
hexanes, eluent 3% acetone in hexanes) provided 2.02j (14 mg) in 72% yield as a yellow 
oil: 1H NMR (500 MHz, CDCl3) δ 7.39 (d, J =7.5 Hz, 2H), 7.34 (t, J = 7.4 Hz, 2H), 7.28 
(t, J = 7.2 Hz, 1H), 7.10 (d, J = 8.9 Hz, 2H), 6.86 (d, J = 8.9 Hz, 2H), 6.61-6.55 (m, 1H), 
5.32 (d, J = 16.5 Hz, 1H), 3.88 (s, 3H), 3.81 (s, 3H), 3.60 (s, 3H), 3.05-2.98 (m, 1H), 
2.95-2.88 (m, 1H), 2.57 (ddd, J = 14.5, 7.3, 0.6 Hz, 1H), 2.43 (ddd, J = 14.4, 7.6, 0.6 Hz, 
1H), 0.79 (t, J = 7.0 Hz, 3H);13C NMR (125 MHz, CDCl3) δ 173.2, 166.8, 158.1, 145.1, 
140.9, 138.9, 131.2, 128.2, 127.7, 127.4, 123.2, 114.0, 74.5, 55.5, 51.7, 51.4, 46.8, 43.7, 
14.7; IR (film) 2951, 2855, 1724, 1655, 1508, 1245, 1035 cm-1; HRMS (ESI) calcd for 
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C23H28NO5 [M+H]+ m/z = 398.1967; found 398.1963; [α]20D = +107.2 (c 0.13, 88 % ee, 
CH2Cl2). 
 
(S,E)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-2-phenylpent-4-enoate (2.02f). 
General procedure C was followed using 2.02d (20 mg, 0.0482 mmol) and HG-II (8.2 
mg, 0.0096 mmol) in dichloroethane (482 µL) and the following modification: ethylene 
gas was sparged through the flask for 10 min and then subjected to µW (100 W, 100 psi, 
90 °C) conditions for 30 min. The mixture was cooled and ethyl vinyl ether (50 µL, 0.523 
mmol) was added and stirred for 30 min. The mixture was passed through SiO2 with 30% 
EtOAc in hexanes and concentrated in vacuo. Purification by column chromatography 
(pre-wash SiO2 with 5% NEt3 in hexanes, eluent 5% EtOAc in hexanes) provided 2.02f 
(3.9 mg) in 24% yield (spectral data agreed with our previous report55) with unreacted 
2.02d (15 mg, 0.036 mmol) recovered.  
 
(S)-Methyl 2-(N-ethyl-N-(4-methoxyphenyl)amino)-5-(4-(tert-butoxy)phenyl)-2-
phenylpentanoate (2.29). General procedure A was followed using 2.02i (17 mg, 0.035 
mmol), 10% Pd/C (3.7 mg, 0.0035 mmol) and EtOAc (1.1 mL). Purification by column 
chromatography (10% EtOAc in Hexanes) provided 2.29 (14.4 mg) in 85% yield as a 
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colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.43 (d, J = 7.7 Hz, 2H), 7.34 (t, J = 7.2 Hz, 
2H), 7.28 (d, J = 7.3 Hz, 1H), 7.07 (d, J = 8.6 Hz, 2H), 6.84 (d, J  = 8.6 Hz, 2H), 6.77 (b, 
4H), 3.83 (s, 3H), 3.01-2.83 (m, 2H), 2.25-2.19 (m, 1H), 2.15-2.09 (m, 1H), 1.72-1.66 
(m, 1H), 1.56-1.50 (m, 1H), 1.29 (s, 9H), 1.28-1.25 (b, 2H); 13C NMR (125 MHz, CDCl3) 
δ 173.5, 157.8, 153.1, 141.9, 139.3, 137.3, 131.1, 128.6, 127.9, 127.8, 127.1, 124.0, 
113.8, 78.1, 74.5, 55.5, 51.3, 46.6, 40.1, 35.5, 29.0, 26.6, 14.7; IR (film) 3337, 2974, 
2930, 1724, 1507, 1241, 1162 cm-1; HRMS (ESI) calcd for C31H40NO4 [M+H]+ m/z = 
490.2957; found 490.2947; [α]25D = +67.9 (c 0.11, 88% ee, CH2Cl2). 
 
(S)-Methyl 2-(ethylamino)-5-(4-(tert-butoxy)phenyl)-2-phenylpentanoate (2.30). 
General procedure B was followed using a solution of 2.29 (15 mg, 0.031 mmol) in 
MeCN (618 µL) and ceric ammonium nitrate (51 mg, 0.092 mmol) in H2O (309 µL). The 
mixture was allowed to warm to ambient temperature, stirred for 45 min, cooled to 0 °C 
and quenched. Purification by column chromatography (5% to 30% EtOAc in Hexanes) 
provided 2.30 (7.5 mg) in 64% yield as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 
7.41 (d, J = 8.4 Hz, 2H), 7.31 (t, J = 7.5 Hz, 2H), 7.27-7.25 (m, 1H), 6.99 (d, J = 8.5 Hz, 
2H), 6.86 (d, J = 8.4 Hz, 2H), 3.66 (s, 3H), 2.52 (t, J = 7.5 Hz, 2H), 2.32-2.24 (m, 2H), 
2.18-2.12 (m, 1H), 2.06-1.97 (m, 1H), 1.54-1.39 (m, 2H), 1.31 (s, 9H), 1.09 (t, J = 7.1 
Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 175.8, 153.2, 142.0 (b), 137.3, 128.8, 128.4, 
127.4, 126.2, 124.2, 78.2, 68.4, 52.4, 37.6, 35.3, 34.4, 29.0, 25.0, 15.8; IR (film) 2965, 
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2928, 1733, 1607, 1505, 1234 cm-1; HRMS (ESI) calcd for C24H34NO3 [M+H]+ m/z = 
384.2539; found 384.2547; [α]24D = -1.5 (c 0.36, 88% ee, CH2Cl2). 
 
(S)-Methyl 1-(N-(4-methoxyphenyl))-2-phenyl-3,6,7-hexahydro-1H-azepine-2-
carboxylate (2.31). General procedure D: A 8 mL microwave vial equipped with stir 
bar was flamed dried under vacuum. The flask was sealed with a septa, put under argon, 
and catalyst HG-II (2.82 mg, 0.003 mmol) and 2.02b (29 mg, 0.066 mmol, 81% ee) in 
toluene (6 mL) were added. The septa was replaced with a microwave cap and the vial 
was subjected to µW (100 W, 100 psi, 115 °C) conditions for 1 h. The mixture was 
allowed to cool to ambient temperature and ethyl vinyl ether (75 uL, 0.784 mmol) was 
added and allowed to stir for 30 min to quench catalyst HG-II. Upon completion, the 
mixture was passed through SiO2 with 30% EtOAc in Hexanes, concentrated in vacuo 
and chromatographed (pre-wash SiO2 with 5% NEt3 in Hexanes, eluent 5% EtOAc in 
Hexanes) to provide 2.31 (23 mg) in >98% yield as a light yellow oil: 1H NMR (500 
MHz, CDCl3) δ 7.56 (d, J = 7.6 Hz, 2H), 7.27-7.24 (m, 2H), 7.21-7.18 (m, 1H), 6.63-6.61 
(m, 2H), 6.56-6.54 (m, 2H), 5.72-5.68 (m, 1H), 5.41-5.37 (m, 1H), 4.11-4.05 (m, 1H), 
3.90-3.85 (m, 1H), 3.68  (s, 3H), 3.63 (s, 3H), 3.23 (dd, J = 15.8, 6.2 Hz, 1H), 2.88 (dd, J 
= 16.0, 6.7 Hz, 1H), 2.67-2.55 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 175.2, 152.0, 
143.6, 141.3, 131.4, 128.2, 127.8, 126.9, 123.3, 118.0, 113.8, 74.6, 55.6, 52.3, 47.8, 40.6, 
32.9; IR (film) 2949, 1729, 1512, 1246, 1037 cm-1; HRMS (ESI) calcd for C21H24NO3 
[M+H]+ m/z = 338.1756; found 338.1755; [α]25D = +37.9 (c 0.25, 81% ee, CH2Cl2). 
N PMP
Ph O
MeO
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(S)-Methyl 1-(N-(4-methoxyphenyl))-2-phenylazepane-2-carboxylate (2.32). General 
procedure A was followed using 2.31 (0.033 M ethyl acetate solution, 0.20 mmol) and 
10% Pd/C (22 mg, 0.020 mmol). Purification by column chromatography (pre-wash SiO2 
with 3% NEt3 in Hexanes, eluent 6% EtOAc in Hexanes) provided 2.32 (55 mg) in 81% 
yield as a white solid. Trituration of 2.32 in CH2Cl2 provided undissolved white solid that 
was close to racemic and liquid that had enhanced ee to 98%. The liquid was 
concentrated and recrystallized from Et2O via slow evaporation over 24 h. mp (98% ee 
material) = 113-110 °C.  1H NMR (500 MHz, CDCl3) δ 7.47 (d, J = 7.6 Hz, 2H), 7.29-
7.26 (m, 2H), 7.22 (t, J = 7.1 Hz, 1H), 6.65-6.63 (m, 2H), 6.54-6.52 (m, 2H), 3.75-3.70 
(m, 4H), 3.59 (s, 3H), 3.53 (dd, J = 15.6, 8.8 Hz, 1H), 2.61 (dd, J = 15.4, 8.9 Hz, 1H), 
2.08 (dd, J = 15.1, 10 Hz, 1H), 1.96-1.93 (b, 1H), 1.88-1.84 (b, 2H), 1.72-1.69 (b, 1H), 
1.63-1.60 (b, 1H), 1.50-1.41 (b, 1H); 13C NMR (125 MHz, CDCl3) δ 175.4, 151.8, 145.1, 
141.1, 128.8, 127.9, 126.9, 117.0, 113.8, 72.2, 55.7, 52.4, 51.6, 44.8, 31.0, 29.7, 23.6; IR 
(film) 2929, 2855, 1731, 1511, 1246, 1222, 1036, 823 cm-1; HRMS (ESI) calcd for 
C21H26NO3 [M+H]+ m/z = 340.1913; found 340.1926; [α]25D = -7.1 (c 0.34, 98% ee, 
CH2Cl2).  
 
(S,Z)-Methyl 1-(N-(4-methoxyphenyl))-2-phenyl-3,6,7,8-octahydro-1H-azocine-2-
carboxylate (2.33). General procedure D was followed using 2.02c (30 mg, 0.066 mmol) 
N PMP
Ph O
MeO
N PMP
Ph OMe
O
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and HG-II (2.82 mg, 0.003 mmol) in toluene (6 mL). Purification by column 
chromatography (pre-wash SiO2 with 5% NEt3 in hexanes, eluent 5% EtOAc in Hexanes) 
provided 2.33 (22 mg) in 95% yield as a light yellow oil: 1H NMR (500 MHz, CDCl3) δ 
7.54 (d, J = 8.34 Hz, 2H), 7.29-7.26 (m, 2H), 7.20 (t, J = 7.0 Hz, 1H), 6.83 (d, J = 8.8 Hz, 
2H), 6.70 (d, J = 8.3 Hz, 2H), 5.92-5.87 (m, 1H), 5.72-5.67 (m, 1H), 3.72 (s, 3H), 3.60-
3.50 (m, 1H), 3.43 (s, 3H), 3.35-3.30 (m, 2H), 3.27-3.15 (b, 1H), 2.11-2.03 (m, 1H), 2.03-
1.93 (b, 1H), 1.92-1.77 (b, 1H), 1.58-1.44 (b, 1H); 13C NMR (125 MHz, CDCl3) δ 174.2, 
152.7, 142.5, 140.7, 132.9, 128.8, 128.0, 127.5, 127.4, 121.1 (b), 113.7, 75.4, 55.5, 52.4, 
48.3, 33.6, 29.1, 24.1; IR (film) 3021, 2860, 1728, 1511, 1244, 1038 cm-1; HRMS (ESI) 
calcd for C22H26NO3 [M+H]+ m/z = 352.1913; found 352.1923; [α]24D = -1.03 (c 0.33,  
83% ee, CH2Cl2). 
 
(S,Z)-Methyl 2-phenyl-3,6,7,8-octahydro-1H-azocine-2-carboxylate (2.34). General 
procedure B was followed using 2.33 (10 mg, 0.029 mmol), CAN (50 mg, 0.086 mmol), 
MeCN (3.2 mL) and H2O (1.6 mL). The mixture was allowed to stir at ambient 
temperature for 15 min then cooled to 0 °C and quenched. Purification by column 
chromatography (pre-wash SiO2 with 3% NEt3 in Hexanes, eluent 5% to 30% EtOAc in 
Hexanes) provided 2.34 (4 mg) in 59% yield as a yellow oil. The reaction did not scale 
up well so it was more effective to run multiple reactions with the scale indicated above 
side-by-side and then combine the material for purification. 1H NMR (500 MHz, CDCl3) 
δ 7.55 (d, J = 7.8 Hz, 2H), 7.34 (t, J = 7.7 Hz, 2H), 7.28-7.27 (m, 1H), 5.98-5.93 (m, 1H), 
5.55-5.50 (m, 1H), 3.67 (s, 3H), 3.06-3.01 (m, 1H), 2.87-2.78 (b, 1H), 2.76-2.72 (m, 1H), 
N H
Ph OMe
O
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2.69-2.57 (b, 1H), 2.22-2.15 (m, 2H), 1.69-1.63 (m, 1H), 1.60-1.51 (m, 1H), 1.3 (b, 1H); 
13C NMR (125 MHz, CDCl3) δ 175.0, 142.3, 134.3, 128.5, 127.6, 126.8, 126.3, 70.0, 
52.6, 44.5, 35.0, 32.2, 26.0; IR (film) 3419, 2924, 1731, 1645, 1220, 1032 cm-1; HRMS 
(ESI) calcd for C15H20NO2 [M+H]+ m/z = 246.1494; found 246.1497; [α]25D = -4.8 (c 
0.09, 90% ee, CH2Cl2).  
 
(S)-Methyl 1-iodo-3-phenyloctahydro-1H-pyrrolizine-3-carboxylate (2.35). A 
solution of 2.34 (23 mg, 0.094 mmol) in CH2Cl2 (1 mL) open to air was cooled to 0 °C in 
a flame dried 5 mL round bottom flask equipped with stirbar. NIS (freshly recrystallized 
from dichloromethane, 42 mg, 0.19 mmol) was added. The mixture was warmed to 
ambient temperature and stirred for 1.5 h. At 0 °C, the mixture was quenched with 500 
µL of 10% aq Na2S2O3. The mixture was diluted with H2O (5 mL) and extracted with 
EtOAc (3 x 10 mL). The combined organic phases were dried over Na2SO4, filtered and 
concentrated in vacuo. Purification by column chromatography (pre-wash SiO2 with 5% 
NEt3 in hexanes, gradient eluent 5% to 30% EtOAc in hexanes) provided 2.35 (23 mg) in 
67% yield as a light yellow oil: 1H NMR (500 MHz, CDCl3) δ 7.44 (d, J = 7.0 Hz, 2H), 
7.36-7.30 (m, 3H), 4.27 (ddd, J = 14, 7.5, 6.5 Hz, 1H, C1-H), 3.65 (s, 3H), 3.60-3.52 (b, 
1H, C8-H), 3.16 (dd, J = 12.3, 6.1 Hz, 1H, C2-Ha), 2.88-2.80 (b, 1H, C5-Ha), 2.58 (t, J = 
12.0 Hz, 1H, C2-Hb), 2.14-2.09 (m, 2H, C7-Ha, C5-Hb), 1.87-1.71 (m, 3H, C7-Hb, C6-Ha, 
C6-Hb); 13C NMR (125 MHz, CDCl3) δ 173.8, 137.4, 128.6, 128.2, 127.6, 77.2, 66.2, 
58.1, 53.2, 52.2, 42.1, 36.7, 25.5; IR (film) 2949, 2868, 1741, 1725, 1448, 1251 cm-1; 
2
35
6
7 8
N
Ph
IH
1
O
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HRMS (ESI) calcd for C15H19NO2I [M+H]+ m/z = 372.0461; found 372.0450; [α]25D = 
+8.2 (c 0.58, 90% ee, CH2Cl2). 
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3.  THE DEVELOPMENT OF THE ASYMMETRIC SPIROCYCLIZATION OF 
ALLENYL KETONES WITH A CHIRAL LEWIS ACID LIBRARY  
3.1. REACTION DEVELOPMENT WITH HIGH-THROUGHPUT 
EXPERIMENTATION 
Chemical methods development has increasingly relied on systematic evaluation 
of catalysts and other variables including solvent, temperature, and supporting ligands. 
High-throughput experimentation (HTE) is an important tool to expedite this process by 
quickly screening conditions and identifying important trends. In 2010, the Penn Merck 
High-Throughput Experimentation Center was established. Our research group has 
increasingly used the HTE Center to support reaction development (Figure 3.1).55,94  
 
Figure 3.1 Reaction development with the aid of HTE. 
We primarily use HTE when a reaction is established and ligand, temperature, 
solvent and additives are explored for reaction optimization. An alternative use of HTE 
would be to identify a class of catalysts and test it on many reactions. This route has been 
successfully applied for selective-oxidative homo-coupling of phenols by my co-worker 
                                                
94) Walvoord, R. R.; Berritt, S.; Kozlowski, M. C. “Palladium-Catalyzed Nitromethylation of Aryl 
Halides: An Orthogonal Formylation Equivalent” Org. Lett. 2012, 14, 4086-4089.  
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Young Eun Lee (Figure 3.2).95 Few non-enzymatic catalytic systems have been reported 
for the oxidative coupling of phenols but many exist for 2-naphthols. Selective phenol 
coupling is challenging especially compared to 2-naphthol coupling because phenols are 
not oxidized as easily and a diverse product mixture is typically seen because of the 
similar stabilities of the different radical resonance forms.  
 
Figure 3.2 Selective phenol coupling (Ref. 95). 
Young and co-workers developed a catalyst library consisting of 72 different 
catalysts (Figure 3.2, left) and desired to establish conditions for selective formation of 
each of the four possible homo-coupling isomers (Figure 3.2, right). The additional 
variables of solvent and additives as well as second-generation catalysts would have 
resulted in an insurmountable number of reactions to conduct at the bench, but HTE 
enabled this challenging problem to be solved. 
This original work from our group has inspired the exploration of other catalyst 
libraries to enable reaction development. Ongoing efforts include the high-throughput 
synthesis of novel, achiral mono-phosphine ligands, and chiral, enantioenriched 
                                                
95) Lee, Y. E.; Cao, T.; Toruellas, C.; Kozlowski, M. C. “Selective Oxidative Homo- and Cross-Coupling 
of Phenols with Aerobic Catalysts” J. Am. Chem. Soc. 2014, 136, 6782-6785.  
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hydrogen-bond catalysts.96 A catalyst library of chiral Lewis acids was envisioned that 
could be synthesized and screened with various reactants.  
 
3.2. CHIRAL LEWIS ACIDS 
3.2.1. Background 
In the Encyclopedia of Reagents for Organic Synthesis edited by Paquette, the 
reagent function index lists the metals in Figure 3.3 as being used as Lewis acid 
reagents.97 Since Paquette’s publication, Re, Ru, Au, Ga, In, Sc and other lanthanides can 
be added to this diverse group of elements. Classically, Friedel-Crafts reactions, ene 
reactions, Diels-Alder reactions, and Mukaiyama-aldol syntheses are catalyzed with 
Lewis acids such as AlCl3, TiCl4, BF3•OEt2 or SnCl4. With the advent of chiral ligands, a 
Lewis acid can exhibit substantial new reactivity with profound stereoselectivity. Thus, 
metal ligand tuning is the most essential component in the design of chiral Lewis acid 
reagents.98  
                                                
96) The phosphine ligand library is being developed by Houng Kang and the hydrogen-bond catalyst 
library by Alison E. Metz.  
97) Paquette, L. A. (ed.) Encyclopedia of Reagents for Organic Synthesis, John Wiley & Sons, Chichester, 
New York, Brisbane, Toronto, Singapore, 1995.   
98) Yamamoto, H. (ed.) Lewis Acid Reagents A Practical Approach, Oxford University Press Inc., New 
York, 1999.   
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Figure 3.3 Known Lewis acidic elements (Ref. 97). 
Lewis acid reagents can react in two distinct modes (Figure 3.4). Mode A involves 
the complex between substrate and Lewis acid to rearrange to produce the product. An 
example of Mode A is the Claisen rearrangement. Mode B involves the formation of a 
stable complex from Lewis acid and substrate; this complex can react with a variety of 
reagents from outside the system to form the product. An example of Mode B is the 
intermolecular Diels-Alder reaction.  
 
Figure 3.4 Modes of reactivity for Lewis acid reagents.  
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 An in-depth review of the literature on asymmetric transformations of Mode B 
reveals a considerable amount of work on reactions involving substrates with two Lewis 
basic sites. Lewis acid reagents that show a preference for two-point binding include Mg, 
Sc and late-transition metals.  
 Boron, aluminum and tin complexes with chiral, enantioenriched ligands have 
demonstrated the most promise for asymmetric transformations on substrates with a 
single Lewis basic site (Figure 3.5). 99,100,101,102,103,104,105,106,107,108,109 The catalysts shown 
have been used for Diels-Alder reactions, Mukaiyama-aldols/-1,4-additions, and Morita-
Baylis-Hilman reactions.  
                                                
99) Maruoka, K.; Itoh, T.; Shirasaka, T.; Yamamoto, H. “Asymmetric Hetero-Diels-Alder Reaction 
Catalyzed by Chiral Organoaluminum Reagent” J. Am. Chem. Soc. 1988, 110, 310-312.  
100) Ketter, A.; Glahsi, G.; Hermann, R. "Asymmetric Diels-Alder reaction of cyclopentadiene and methyl 
acrylate catalyzed by chiral Lewis acids" J. Chem. Res. (S) 1990, 9, 278-279. 
101) Corey, E. J.; Imwinkerlried, R.; Pikul, S.; Xiang, Y. B. “Practical Enantioselective Diels-Alder and 
Aldol Reactions Using a New Chiral Controller System” J. Am. Chem. Soc. 1989, 111, 5493-5495.  
102) Maruoka, K.; Saito, S.; Yamamoto, H. “Molecular Design of a Chiral Lewis Acid for the Asymmetric 
Claisen Rearrangement” J. Am. Chem. Soc. 1995, 117, 1165-1166.   
103) Mukaiyama, T.; Kobayashi, S.; Uchiro, H.; Shiina, I. “Catalytic Asymmetric Aldol Reaction of Silyl 
Enol Ethers with Aldehydes by the Use of Chiral Diamine Coordinated Tin(II) Triflate” Chem. Lett. 
1990, 129-132.  
104) Hawkins, J. M.; Loren, S. “Two-Point-Binding Asymmetric Diels-Alder Catalysts: Aromatic 
Alkyldichloroboranes” J. Am. Chem. Soc. 1991, 113, 7794-7795.  
105) Furuta, K.; Miwa, Y.; Iwanaga, K.; Yamamoto, H. “Acyloxyborane: An Activating Device for 
Carboxylic Acids” J. Am. Chem. Soc. 1988, 110, 6254-6255.  
106) Corey, E. J.; Cywin, C. L.; Roper, T. D. “Enantioselective Mukaiyama-Aldol and Aldol-
Dihydropyrone Annulation Reactions Catalyzed by a Tryptophan-Derived Oxazaborolidine” 
Tetrahedron Lett. 1992, 33, 6907-6910.  
107) Hayashi, Y.; Rohde, J. J.; Corey, E. J. “A Novel Chiral Super-Lewis Acidic Catalyst for 
Enantioselective Synthesis” J. Am. Chem. Soc. 1996, 118, 5502-5503.  
108) For Brønsted Acid assisted Lewis Acid (BLA), see: Payette, J. N.; Yamamoto, H. “Regioselective and 
Asymmetric Diels-Alder Reaction of 1- and 2-Substituted Cyclopentadienes Catalyzed by a Brønsted 
Acid Activated Chiral Oxazaborolidine” J. Am. Chem. Soc. 2007, 129, 9536-9537. For Lewis acid 
assisted Lewis Acid (LLA), see: Futatsugi, K.; Yamamoto, H. “Oxazaborolidine-Derived Lewis Acid 
Assisted Lewis Acid as a Moisture-Tolerant Catalyst for Enantioselective Diels-Alder Reactions” 
Angew. Chem., Int. Ed. 2005, 44, 1484-1487.  
109) For BLA, see: Corey, E. J.; Shibata, T.; Lee, T. W. “Asymmetric Diels-Alder Reactions Catalyzed by 
a Triflic Acid Activated Chiral Oxazaborolidine” J. Am. Chem. Soc. 2002, 124, 3808-3809. For LLA, 
see: Liu, D.; Canales, E.; Corey, E. J. “Chiral Oxazaborolidine-Aluminum Bromide Complexes Are 
Unusually Powerful and Effective Catalysts for Enantioselective Diels-Alder Reactions” J. Am. 
Chem. Soc. 2007, 129, 1498-1499.  
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Figure 3.5 Chiral Lewis acid reagents with affinity for single Lewis basic substrates. 
 Jacobsen has conducted a significant amount of work with salen ligands with Cr, 
Co, Al, Mn and Ti, including the enantioselective opening of epoxides and alkylation of 
tin-enolates.110 Evans111 and Franz112 have demonstrated that PYBOX catalysts can be 
combined with various lanthanides to catalyze nucleophilic additions to carbonyls. With 
this significant body of work, we designed a chiral Lewis acid library for monodentate 
substrates. 
 
                                                
110) (a) Schaus, S. E.; Brandes, B. D.; Larrow, J. F.; Tokunaga, M.; Hansen, K. B.; Gould, A. E.; Furrow, 
M. E.; Jacobsen, E. N. “Highly Selective Hydrolytic Kinetic Resolution of Terminal Epoxides 
Catalyzed by Chiral (salen)CoIII Complexes. Practical Synthesis of Enantioenriched Terminal 
Epoxides and 1,2-Diols” J. Am. Chem. Soc. 2002, 124, 1307-1315. (b) Doyle, A. G.; Jacobsen, E. N. 
“Enantioselective Alkylations of Tributyltin Enolates Catalyzed by Cr(salen)Cl: Access to 
Enantiomerically Enriched All-Carbon Quaternary Centers” J. Am. Chem. Soc. 2004, 127, 62-63.  
111) Evans, D. A.; Scheidt, K. A.; Fandrick, K. R.; Lam, H. W.; Wu, J. “Enantioselective Indole Friedel-
Crafts Alkylations Catalyzed by Bis(oxazolinyl)pyridine-Scandium(III) Triflate Complexes” J. Am. 
Chem. Soc. 2003, 125, 10780-10781.  
112) Gutierrez, E. G.; Wong, C. J.; Sahin, A. H.; Franz, A. K. “Enantioselective and Regioselective 
Indium(III)-Catalyzed Addition of Pyrroles to Isatins” Org. Lett. 2011, 13, 5754-5757.    
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3.2.2. Synthesis of a Chiral Lewis Acid Library  
 After a careful survey of the literature (see above), the following library was 
generated for HTE (Figure 3.6). Seven 24 well plates were obtained from 
dichloromethane solutions of oxazaborolidine (CBS), TADDOL, STIEN, PYBOX, and 
salen Lewis acid complexes. The PYBOX catalysts of Al, In, Sc and Yb were generated 
in the HTE glovebox as solutions of metal and PYBOX. Once all catalysts solutions were 
distributed onto the 24 well plates, they were concentrated, sealed with plastic mat caps 
and stored in a zip-lock bag in the glovebox.   
 
Figure 3.6 Chiral Lewis acid library for HTE. 
 
3.2.3. Intramolecular Diels-Alder Reaction of Allenylamides  
Thirty years ago, Himbert discovered the intramolecular Diels-Alder 
cycloaddition of allenylamides, permitting rapid access to strained polycyclic compounds 
(Figure 3.7).113 Ester, thioester, imide, phosphinamide, and phosphinic ester tethers can 
be used in place of the amide. Himbert published more than 20 studies on this reaction, 
                                                
113) (a) Himbert, G.; Diehl, K.; Schlindwein, H.−J. “Intramolekulare Diels-Alder-Reaktion bei 
Allencarboxaniliden; Einbau des 1-Naphthyl-Restes an Stelle monocyclischer Aromatensysteme” 
Chem. Ber. 1986, 119, 3227-3235. (b) Himbert, G.; Fink, D. “Intramolekulare Diels-Alder-Reaktion 
Bei Allencarbonsaure-Arylestern” Tetrahedron Lett. 1985, 26, 4363-4366.   
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but not until 2012 was it exploited by other scientists.114 Our laboratory was interested in 
developing an asymmetric modification of this reaction because of its ease at providing 
complex polycycles from readily available starting materials.  
 
Figure 3.7 Intramolecular Diels-Alder cycloaddition of allenylamides and allenylesters 
(Ref. 113). 
 Ryan Walvoord, a former co-worker, and Claire Gober, a visiting undergraduate, 
investigated the intramolecular Diels-Alder cycloaddition of allenylamide (3.01) and 
allenylester (3.03) with various hydrogen-bonding catalysts. Ryan and Claire found that 
bisamidinium accelerated the rate of reaction compared to thermal conditions but that no 
selectivity was observed (Scheme  3.1). This result prompted an investigation of the 
intramolecular Diels-Alder reaction of allenylamides with our chiral Lewis acid library. 
Scheme  3.1 Intramolecular Diels-Alder cycloaddition of allenylcarbonyls catalyzed by a 
hydrogen-bond catalyst.  
                                                
114) Lam, J. K.; Schmidt, Y.; Vanderwal, C. D. “Complex Polycyclic Scaffolds by Metathesis 
Rearrangement of Himbert Arene/Allene Cycloadducts” Org. Lett. 2012, 14, 5566-5569.    
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 Allenylamide (3.01) was explored with the 23 chiral Lewis acids (40 mol %) at 45 
°C for 60 h (Table 3.1). A marginal increase in P/IS was observed with (+)-Cy-salen-
CrCl (entry 9) and (-)-PYBOX-Yb(OTf)3 (entry 19) compared to the thermal background 
reaction (entry 24). (-)-Cl2Ti-TADDOLate (entry 4) and (+)-Cy-salen-CrCl (entry 9) 
were the only catalysts to provide product with enantiopurity above 5% ee.  
Table 3.1 Studies on allenylamide with the chiral Lewis acid library in HTE. 
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(S)-Phenyl-CBS
(S)-Phenyl-CBS/SnCl4
(-)-MeAl-TADDOLate
(-)-Cl2Ti-TADDOLate
(R,R)-STIEN-AlMe
(R,R)-STIEN-TiCl2
(+)-Cy-salen-AlCl
(+)-Cy-salen-Co(OAc)
(+)-Cy-salen-CrCl
(+)-Cy-salen-Cu
(+)-Cy-salen-Pd
(+)-Cy-salen-Ni
(-)-PYBOX-AlCl3
(-)-PYBOX-In(OTf)3
(-)-PYBOX-Sc(OTf)3
(-)-PYBOX-Yb(OTf)3
(-)-PYBOX-CuCl2/AgSbF6
(-)-PYBOX-PdCl2/AgSbF6
(-)-PYBOX-NiCl2/AgSbF6
(-)-PYBOX-ZnCl2/AgSbF6
No Catalyst
(+)-Cy-salen-MnCl
(+)-Cy-salen-TiCl2
(+)-Cy-salen-Zn
1.7
1.5
1.6
1.2
2.6
2.2
2.5
0.1
2.8
0.7
0.5
0.5
0.8
2.0
0.6
2.4
2.1
2.4
2.8
1.4
0.2
1.7
2.3
2.7
3.01 3.02
entry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
entry
N
O
Et
N
OEt
"Chiral Lewis Acid
Library"
ClCH2CH2Cl  (0.1 M)
45 °C, 43 h
•
*
*
3
4
4
10
1
0
4
1
6
1
2
1
3
2
2
1
2
2
2
2
0
0
1
0
aDetermined by HPLC. bDetermined by CSP-SFC AD column.
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Concurrently with our investigation, Christopher Vanderwal and Ken Houk 
published a mechanistic investigation of a similar Diels-Alder reaction.115 Their results 
reveal the concerted [4+2] cycloaddition competes with a stepwise, radical type 
mechanism (Figure 3.8). In the concerted mechanism, substitution at the α-carbon 
increases the rate of the reaction; presumably it forces the β,γ-anti-bonding orbitals of the 
allene to overlap better with the diene in the aromatic ring. The β,γ-anti-bonding orbitals 
of the allene are nearly unaffected by Lewis acid coordination of the carbonyl oxygen. 
We reasoned that to induce high stereoselectivity, we would need to design a catalyst that 
interacts with the allene π-bonds rather than the carbonyl oxygen, such as gold or 
mercury. This endeavor has not been explored.  
 
Figure 3.8 Vanderwal and Houk concerted and stepwise radical mechanism (Ref. 115).  
The initial screen of the chiral Lewis acid library for Diels-Alder reactions 
revealed that allenyl carbonyls were only weakly activated. However, Jacobsen and co-
workers have detailed some very elegant work for the synthesis of sesquiterpene 
skeletons from various acrylates by the use of transannular intramolecular Diels-Alder 
                                                
115) Schmidt, Y.; Lam, J. K.; Pham, H. V.; Houk, K. N.; Vanderwal, C. D. “Studies on the Himbert 
Intramolecular Arene/Allene Diels-Alder Cycloaddition. Mechanistic Studies and Expansion of Scope 
to All-Carbon Tethers” J. Am. Chem. Soc. 2013, 135, 7339-7348.  
N
O
N
O
•
*
Me
Me
Me
Me
diradical spirocycle
formation N
O
Me
MeH
diradical ring
closure
concerted cycloaddition
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reaction.116 This information prompted our review of 1,4-additions to allenyl carbonyls 
and inspired our interest in the spirocyclization of allenyl ketones.  
 
3.3. ASYMMETRIC SPIROCYCLIZATION OF ALLENYL KETONES 
3.3.1. Background on the Intramolecular Spirocyclization of Allenyl ketones 
  In 1995, Nagao and co-workers discovered a novel dearomatization 
spirocyclization of allenyl ketones catalyzed by strong Lewis acids (BF3•OEt2 or ZnI2)  
(Scheme  3.2, left).117 The aromatic ring had to be sufficiently rich for the reaction to be 
successful; the mono-methoxy substrate produced the spirocyclic product in 8% yield. 
Hashmi and co-workers followed up on this work in 1998 with a catalytic variant using 
Hg(ClO4)2 and H2O (Scheme  3.2, right).118 The mono-methoxy substrate was successful 
in forming the spirocycle with these conditions. Hashmi proposed that the soft-
nucleophile Hg activates the allene π-bond via a mercurinium intermediate.  
Scheme  3.2 Previous work on the Lewis acid catalyzed spirocyclization of allenyl 
ketones. 
 
                                                
116) Balskus, E. P.; Jacobsen, E. N. “Asymmetric Catalysis of the Transannular Diels-Alder Reaction” 
Science 2007, 317, 1736-1740. 
117) Nagao, Y.; Lee, W. S.; Jeong, I.−Y.; Shiro, M. “New Intramolecular Spiro-Endo-Mode Ring Closure 
of Allenyl (Methoxy-Substituted Phenyl)alkyl Ketones” Tetrahedron Lett. 1995, 36, 2799-2802.  
118) Hashmi, A. S. K.; Schwarz, L.; Bolte, M. “Mercury(II)-Catalyzed Synthesis of 
Spiro[4.5]decatrienediones in the Presence of Water” Tetrahedron Lett. 1998, 39, 8969-8972.   
Hg(ClO4)2,  (1 mol %)
H2O (2 equiv)
80%
O
CH3
O
MeO/H
O
OMe
MeO •
O
OMe
MeO/H •
BF3•OEt2 or ZnI2 
(1.1 equiv)
62-83%
CH2Cl2. 
-78 → 0 °C, 2 h
MeCN 
rt, 2 h
a. Nagao, 1995 b. Hashmi, 1998
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The spirocycle generated from the work by Nagao and Hashmi is present in many 
natural products, such as the sesquiterpenes of the vetivone and acorenone classes (Figure 
3.9). The challenge in the synthesis of enantioenriched spirocyclic natural products is the 
efficient assembly of the stereogenic spiro carbon center in a stereoselective manner. The 
many interesting natural products that exist with the spirocyclic skeleton have led to 
extensive efforts to solve this synthetic problem.119  
 
Figure 3.9 Natural products with a spirocyclic framework.  
 We envisioned that we could investigate the spirocyclization of allenyl ketones 
utilizing our chiral Lewis acid library (Figure 3.10).120 If conditions were found that were 
successful in generating the spirocycle product in high ee, then we could access various 
natural products (see above).    
                                                
119) For reviews on spirocyclization reactions, see: (a) Rios, R. “Enantioselective methodologies for the 
synthesis of spiro compounds” Chem. Soc. Rev. 2012, 41, 1060-1074. (b) Pradhan, R.; Patra, M.; 
Behera, A. K.; Mishra, B. K.; Behera, R. J. “A synthon approach to spiro compounds” Tetrahedron 
2006, 62, 779-828.  (c) Sannigrahi, M. “Stereocontrolled Synthesis of Spirocyclics” Tetrahedron 
1999, 55, 9007-9071. (d) Krapcho, A. P. “Synthesis of Carbocyclic Spiro Compounds via 
Intramolecular Alkylation Routes” Synthesis 1974, 383-419.  
120) My co-worker, Alison E. Metz, investigated the spirocyclization reaction with hydrogen-bond 
catalysts and found that bisamidinum (20 mol %) catalyzed the reaction (81% conv at 50 °C for 5 h) 
but that no selectivity was observed.  
O
Spirodionic Acidβ-vetivone Acorenone B
HO2C O
O
O
Spirolaurenone
Br
O
MeN
HO
(-)-Sibirine
Cl
Br
OH
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Figure 3.10 Proposed asymmetric spirocyclization of allenyl ketones by chiral Lewis 
acid reagents.  
 
3.3.2. Results on the Spirocyclization of Allenyl Ketones 
High-throughput experimentation (HTE) was used to investigate 2,4-dimethoxy 
allenyl ketone (3.05) with the chiral Lewis acid library (40 mol %) at rt for 4 h (Table 
3.2). The activated CBS catalysts, as well as Sc(OTf)3 and Yb(OTf)3 with the PYBOX 
ligand were the most active catalysts for product formation (entries 1-2 and 18-19).  To 
our surprise, aluminum and titanium catalysts were only weakly active for catalyzing 
formation of the spiro product (entries 3-7, 11, 16), but (R,R)-STIEN-AlMe did provide 
the best selectivity (entry 5). Late-transition metals were not strong enough Lewis acids 
to catalyze formation of product (entries 12-15, 20-22).    
Table 3.2 HTE on 2,4-dimethoxy allenyl ketone with the chiral Lewis acid library.  
∗
O
OR2
R1 •
O
OR2
R1
LA* O
CH3
O
R1
Chiral 
Lewis Acid
 
 
117 
 
 The catalysts that formed the spiro product from the HTE screen with measurable 
enantioselectivity were validated at bench top scale (Table 3.3). CBS and Sc(OTf)3 were 
the best catalysts for generating product (entries 1 and 4) but only the CBS catalyst 
combined good conversion with high selectivity. Disappointingly, (R,R)-STIEN-AlMe at 
bench top scale gave considerably lower selectivity than on the microscale (entry 2). 
Potentially, the catalyst is not stable and degraded over time, but conversion did remain 
consistent. The CBS catalyst class was chosen for further exploration.  
Table 3.3 Bench-top scale of the HTE leads. 
O
CH3
O
MeO
O
OMe
MeO • "Chiral Lewis Acid
Library"
ClCH2CH2Cl (0.1 M)
rt, 4 h
catalyst (40 mol %) P/ISa ee (%)b catalyst (40 mol %) P/ISa ee (%)b
(S)-Methyl-CBS/SnCl4
No Catalyst
3.05 3.06
entry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
entry
∗
4.1
22.9
0.0
0.3
1.8
1.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
1.6
9.0
3.8
0.2
0.0
0.0
1.7
0.0
76
NDc
87
ND
-
-
-
-
-
-
-
-
-
ND
ND
17
49
ND
-
-
2
-
14
-
aDetermined by HPLC. bDetermined by CSP-SFC AD column. cND = not determined.
(S)-Phenyl-CBS/SnCl4
(-)-MeAl-TADDOLate
(-)-Cl2Ti-TADDOLate
(R,R)-STIEN-AlMe
(R,R)-STIEN-TiCl2
(+)-Cy-salen-AlCl
(+)-Cy-salen-Co(OAc)
(+)-Cy-salen-CrCl
(+)-Cy-salen-Cu
(+)-Cy-salen-Pd
(+)-Cy-salen-Ni
(-)-PYBOX-AlCl3
(-)-PYBOX-In(OTf)3
(-)-PYBOX-Sc(OTf)3
(-)-PYBOX-Yb(OTf)3
(-)-PYBOX-CuCl2/AgSbF6
(-)-PYBOX-PdCl2/AgSbF6
(-)-PYBOX-NiCl2/AgSbF6
(-)-PYBOX-ZnCl2/AgSbF6
(+)-Cy-salen-MnCl
(+)-Cy-salen-TiCl2
(+)-Cy-salen-Zn
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Lewis acid assisted Lewis acids (LLA) with oxazborolidine type catalysts were 
first discovered by Yamamoto108b and Corey.109b The Lewis basic nitrogen on the 
oxazborolidine coordinates to the Lewis acid activator (e.g., SnCl4 or AlBr3), which 
enhances the Lewis acidity of the boron, enabling coordination to various Lewis bases. A 
quantum chemical study by Sakata and Fujimoto support this mode of reactivity for 
oxazborolidine catalysts with AlBr3.121 This hypothesis was tested experimentally with 
allenyl ketone (3.05); upon removal of SnCl4 from the (S)-phenyl-CBS catalyst, no spiro 
product was observed (Table 3.4, entry 1). Notably, SnCl4 (100 mol %) in the absence of 
the CBS catalyst provided the spiro product in 95% yield.   
Lewis and Brønsted acids were explored with (S)-Phenyl-CBS and allenyl ketone 
(3.05) (Table 3.4). In Yamamoto’s seminal publication, various Lewis acids (AlCl3, 
Et2AlCl, FeCl3, Sc(OTf)3, Sn(Cl4), [CpTiCl3], and TiCl4) were efficient activators for the 
LLA catalyzed Diels-Alder reaction between cyclopentadiene and methacrolein.108b This 
trend was in contrast to our observations with allenyl ketone (3.05); SnCl4, TiCl4 and 
TMSOTf with (S)-phenyl-CBS were the only catalysts that provided spirocyclic product 
                                                
121) Sakata, K.; Fujimoto, H. “Quantum Chemical Study of Diels-Alder Reactions Catalyzed by Lewis 
Acid Activated Oxazaborolidines” J. Org. Chem. 2013, 78, 3095-3103.    
O
CH3
O
MeO
O
OMe
MeO •
"Chiral Lewis Acid"
ClCH2CH2Cl (0.1 M)
rt, 20 h
catalyst (40 mol %) conv (%)a ee (%)b catalyst (40 mol %) conv (%)a ee (%)b
(S)-Phenyl-CBS/SnCl4
(R,R)-STIEN-AlMe
100c
15
23
50
0
66
18
2
2
-
3.05 3.06
entry
1
2
3
4
5
entry
(R,R)-STIEN-TiCl2
(-)-PYBOX-Sc(OTf)3
(-)-PYBOX-Yb(OTf)3
∗
aDetermined from 1H NMR. bDetermined by CSP-HPLC. cRxn time was 4 h instead of 20 h.
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3.06 (Table 3.4, entries 2, 6 and 8). Brønsted acid activation of (S)-phenyl-CBS did not 
provide the spirocycle product; rather, decomposition was observed with no starting 
material remaining after 4 h (Table 3.4, entries 11-12).   
Table 3.4 Screen of Lewis and Brønsted acid assisted CBS catalysts for spirocyclization. 
 
 The selectivity of the CBS/SnCl4 catalyzed spirocycle formation from allenyl 
ketone (3.05) was enhanced when the boron substituent was changed from methyl to 
phenyl (see Table 3.2, entries 1-2). (S)-o-Tolyl-CBS and (S)-naphthyl-CBS with SnCl4 
both improved the selectivity of the spirocycle product from 66 to 72% but yield was 
reduced.  
Scheme  3.3 Exploration of (S)-aryl-CBS catalyst with SnCl4.   
MeO
OMe
O
O
MeO CH3
O
*
•
catalyst activator conv (%)a ee (%)b
SnCl4
AlCl3
FeCl3
Sc(OTf)3
TiCl4
89% yc,d
0
0
>90
>90
66
-
-
0
62
N B
O
Ph
Ph
H
Ph
Acid (40 mol %)
MeO
OMe
OB
+
O
N
Ph
Ph Ph
H
A
+
_
_
Tf2NH
TsOH decomp
decomp
-
-
ClCH2CH2Cl
rt, 20 h
catalyst activator conv (%)a ee (%)bentryentry
1
2
3
4
5
6
9
10
(50 mol %)
3.05 3.06
7
8
11
TMSOTfe
MeIe
TMSCle
47% yd
0
0
45
-
-
BBr3 0 -none 0 -
12
aDetermined from 1H NMR. bDetermined by CSP-HPLC. cRxn time was 4 h instead of 20 h.
disolated by column chromatography. eRxns were performed by Sergei Tcyrulnikov.
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 Throughout the development of the asymmetric spirocyclization of allenyl ketone 
(3.05), it was not readily apparent how catalytic turnover was occurring. The catalyst 
activates the ketone to form an allylic carbocation (3.07a), promoting a Friedel-Crafts 
1,4-addition to produce 3.07b (Table 3.5, top). The CBS-enolate complex (3.07b) is 
likely more stable than the CBS-ketone (3.07a) and for the CBS/SnCl4 catalyst to be 
regenerated the enolate would need to undergo protonation (Table 3.5, top). Ostensibly, 
adventitious water in the solvent permitted the observed catalyst turnover. However, 
addition of 3 Å molecular sieves with catalyst (50 mol %) still provided similar amounts 
of product (86% NMR yield, 70% ee).  
 We envisioned that catalyst loading could be reduced from 50 mol % to 10 mol % 
if a proton source was added to the reaction conditions.122 In 1999, Evans and co-workers 
had found the selectivity for the Cu(II) bisoxazoline catalyzed addition of enolsilanes to 
unsaturated ester derivatives was improved with the addition of i-PrOH.123 In 2002, 
Harada and co-workers had similar problems with catalyst turnover in a Mukaiyama-1,4- 
                                                
122) Yamamoto had found in ref. 109b that the oxazaborolidine/SnCl4 complex was relatively stable to wet 
solvents.    
123) Evans, D. A.; Willis, M. C.; Johnston, J. J. “Catalytic Enantioselective Michael Additions to 
Unsaturated Ester Derivatives Using Chiral Copper(II) Lewis Acid Complexes” Org. Lett. 1999, 1, 
865-868.  
N B
O
Ph
Ph
H
Me
N B
O
Ph
Ph
H
(S)-o-tolyl-CBS (S)-naphthyl-CBS
O
CH3
O
MeO
O
OMe
MeO •
CBS catalyst (50 mol %)
SnCl4 (40 mol %)
ClCH2CH2Cl  (0.1 M)
rt, 15 h
3.05 3.06
∗
46%, 72% ee 40%, 72% ee
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addition and found that 2,6-diisopropylphenol was required.124 Proton sources were 
explored with the (S)-phenyl-CBS/SnCl4 and allenyl ketone (3.05) (Table 3.5). H2O, 
MeOH and i-PrOH not only reduced yield, but the spiro product produced was less 
enantiopure (Table 3.5, entries 1-3). These disappointing results prompted the exploration 
of oxophilic electrophiles by my co-worker Sergei Tcyrulnikov. Sergei found that 
TMSOTf, TMSCl and MeI did not improve the reaction yield or selectivity (Table 3.5, 
entries 4-6). 
Table 3.5 Additives for catalyst turnover.  
 
 We have utilized a chiral Lewis acid library in HTE to find conditions for the first 
asymmetric spirocyclization of allenyl ketones. However, the challenges encountered 
with catalyst turnover prompted us to reexamine our hypothesis that the enantioenriched 
spirocycle product could be formed from the allenyl ketone (3.05) with a sub-
stoichiometric amount of a chiral Lewis acid. To date, the only successful formation of 
                                                
124) Harada, T.; Iwai, H.; Takatsuki, H.; Fujita, K.; Kubo, M.; Oku, A. “Asymmetric Mukaiyama-Michael 
Addition of Acyclic Enones Catalyzed by allo-Threonine-Derived B-Aryloxazaborolidinones” Org. 
Lett. 2001, 3, 2101-2103.  
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+
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3.05
3.07a 3.07b
3.06
proton source (1 equiv) yield (%)a ee (%)b
H2O
MeOH
i-PrOHc
TMSOTf
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29
37
27
33
5334
50
5
57
57
MeI 32 58
oxophilic electrophile (1 equiv)c yield (%)a ee (%)bentryentry
1
2
3
4
5
6
SnCl4 (40 mol %)
ClCH2CH2Cl (0.1 M)
rt, 20 h
(50 mol %)
aIsolated by column chromatography. bDetermined by CSP-HPLC. cRxns were performed by Sergei Tcyrulnikov.
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the spirocycle product with sub-stoichiometric amount of a catalyst was Hashmi and co-
workers with Hg(OCl4)2 and H2O (see Scheme  3.2). Inspired by the various accounts on 
Mukaiyama-aldol reactions, we proposed that modification of the phenol protecting 
group from a methyl to silyl, would permit turnover of the CBS catalyst by means of silyl 
migration to the newly formed enolate.  
 
3.3.3. Asymmetric Spirocyclization of 2-TBSO,4-MeO-Allenyl Ketone 
 Multiple examples in the literature have demonstrated that Mukaiyama-aldol/-1,4-
additions can be catalyzed by oxazaborolidines with high enantioselctivity.106,124 Notably, 
the corresponding para-TBSO-allenyl ketone (3.08) cyclizes to the spiro product in good 
yield with a mercury catalyst (Scheme  3.4).118  
Scheme  3.4 Spirocyclization of 4-TBSO-allenyl ketone with Hg(ClO4)2 (Ref. 118) 
 
 The results of the CBS catalyst in the Mukiayama-1,4-addition and the work by 
Hashmi inspired our proposal for catalyst turnover (Figure 3.11). The CBS/LA complex 
bound to the enolate (3.11b) can be displaced by a silyl migration to provide the enol-
silane (3.12) and regeneration of the CBS/LA complex. This would be the first example 
of ortho-quinone formation from spirocyclization of an allenyl ketone.  
Hg(ClO4)2,  (1 mol %)
H2O (2 equiv)
84%
O
CH3
O
O
OTBS
•
MeCN 
rt, 2 h
3.08 3.09
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Figure 3.11 Proposal for ortho-quinone formation by pseudo Mukiayama-1,4-addition.  
 This hypothesis was explored with allenyl ketone (3.13) and various CBS 
catalysts (Scheme  3.5). The yield and selectivity with the ortho-TBSO with the (S)-
phenyl-CBS catalyst was similar to that observed with the 2,4-dimethoxy allenyl ketone 
(c.f., Table 3.4). The yield and selectivity improved when (S)-naphthyl-CBS was used 
(96%, 72% ee); however, these conditions at cooler temperatures did not result in 
improved selectivity.  
Scheme  3.5 Exploration of (S)-aryl-CBS with SnCl4 to catalyze formation of ortho-
quinone. 
 
 In 1990, Mukaiyama disclosed the first asymmetric addition of enol-silane to 
aldehydes catalyzed by Sn(II) chiral diamine complexes.103 They found that slow addition 
of aldehyde was very important for high yield and selectivity because catalyst turnover 
was sluggish and TMSOTf generated from the Sn(OTf)2 over the course of the reaction 
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provided racemic product. Harada observed a similar result; slow addition of the 
electrophile and a bulky proton source was necessary for high yield and selectivity.124 
These experiments could potentially improve the results observed in Scheme  3.5. 
 Current efforts in developing catalytic conditions for the asymmetric 
spirocyclization of 2-TBSO,4-MeO-allenyl ketone are being investigated by my co-
worker Sergei Tcyrulnikov. Sergei is exploring computationally the transition states for 
the CBS-SnCl4 complex catalyzing spirocyclization. These results will hopefully aid in 
overcoming challenges with catalyst turnover and selectivity.  
 
3.4. CONCLUSIONS 
  In summary, we have synthesized a chiral Lewis acid library to be utilized in 
HTE for the development of asymmetric transformations. This library was used to 
explore the intramolecular Diels-Alder reaction of allenylamides and the spirocyclization 
of allenyl ketones. We have developed the first asymmetric spirocyclization of allenyl 
ketones using a Lewis acid assisted Lewis acid catalyst system, which was determined 
from HTE. Through protecting group manipulation on the allenyl ketone, the para-
quinone and ortho-quinone can be accessed. This orthogonality allows access to the 
spirocyclic core of various natural products. Challenges were incurred with catalyst 
turnover and future efforts will focus on finding conditions that promote turnover and 
improve selectivity.   
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3.5. EXPERIMENTAL SECTION 
General Considerations 
 All non-aqueous reactions were carried out under an atmosphere of dry argon 
unless otherwise noted. Commercial reagents were used as received without additional 
purification unless otherwise noted. Dichloromethane and 1,2-dichloroethane were 
distilled from CaH2, and toluene was distilled from metallic sodium prior to use. 
Reactions were monitored by thin layer chromatography (TLC) using Silicycle glass-
backed TLC plates with 250 µm silica and F254 indicator. Visualization was 
accomplished by UV light and/or KMnO4.  
1H NMR and 13C NMR spectra were recorded on a AM-500 Fourier transform 
NMR spectrometer at 500 MHz and 125 MHz, respectively.  Chemical shifts are reported 
relative to the solvent resonance peak δ 7.26 (CDCl3) for 1H and δ 77.16 (CDCl3) for 13C.  
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, b = broad singlet, m = multiplet), coupling constants, and number of 
protons.  High resolution mass spectra were obtained using a VG autospec with an 
ionization mode of either ESI or CI.  Infrared spectra are reported in cm-1. Melting points 
are uncorrected. Unless otherwise noted, yields refer to isolated material on the basis of 
product purity (≥95%) by 1H NMR following silica gel chromatography with Silica-P 
flash silica gel (50-63 µm mesh particle size). Enantiomeric excess was determined 
utilizing chiral stationary phase (CSP) HPLC or SFC on OD [cellulose tris(3,5-
dimethylphenylcarbamate) coated on silica gel] 0.46 cm x 25 cm or IA [amylose tris(3,5-
dimethylphenylcarbamate) immobilized on silica gel] 0.46 cm x 25 cm columns. 
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Synthesis of chiral Lewis acids:  
CBS catalysts (Figure 3.12, C2 and C3) were purchased from Strem Chemicals 
Inc. The (-)-IndaPYBOX ligand was synthesized following a known procedure.112 The 
following catalysts (Figure 3.12) for the chiral Lewis acid plate were made following 
known procedures: A1125, A2110a, A3126, A4127, A5128, A6129, B1130, B2131, B3131, B4132, 
B5132, B6132, C1132, C4133, C5134, C6133, D1134, D2112, D3112, D4112, and D5112.  
Preparation of chiral Lewis acid 24-well plate for HTE: 
Solutions of A1-D1 (0.04 M solution in 1,2-dichloroethane) were prepared in a 
glovebox and allowed to stir at ambient temperature for 30 min. The solutions were 
                                                
125) Duxbury, J. P.; Warne, J. N. D.; Mushtaq, R.; Ward, C.; Thornton-Pett, M.; Jiang, M.; Greatrex, R.; 
Kee, T. P. “Phospho-Aldol Catalysis via Chiral Schiff Base Complexes of Aluminum” 
Organometallics 2000, 19, 4445-4457.  
126) Martinez, L. E.; Leighton, J. L.; Carsten, D. H.; Jacobsen, E. N. “Highly Enantioselective Ring 
Opening of Epoxides Catalyzed by (salen)Cr(III) Complexes” J. Am. Chem. Soc. 1995, 117, 5897-
5898.  
127) Larrow, J. F.; Jacobsen, E. N. “A Practical Method for the Large-Scale Preparation of [N,N’-Bis(3,4-
di-tert-butylsalicylidene)-1,2-cyclohexanediaminato(2-)]manganese(III) Chloride, a Highly 
Enantioselective Epoxidation Catalyst” J. Org. Chem. 1994, 59, 1939-1942.  
128) Belokon, Y. N.; Caveda-Cepas, S.; Green, B.; Ikonnikov, N. S.; Khrustalev, V. N.; Larichev, V. S.; 
Moscalenko, M. A.; North, M.; Orizu, C.; Tararov, V. I.; Tasinazzo, M.; Timofeeva, G. I.; Yashkina, 
L. V. “The Asymmetric Addition of Trimethylsilyl Cyanide to Aldehydes Catalyzed by Chiral 
(Salen)Titanium Complexes” J. Am. Chem. Soc. 1999, 121, 3968-3973.   
129) Morris, G. A.; Zhou, H.; Stern, C. L.; Nguyen, S. T. “A General High-Yield Route to 
Bis(salicylaldimine) Zinc(II) Complexes: Application to the Synthesis of Pyridine-Modified Salen-
Type Zinc(II) Complexes” Inorg. Chem. 2001, 40, 3222-3227.  
130) Sabarinathan, S.; Vasuki, G.; Rao, P. S. “Chiral Cu(II) salen complexes catalyzed aerobic oxidative 
biaryl coupling-probing the reaction by EPR” Eur. J. Chem. 2010, 1, 360-367.  
131) Shimazaki, Y.; Yajima, T.; Tani, F.; Karasawa, S.; Fukui, K.; Naruta, Y.; Yamauchi, O. “Syntheses 
and Electronic Structures of One-Electron-Oxidized Group 10 Metal(II)-(Disalicylidene)diamine 
Complexes (Metal = Ni, Pd, Pt)” J. Am. Chem. Soc. 2007, 129, 2559-2568.  
132) Jiang, M.; Dalgarno, S.; Kilner, C. A.; Halcrow, M. A.; Kee, T. P. “Chiral bis(oxazoline) complexes. 
Synthesis, structure and applications in catalytic phosphor-transfer” Polyhedron 2001, 20, 2151-2162.  
133) Corey, E. J.; Sarshar, S. “X-ray Crystallographic and NMR Studies on the Origins of High 
Enantioselectivity oin Diels-Alder Reactions Catalyzed by a Chiral Diazaaluminolidine” J. Am. 
Chem. Soc. 1992, 114, 7938-7939.   
134) Seebach, D.; Plattner, D. A.; Beck, A. K.; Wang, Y. M.; Hunziker, D. “161. On the Mechanism of 
Enantioselective Reactions Using α,α,α’,α’-Tetraaryl-1,3-dioxolane-4,5-dimethanol(TADDOL)-
Derived Titanates: Differences between C2- and C1-Symmetrical TADDOLs-Facts, Implications and 
Generalizations)” Helv. Chim. Acta. 1992, 75, 2171-2209.  
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transferred to the corresponding vial on a 24-well reactor block (0.004 mmol, 100 µL). 
Catalysts D2-D5 were prepared in situ: AlCl3 (5.3 mg, 0.040 mmol), In(OTf)3 (22.5 mg, 
0.040 mmol), Sc(OTf)3 (19.7 mg, 0.040 mmol) or Yb(OTf)3 (24.8 mg, 0.040 mmol) was 
added to a 20 dram vial equipped with stirbar in the glovebox. (-)-IndaPYBOX (15.7 mg, 
0.040 mmol) and 1,2-dichloroethane (960 µL) were added to each vial and stirred for 2 h. 
100 µL of each catalyst (0.004 mmol) was added to the 24-well reactor block in locations 
D2-D5 respectively. 1,2-Dichloroethane was removed on the Genevac and the 24-well 
reactor block was sealed with a polypropylene 1 mL cap mat. The catalyst library (7 were 
prepared) was stored in a zip-lock bag in the glovebox 
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Figure 3.12 24 well-plate with chiral Lewis acids. 
Preparation of a racemic sample of 3.02:  
 
1-Ethyl-4,5-dihydro-5,9b-ethenobenzo[g]indol-2(1H)-one (3.02). Allenyl amide (3.01) 
(7 mg, 0.030 mmol) was added to a flame dried 8 mL microwave vial equipped with stir 
bar. 1,2-Dichloroethane (300 µL) was added. The vial was backfilled with argon, sealed 
with a Teflon cap, placed in a 45 °C oil bath and stirred for 65 h. The mixture was 
allowed to cool to ambient temperature and purified directly by column chromatography 
(40% EtOAc in Hexanes) providing 3.02 (6.7 mg) in 96% yield: 1H NMR (500 MHz, 
CDCl3) δ 7.29-7.25 (m, 2H), 7.19 (t, J = 2.3 Hz, 2H), 6.70 (dd, J = 8.3, 6.3 Hz, 1H), 6.53 
(d, J = 7.8 Hz, 1H), 5.80 (t, J = 1.9 Hz, 1H), 4.36-4.29 (m, 1H), 4.20-4.05 (m, 1H), 3.78-
3.63 (m, 1H), 2.57 (dt, J = 17.2, 2.0 Hz, 1H), 2.41 (dt, J = 17.2, 2.0 Hz, 1H), 1.51 (t, J = 
7.1 Hz, 3H). Spectroscopic data match those reported in the literature.113a 
High-Throughput Experimentation with Allenyl Amide (Table 3.1) 
 
 A 24-well reactor equipped with 1 mL vials was pre-dosed with the chiral Lewis 
acids (0.004 mmol) described above with the following modification: (S)-phenyl-CBS 
was substituted for (S)-methyl-CBS in well C2. A solution of AgSbF6 (0.008 mmol, 32 
N
OEt
3.01 3.02
N
O
Et
N
OEt
"Chiral Lewis Acid
Library"
ClCH2CH2Cl (0.1 M)
45 °C, 43 h
•
*
*
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µL of a 0.25 M solution in CH2Cl2) was added to wells B4-C1. A solution of SnCl4 
(0.002 mmol, 16 µL of a 0.13 M solution in CH2Cl2) was added to well C3. A parylene 
stir-bar was added to each vial. The reactor block was sealed, removed from the glovebox 
and heated to 40 °C for 45 minutes on an Alligator tumble stirrer (1000 rpm). The reactor 
block was brought into the glovebox after cooling to ambient temperature and 1,2-
dichloroethane (50 µL) was added to wells A1-D6. A solution of 3.01 (0.010 mmol, 50 
µL of a 0.2 M solution in 1,2-dichloroethane) was added to wells A1-D6. The reactor 
block was sealed, removed from the glove box and heated to 45 °C for 43 h on an 
Alligator tumble stirrer (1200 rpm). After cooling to ambient temperature, the reactions 
were quenched via dilution with a solution of internal standard in 25% DMSO/MeCN 
(1.4 µmol, 0.002 M, 700 µL), and the contents were stirred for 15 minutes. Into a 
separate 96-well plate LC block was added 700 µL of MeCN and 25 µL of the diluted 
reaction mixtures. The 96-well plate LC block was sealed with a polypropylene 1 mL cap 
mat. The reaction mixtures were analyzed using an Agilent Technologies 1200 series 
HPLC with a 96 well-plate auto-sampler. Assay conditions: C18 column with reverse 
phase eluents (MeCN and 0.1 % H3PO4 in H2O). 1.8 mL/min; 10% in MeCN to 95% 
MeCN in 6 min, hold for 2 min. Post time 2 min. Column at 40 °C; 210 nm. The reaction 
mixtures were analyzed for enantiopurity with supercritical fluid chromatography (SFC) 
(AD column, 1.8 mL/min, 5% MeOH/CO2, 120 bar, 220 nm): tR of 3.02: 6.5 min and 7.7 
min.   
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High-Throughput Experimentation with Allenyl Ketone (Table 3.2) 
 
A 24-well reactor equipped with 1 mL vials was pre-dosed with the chiral Lewis 
acids (0.004 mmol) described above. A solution of AgSbF6 (0.008 mmol, 25 µL of a 0.32 
M solution in CH2Cl2) was added to wells B4-C1. A solution of SnCl4 (0.002 mmol, 25 
µL of a 0.08 M solution in CH2Cl2) was added to well C2-C3. A parylene stir-bar was 
added to each vial. The reactor block was sealed, removed from the glovebox and stirred 
for 45 minutes on an Alligator tumble stirrer (1000 rpm). The reactor block was brought 
into the glovebox after cooling to ambient temperature and 1,2-dichloroethane (50 µL) 
was added to wells A1-D6. A solution of 3.05 (0.010 mmol, 50 µL of a 0.2 M solution in 
1,2-dichloroethane) was added to wells A1-D6. The reactor block was sealed, removed 
catalyst (40 mol %) P/IS ee (%) catalyst (40 mol %) P/IS ee (%)
(S)-phenyl-CBS
(S)-phenyl-CBS/SnCl4
(-)-MeAl-TADDOLate
(-)-Cl2Ti-TADDOLate
(R,R)-STIEN-AlMe
(R,R)-STIEN-TiCl2
(+)-Cy-salen-AlCl
(+)-Cy-salen-Co(OAc)
(+)-Cy-salen-CrCl
(+)-Cy-salen-Cu
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(+)-Cy-salen-Ni
(-)-PYBOX-AlCl3
(-)-PYBOX-In(OTf)3
(-)-PYBOX-Sc(OTf)3
(-)-PYBOX-Yb(OTf)3
(-)-PYBOX-CuCl2/AgSbF6
(-)-PYBOX-PdCl2/AgSbF6
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1.7
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0
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0
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from the glove box and stirred for 43 h on an Alligator tumble stirrer (1200 rpm). The 
reactions were quenched via dilution with a solution of internal standard in 25% 
DMSO/MeCN (1.0 µmol, 0.002 M, 500 µL), and the contents were stirred for 15 
minutes. Into a separate 96-well plate LC block was added 700 µL of MeCN and 25 µL 
of the diluted reaction mixtures. The 96-well plate LC block was sealed with a 
polypropylene 1 mL cap mat. The reaction mixtures were analyzed (SM/IS and P/IS) 
using an Agilent Technologies 1200 series HPLC with a 96 well-plate auto-sampler. 
Assay conditions: C18 column with reverse phase eluents (MeCN and 0.1 % H3PO4 in 
H2O); 1.8 mL/min; 10 % in MeCN to 95 % MeCN in 6 min, hold for 2 min. Post time 2 
min. Column at 40 °C; 210 nm. Select reaction mixtures (C1-C4 and D4-D5) were 
analyzed for enantiopurity with supercritical fluid chromatography (SFC) (AD column, 
1.8 mL/min, 5% MeOH/CO2, 120 bar, 220 nm): tR of 3.06: 13.0 and 15.5 min.    
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6-Methoxy-4-methylspiro[4.5]deca-3,6,9-triene-2,8-dione (3.06). General Procedure 
A: (S)-Phenyl-CBS catalyst (11.7 mg, 0.035 mmol) was added to a flame dried 8 mL 
microwave vial equipped with stir bar in the glovebox. The vial was sealed with a Teflon 
cap, taken out of the glovebox, put under an argon atmosphere and dissolved in 1,2-
dichloroethane (416 µL). A solution of SnCl4 (0.028 mmol, 100 µL of a 0.28 M solution 
in CH2Cl2/1,2-dichloroethane) was added and the mixture was allowed to stir for 30 
minutes. Allenyl ketone (3.05) (0.069 mmol, 200 µL of a 0.35 M solution in 1,2-
dichloroethane) was added to the reaction mixture and stirred for an additional 4 h. The 
resultant reaction mixture was diluted with CH2Cl2 (5 mL), quenched with 1 M HCl (5 
mL), and extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were washed 
with brine, dried over Na2SO4, filtered and concentrated in vacuo. Purification by column 
chromatography (20% EtOAc in hexanes to 80% EtOAc in hexanes) provided 3.06 (12.4 
mg) in 89% yield: 1H NMR (500 MHz, CDCl3) δ 6.37 (d, J = 9.8 Hz, 1H), 6.33 (dd, J = 
9.8, 1.0 Hz, 1H), 6.17 (d, J = 1.0 Hz, 1H), 5.75 (s, 1H), 3.73 (s, 3H), 2.84 (d, J = 18.4 Hz, 
1H), 2.47 (d, J = 18.4 Hz, 1H), 1.84 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 205.4, 187.5, 
176.0, 173.5, 145.6, 133.0, 129.7, 104.3, 56.3, 54.4, 45.2, 15.0; chiral HPLC (OD 
column, 70:30 hexanes:i-PrOH, 0.8 mL/min, 220 nm): tR of 3.06: 17.3 min and 20.8 min. 
Spectroscopic data match those reported in the literature.117  
Preparation of a racemic sample of 3.06. 
O
CH3
O
MeO ∗
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Allenyl ketone (3.05) (0.032 mmol, 320 µL of a 0.1 M solution in CH2Cl2) was 
added to a flame dried 8 mL microwave vial equipped with stir bar under argon and 
placed in a 0 °C ice bath. SnCl4 (0.032 mmol, 32 µL of a 1.0 M solution in CH2Cl2) was 
added dropwise. The mixture was allowed to warm to ambient temperature and stirred for 
1 h. The resultant reaction mixture was diluted with CH2Cl2 (5 mL), quenched with 1 M 
HCl (5 mL), and extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were 
washed with brine, dried over Na2SO4, filtered and concentrated in vacuo providing 3.06 
(6.8 mg) in 98% yield.  
Bench-top scale of the HTE leads (Table 3.3) 
 (R,R)-STIEN-AlMe (9.5 mg, 0.0184 mmol) or (R,R)-STIEN-TiCl2 (10.9 mg, 
0.018 mmol) were added to a flame dried 8 mL microwave vial equipped with a stir bar, 
dissolved in 1,2-dichloroethane (230 µL), sealed with a Teflon cap, removed from the 
glovebox and put under an argon atmosphere. A solution of 3.05 (0.046 mmol, 230 µL of 
a 0.2 M solution in 1,2-dichloroethane) was added to the reaction mixture and stirred for 
20 h. The products were isolated following general procedure A.  
PYBOX-Sc(OTf)3 and PYBOX-Yb(OTf)3 were made in situ: indaPYBOX (7.6 
mg, 0.019 mmol) and Sc(OTf)3 (9.1 mg, 0.018 mmol) or Yb(OTf)3 (11.4 mg, 0.018 
mmol) were added to a flame dried 8 mL microwave vial equipped with stir bar, 
dissolved in 1,2-dichloroethane (230 µL), sealed with a Teflon cap, removed from the 
glovebox and placed in a 50 °C oil bath for 10 min, allowed to cool to ambient 
temperature and stirred for an additional 2 h. A solution of 3.05 (0.046 mmol, 230 µL of 
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a 0.2 M solution in 1,2-dichloroethane) was added to each reaction mixture and allowed 
to stir for 20 h. The products were isolated following general procedure A.  
Screen of Lewis and Brønsted acid assisted CBS catalysts for spirocyclization (Table 
3.4). 
General procedure A was followed using (S)-phenyl-CBS (7.8 mg, 0.023 mmol) 
and designated Lewis/Brønsted acid (0.018 mmol) in 1,2-dichloroethane (230 µL). 
Addition of 3.05 (0.046 mmol, 20 µL of a 0.2 M solution in 1,2-dichloroethane) was 
done at 0 °C. The mixture was allowed to warm to ambient temperature and stirred for 20 
h. My co-worker Sergei Tcyrulnikov conducted the experiments using TMSOTf, TMSCl 
and MeI.   
Exploration of (S)-aryl-CBS catalyst with SnCl4  (Scheme  3.3). 
(S)-o-Tolyl-CBS was purchased from Sigma-Aldrich but was impure and not 
suitable for use. (S)-o-Tolyl-CBS (0.023 mmol, 451 µL of a 0.05 M solution in toluene) 
and (S)-naphthyl-CBS (0.023 mmol, 230 µL of a 0.1 M solution in toluene) were both 
synthesized by known procedures109a,135 General procedure A was followed using SnCl4 
(0.018 mmol, 18 µL of a 1 M solution in CH2Cl2). Addition of 3.05 (0.046 mmol,  110 
µL of 0.48 M solution in 1,2-dichloroethane) was done at 0 °C, allowed to warm to 
ambient temperature and stirred for 16 h.   
Additives for catalyst turnover (Table 3.5). 
                                                
135) Lee, S. I.; Jang, J. H.; Hwang, G.−S.; Ryu, D. H. “Asymmetric Synthesis of α-Alkylidene-β-hydroxy-
γ-butyrolactones via Enantioselectivity Tandem Michael-Aldol Reaction” J. Org. Chem. 2013, 78, 
770-775.  
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General procedure A was followed using (S)-phenyl-CBS (11.5 mg, 0.034 mmol) 
dissolved in 1,2-dichloroethane (200 µL) and SnCl4 (0.028 mmol, 125 µL of a 0.2 M 
solution in CH2Cl2/1,2-dichloroethane). After the reaction mixture stirred for 30 minutes, 
3.05 (0.069 mmol, 165 µL 0.4 M solution in 1,2-dichloroethane) was added, followed by 
the indicated additive (0.069 mmol). The reaction mixture was stirred for 4 h with H2O 
and MeOH. My co-worker Sergei Tcyrulnikov conducted the experiments using iPr-OH, 
TMSOTf, TMSCl and MeI following the above procedure but allowing the reaction 
mixture to stir for 15 h, 4 h, 1 h and 15 h, respectively.  
 
8-Methoxy-4-methylspiro[4.5]deca-3,7,9-triene-2,6-dione (3.14). General procedure A 
was followed using (S)-naphthyl-CBS (0.016 mmol, 320 µL of a 0.05 M solution in 
toluene) and SnCl4 (0.013 mmol, 113 µL of a 0.12 M solution in CH2Cl2/1,2-
dichloroethane). After the reaction mixture stirred for 1 h, 3.13 (0.033 mmol, 150 µL of a 
0.22 M solution in 1,2-dichloroethane) was added and allowed to stir for 5 h. Purification 
by column chromatography (20% EtOAc in Hexanes to 80% EtOAc in Hexanes) 
provided 3.14 (6.4 mg) in 96% yield: 1H NMR (500 MHz, CDCl3) δ 6.31 (dd J = 9.9, 2.0 
Hz, 1H), 6.21 (d, J = 9.8 Hz, 1H), 6.12 (d, J = 2.0, 1H), 5.60 (s, 1H), 3.82 (s, 3H), 2.80 
(d, J = 18.1 Hz, 1H), 2.36 (d, J = 18.1 Hz, 1H), 1.86 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 206.8, 198.5, 176.4, 172.3, 143.1, 132.5, 123.3, 100.7, 60.9, 56.3, 47.1, 15.5; IR 
(film) 2925, 2854, 1721, 1693, 1652, 1622, 1571 cm-1; HRMS (ESI) calcd for C12H13O3 
O
CH3
OMe
O
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[M+H]+ m/z = 205.0865; found 205.0873; chiral HPLC (IA, 90:10 hexanes:i-PrOH, 0.8 
mL/min, 220 nm): tR of 3.14: 22.89 min (major) and 24.71 min (minor). 
Preparation of a racemic sample of 3.14: 
Allenyl ketone (3.13) (0.021 mmol, 60 µL of a 0.33 M solution in CH2Cl2) was 
added to a flame dried 8 mL microwave vial equipped with stir bar under argon and 
placed in a -10 °C NaCl ice bath. BF3•OEt2 (0.025 mmol, 60 µL of a 0.47 M solution in 
CH2Cl2) was added dropwise. The mixture was allowed to warm to 0 °C and stirred for 1 
h. The resultant reaction mixture was diluted with CH2Cl2 (5 mL), quenched with 1 M 
HCl (5 mL), and extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were 
washed with brine, dried over Na2SO4, filtered and concentrated in vacuo. Purification by 
column chromatography (20% EtOAc in hexanes to 80% EtOAc in hexanes) provided 
3.14 (4.3 mg) in 86% yield. 
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4. CHEMOSELECTIVE ACTIVATION OF C(sp3)−H BOND OVER C(sp2)−H 
BOND WITH Pd(II) 
4.1. BACKGROUND 
4.1.1. C−H Activation 
The ability of metals, and particularly Pd catalysts, to insert selectively into C–H 
bonds has provided a host of new, useful methods for the construction of organic 
structure.136 C–H Activation is highly significant because additional steps to preactivate a 
center for a bond construction (e.g., halogenation) can be avoided, thereby increasing 
efficiency by reducing step-count and decreasing waste streams.  
Cross dehydrogenative coupling (CDC) is the ideal reaction where a C–H from 
each of the two reacting partners is selectively removed, accompanied by an oxidative 
fragment union, and much progress in this area has been made to date.137 In this strategy, 
directing groups commonly play a key role by coordinating substrate to the catalyst, thus 
lowering the energy barrier for C−H bond functionalization.138 Although advances with 
metal catalysts in alkyl C−H activation at unactivated positions have been reported, much 
                                                
136) (a) Alberico, D.; Scott, M. E.; Lautens, M. "Aryl-Aryl Bond Formation by Transition-Metal-
Catalyzed-Direct Arylation" Chem. Rev. 2007, 107, 174-238. (b) McGlacken, G. P.; Bateman, L. M. 
"Recent advances in aryl-aryl bond formation by direct arylation" Chem. Soc. Rev. 2009, 38, 2447-
2464. (c) Wencel-Delord, J.; Droge, T.; Liu, F.; Glorius, F. "Towards mild metal-catalyzed C-H bond 
activation" Chem. Soc. Rev. 2011, 40, 4740-4761. (d) Kuhl, N.; Hopkinson, M. N.; Wencel-Delord, 
J.; Glorius, F. "Beyond Directing Groups: Transition-Metal-Catalyzed C-H Activation of Simple 
Arenes" Angew. Chem., Int. Ed. 2012, 51, 10236-10254. 
137) (a) Yeung, C. S.; Dong, V. M. "Catalytic Dehydrogenative Cross-Coupling: Forming Carbon-Carbon 
Bonds by Oxidizing Two Carbon-Hydrogen Bonds" Chem. Rev. 2011, 111, 1215-1292. (b) Liu, C.; 
Zhang, H.; Shi, W.; Lei, A. "Bond Formations between Two Nucleophiles: Transition Metal 
Catalyzed Oxidative Cross-Coupling Reactions" Chem. Rev. 2011, 111, 1780-1824. 
138) (a) Lyons, T. W.; Sanford, M. S. "Palladium-Catalyzed Ligand-Directed C-H Functionalization 
Reactions" Chem. Rev. 2010, 110, 1147-1169. (b) Li, B.; Dixneuf, P. H. "sp2 C-H bond activation in 
water and catalytic cross-coupling reactions" Chem. Soc. Rev. 2013, 42, 5744-5767. 
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progress remains to be made, and the versatility that Pd exhibits in bond formation (C–C, 
C–N, C–O, C–F, C–F, etc.) renders it appealing for further development.139   
4.1.2. Orthogonal Reactivity of Toluene in C(sp2)−H Activation 
Toluene derivatives are stable, commercially available, and easy to handle and 
may be potentially used as a benzylation reagents. The benzyl C−H bond in toluene is 20-
30 kcal/mol weaker than the arene C−H but palladium displays a remarkable selectivity 
for C−H insertion into the C(sp2)−H bond (Figure 4.1, left).140 In fact, methyl and other 
alkyl substituents on arenes have been shown to be compatible with Pd-catalyzed 
C(sp2)−H insertion (Figure 4.1, right).141 
 
Figure 4.1 C(sp2)−H activation of toluene with Pd. 
                                                
139) For select examples of C-H activation of C(sp3)−H bonds without directing groups or pre-activation, 
see: (a) Davies, H. M. L.; Hansen, T. "Asymmetric Intermolecular Carbenoid C-H Insertions 
Catalyzed by Rhodium(II) (S)-N-(p-Dodecylphenyl)sulfonylprolinate" J. Am. Chem. Soc. 1997, 119, 
9075-9076. (b) Waltz, K. M.; Hartwig, J. F. "Functionalization of Alkanes by Isolated Transition 
Metal Boryl Complexes" J. Am. Chem. Soc. 2000, 122, 11358-11369. (c) Chen, M. S.; White, M. C. 
“A Predictably Selective Aliphatic C-H Oxidation Reaction for Complex Molecule Synthesis” 
Science 2007, 318, 783-787. 
140) Blanksby, S. J.; Ellison, G. B. Acc. Chem. Res. 2003, 36, 255.   
141) (a) Li, B.-J.; Tian, S.-L.; Fang, Z.; Shi, Z.-J. “Multiple C−H Activations to Construct Biologically 
Active Molecules in a Process Completely Free of Organohalogen and Organometallic Components” 
Angew. Chem., Int. Ed. 2008, 47, 1115-1118. (b) Potavathri, S.; Pereira, K. C.; Gorelsky, S. I.; Pike, 
A.; LeBris, A. P.; DeBoef, B. “Regioselective Oxidation Arylation of Indoles Bearing N-Alkyl 
Protecting Groups: Dual C-H Functionalization via a Concerted Metalation-Deprotonation 
Mechanism” J. Am. Chem. Soc. 2010, 132, 14676-14681  
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Presumably, favorable coordination of the palladium catalyst to the π-system of 
the arene positions the metal carboxylate for a favorable deprotonative insertion (Figure 
4.2).142  
 
Figure 4.2 C(sp2)−H vs C(sp3)−H activation of toluene with Pd. 
 
4.1.3. C(sp3)−H Activation of Toluene via Radical Pathways 
Of late, radical mediated processes for activation of toluene have shown 
considerable promise in CDC.143-146 A benzylic radical is easily formed at elevated 
temperatures with (t-BuO)2. Huang and co-workers have demonstrated that the tolyl and 
heteroatom radical can be transformed to benzylic amides and esters from CO insertion 
                                                
142) (a) Lapointe, D.; Fagnou, K. “Overview of the Mechanistic Work on the Concerted Metallation-
Deprotonation Pathway” Chem. Lett. 2010, 39, 1118-1126. (b) Balcells, D.; Clot, E.; Eisenstein, O. 
“C−H Bond Activation in Transition Metal Species from a Computational Perspective” Chem. Rev. 
2010, 110, 749-823. 
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with Pd (Figure 4.3, top).143 Powell and co-workers have successfully used Cu to catalyze 
the formation of benzylic amines (Figure 4.3, bottom).144 
 
Figure 4.3 CDC via diradical formation.  
CDC can be achieved when a toluene radical is combined with Pd catalyzed C−H 
activation. The tolyl radical formed from (t-BuO)2 can be transformed to benzaldehyde if 
exposed to air.145,146 Yin and Sun pioneered the facile ortho-acylation of acetanilides by 
combining in situ acyl radical formation with Pd catalyzed C(sp2)-H activation (Figure 
4.4).145 This reaction motif has proven to be general for toluene with various arenes 
containing directing groups such as carbamate, azoarenes and pyridine.146 
                                                
143) (a) Xie, P.; Xie, Y.; Qian, B.; Zhou, H.; Xia, C.; Huang, H. “Palladium-Catalyzed Oxidative 
Carbonylation of Benzylic C−H Bonds via Nondirected C(sp3)−H Activation” J. Am. Chem. Soc. 
2012, 134, 9902-9905. (b) Xie, P.; Xia, C.; Huang, H. “Palladium-Catalyzed Oxidative 
Aminocarbonylation: A New Entry to Amides via C−H Activation” Org. Lett. 2013, 15, 3370-3373. 
(c) Liu, H.; Laurenczy, G.; Yan, N.; Dyson, P. J. “Amide bond formation via C(sp3)-H bond 
functionalization and CO insertion” Chem. Commun. 2014, 50, 341-343. 
144) Powell, D. A.; Fan, H. “Copper-Catalyzed Amination of Primary Benzylic C−H Bonds with Primary 
and Secondary Sulfonamides” J. Org. Chem. 2010, 75, 2726-2729.  
145) Yin, Z.; Sun, P. “Palladium-Catalyzed Direct ortho-Acylation through an Oxidative Coupling of 
Acetanilides with Toluene Derivatives” J. Org. Chem. 2012, 77, 11339-11344. 
146) (a) Wu, Y.; Choy, P. Y.; Mao, F.; Kwong, F. Y. “Toluene derivatives as simple coupling precursors 
for cascade palladium-catalyzed oxidative C-H bond acylation of acetanilides” Chem. Comm. 2013, 
49, 689-691. (b) Xiong, F.; Qian, C.; Lin, D.; Zeng, W.; Lu, X. “Palladium-Catalyzed Cascade 
Oxidation/sp2 C−H Acylation of Azoarenes with Aryl Methanes” Org. Lett. 2013, 15, 5444-5447. (c) 
Xu, Z.; Xiang, B.; Sun, P. “Palladium catalyzed direct ortho C-H acylation of 2-arylpyridines using 
toluene derivatives as acylation reagents” RSC Advances 2013, 3, 1679-1682. 
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Figure 4.4 CDC via radical mediated oxidation.  
 
4.1.4. C(sp3)−H Activation of Toluene via non-Radical Processes 
Palladium catalyzed alkyl C−H activation without radicals or directing groups is 
rare.147 In 2008, Shi148 and White149 developed the regioselective C−H activation of 
allylbenzene (Figure 4.5).150 Each research group found that it was necessary to use the 
preformed 1,2-bis(benzylsulfinyl)-ethane Pd(OAc)2 complex. However, activation of 
toluene by non-radical processes is a long-standing challenge. Some success has been 
seen with ortho-directing groups on tolyl analogs.151,152 
                                                
147) For benzylation from benzyl acetates and Pd, see: (a) Trost, B. M.; Czabaniuk, L. C. “Palladium-
Catalyzed Asymmetric Benzylation of 3-Aryl Oxindoles” J. Am. Chem. Soc. 2010, 132, 15534-
15536. (b) Kuwano, R. “Catalytic Transformations of Benzylic Carboxylates and Carbonates” 
Synthesis 2009, 7, 1049-1061.   
148) Lin, S.; Song, C.-X.; Cai, G.-X.; Wang, W.-H.; Shi, Z.-J. “Intra/Intramolecular Direct Allylic 
Alkylation via Pd(II)-Catalyzed Allylic C-H Activation” J. Am. Chem. Soc. 2008, 130, 12901-12903. 
149) Young, A. J.; White, M. C. “Catalytic Intermolecular Allylic C−H Alkylation” J. Am. Chem. Soc. 
2008, 130, 14090-14091. 
150) Tang, S.; Wu, X.; Liao, W.; Liu, K.; Liu, C.; Luo, S.; Lei, A. “Synergistic Pd/Enamine Catalysis: A 
Strategy for the C−H/C−H Oxidative Coupling of Allylarenes with Unactivated Ketones” Org. Lett. 
2014, 16, 3584-3587.      
151) For seminal work on Pd catalyzed benzylic C-H activation, see: (a) Chen, X.; Goodhue, C.E.; Yu, J.-
Q. "Palladium-Catalyzed Alkylation of sp2 and sp3 C-H Bonds with Methylboroxine and 
Alkylboronic Acids: Two Distinct C-H Activation Pathways" J. Am. Chem. Soc. 2006, 128, 12634-
12635. (b) Campeau, L.-C.; Schipper, D.J.; Fagnou, K. "Site-Selective sp2 and Benzylic sp3 
Palladium-Catalyzed Direct Arylation" J. Am. Chem. Soc. 2008, 130, 3266-3267. (c) Stowers, K.J.; 
Fortner, K.C.; Sanford, M.S. "Aerobic Pd-Catalyzed sp3 C-H Olefination: A Route to Both N-
Heterocyclic Scaffolds and Alkenes" J. Am. Chem. Soc. 2011, 133, 6541-6544. 
152) For reviews on sp3 C-H activation, see: (a) Chen, X.; Engle, K.M.; Wang, D.-H.; Yu J.-Q. 
"Palladium(II)-Catalyzed C-H Activation/C-C Cross-Coupling Reactions: Versatility and Practicality" 
Angew. Chem., Int. Ed. 2009, 48, 5094-5115. (b) Baudoin, O. "Transition metal-catalyzed arylation of 
unactivated C(sp3)-H bonds" Chem. Soc. Rev. 2011, 40, 4902-4911. (c) Li, H.; Li, B.-J.; Shi, Z.-J. 
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Figure 4.5 C(sp3)−H activation of allylbenzene.  
In 2007, Lu and co-workers provided evidence that regioselective C−H activation 
of toluene was feasible (Figure 4.6).153 They found when toluene was treated with 
Pd(OAc)2 at 45 °C for prolonged reaction times that homo-sp2-sp3 coupling and homo-
sp2 coupling could be favored with either an excess (7.5 mmol) or minimal amount of 
TFA (0.5 mmol). Sterics play an important role in the regioselective coupling; 
substitution of mesitylene for toluene results in only homo-sp2-sp3 coupling. Kinetic 
isotope effect studies were inconclusive in determining if the C(sp3)−H activation was the 
rate-determining step.  
 
Figure 4.6 Regioselective C−H activation of toluene with Pd(II).   
                                                                                                                                            
"Challenges and progress: palladium-catalyzed sp3 C-H activation" Catal. Sci. Technol. 2011, 1, 191-
206. 
153) Rong, Y.; Li, R.; Lu, W. “Palladium(II)-Catalyzed Coupling of p-Xylene via Regioselective C−H 
Activation in TFA” Organometallics 2007, 26, 4376-4378. 
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The Pd catalyzed acetoxylation of toluene was developed in 1968 by Bryant.154 In 
2013, Zhang and co-workers found that this process could be improved with benzoic acid 
derivatives (Figure 4.7).155 Zhang proposes that Pd(OAc)2 can insert into the C−H bond 
of toluene, generating the Pd-benzyl intermediate and AcOH. An intermolecular attack of 
the carboxylic acid on the benzyl or reductive elimination from carboxylate ligand 
exchange on the Pd can provide the observed product. A kH/kD = 2.4 was observed for 
toluene vs d8-toluene, suggesting the C−H activation step is the RDS.  
 
Figure 4.7 Benzylation of carboxylic acids by Pd catalyzed C−H activation of toluene. 
 The work by Lu,153 Bryant154 and Zhang155 are rare examples of Pd catalyzed 
activation of toluene. In fact, toluene is considered benign in most Pd processes, and is 
often used as a reaction solvent. Our longstanding interest95,156 in metal catalyzed C−H 
activation prompted our investigation of the Pd catalyzed benzylic activation of toluene.  
 
                                                
154) Bryant, D. R.; McKeon, J. E.; Ream, B. C. “A Palladium-Catalyzed Synthesis of Benzyl Esters from 
Methylbenzenes” J. Org. Chem. 1968, 33, 4123-4127. 
155) Liu, H.; Shi, G.; Pan, S.; Jiang, Y.; Zhang, Y. “Palladium-Catalyzed Benzylation of Carboxylic Acids 
with Toluene via Benzylic C−H Activation” Org. Lett. 2013, 15, 4098-4101. 
156) Li, X.; Yang, J.; Kozlowski, M. C. “Enantioselective Oxidative Biaryl Coupling Reactions Catalyzed 
by 1,5-Diazadecalin Metal Complexes” Org. Lett. 2001, 3, 1137-1140.   
+
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4.2. RESULTS 
4.2.1.  Serendipitous Discovery 
 Initial studies on the chemoselective activation of toluene arose from a 
serendipitous discovery. In 2003, Hartwig and co-workers published the first Pd 
catalyzed α-arylation of azlactones.157 We envisioned that an asymmetric variant of this 
reaction could be achieved with the aid of high-throughput experimentation (HTE). Initial 
PME screens proved unsuccessful and led to a wider survey of non-traditional ligands 
such as alkyl phosphites and phosphoramidites. Treatment of phenylglycine azlactone 
(4.01) with the standard arylation conditions [Pd(OAc)2, P(t-Bu)3, 3-iodo-
benzotrifluoride, K2CO3 in toluene] developed by Hartwig provided the desired arylated 
azlactone (4.02) in 63% yield. However, when P(OEt)3 was substituted for P(t-Bu)3 and 
3-bromo-benzotrifluoride for 3-iodo-benzotrifluoride, the arylated product was not 
observed. After careful examination of the reaction mixture, it was found that the 
phenylglycine azlactone had undergone benzylation (4.03) in 20% yield (Scheme  4.1).  
Scheme  4.1 Unexpected benzylation of phenylglycine azlactone. 
 
 This unexpected result from modification of the Hartwig conditions was very 
intriguing. Benzylation occurred from incorporation of the solvent with the phenylglycine 
                                                
157) Liu, X.; Hartwig, J. F. “Palladium-Catalyzed α-Arylation of Azlactones to Form Quaternary Amino 
Acid Derivatives” Org. Lett. 2003, 5, 1915-1918.  
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azlactone. The conditions used were fairly common but insertion into the C−H bond of 
toluene is rare (see Sections 4.1.3. – 4.1.4.). Our initial goals were to determine which 
components of the reaction mixture were necessary for benzylation, whether the 
transformation operates with other tolyl analogs, and whether the process occurs via free-
radicals or via Pd mediated C(sp3)−H activation. 
 
4.2.2.  Optimization of Stoichiometric Pd Conditions 
 Further analysis of the original conditions found for benzylation (see Scheme  
4.1), revealed that benzylation occurred when aryl halide, phosphite and base were 
removed. This result prompted our exploration of various late-transition metals for the 
selective C(sp3)−H activation of toluene (Table 4.1). To our surprise, only Pd(II) 
provided the benzylated product (Table 4.1, entries 6 and 7). PdCl2 provided the 
phenylglycine azlactone dimer but all other Pd sources promptly caused decomposition 
of starting material (Table 4.1, entries 8-12). Palladium carboxylates have been shown to 
be very successful at C(sp2)−H activation when combined with a directing group; the 
preferential C(sp3)−H activation observed in this new technology is novel and without 
precedent.    
Table 4.1 Metal sources for C−H activation of toluene. 
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 The protecting group on the phenylglycine azlactone was modified to determine if 
electronics played an important role in this transformation (Table 4.2). Electron-rich and 
–poor phenyl protecting groups provided the benzylated product in similar yields (Table 
4.2, entries 1-3). However, when alkyl substituents were substituted for the phenyl ring, 
benzylation was either less efficient or not observed (Table 4.2, entries 4-6). With the 
CF3 protecting group, the phenylglycine azlactone dimer was not observed (Table 4.2, 
entry 6). PMP was chosen as the protecting group on phenylglycine azlactone for further 
studies because it provided the benzylation product in the highest yield and the methoxy 
substituent was easily observed in the 1H NMR.  
Table 4.2 Modification of the phenylglycine azlactone protecting group. 
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 With the goal of finding conditions that engendered suitable reactivity while 
minimizing the amount of toluene, a focused screen of co-solvents was designed (Table 
4.3). 1,4-Dioxane was identified as the optimal co-solvent for reducing toluene loading 
(80 equiv to 25 equiv) while providing the benzylation product in good conversion. 
Reduction of toluene to 10 equiv reduced the formation of the benzylated product (Table 
4.3, entries 5-7). Solvents that are strong Pd coordinators (e.g., DMSO, DMF) prevented 
benzylation entirely.  
Table 4.3 Survey of co-solvents. 
 
 
4.2.3.  Substrate Scope with Stoichiometric Pd 
 The benzylation of phenylglycine azlactone with a series of tolyl analogs under 
the optimal conditions was performed and the results are displayed in Table 4.4.158 For 
most substrates, the novel technology developed provided moderate to good yields. In 
contrast to Bryant’s results with acetoxylation of xylene isomers, the mono-benzylated 
product was the only product observed (Table 4.4, 4.09-4.11).154 This technology affords 
                                                
158) Tolyl analogs that did not provide benzylated product are detailed in the supporting information. 
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complete chemoselectivity for C(sp3)−H activation, as no arlyation of the phenylglycine 
azlactone was observed. Mesitylene only provided the benzylated product in 14% yield; 
increased temperatures and prolonged reaction times did not improve product formation 
(Table 4.4, 4.10b). Electron-rich tolyl analogs were more efficient (Table 4.4, 4.12 vs 
4.13).   
Table 4.4 C−H Activation of tolyl analogs with phenylglycine azlactone.  
 
 We desired to expand the scope of this technology to naphthalene analogs, 
because 1- and 2-bromomethylnaphthalene derivatives are relatively unstable for SN2 
transformation and are not widely commercially available. The use of 1- and 2-
methylnaphthalene in CDC via radical mediated processes is uncommon because the 
tolyl analog is typically used neat, whereas the naphthyl compounds are typically solids. 
A series of methylnaphthalenes were explored with the optimal conditions (Table 4.5).  
Table 4.5 C−H Activation of methylnaphthalene analogs with phenylglycine azlactone.  
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The success with the selective C(sp3)−H bond activation of tolyl and 
methylnaphthyl analogs prompted our exploration of secondary benzylic C−H bonds.159 
The optimal conditions for benzylation of phenylglycine azlactone was studied with 
ethylbenzene and 2-ethylnaphthalene (Table 4.6). Unexpectedly, the benzyl product was 
not observed; instead, the ethylated product was formed in good yield (72% and 65%) 
with both substrates.160 
 
Table 4.6 Alkyl C−H activation with phenylglycine azlactone. 
 
 Extension of the alkyl chain on benzene to propyl and butyl most surprisingly 
gave rise to the alkylated product while <5% of the other insertion isomers were observed 
                                                
159) Diphenylmethane and cumene were explored with the optimal conditions but did not provide the 
benzyl product. A chart of various alkyl substrates explored with phenylglycine azlactone has been 
included in the supporting information.  
160) Ethylbenzene was explored by Bryant (ref. 154) and acetoxylation at the terminal methyl was 
observed as a complex product mixture in 8% isolated yield. 
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(Scheme  4.2, 4.21a and 4.21b). This chemoselectivity provides access to chemical space 
that would not be feasible via a radical mediated process. Allylbenzene was also explored 
and 4.21c was formed in 41% yield; White’s catalyst, 1,2-bis(benzylsulfinyl)-ethane 
Pd(OAc)2 was also explored but the alkylated product was not observed.149 
Scheme  4.2 Alkyl vs allylic C−H activation. 
 
 
4.2.4.  Optimization of C(sp3)−H Activation of Tolyl with Catalytic Pd 
 We have successfully discovered a novel C(sp3)−H activation of benzylic C−H 
bonds that can be coupled with phenylglycine azlactone by Pd(OAc)2. We envisioned 
that if catalytic conditions could be found then this transformation would not only be 
novel but its utility would be heightened. A parallel microscale experimentation (PME) 
screen was designed to study 23 diverse oxidants and 2 palladium carboxylates with 
phenylglycine azlactone and toluene (Table 4.7). Transition metal oxidants that have 
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Pd(II)/Pd(0) catalytic cycle proved to be ineffective in this transformation. Peroxides did 
not stop product formation but were inefficient in turning over Pd. 
Table 4.7 Exploration of oxidant and Pd source via PME 
 
 The oxidants highlighted in green in Table 4.7 were targeted as optimal leads to 
explore on larger scale (Table 4.8). Replication of the PME conditions provided the 
benzylated product in 73% isolated yield with 2,6-dimethylbenzoquinone (2,6-DMBQ) 
and Pd(OAc)2 (Table 4.8, entry 4). Reduction of Pd loading, while maintaining high 
levels of oxidant concentration, caused many unfavorable side reactions and product 
formation was reduced significantly (Table 4.8, entry 6). However, reduction of 2,6-
DMBQ loading (200 vs 100 mol %) provided the benzylated product in 56% isolated 
yield (Table 4.8, entry 7).  
Table 4.8 Scale up of PME leads. 
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The reduced yield when Pd loading was lowered motivated our exploration of 
additives with 2,6-DMBQ. Known Pd(0) stabilizers  (DMSO, White’s sulfoxide 
ligand,149 DMA, phenanthroline, BIPY and cyclohexene) were explored without success. 
However, the addition of AcOH or PivOH enhanced the transformation (Table 4.9, 
entries 1-2). Presumably, the carboxylic acid additive promotes dissociation of the 1,4-
quinone alkoxide from Pd(II). 2,6-DMBQ loading could also be reduced with the 
addition of the inexpensive co-oxidant, MnO2 (Table 4.9).  
Table 4.9 Additives with catalytic Pd(OAc)2 and 2,6-DMBQ.a 
 
Pd source (30 mol %) oxidant (200 mol %) conv (%)aentry
1
2
3
4
entry
BQ
83
>90 (73)c
17
decomp.b
aDetermined by 1H NMR. bProduct was not obverved, only phenylglycine azlactone dimer was isolated. cIsolated yield.
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Pd(OAc)2 2,6-DMBQ (100 mol %) 80 (56)c7
Pd source (10 mol %) oxidant
4.01 4.03
N
O
Ph
O
PMP
H
+
O
N
PMP
O
Ph H H
(0.05 M)
[Pd] 
oxidant
CH3
90 °C, 13 h
additive (100 mol %) yield (%)bentry
1
2
3
entry
84
75
0
aPd(OAc)2 (10 mol %) and 2,6-DMBQ (100 mol %). bIsolated yield. cPd(OAc)2 (20 mol %)
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With the goal of finding conditions that engendered suitable reactivity while 
minimizing the amount of toluene, a focused PME screen was designed (Table 4.10). 
Pd(OAc)2 and Pd(TFA)2 were explored with six high boiling solvents that provided some 
stabilization to prevent Pd black formation. 1,4-Dioxane was identified as the best co-
solvent with both Pd sources (Table 4.10, entries 3 and 9). A PME screen of acid sources 
was also conducted but proved that our initial acid choices (AcOH and PivOH) were 
optimal.  
Table 4.10 PME screen of co-solvents with optimal catalytic conditions. 
 
 The benzylation of phenylglycine azlactone with a series of tolyl and 
methylnaphthyl derivatives with the optimal conditions for catalytic Pd was performed. 
However, the transformation proved to not be universal. Further studies on additives were 
initiated and the addition of charcoal was found to improve upon the initial catalytic 
findings (Table 4.11). Toluene and 2-methylnaphthalene provided the benzylated product 
in good yields (Table 4.11, 4.03 and 4.16). However, tolyl analogs that proved to react 
slower than toluene were not successful, and decomposition of phenylglycine azlactone 
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over the course of the reaction was observed. Similar reactivity was not observed with 
stoichiometric Pd (see Table 4.4 and Table 4.5). Unidentifiable side products that are 
intense purple and pink colors in solution are formed with the recalcitrant substrates. 
Presumably, oxidation of the azlactone is occurring in the presence of 2,6-DMBQ. Future 
work will focus on modifying the protecting group of the azlactone from PMP to phenyl 
to improve catalytic turnover and minimize side reactions.  
Table 4.11 C(sp3)−H activation catalyzed by Pd(OAc)2. 
 
The catalytic conditions were explored with ethylbenzene and provided the 
ethylated phenylglycine azlactone product in moderate yield (Scheme  4.3). The 
secondary benzylated product was not observed. This unprecedented C−H activation of 
the unactivated terminal methyl of ethylbenzene provides access to chemical space that 
would not be feasible via a radical mediated process.  
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Scheme  4.3 C(sp3)−H activation of ethylbenzene catalyzed by Pd(OAc)2. 
 
 
4.2.6.  Mechanistic Studies 
 These novel findings prompted our interest in elucidating the C−H activation 
mechanism. Kinetic isotope studies were undertaken with phenylglycine azlactone and 
Pd(OAc)2. An equimolar mixture of toluene and d8-toluene provided the benzylated 
product in 3.55/1 kH/kD, which suggests the C−H activation step is rate-determining 
(Scheme  4.4).148,155 Radical mediated processes such as those described in Figure 4.3 
typically provide a more significant isotopic effect >5.143a,161,162 
Scheme  4.4 Kinetic isotope study of toluene vs d8-toluene. 
 
To probe the reaction mechanism further, toluene and d5-toluene were 
investigated, and in this case isotopic effects were not observed (Scheme  4.5). Based on 
literature precedence, a mechanism involving arene insertion seemed plausible, but 
                                                
161) Rout, S. K.; Guin, S.; Banerjee, A.; Khatun, N.; Gogoi, A.; Patel, B. K. “Directing Group Assisted 
Copper-Catalyzed Chemoselective O-Aroylation of Phenols and Enols Using Alkylbenzenes” Org. 
Lett. 2013, 15, 4106-4109. 
162) ShiGuang, P.; JinHua, L.; YuanMing, L.; ZhiPing, L. “Iron-catalyzed benzylation of 1,3-dicarbonyl 
compounds by simple toluene derivatives” Chin. Sci. Bull. 2012, 57, 2382-2386. 
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deuterium scrambling and an isotope effect were not observed on the benzylated product 
(4.03c) from d5-toluene. This result suggests this process does not involve Pd insertion 
into the ortho-arene C−H. A stabilized [η3-tolyl•Pd complex] is feasible from direct 
insertion into the benzylic C−H bond.  
Scheme  4.5 Kinetic isotope effect study of toluene vs d5-toluene. 
 
 The results observed when phenylglycine was treated with Pd(OAc)2 and 
ethylbenzene/2-ethylnaphthalene were highly unusual. A deuterium labeling study was 
therefore conducted with d2-ethylbenzene. The azlactone product from C(sp3)−H 
activation at the terminal methyl of ethylbenzene was a mixture of deuterium/hydrogen at 
the ethyl carbons (Scheme  4.6). The observation of deuterium scrambling provides 
evidence that the initial C−H insertion by Pd occurs at the benzylic carbon; β-hydride 
elimination, insertion of Pd into the terminal carbon and cross-coupling with the 
phenylglycine azlactone would presumably provide the ethylated product. This result is 
in agreement with the observed product from propylbenzene (see Scheme  4.2). However, 
when styrene was introduced with phenylglycine azlactone and Pd(OAc)2, the desired 
ethylated product (4.19) was not observed, but rather styrene polymerization occurred, 
indicating that the styrene intermediate remains bound to palladium and reacts rapidly.  
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Scheme  4.6 Deuterium scrambling study with ethylbenzene. 
 
 The ethylated product from phenylglycine azlactone and ethylbenzene provided 
an opportunity to interrogate radical pathways further. It has been shown that (t-BuO)2 
undergoes homolysis at 100 °C, providing the oxy-radical. 163 When phenylglycine 
azlactone was treated with ethylbenzene at 90 °C, below the hemolysis threshold, with 
Pd(OAc)2 and (t-BuO)2 only the ethylated product (4.19) was observed (Table 4.12, entry 
1). In the absence of Pd, when the reaction temperature was increased to 125 °C to 
promote oxy-radical formation, the benzylated products (4.22a and 4.22b) were the only 
product observed (Table 4.12, entry 2).164 However, when the reaction temperature was 
maintained at 125 °C and Pd(OAc)2 was present, a mixture of the ethylated (4.19) and 
benzylated products (4.22a and 4.22b) were observed (Table 4.12, entry 3).  
 
 
 
 
                                                
163) Pryor, W. A.; Lee, A.; Witt, C. E. “Reaction of Radicals. IX. t-Butyl Peroxide” J. Am. Chem. Soc. 
1964, 86, 4229-4234. 
164) A mixture of carbon and oxygen benzylation were observed with six diastereomers. This mixture was 
separated and identified through collaborative efforts, see: Regalado, E. L.; Kozlowski, M. C.; Curto, 
J. M.; et al. "Support of Academic Synthetic Chemistry using Advanced Separation Technologies 
from the Pharmaceutical Industry" Org. Biomol. Chem. 2014, 12, 2161-2166. 
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Table 4.12 Radical studies with ethylbenzene. 
 
Radical scavengers, such as TEMPO, BHT or 1,1-diphenylethylene, were 
introduced into the standard reaction with toluene and Pd(OAc)2 and the desired 
benzylated product was produced in comparable yields.165 These studies in addition to the 
information gained from the (t-BuO)2 studies contraindicate a radical process in the C−H 
alkylation of phenylglycine azlactone. 
In the course of developing this technology, the azlactone dimer was observed 
frequently. Its presence prompted further studies to determine if it was necessary for 
benzylation or was an unwanted side-product.  Dimer formation can be initiated with an 
oxidant (e.g., NiO2, MnO2), or in a polar solvent (DMSO) and air.166,167 ,168 Mild 
conditions were developed to form the azlactone dimer (4.23) from phenylglycine 
azlactone (4.01) in 83% yield with Pd(OAc)2 (5 mol %) and Ag2O (100 mol %) at rt 
                                                
165) The benzylated product was provided in 54, 85, and 59% yield with TEMPO, 1,1-diphenylethylene 
and BHT, respectively. 1,1-Diphenylethylene and BHT were recovered in 58 and 67% yield. 
166) Marquez, A.; Chuaqui, C. A.; Rodriquez, H.; Zagal, L. “Generation and Fate of Free Radicals of 
oxazolin-5-ones” Tetrahedron 1985, 41, 2341-2346.  
167) Rodriguez, H.; Marquez, A.; Chuaqui, C. A.; Gomez, B. “Oxidation of Mesoionic Oxazolones by 
Oxygen” Tetrahedron 1991, 47, 5681-5688.  
168) Andersen, K. K.; Gloster, D. F.; Bray, D. D.; Shoja, M. “Synthesis of Symmetrical 2,2’,4,4’-
Tetrasubstituted[4,4’-bioxazole]-5,5’(4H,4’H)-diones and their Reaction with some Nucleophiles” J. 
Het. Chem. 1998, 35, 317-324. 
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(Scheme  4.7). When the dimer was subjected to catalytic Pd(OAc)2 and toluene, the 
benzylated product was formed in 72% yield (Scheme  4.7).169 Catalytic turnover of the 
Pd(II) catalyst without the addition of an oxidant suggests that from the dimer the 
catalytic cycle is redox neutral. Unfortunately, starting from dimer did not improve the 
efficiency of the benzylation step with recalcitrant substrates such as mesitylene.  
Scheme  4.7 Benzylation from the phenylglycine azlactone dimer. 
 
 The intriguing reactivity of the phenylglycine azlactone dimer (4.23) prompted 
further mechanistic studies. The dimer was exposed to Pd(II) complexes in d6-benzene 
and monitored by 1H NMR. When the chosen Pd(II) source was Pd(TFA)2, the dimer-Pd 
complex (4.24) was observed (Figure 4.8, top); the ortho-hydrogen on the C-4 phenyl 
ring shifted significantly downfield (7.31 to 9.47 ppm) (Figure 4.8, bottom). The dimer-
Pd complex structure was confirmed by X-ray crystallography (Figure 4.8, right).  
                                                
169) Palladium(0) sources did not provide the benzylated product with dimer and toluene. 
N
O
Ph
O
PMP
H
Pd(OAc)2 (5 mol %)
Ag2O (1 equiv)
toluene
rt, 5 h
N
O
O
PMP
O
NO
PMP
PhPh
4.234.01
Pd(OAc)2 (13 mol %)
95 °C, 5 h
CH3
(0.1 M)
O
N
PMP
O
Ph H H
4.03
83% 72%
 
160 
 
Figure 4.8 Phenylglycine azlactone dimer-Pd complex. 
Identification of the dimer-Pd complex prompted us to investigate if its formation 
was part of the reaction cycle. Treatment of the complex with toluene at elevated 
temperatures provided the benzyl product (Scheme  4.8), although in reduced yield 
relative to the monomer and Pd(TFA)2 (see Table 4.1, entry 7). The dimer-Pd complex 
was monitored in d8-toluene. After thirty minutes at rt the complex had dissociated and 
the uncomplexed dimer was present. Based on these results, we believe the dimer-Pd 
complex is not a reactive intermediate. 
Scheme  4.8 Benzylation from the dimer-Pd complex. 
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 Phenylalanine azlactone dimer has been shown to undergo homolytic cleavage at 
temperatures above 115 °C.168 Potentially, formation of the azlactone radical from the 
dimer could be responsible for the observed benzylation with tolyl analogs. However, our 
studies suggest this is not likely with phenylglycine azlactone. Benzylation is not 
observed without Pd(II). The ethylated product is not formed under conditions with free 
radicals present (see Table 4.12, entry 2). Dimer crossover studies have been conducted 
with the PMP-phenylglycine dimer (4.23) and Ph-phenylglycine dimer (4.25) at 85-95 °C 
with and without Pd(OAc)2, and dimer crossover from recombination has not been 
observed (Scheme  4.9).170  
Scheme  4.9 Dimer crossover study. 
 
Although the full mechanistic details of this transformation remain to be 
elucidated, we tentatively propose the following mechanism (Figure 4.9). 1H NMR 
studies of the reaction reveal that the phenylglycine azlactone is converted to the 
azlactone dimer in the first 30 minutes when exposed to Pd(OAc)2 and heat. Toluene can 
undergo C−H activation with Pd(OAc)2 at elevated temperatures in a redox neutral 
process. The electron-rich benzyl Pd(II) is poised to undergo oxidation with the labile C-
C bond of the azlactone dimer, forming a Pd(IV) intermediate. Alternatively, this 
transformation could occur from two Pd(II) complexes providing a Pd(III) complex.  
                                                
170) In contrast to ref 168, we did observe dimer mixing from ionization in the MS with a control 
experiment. Thus, MS cannot be used to track crossover. 
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Reductive elimination would provide the benzylated azlactone. Pd(OAc)2 can be 
regenerated in the presence of AcOH. The reformation of the phenylglycine azlactone 
monomer consumes the remaining Pd(OAc)2 in the production of the azlactone dimer, 
thus the 72% yield observed in Scheme  4.7 with 13 mol % Pd. Presumably, the resting 
state of Pd in the active cycle is Pd(II), but in the formation of the dimer, Pd(0) is the 
resting state. A Pd-black and/or Pd-mirror are evident in these reactions and are 
consistent with our proposed mechanism.171  
 
Figure 4.9 Tentative mechanism. 
 
4.2.7.  Future Goals 
 We have successfully discovered a novel C(sp3)−H activation of benzylic C−H 
bonds that can be coupled with phenylglycine azlactone by Pd(OAc)2. Our primary goals 
                                                
171) Pun, D.; Diao, T.; Stahl, S. S. “Aerobic Dehydrogenation of Cyclohexanone to Phenol Catalyzed by 
Pd(TFA)2/2-Dimethylaminopyridine: Evidence for the Role of Pd Nanoparticles” J. Am. Chem. Soc. 
2013, 135, 8213-8221.  
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of optimizing the initial conditions, exploring if the reaction was general for tolyl 
analogs, and conducting mechanistic studies were successfully completed. Our secondary 
goal of determining conditions for catalytic Pd were successful but were not universal for 
all tolyl analogs. Our last goal was to extend the scope of the acidic C−H partner.  
 Analogs of phenylglycine were explored with toluene and stoichiometric Pd 
(Scheme  4.10). Electron-donating and –withdrawing substitution at the para position 
provided the benzylated product in yields similar to that of the parent azlactone. Reduced 
toluene loading with the addition of a co-solvent has not been explored. ortho-
Substitution reduced the amount of benzylated product, presumably because of sterics.172 
Phenylalanine was also explored and the benzylated product was observed as a 50:50 
mixture with starting material after 14 h. Glycine azlactone was unsuccessful and all 
starting material decomposed under the reaction conditions without providing benzylated 
product.  
Scheme  4.10 Exploration of phenylglycine azlactone analogs with toluene. 
 
The valine azlactone (4.29) was prepared and reacted with toluene and Pd(OAc)2. 
The benzylated product was observed, but the reaction rate was sufficiently slower than 
the corresponding phenylglycine azlactone (45 h vs 6 h). Interestingly after complete 
consumption of starting material, the benzylated product was isolated as a 3:1 mixture 
                                                
172) ortho-Ethoxy phenylglycine azlactone was benzylated in 30% yield.    
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with the azlactone alkene (4.31) in 81% yield (Scheme  4.11). Ostensibly, the alkene is 
produced from β-hydride elimination with Pd, post C−H insertion. A modification of this 
“Saegusa” oxidation has been reported by Stammer with phenylalanine azlactone.173 
Treatment of the azlactone with TMSCl and Et3N, followed by stoichiometric Pd(OAc)2, 
produced the corresponding alkene azlactone in 16% yield. The authors suggest α-alkyl 
α-amino acids do not undergo this transformation. When toluene was replaced with 
benzene, the alkene (4.31) was produced in 43% yield (Scheme  4.11, bottom).  
Scheme  4.11 Benzylation of valine azlactone. 
 
Acyclic α-amino acids were explored, the Schiff base of glycine, valine and 
phenylglycine were prepared and subject to stoichiometric Pd(OAc)2 and toluene; 
benzylation was not observed. The Schiff base-Pd complex was formed from insertion of 
Pd into the ortho-phenyl C−H of the ketamine protecting group; this type of reactivity has 
been observed previously.174   
                                                
173) Lott, R. S.; Breitholle, E. G.; Stammer, C. H. “Azlactone Oxidation” J. Org. Chem. 1980, 45, 1151-
1153. 
174) Bohm, A.; Schreiner, B.; Steiner, N.; Urban, R.; Sunkel, K.; Polborn, K.; Beck, W. “Metal Complexes 
of Biologically Important Ligands, XCVIII [1] Cyclopalladated Schiff Bases of α-Amino Acid and 
Peptide Esters” Z. Naturforsch 1998, 53 b, 191-205. 
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Seidel and co-workers have found that O-acylated azlactones can add to 
isoquinolines in an asymmetric Steglich rearrangement.175 The O-acyl phenylglycine 
azlactone was prepared (4.32) and subject to toluene and Pd(OAc)2 (100 mol %), 
providing the benzylated product in 81% yield. Catalytic Pd with oxygen as the oxidant 
was examined and the benzylated product was observed in 53% yield (Scheme  4.12). 
This catalytic system is currently being explored and we envision the low catalytic 
loadings combined with the cheap, environmentally friendly O2 could be an important 
extension to this work. 
Scheme  4.12 Benzylation of the O-acylated azlactone with catalytic Pd. 
 
 Double C−H activation for C−C bond formations are rare and we hope to extend 
the scope of this technology beyond cyclic α-amino acids. We are currently exploring 
acidic C−H partners that have been shown to dimerize in the literature.176 , 177 , 178 
Tetralones, oxindoles and arylcyanoacetic esters have been chosen as future targets for 
                                                
175) De, C. K.; Mittal, N.; Seidel, D. “A Dual-Catalysis Approach to the Asymmetric Steglich 
Rearrangement and Catalytic Enantioselective Addition of O-Acylated Azlactones to Isoquinolines” 
J. Am. Chem. Soc. 2011, 133, 16802-16805. 
176) Nicolaou, K. C.; Gray, D. L. F. “Total Synthesis of Hybocarpone and Analogues Thereof. A Facile 
Dimerization of Naphthazarins to Pentacyclic Systems” J. Am. Chem. Soc. 2004, 126, 607-612.  
177) Fang, C.-L.; Horne, S.; Taylor, N.; Rodrigo, R. “Dimerization of a 3-Substituted Oxindole at C-3 and 
Its Application to the Synthesis of (+/−)-Folicanthine” J. Am. Chem. Soc. 1994,  116, 9480-9486.  
178) De Jongh, H. A. P.; De Jonge, C. R. H. I.; Sinnige, H. J. M.; De Klein, W. J.; Huysman, W. G. B.; 
Mijs, W. J. “Oxidative Carbon-Carbon Coupling. II. The Effect of Ring Substituents on the Oxidative 
Carbon-Carbon Coupling of Arylmalonic Esters, Arylmalonodinitriles, and Arylcyanoacetic Esters” 
J. Org. Chem. 1972, 37, 1960-1966.  
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benzylation. Our preliminary work is shown in Scheme  4.13.179 α-Substituted tetralone 
and oxindole look like promising substrates. Interestingly, neither has an α-nitrogen for 
pre-coordination to Pd; the α-nitrogens on the phenylglycine azlactone dimer formed a 
complex with Pd (see Figure 4.8). Future work will focus on applying the catalytic 
conditions for Pd with these promising substrates.  
Scheme  4.13 Preliminary work on benzylation of various acidic C−H partners. 
 
 
4.3. CONCLUSIONS 
In summary, a novel reactivity mode for alkylarene derivatives has been 
discovered.  With a simple system consisting of Pd(OAc)2 and pivalic acid, CDC with a 
carbon nucleophile occurs readily for the terminal methyl positions of methyl, ethyl, 
propyl and butyl arenes.  The resultant azlactone products are masked α-amino acids, 
with hindered a,a-disubstitution patterns that are difficult to achieve via other means. 
Notably, selective C(sp3)–H insertion is observed in benzylic systems even though 
                                                
179) Various acidic C−H partners that have been explored with toluene and Pd(OAc)2 are listed in the 
supporting information. 
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Pd(OAc)2 typically causes arene C–H insertion. Mechanistic studies were initiated, and it 
was determined that C(sp3)−H activation is the RDS. Studies are ongoing to improve 
turnover and to extend the scope of the acidic C−H partner in these couplings 
 
4.4. EXPERIMENTAL SECTION 
General Considerations 
All non-aqueous reactions were carried out under an atmosphere of dry argon 
unless otherwise noted. Commercial reagents were used as received without additional 
purification unless otherwise noted. Dichloromethane was distilled from CaH2, and 
toluene was distilled from metallic sodium prior to use. Anhydrous 1,4-dioxane was 
purchased from Sigma Aldrich as 100 mL Sure-Seal bottles and stored in the glovebox. 
Activated charcoal (Darco G-60) was dried overnight at 80 °C in vacuo. Reactions were 
monitored by thin layer chromatography (TLC) using Silicycle glass-backed TLC plates 
with 250 µm silica and F254 indicator. Visualization was accomplished by UV light.  
1H NMR and 13C NMR spectra were recorded on a AM-500 Fourier transform 
NMR spectrometer at 500 MHz and 125 MHz, respectively.  Chemical shifts are reported 
relative to the solvent resonance peak δ 7.26 (CDCl3) for 1H and δ 77.16 (CDCl3) for 13C.  
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, b = broad singlet, m = multiplet), coupling constants, and number of 
protons. High resolution mass spectra were obtained using a VG autospec with an 
ionization mode of either ESI or CI.  Infrared spectra are reported in cm-1. Melting points 
are uncorrected. Unless otherwise noted, yields refer to isolated material on the basis of 
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product purity (≥95%) by 1H NMR following silica gel chromatography with Silica-P 
flash silica gel (50-63 µm mesh particle size).  
General Procedure A – Synthesis of Azlactones180,181,182 
 
N-Protecting group-phenylglycine (0.39 mmol) was added to a flame dried 25 mL 
round bottom flask equipped with a stir bar under an argon atmosphere. The mixture was 
dissolved in CH2Cl2 (6 mL) and cooled to 0 °C. N-(3-Dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDCl) (90 mg, 0.47 mmol) was added and the mixture 
was allowed to warm to ambient temperature. After 1 h at ambient temperature, the 
mixture was diluted with CH2Cl2 (10 mL), washed with H2O (2 x 10 mL), 0.1 M NaOAc 
(2 x 10 mL), H2O (10 mL) and brine (15 mL), dried over Na2SO4, filtered and 
concentrated in vacuo providing the corresponding azlactone.  
 
2-(4-Methoxyphenyl)-4-phenyloxazol-5(4H)-one (4.01). General procedure A was 
followed using N-para-methoxy-phenylglycine (110 mg, 0.39 mmol) and EDCl (90 mg, 
                                                
180) For R = p-Cl-C6H4, see: Hofle, G.; Steglich, W.; Daniel, H. “Notiz zur Isolierung der 2-Oxazolinon- 
und Oxazolium-5-olat-Formen bei 2,4-Diaryloxazolin-5-onen” Chem. Ber. 1976, 109, 2648-2650.   
181) For R = Ph, see: Liang, J.; Ruble, J. C.; Fu, G. C. “Dynamic Kinetic Resolutions Catalyzed by a 
Planar-Chiral Derivative of DMAP: Enantioselective Synthesis of Protected α-Amino Acids from 
Racemic Azlactones” J. Org. Chem. 1998, 63, 3154-3155.  
182) For R = Me, see: Padwa, A.; Wetmore, Jr. S. I. “Studies on the Photoextrusion of Carbon Dioxide 
from the Δ3-Oxazolin-5-one System” J. Am. Chem. Soc. 1974, 96, 2414-2421.  
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0.47 mmol) in CH2Cl (6 mL). After work up, 4.01 (15.1 mg) was isolated in 72% yield: 
1H NMR (500 MHz, CDCl3) δ 8.04 (d, J = 8.9 Hz, 2H), 7.47-7.33 (m, 5H), 7.01 (d, J = 
8.9 Hz, 2H), 5.49 (s, 1H), 3.90 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 176.6, 163.6, 
162.4, 133.9, 130.2, 129.1, 128.8, 127.0, 118.1, 114.4, 68.3, 55.7; IR (film) 3008, 2935, 
2839, 1827, 1648, 1608, 1512, 1260 cm-1; HRMS (CI) calcd for C16H13NO3 [M]+ m/z = 
267.0895; found 267.0895.    
General Procedure B −  Benzylation with Stoichiometric Pd 
 
Phenylglycine azlactone (4.01) (0.056 mmol) and Pd(OAc)2 (12.5 mg, 0.056 
mmol) were added to a flame dried 8 mL microwave vial equipped with stir bar and 
brought into the glovebox. The indicated tolyl analog (0.05 M, ~10.5 mmol) was added to 
the mixture. The microwave vial was sealed with a Teflon cap, removed from the 
glovebox, and placed in a 95 °C oil bath. After 6 h, the mixture was allowed to cool to 
ambient temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 with 30% EtOAc 
in hexanes, and concentrated in vacuo. The resulting residue was purified by column 
chromatography to afford the alkylated azlactone.  
Metal sources for C−H activation of toluene (Table 4.1) 
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For Table 1, entries 1-5: Phenylglycine azlactone dimer (4.23) (10 mg, 0.019 
mmol) was added to a flame dried 8 mL microwave vial equipped with stir bar and 
brought into the glovebox. The indicated metal source183 (0.008 mmol) was added 
followed by toluene (377 µL). The microwave vial was sealed with a Teflon cap, 
removed from the glovebox, placed in a 90 °C oil bath. After 5 h, the mixture was 
allowed to cool to ambient temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 
with 30% EtOAc in hexanes, and concentrated in vacuo. The resulting residues were 
analyzed by 1H NMR spectroscopy and each experiment provided only unreacted 
phenylglycine azlactone dimer (4.23).   
For Table 1, entries 6-12: General procedure B was followed with phenylglycine 
azlactone (4.01) (10 mg, 0.038 mmol), the indicated metal source (0.038 mmol) and 
toluene (750 µL). After 12 h at 90 °C oil bath, the resulting residues were analyzed by 1H 
NMR spectroscopy: entries 6 and 7 provided full conversion to benzylated product, entry 
8 provided full conversion to phenylglycine azlactone dimer and entries 9-11 provided 
minimal phenylglycine azlactone dimer (4.23) and decomposition of phenylglycine 
azlactone (4.01).  
Modification of the phenylglycine azlactone protecting group (Table 4.2).  
 
                                                
183) Au(OAc)3, Cu(OAc)2, Rh2(OAc)4 and Ni(OAc)2 were avaialble from commercial sources. 
[Pt4(OAc)8]•HOAc was synthesized following a known procedure, see: Basato, M.; Biffis, A.; 
Martinati, G.; Tubaro, C.; Venzo, A.; Ganis, P.; Benetolo, F. “Reaction of platinum acetate with 
phosphines and molecular structure of trans-[Pt(OAc)2(PPh3)2]” Inorg. Chim. Acta 2003, 355, 399-
403. 
O
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General procedure B was followed using 4.01b (10 mg, 0.038 mmol) and 
Pd(OAc)2 (8.4 mg, 0.038 mmol) in toluene (750 µL) at 90 °C for 3 h. After isolation, 
concentration and column chromatography (10% EtOAc in hexanes), 4.04 (9.4 mg) was 
obtained in 69% yield. 
 
General procedure B was followed using 4.01c (8.9 mg, 0.038 mmol) and 
Pd(OAc)2 (8.4 mg, 0.038 mmol) in toluene (750 µL) at 95 °C for 3 h. After isolation, 
concentration and column chromatography (7% EtOAc in hexanes), 4.05 (8.6 mg) was 
obtained in 70% yield: 1H NMR (500 MHz, CDCl3) δ 7.92 (d, J = 8.0 Hz, 2H), 7.79 (d, J 
= 8.0 Hz, 2H), 7.54 (t, J = 7.5 Hz, 1H), 7.47-7.38 (m, 4H), 7.35 (t, J = 7.3 Hz, 1H), 7.23-
7.12 (m, 5H), 3.53 (d, J = 13.5 Hz, 1H), 3.47 (d, J = 13.5 Hz, 1H). Spectral data agreed 
with those reported by Hartwig.157 
Screen of co-solvents (Table 4.3) 
 
General procedure C was followed using 4.01 (10 mg, 0.037 mmol) and 
Pd(OAc)2 (8.3 mg, 0.037 mmol) in toluene (0.37 or  0.93 mmol) and co-solvent (133 µL) 
at 90 °C for 5 h. 
General Procedure C – Alkylation with stoichiometric Pd in 1,4-dioxane  
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Phenylglycine azlactone (4.01) (0.056 mmol) and Pd(OAc)2 (12.5 mg, 0.056 
mmol) were added to a flame dried 8 mL microwave vial equipped with stir bar and 
brought into the glovebox. The indicated tolyl analog (1.12 mmol) and 1,4-dioxane (200 
µL) were added to the mixture. The microwave vial was sealed with a Teflon cap, 
removed from the glovebox and placed in a 90 °C oil bath. After 24 h, the mixture was 
allowed to cool to ambient temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 
with 30% EtOAc in hexanes, and concentrated in vacuo. The resulting residue was 
purified by column chromatography to afford the alkylated azlactone.  
 
4-Benzyl-2-(4-methoxyphenyl)-4-phenyloxazol-5(4H)-one (4.03). General procedure C 
was followed using 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 mg, 0.056 mmol) in 
toluene (118 µL, 1.12 mmol) and 1,4-dioxane (200 µL) at 90 °C for 24 h. Purification by 
column chromatography (eluent 7% EtOAc in hexanes) provided 4.03 (16.5 mg) in 83% 
yield: 1H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 8.8 Hz, 2H), 7.79 (d, J = 8.0 Hz, 2H), 
7.41 (t, J = 7.6 Hz, 2H), 7.34 (t, J = 7.4 Hz, 1H), 7.24-7.12 (m, 5H), 6.93 (d, J = 8.8 Hz, 
2H), 3.85 (s, 3H), 3.51 (d, J = 13.4 Hz, 1H), 3.44 (d, J = 13.4 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 178.4, 163.2, 159.7, 138.4, 134.4, 130.6, 129.9, 128.8, 128.4, 128.2, 
127.4, 126.0, 118.2, 114.2, 75.6, 55.6, 47.4; IR (film) 3031, 2925, 1813, 1653, 1608, 
4.01
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1513, 1260 cm-1; HRMS (CI) calcd for C16H12NO3 [M-C7H7]+ m/z = 266.0817; found 
266.0826.   
 
2-(4-Methoxyphenyl)-4-(4-methylbenzyl)-4-phenyloxazol-5(4H)-one (4.09). General 
procedure C was followed using 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 mg, 
0.056 mmol) in para-xylene (140 µL, 1.12 mmol) and 1,4-dioxane (200 µL) at 90 °C for 
24 h. Purification by column chromatography (eluent 7% EtOAc in hexanes) provided 
4.09 (16.2 mg) in 78% yield: 1H NMR (500 MHz, CDCl3) δ 7.88 (d J = 8.8 Hz, 2H), 7.78 
(d, J = 7.9 Hz, 2H), 7.40 (t, J = 7.5 Hz, 2H), 7.34 (t, J = 7.3 Hz, 1H), 7.09 (d, J = 7.9 Hz, 
2H), 6.98 (d, J = 7.8 Hz, 2H), 6.94 (d, J = 8.9 Hz, 2H), 3.86 (s, 3H), 3.47 (d, J = 13.6 Hz, 
1H), 3.40 (d, J = 13.4 Hz), 2.23 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 178.4, 163.2, 
159.7, 138.6, 136.9, 131.3, 130.4, 130.0, 128.9, 128.8, 128.3, 126.0, 118.3, 114.2, 75.7, 
55.6, 47.1, 21.2; IR (film) 3007, 2962, 2927, 1813, 1654, 1608, 1512, 1260 cm-1; HRMS 
(ESI) calcd for C24H22NO3 [M+H]+ m/z = 372.1600; found 372.1594.   
 
2-(4-Methoxyphenyl)-4-(3-methylbenzyl)-4-phenyloxazol-5(4H)-one (4.10). General 
procedure C was followed using 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 mg, 
0.056 mmol) in meta-xylene (140 µL, 1.12 mmol) and 1,4-dioxane (200 µL) at 90 °C for 
24 h. Purification by column chromatography (eluent 7% EtOAc in hexanes) provided 
4.10 (16.3 mg) in 78% yield: 1H NMR (500 MHz, CDCl3) δ 7.86 (d J = 8.9 Hz, 2H), 7.79 
O
N
PMP
O
Ph H H
CH3
O
N
PMP
O
Ph H H CH3
 
174 
(d, J = 7.8 Hz, 2H), 7.41 (t, J = 7.6 Hz, 2H), 7.34 (t, J = 7.3 Hz, 1H), 7.08-7.00 (m, 3H), 
6.96-6.92 (m, 3H), 3.85 (s, 3H), 3.47 (d, J = 13.2 Hz, 1H), 3.40 (d, J = 13.2 Hz), 2.19 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ 178.4, 163.2, 159.7, 138.5, 137.6, 134.3, 131.5, 
129.9, 128.8, 128.4, 128.1, 128.0, 127.5, 126.0, 118.3, 114.2, 75.6, 55.6, 47.5, 21.4; IR 
(film) 3062, 2929, 1813, 1653, 1604, 1512, 1257 cm-1; HRMS (ESI) calcd for C24H22NO3 
[M+H]+ m/z = 372.1600; found 372.1600.   
 
2-(4-Methoxyphenyl)-4-(2-methylbenzyl)-4-phenyloxazol-5(4H)-one (4.11). General 
procedure C was followed using 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 mg, 
0.056 mmol) in ortho-xylene (140 µL, 1.12 mmol) and 1,4-dioxane (200 µL) at 90 °C for 
24 h. Purification by column chromatography (eluent 7% EtOAc in hexanes) provided 
4.11 (8.4 mg) in 40% yield.  
General procedure B was followed with 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 
mg, 0.056 mmol) in ortho-xylene (1.1 mL, 8.8 mmol). The mixture was allowed to stir at 
90 °C for 5 h and purification by column chromatography provided 4.11 (14 mg) in 67% 
yield: 1H NMR (500 MHz, CDCl3) δ 7.84 (d J = 8.8 Hz, 2H), 7.80 (d, J = 8.6 Hz, 2H), 
7.42 (t, J = 7.5 Hz, 2H), 7.34 (t, J = 7.4 Hz, 1H), 7.15 (d, J = 7.3 Hz, 1H), 7.04-6.99 (m, 
3H), 6.92 (d, J = 8.9 Hz, 2H), 3.85 (s, 3H), 3.55 (d, J = 13.7 Hz, 1H), 3.51 (d, J = 13.7 
Hz, 1H), 2.39 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 178.9, 163.2, 159.4, 138.8, 138.1, 
133.1, 130.8, 130.5, 129.9, 128.8, 128.3, 127.5, 126.0, 125.7, 118.3, 114.3, 76.2, 55.6, 
O
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44.1, 20.2; IR (film) 2963, 2928, 1813, 1653, 1609, 1512, 1260 cm-1; HRMS (ESI) calcd 
for C24H22NO3 [M+H]+ m/z = 372.1600; found 372.1588.   
 
4-(3,5-Dimethylbenzyl)-2-(4-methoxyphenyl)-4-phenyloxazol-5(4H)-one (4.10b). 
General procedure B was followed using 4.01 (10 mg, 0.037 mmol ) and Pd(OAc)2 (8.3 
mg, 0.037 mmol) in mesitylene (750 µL,  5.4 mmol). The mixture was allowed to stir at 
140 °C for 15 h and purification by column chromatography provided 4.10b (2.0 mg) in 
14% yield: 1H NMR (500 MHz, CDCl3) δ 7.87 (d, J  = 9.0 Hz, 2H), 7.79 (d, J = 8.4 Hz, 
2H), 7.41 (t, J = 7.6 Hz, 2H), 7.34 (d, J = 7.4 Hz, 1H), 6.93 (d, J = 9.0 Hz, 2H), 6.82 (s, 
2H), 6.76 (s, 1H), 3.86 (s, 3H) 3.43 (d, J = 13.4 Hz, 1H), 3.37 (d, J = 13.4 Hz, 1H), 2.15 
(s, 6H); 13C NMR (125 MHz, CDCl3) δ 178.4, 163.2, 159.7, 138.6, 137.5, 134.2, 129.9, 
128.9, 128.8, 128.3, 126.0, 118.3, 114.2, 113.9, 75.7, 55.6, 47.5, 21.2; HRMS (ESI) calcd 
for C25H24NO3 [M+H]+ m/z = 386.1756; found 386.1750.  
 
2-(4-Methoxyphenyl)-4-(4-methoxybenzyl)-4-phenyloxazol-5(4H)-one (4.13). General 
procedure C was followed using 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 mg, 
0.056 mmol) in para-methylanisole (140 µL, 1.12 mmol) and 1,4-dioxane (200 µL) at 90 
°C for 24 h. Purification by column chromatography (eluent 7% EtOAc in hexanes) 
provided 4.13 (15.4 mg) in 71% yield: 1H NMR (500 MHz, CDCl3) δ 7.88 (d, J = 8.0 Hz, 
2H), 7.77 (d, J = 8.0 Hz, 2H), 7.40 (t, J = 7.3 Hz, 2H), 7.33 (t, J = 7.3 Hz, 1H), 7.12 (d, J 
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= 7.4 Hz, 2H), 6.93 (d, J = 8.4 Hz, 2H), 6.71 (d, J = 8.4 Hz, 2H), 3.86 (s, 3H), 3.71 (s, 
3H), 3.45 (d, J = 13.6 Hz, 1H), 3.38 (d, J = 13.6 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 
178.5, 163.3, 159.7, 158.9, 138.5, 131.7, 129.9, 128.8, 128.3, 126.5, 126.0, 118.3, 114.3, 
113.6, 75.8, 55.6, 55.3, 46.7; IR (film) 2961, 2926, 2851, 1812, 1760, 1655, 1610, 1513, 
1259 cm-1; HRMS (ESI) calcd for C24H22NO4 [M+H]+ m/z = 388.1549; found 388.1551.   
 
2-(4-Methoxyphenyl)-4-(4-fluorobenzyl)-4-phenyloxazol-5(4H)-one (4.14). General 
procedure C was followed using 4.01 (15 mg, 0.056 mmol ) and Pd(OAc)2 (12.5 mg, 
0.056 mmol) in para-fluorotoluene (123 µL, 1.10 mmol) and 1,4-dioxane (200 µL) at 90 
°C for 24 h. The phenylglycine azlactone dimer was isolated with only a minimal amount 
of the benzylated product observed.  
General procedure B was followed with 4.01 (10 mg, 0.037 mmol ) and Pd(OAc)2 (8.3 
mg, 0.037 mmol) in para-fluorotoluene (750 µL,  6.8 mmol). The mixture was allowed to 
stir at 120 °C for 14 h and purification by column chromatography provided 4.14: HRMS 
(ESI) calcd for C23H19FNO3 [M+H]+ m/z = 376.1349; found 376.1352. 
 
2-(4-Methoxyphenyl)-4-(naphthalen-1-ylmethyl)-4-phenyloxazol-5(4H)-one (4.15) 
General procedure C was followed using 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 
mg, 0.056 mmol) in 1-methylnaphthalene (159 µL, 1.12 mmol) and 1,4-dioxane (200 µL) 
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at 90 °C for 24 h. Purification by column chromatography (eluent 7% EtOAc in hexanes) 
provided 4.15 (15.5 mg) in 68% yield: 1H NMR (500 MHz, CDCl3) δ 8.27 (d, J = 8.6 Hz, 
1H), 7.88 (d, J = 8.1 Hz, 2H), 7.72 (d, J = 8.2 Hz, 1H), 7.67 (d, J = 8.2 Hz, 1H), 7.58 (d, 
J = 8.8 Hz, 2H), 7.53 (t, J = 7.7 Hz, 1H), 7.46-7.34 (m, 5H), 7.30 (t, J = 7.6 Hz, 1H), 6.78 
(d, J = 8.9 Hz, 2H), 4.02 (d, J = 13.7 Hz, 1H), 3.94 (d, J = 13.7 Hz, 1H), 3.78 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 178.7, 163.0, 159.4, 138.7, 133.8, 132.9, 131.0, 129.8, 129.0, 
128.9, 128.4, 128.4, 128.4, 126.0, 125.6, 125.5, 125.4, 125.2, 118.0, 114.0, 76.2, 55.5, 
43.6; IR (film) 2926, 2051, 1812, 1652, 1609, 1512, 1260 cm-1; HRMS (ESI) calcd for 
C27H22NO3 [M+H]+ m/z = 408.1600; found 408.1612.   
 
2-(4-Methoxyphenyl)-4-(naphthalen-2-ylmethyl)-4-phenyloxazol-5(4H)-one (4.16) 
General procedure C was followed using 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 
mg, 0.056 mmol) in 2-methylnaphthalene (160 mg, 1.12 mmol) and 1,4-dioxane (200 µL) 
at 95 °C for 24 h. Purification by column chromatography (eluent 8% EtOAc in hexanes) 
provided 4.16 (22 mg) in 96% yield: 1H NMR (500 MHz, CDCl3) δ 7.87-7.80 (m, 4H), 
7.74-7.70 (m, 2H), 7.68 (s, 1H), 7.64 (d, J = 8.4 Hz, 1H), 7.45-7.37 (m, 4H) 7.35 (t, J = 
7.8 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 3.83 (s, 3H), 3.68 (d, J = 13.5 Hz, 1H) 3.61 (d, J = 
13.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 178.4, 163.3, 159.9, 138.6, 133.3, 132.7, 
132.2, 130.0, 129.6, 128.8, 128.7, 128.4, 128.0, 127.6, 127.6 126.0, 126.0, 125.8, 118.2, 
114.2, 75.7, 55.6, 47.5; IR (film) 3057, 2927, 1813, 1654, 1609, 1511, 1260 cm-1; HRMS 
(ESI) calcd for C27H22NO3 [M+H]+ m/z = 408.1600;  found 408.1590.   
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2-(4-Methoxyphenyl)-4-((3-methylnaphthalen-2-yl)methyl)-4-phenyloxazol-5(4H)-
one (4.17). General procedure C was followed using 4.01 (15 mg, 0.056 mmol) and 
Pd(OAc)2 (12.5 mg, 0.056 mmol) in 2,3-dimethylnaphthalene (175 mg, 1.12 mmol) and 
1,4-dioxane (200 µL) at 90 °C for 24 h. Purification by column chromatography (eluent 
8% EtOAc in hexanes) provided unreacted 2,3-dimethylnapthalene (~150 mg) and 4.17 
(23.4 mg) in 98% yield: 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 7.4 Hz, 2H), 7.80 (d, 
J = 8.5 Hz, 2H), 7.68-7.61 (m, 3H), 7.51 (s, 1H), 7.43 (t, J = 7.8 Hz, 2H), 7.39-7.30 (m, 
3H), 6.87 (d, J = 8.6 Hz, 2H), 3.82 (s, 3H), 3.72 (d, J = 13.7 Hz, 1H), 3.67 (d, J = 13.7 
Hz, 1H), 2.58 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 178.9, 163.2, 159.5, 144.8, 138.9, 
136.1, 133.0, 132.2, 132.0, 129.9, 128.9, 128.4, 128.3, 127.7, 126.8, 126.0, 125.9, 125.1, 
118.2, 114.2, 76.4, 55.6, 44.0, 20.8; IR (film) 3057, 2961, 2932, 1813, 1653, 1609, 1512, 
1259 cm-1; HRMS (ESI) calcd for C28H24NO3 [M+H]+ m/z = 422.1756; found 422.1758.   
 
2-(4-Methoxyphenyl)-4-((6-methylnaphthalen-2-yl)methyl)-4-phenyloxazol-5(4H)-
one (4.18). General procedure C was followed using 4.01 (15 mg, 0.056 mmol) and 
Pd(OAc)2 (12.5 mg, 0.056 mmol) in 2,6-dimethylnaphthalene (175 mg, 1.12 mmol) and 
1,4-dioxane (200 µL) at 90 °C for 24 h. Purification by column chromatography (eluent 
8% EtOAc in hexanes) provided unreacted 2,6-dimethylnaphthalene (~150 mg) and 4.18 
(18.1 mg) in 76% yield: 1H NMR (500 MHz, CDCl3) δ 7.87-7.79 (m, 4H), 7.62 (d, J = 
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8.1 Hz, 2H), 7.55 (d, J = 8.5 Hz, 1H), 7.48 (s, 1H), 7.41 (t, J = 7.6 Hz, 2H), 7.35 (t, J = 
7.2 Hz, 1H), 7.30 (d, J = 8.4 Hz, 1H), 7.23 (d, J = 8.4 Hz, 1H), 6.89 (d, J = 8.8 Hz, 2H), 
3.83 (s, 3H), 3.66 (d, J = 13.5 Hz, 1H), 3.58 (d, J = 13.5 Hz, 1H), 2.45 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 178.5, 163.2, 159.8, 138.6, 135.5, 132.9, 131.6, 131.2, 130.0, 129.3, 
128.8, 128.8, 128.4, 128.2, 127.8, 126.9, 126.6, 126.0, 118.2, 114.2, 75.8, 55.6, 47.5, 
21.8; IR (film) 3055, 2923, 2852, 1812, 1653, 1609, 1512, 1260 cm-1; HRMS (ESI) calcd 
for C28H24NO3 [M+H]+ m/z = 422.1756; found 422.1751.   
 
2-(4-Methoxyphenyl)-4-phenethyl-4-phenyloxazol-5(4H)-one (4.19). General 
procedure C was followed using 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 mg, 
0.056 mmol) in ethylbenzene (140 µL, 1.12 mmol) and 1,4-dioxane (200 µL) at 90 °C for 
24 h. Purification by column chromatography (eluent 7% EtOAc in hexanes) provided 
4.19 (15.1 mg) in 72% yield: 1H NMR (500 MHz, CDCl3) δ 8.07 (d, J = 8.6 Hz, 2H), 
7.71 (d, J = 7.3 Hz, 2H), 7.39 (t, J = 7.8 Hz, 2H), 7.32 (t, J = 7.1 Hz, 1H), 7.24 (t, J = 7.6 
Hz, 2H), 7.18-7.12 (m, 3H), 7.02 (d, J = 8.6 Hz, 2H), 3.90 (s, 3H), 2.66-2.58 (m, 2H), 
2.56-2.43 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 179.0, 163.5, 160.3, 140.7, 138.5, 
130.2, 128.8, 128.6, 128.5, 128.3, 126.3, 125.8, 118.3, 114.4, 74.2, 55.7, 42.8, 30.8; IR 
(film) 3027, 2933, 1814, 1652, 1609, 1512, 1260 cm-1; HRMS (ESI) calcd for C24H22NO3 
[M+H]+ m/z = 371.2600; found 372.1613.   
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2-(4-Methoxyphenyl)-4-(2-(naphthalen-2-yl)ethyl)-4-phenyloxazol-5(4H)-one (4.20). 
General procedure C was followed using 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 
mg, 0.056 mmol) in 2-ethylnaphthalene (175 µL, 1.12 mmol) and 1,4-dioxane (200 µL) 
at 90 °C for 24 h. Purification by column chromatography (eluent 8% EtOAc in hexanes) 
provided 4.20 (15.3 mg) in 65% yield: 1H NMR (500 MHz, CDCl3) δ 8.06 (d, J = 8.6 Hz, 
2H), 7.77 (d, J = 7.3 Hz, 1H), 7.75-7.68 (m, 4H), 7.57 (s, 1H), 7.45-7.36 (m, 4H), 7.33 (t, 
J = 7.3 Hz, 1H), 7.28 (d, J = 8.6 Hz, 1H), 7.02 (d, J = 9.0 Hz, 2H), 3.90 (s, 3H), 2.86-2.74 
(m, 2H), 2.65-2.52 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 179.0, 163.5, 160.3, 138.5, 
138.1, 133.7, 132.2, 130.2, 128.8, 128.3, 128.1, 127.7, 127.5, 127.2, 126.6, 126.1, 125.8, 
125.4, 118.2, 114.4, 74.2, 56.7, 42.6, 30.9; IR (film) 3056, 2930, 1813, 1652, 1608, 1511, 
1260 cm-1; HRMS (ESI) calcd for C28H23NO3Na [M+Na]+ m/z = 444.1576; found 
444.1571.   
 
2-(4-methoxyphenyl)-4-phenyl-4-(3-phenylpropyl)oxazol-5(4H)-one (4.21a). General 
procedure C was followed using 4.01 (15 mg, 0.056 mmol) and Pd(OAc)2 (12.5 mg, 
0.056 mmol) in propylbenzene (140 µL, 1.00 mmol) and 1,4-dioxane (200 µL) at 90 °C 
for 24 h. Purification by column chromatography (eluent 7% EtOAc in hexanes) provided 
4.21a (15.3 mg) in 62% yield as a yellow oil: 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 
9.1 Hz, 2H), 7.66 (d, J = 7.9 Hz, 2H), 7.37 (t, J = 7.5 Hz, 2H), 7.31 (t, J = 7.2 Hz, 1H), 
7.24 (d, J = 7.7 Hz, 2H), 7.16 (t, J = 7.3 Hz, 1H), 7.12 (d, J = 7.9 Hz, 2H), 7.00 (d, J = 
9.0 Hz, 2H), 3.89 (s, 3H), 2.70-2.55 (m, 2H), 2.30-2.18 (m, 2H), 1.71-1.61 (m, 2H); 13C 
NMR (125 MHz, CDCl3) δ 179.2, 163.4, 160.0, 141.6, 138.7, 130.1, 128.7, 128.5, 128.5, 
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128.2, 126.0, 125.8, 118.3, 114.4, 74.3, 55.7, 40.8, 35.7, 26.2; IR (film) 2952, 2933, 
1815, 1653, 1601, 1512, 1260 cm-1; HRMS (ESI) calcd for C25H24NO3 [M+H]+ m/z = 
386.1756; found 386.1739.   
 
2-(4-methoxyphenyl)-4-phenyl-4-(4-phenylbutyl)oxazol-5(4H)-one (4.21b). General 
procedure C was followed using 4.01 (20 mg, 0.075 mmol) and Pd(OAc)2 (16.9 mg, 
0.075 mmol) in butylbenzene (190 µL, 1.21 mmol) and 1,4-dioxane (270 µL) at 90 °C for 
24 h. Purification by column chromatography (eluent 7% EtOAc in hexanes) provided 
4.21b (13.8 mg) in 46% yield as a yellow oil: 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 
8.1 Hz, 2H), 7.67 (d, J = 8.1 Hz, 2H), 7.37 (t, J = 7.4 Hz, 2H), 7.31 (t, J = 7.4 Hz, 1H), 
7.23 (t, J = 7.5 Hz, 2H), 7.14 (t, J = 7.2 Hz, 2H), 7.10 (d, J = 7.5 Hz, 2H), 7.01 (d, J = 8.1 
Hz, 2H), 3.89 (s, 3H), 2.55 (t, J = 7.9 Hz, 2H), 2.22 (t, J = 8.2 Hz, 2H), 1.61 (m, 2H), 
1.37 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 179.3, 163.4, 160.0, 142.4, 138.8, 130.1, 
128.8, 128.4, 128.4, 128.2, 125.8, 125.8, 118.4, 114.4, 74.4, 55.7, 41.1, 35.8, 31.4, 24.1; 
IR (film) 2931, 2856, 1811, 1652, 1609, 1512, 1260 cm-1; HRMS (ESI) calcd for 
C26H26NO3 [M+H]+ m/z = 400.1913; found 400.1913.   
 
4-Cinnamyl-2-(4-methoxyphenyl)-4-phenyloxazol-5(4H)-one (4.21c). General 
procedure C was followed using 4.01 (20 mg, 0.075 mmol) and Pd(OAc)2 (16.9 mg, 
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0.075 mmol) in allylbenzene (188 µL, 1.25 mmol) and 1,4-dioxane (270 µL) at 95 °C for 
24 h. Purification by column chromatography (eluent 7% EtOAc in hexanes) provided 
4.21c (11.8 mg) in 41% yield as a yellow oil: 1H NMR (500 MHz, CDCl3) δ 8.02 (d, J = 
8.9 Hz, 2H), 7.74 (d, J = 8.3 Hz, 2H), 7.40 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 7.4 Hz, 1H), 
7.25-7.22 (m, 4H), 7.21-7.15 (m, 1H), 6.98 (d, J = 8.9 Hz, 2H), 6.52 (d, J = 15.7 Hz, 1H), 
6.04 (dt, J = 15.7, 7.5 Hz, 1H), 3.88 (s, 3H), 3.09 (d, J = 7.5 Hz, 2H); 13C NMR (125 
MHz, CDCl3) δ 178.5, 163.4, 160.1, 138.3, 137.0, 135.7, 130.1, 128.8, 128.6, 128.4, 
127.6, 126.5, 125.9, 122.2, 118.2, 114.4, 74.8, 55.6, 44.6; IR (film) 3027, 2934, 1815, 
1652, 1609, 1512, 1260 cm-1; HRMS (ESI) calcd for C25H22NO3 [M+H]+ m/z = 
384.1600; found 384.1587.   
Chart S4.1 Tolyl analogs explored with phenylglycine azlactone and Pd(OAc)2 at 95 °C 
for 7 h in neat solution. 
 
Chart S4.2 Alkyl analogs explored with phenylglycine azlactone and Pd(OAc)2 at 95 °C 
for 7 h in neat solution. 
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PME studies with 23 oxidants and 2 Pd sources (Table 4.7) 
 
To a 96-well reactor equipped with 1 mL vials was added the indicated oxidant 
(Table S2, entries 1-18, 0.010 mmol, 50 µL of a 0.2 M solution in toluene, respectively). 
The solvent was evacuated on a Genevac. To each vial was added 4.01 (0.005 mmol) and 
the indicated Pd source (0.0015 mmol) (100 µL of a 0.05 M solution in tolyl analog). 
Oxidants (Table S2, entries 19-23, 0.010 mmol) were added to the respective vial. The 
control reactions were prepared from a solution of 4.01 (0.005 mmol) and Pd source 
(0.005 mmol) (100 µL of a 0.05 M solution in tolyl analog) into the respective vial. A 
parylene stir-bar was added to each vial. The reactor block was sealed, removed from the 
glovebox and stirred for 13 h on an Alligator tumble stirrer (1000 rpm) at 90 °C. The 
reactions were quenched via dilution with a solution of internal standard in 25% 
DMSO/MeCN (1.0 µmol, 0.002 M, 500 µL), and the contents were stirred for 15 
minutes. Into a separate 96-well plate LC block was added 700 µL of MeCN and 25 µL 
of the diluted reaction mixtures. The 96-well plate LC block was sealed with a 
polypropylene 1 mL cap mat. The reaction mixtures were analyzed (P/IS and dimer/IS) 
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using an Agilent Technologies 1200 series HPLC with a 96 well-plate auto-sampler. 
Assay conditions: Acquity CORTECS BEH 1.6 µm C18; 50 mm x 2.1 mm; 1 mL/min; 
MeCN:H2O:NH4HCO2; gradient: 5% MeCN to 99% in 1.5 min, hold to 2.4 min to 5% 
MeCN at 2.41 min; ESC pos/neg; nebulizer: 700 L/h; cone gas: 30 L/h; source 150 °C; 
desolvation 450 °C; 210 nm: tR of 4.03 = 2.46, 4.19 = 2.73 and 4.23 = 2.73 min.   
 
Optimization of catalytic benzylation (Table 4.8, Table 4.9)  
 
Phenylglycine azlactone (4.01) (10 mg, 0.038 mmol) was added to a flame dried 8 
mL microwave vial equipped with stir bar and brought into the glovebox. Pd carboxylate 
was added, followed by additive and toluene (750 µL, 0.05 M). The microwave vial was 
sealed with a Teflon cap, removed from the glovebox and placed in a 95 °C oil bath. 
After 13 h, the mixture was allowed to cool to ambient temperature, diluted with CH2Cl2 
aDetermined by UPLC. bF+1 = 1-fluoropyridinium tetrafluoroborate. cF+2 = 1-fluoro-2,4,6-trimethylpyridinium triflate. 
dF+3 = N-fluorobenzenesulfonimide.
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(1 mL), passed through SiO2 with 30% EtOAc in hexanes, and concentrated in vacuo. 
The resulting residue was analyzed by 1H NMR and if necessary purified by column 
chromatography to afford 4.03. See above for characterization. 
PME screen of co-solvents with optimal catalytic conditions (Table 4.10)  
 
To a 24-well reactor equipped with 1 mL vials was added 4.01 (0.005 mmol) and 
2,6-DMBQ (0.005 mmol) in THF (100 µL of a 0.05 M solution). The solvent was 
evacuated on a Genevac. A solution of Pd carboxylate (0.0015 mmol) and PivOH (0.005 
mmol) (40 µL of a 0.038 M solution in co-solvent), respectively, was added to the 24-
well reactor. Toluene (22 µL, 0.1 mmol) and a parylene stir-bar were added to each vial. 
The reactor block was sealed, removed from the glovebox and stirred for 14 h on an 
Alligator tumble stirrer (1000 rpm) at 95 °C. The reactions were quenched via dilution 
with a solution of internal standard in 25% DMSO/MeCN (1.0 µmol, 0.002 M, 500 µL), 
and the contents were stirred for 15 minutes. Into a separate 96-well plate LC block was 
added 700 µL of MeCN and 25 µL of the diluted reaction mixtures. The 96-well plate LC 
block was sealed with a polypropylene 1 mL cap mat. The reaction mixtures were 
analyzed (P/IS and dimer/IS) using an Agilent Technologies 1200 series HPLC with a 96 
well-plate auto-sampler. Assay conditions: Supeclco Ascentis Express C18 column 100 
mm x 4.6 mm, 1.8 µm with reverse phase eluents (MeCN and 0.1 % H3PO4 in H2O); 1.8 
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mL/min; 10 % in MeCN to 95 % MeCN in 6 min, hold for 2 min. Post time 2 min. 
Column at 40 °C; 210 nm: tR of 4.01 = 4.7, 4.03 = 5.9 and 4.23 = 6.5 min.   
General Procedure D – Alkylation with catalytic Pd  
 
Phenylglycine azlactone (4.01) (15 mg, 0.056 mmol), Pd(OAc)2 (1.3 mg, 0.0056 
mmol), PivOH (5.7 mg, 0.056 mmol), 2,6-DMBQ (7.6 mg, 0.056 mmol) and charcoal (13 
mg, 10x weight of Pd)  were added to a flame dried 8 mL microwave vial equipped with 
stir bar and brought into the glovebox. The indicated tolyl analog (1.12 mmol) was added 
to the mixture followed by 1,4-dioxane (467 µL, 0.12 M). The microwave vial was sealed 
with a Teflon cap, removed from the glovebox, and placed in a 95 °C oil bath. After 45 h, 
the mixture was allowed to cool to ambient temperature, diluted with CH2Cl2 (1 mL), and 
purified directly by column chromatography to afford the alkylated azlactone.  
 
4-Benzyl-2-(4-methoxyphenyl)-4-phenyloxazol-5(4H)-one (4.03). General procedure D 
was followed using toluene (118 uL, 1.12 mmol). Purification by column 
chromatography (eluent 8% EtOAc in hexanes) provided 4.03 (16.3 mg) in 82% yield. 
See above for characterization. 
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2-(4-Methoxyphenyl)-4-(naphthalen-2-ylmethyl)-4-phenyloxazol-5(4H)-one (4.16). 
General procedure D was followed using 2-methylnaphthalene (159 mg, 1.12 mmol). 
Purification by column chromatography (eluent 8% EtOAc in hexanes) provided 4.16 
(20.1 mg) in 88% yield. See above for characterization. 
 
2-(4-Methoxyphenyl)-4-phenethyl-4-phenyloxazol-5(4H)-one (4.19). General 
procedure D was followed using ethylbenzene (137 uL, 1.12 mmol). Purification by 
column chromatography (eluent 8% EtOAc in hexanes) provided 4.19 (14.1 mg) in 68% 
yield. See above for characterization. 
KIE Studies: d8-toluene (Scheme  4.5) 
 
Phenylglycine azlactone (4.01) (10 mg, 0.038 mmol) was added to a flame dried 8 
mL microwave vial equipped with stir bar and brought into the glovebox. Pd(OAc)2 (8.4 
mg, 0.038 mmol) was added followed by toluene (138 µL, 1.5 mmol) and d8-toluene (150 
µL, 1.5 mmol). The microwave vial was sealed with a Teflon cap, removed from the 
glovebox and placed in a 95 °C oil bath. After 7 h, the mixture was allowed to cool to 
ambient temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 with 30% EtOAc 
in hexanes, and concentrated in vacuo. The resulting residue was purified by column 
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chromatography (7% EtOAc in hexanes) to afford a mixture of 4.03 and 4.03b (12 mg) in 
89% yield. Two trials were conducted and the kH/kD = 3.4 ± 0.15. 1H NMR (500 MHz, 
CDCl3) δ  7.86 (d, J = 8.7 Hz, 2H), 7.78 (d, J = 8.0 Hz, 2H), 7.40 (t, J = 7.7 Hz, 2H), 7.34 
(t, J = 7.3 Hz, 1H), 7.22-7.11 (m, 3.8H), 6.93 (d, J = 8.9 Hz, 2H), 3.86 (s, 3H), 3.51 (d, J 
= 13.4 Hz, 0.74H), 3.44 (d, J = 13.4 Hz, 0.77H). 
KIE Studies: d3-toluene (Scheme  4.5) 
 
Phenylglycine azlactone (4.01) (27 mg, 0.1 mmol) was added to a flame dried 8 
mL microwave vial equipped with stir bar and brought into the glovebox. Pd(OAc)2 (23 
mg, 0.1 mmol) was added followed by toluene (319 µL, 3.0 mmol) and d5-toluene (336 
µL, 3.0 mmol). The microwave vial was sealed with a Teflon cap, removed from the 
glovebox and placed in a 95 °C oil bath. After 7 h, the mixture was allowed to cool to 
ambient temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 with 30% EtOAc 
in hexanes, and concentrated in vacuo. The resulting residue was purified by column 
chromatography (7% EtOAc in hexanes) to afford a mixture of 4.03 and 4.03c (19 mg) in 
53% yield with kH/kD = 1.08. 1H NMR (500 MHz, CDCl3) 7.87 (d, J = 8.9 Hz, 2H), 7.79 
(d, J = 7.5 Hz, 2H), 7.41-7.34 (m, 3H), 7.21-7.15 (m, 2.6H), 6.93 (d, J = 8.8 Hz, 2H), 
3.86 (s, 3H), 3.52 (d, J = 13.4 Hz, 1H), 3.45 (d, J = 13.4 Hz, 1H). 
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Phenylglycine azlactone (4.01) (7.0 mg, 0.026 mmol) and Pd(OAc)2 (6.0 mg, 
0.026 mmol) were added to a flame dried 8 mL microwave vial equipped with stir bar 
and brought into the glovebox. d5-Toluene (200 µL, 2.0 mmol) was added to the mixture. 
The microwave vial was sealed with a Teflon cap, removed from the glovebox, and 
placed in a 95 °C oil bath. After 7 h, the mixture was allowed to cool to ambient 
temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 with 30% EtOAc in 
hexanes, and concentrated in vacuo. The resulting residue was purified by column 
chromatography (7% EtOAc in hexanes) to afford a mixture of 4.03c (9 mg) in 98% 
yield. 1H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 8.5 Hz, 2H), 7.78 (d, J = 8.1 Hz, 2H), 
7.41 (t, J = 7.6 Hz, 2H), 7.34 (t, J = 7.3 Hz, 1H), 6.93 (d, J = 8.5 Hz, 2H), 3.86 (s, 3H), 
3.51 (d, J = 13.4 Hz, 1H), 3.44 (d, J = 13.4 Hz, 1H).  
Deuterium scrambling with ethylbenzene (Scheme  4.6) 
 
Phenylglycine azlactone (4.01) (10 mg, 0.038 mmol) and Pd(OAc)2 (9.5 mg, 
0.038 mmol) were added to a flame dried 8 mL microwave vial equipped with a stir bar 
and brought into the glovebox. d2-Ethylbenzene (700 µL, 5.7 mmol) was added to the 
mixture. The microwave vial was sealed with a Teflon cap, removed from the glovebox 
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and placed in a 95 °C oil bath. After 12 h, the mixture was allowed to cool to ambient 
temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 with 30% EtOAc in 
hexanes, and concentrated in vacuo. The resulting residue was purified by column 
chromatography (7% EtOAc in hexanes) to afford 4.19b (3.1 mg) in 22% yield. 
Radical studies with ethylbenzene (Table 4.12) 
 
Phenylglycine azlactone (4.01) (11.2 mg, 0.042 mmol) and Pd(OAc)2 (1.9 mg, 
0.008 mmol) were added to a flame dried 8 mL microwave vial equipped with a stir bar 
and brought into the glovebox. A solution of di-tert-butyl peroxide [(t-BuO)2]] in 
ethylbenzene (855 µL, 0.1 M) was added to the mixture. The microwave vial was sealed 
with a Teflon cap, removed from the glovebox and placed in a 90 °C oil bath. After 14 h, 
the mixture was allowed to cool to ambient temperature, diluted with CH2Cl2 (1 mL), 
passed through SiO2 with 30% EtOAc in hexanes, and concentrated in vacuo. The 
resulting residue was purified by column chromatography (7% EtOAc in hexanes) to 
afford 4.19 (5.9 mg) in 38% yield. The remaining product was phenylglycine azlactone 
dimer. See above for characterization. 
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Phenylglycine azlactone (4.01) (60 mg, 0.23 mmol) was added to a flame dried 8 
mL microwave vial equipped with stir bar, and brought into the glovebox. A solution of 
(t-BuO)2  in ethylbenzene (4.58 mL, 0.1 M) was added. The microwave vial was sealed 
with a Teflon cap, removed from the glovebox and placed in a 125 °C oil bath. After 13 
h, the mixture was allowed to cool to ambient temperature, diluted with CH2Cl2 (2 mL), 
passed through SiO2 with 30% EtOAc in hexanes, and concentrated in vacuo. The 
resulting residue was purified by column chromatography (15% EtOAc in hexanes) to 
afford a 9:1 inseperable mixture of 4.22a and 4.22b (50 mg) in 60% yield. This mixture, 
which consisted of six isomers of 4.22a and 4.22b, was further analyzed in a 
collaboration with Erik Regalado and Christopher Welch at Merck Research 
Laboratories, Rahway, NJ.164 
 
Phenylglycine azlactone (4.01) (11.2 mg, 0.042 mmol) and Pd(OAc)2 (1.9 mg, 
0.008 mmol) were added to a flame dried 8 mL microwave vial equipped with a stir bar 
and brought into the glovebox. A solution of (t-BuO)2  in ethylbenzene (855 µL, 0.1 M) 
was added to the mixture. The microwave vial was sealed with a Teflon cap, removed 
from the glovebox and placed in a 125 °C oil bath. After 13 h, the mixture was allowed to 
cool to ambient temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 with 30% 
EtOAc in hexanes, and concentrated in vacuo. The resulting residue was purified by 
column chromatography (7% EtOAc in hexanes) to afford a 1:8:1 mixture of 4.19, 4.22b, 
and 4.22c.  
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Table 4.13 Radical scavengers study  
 
Phenylglycine azlactone (4.01) (10 mg, 0.037 mmol) and radical scavenger (0.019 
mmol) were added to a flame dried 8 mL microwave vial equipped with a stir bar and 
brought into the glovebox. Pd(OAc)2 (8.3 mg, 0.037 mmol) was added followed by 
toluene (370 µL, 3.7 mmol). The microwave vial was sealed with a Teflon cap, removed 
from the glovebox, and placed in a 95 °C oil bath. After 16 h, the mixture was allowed to 
cool to ambient temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 with 30% 
EtOAc in hexanes, and concentrated in vacuo. The resulting residue was purified by 
column chromatography (7% EtOAc in hexanes) to afford 4.03. See above for 
characterization. 
 
 
2,2'-bis(4-Methoxyphenyl)-4,4'-diphenyl-[4,4'-bioxazole]-5,5'(4H,4'H)-dione (4.23). 
Phenylglycine azlactone (4.01) (60 mg, 0.23 mmol), Pd(OAc)2 (2.5 mg, 0.011 mmol) and 
Ag2O (52 mg, 0.23 mmol) were added to a flame dried 8 mL microwave vial equipped 
with a stir bar and brought into the glovebox. Toluene (2.3 mL, 0.1 M) was added to the 
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mixture. The microwave vial was sealed with a Teflon cap, removed from the glovebox 
and allowed to stir at ambient temperature. After 5 h, the mixture was purified directly by 
column chromatography (20% EtOAc in hexanes) to afford 4.23 (50 mg) in 83% yield. A 
single crystal for X-ray structural analysis was obtained by slow-evaporation from 
CH2Cl2. 1H NMR (500 MHz, CDCl3) δ major: 7.88 (d, J = 8.7 Hz, 2H), 7.44 (d, J = 7.6 
Hz, 2H), 7.20 (m, 3H), 6.85 (d, J = 8.7 Hz, 2H), 3.82 (s, 3H); minor: 7.9.4 (d, J = 8.7 Hz, 
2H), 7.69 (d, J = 7.6 Hz, 2H), 7.30 (m, 3H), 6.90 (d, J = 8.7 Hz, 2H), 3.87 (s, 3H). 
Spectral data matched those reported previously by Marquez.166  
Dimer with catalytic Pd (Scheme  4.7) 
 
Phenylglycine azlactone dimer (4.23) (10.0 mg, 0.019 mmol) and Pd(OAc)2 (1.1 
mg, 0.0049 mmol) were added to a flame dried 8 mL microwave vial equipped with a stir 
bar, and brought into the glovebox. Toluene (375 µL, 0.1 M) was added to the mixture. 
The microwave vial was sealed with a Teflon cap, removed from the glovebox and 
placed in a 95 °C oil bath. After 5 h, the mixture was allowed to cool to ambient 
temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 with 30% EtOAc in 
hexanes, and concentrated in vacuo. The resulting residue was purified by column 
chromatography (7% EtOAc in hexanes) to afford 4.03 (9.5 mg) in 72% yield. See above 
for characterization. 
Dimer with Pd(TFA)2 complex (Figure 4.8) 
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Phenylglycine azlactone dimer (4.23) (25 mg, 0.047 mmol) and Pd(TFA)2 (17.4 
mg, 0.0052 mmol) were added to an NMR tube equipped with a J Young valve. The 
reaction mixture was put under argon and C6D6 (524 µL, 0.1 M), which had been sparged 
with argon, was added. The NMR tube was sealed and placed in a 60 °C oil bath. After 
24 h, the mixture was allowed to cool to ambient temperature, and subsequently decanted 
from the black precipitate formed during heating and concentrated in vacuo. A single 
crystal for X-ray structural analysis was obtained by dissolving the resulting residue in 
THF, layering hexanes on top and storing the mixture in a -8 °C freezer overnight. 1H 
NMR (500 MHz, CDCl3) δ 9.53 (d, J = 7.9 Hz, 2H), 7.94 (d, J = 9.0 Hz, 2H), 7.32 (t, J = 
8.0 Hz, 2H), 6.90 (t, J = 7.5 Hz, 1H), 6.41 (d, J = 9.2 Hz, 2H), 3.00 (s, 3H).  
Dimer-Pd complex with toluene (Scheme  4.8) 
 
Phenylglycine azlactone dimer (4.24) (8 mg, 0.015 mmol) and Pd(TFA)2 (5.5 mg, 
0.017 mmol) were added to an NMR tube equipped with a J Young valve. The reaction 
mixture was put under argon and C6D6 (524 µL, 0.1 M), that had been sparged with 
argon, was added. The NMR tube was sealed and placed in a 60 °C oil bath. After 24 h, 
N
O
O
PMP
O
NO
PMP
PhPh
Pd(TFA)2 (1.05 equiv)
C6H6
60 °C, 24 h
O
N
O
N
Ph
Ph
O
O
PMP
PMP
Pd
O
O
O
CF3
O
CF3
4.244.23
C6H6
95 °C, 4 h
CH3
+
(40 equiv)
O
N
PMP
O
Ph H H
4.03
O
N
O
N
Ph
Ph
O
O
PMP
PMP
Pd
O
O
O
CF3
O
CF3
4.24
 
195 
the mixture was allowed to cool to ambient temperature. Toluene (165 µL, 0.1 M) was 
added and the mixture was placed in a 95 °C oil bath. After 4 h, the mixture was allowed 
to cool to ambient temperature and purified directly by column chromatography (7% 
EtOAc in hexanes) to afford 4.03 (4.0 mg) in 37% yield. See above for characterization. 
Dimer crossover experiment (Scheme  4.9) 
 
Phenylglycine azlactone dimer (4.23) (6.3 mg, 0.012 mmol), phenylglycine 
azlactone dimer (4.25) (5.6 mg, 0.012 mmol) and additive [Pd(OAc)2 (5.4 mg, 0.024 
mmol] or no additive was added to a flame dried 8 mL microwave vial equipped with a 
stir bar and brought into the glovebox. To each mixture, benzene (240 µL, 0.1 M) was 
added. The microwave vial was sealed with a Teflon cap, removed from the glovebox 
and placed in an 90 °C oil bath. After 12 h, each mixture was allowed to cool to ambient 
temperature, diluted with CH2Cl2 (1 mL), and purified directly by column 
chromatography (15% EtOAc in hexanes) to afford only recovered 4.23 and 4.25. 
Analysis by UPLC MS suggested dimer mixing, but further investigation with a control 
(4.23 and 4.25 mixed together at rt and analyzed) revealed ionization causes mixing 
during the MS analysis.  
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4-Benzyl-2,4-bis(4-methoxyphenyl)oxazol-5(4H)-one (4.27). General procedure B was 
followed using para-methoxy-phenylglycine azlactone (11.5 mg, 0.037 mmol ) and 
Pd(OAc)2 (8.3 mg, 0.037 mmol) in toluene (750 µL,  5.4 mmol). The mixture was 
allowed to stir at 95 °C for 5 h and purification by column chromatography provided 4.27 
(9.0 mg) in 70% yield: 1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 8.9 Hz, 2H), 7.68 (d, J 
= 9.1 Hz, 2H), 7.22-7.11 (m, 5H), 6.93 (d, J = 8.9 Hz, 4H), 3.86 (s, 3H), 3.82 (s, 3H), 
3.49 (d, J = 13.4 Hz, 1H), 3.41 (d, J = 13.4 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 
178.7, 163.2, 159.6, 159.6, 134.5, 130.6, 130.5, 129.9, 128.2, 127.3, 127.2, 118.2, 114.2, 
114.1, 75.2, 55.6, 55.5, 47.3; IR (film) 2932, 1812, 1653, 1608, 1511, 1255 cm-1; HRMS 
(ESI) calcd for C24H22NO4 [M+H]+ m/z = 388.1549; found 388.1549. 
 
4-Benzyl-4-(4-chlorophenyl)-2-(4-methoxyphenyl)oxazol-5(4H)-one (4.28). General 
procedure B was followed using para-chloro-phenylglycine azlactone (11.7 mg, 0.037 
mmol ) and Pd(OAc)2 (8.3 mg, 0.037 mmol) in toluene (750 µL,  5.4 mmol). The mixture 
was allowed to stir at 95 °C for 5 h and purification by column chromatography provided 
4.28 (9.3 mg) in 68% yield.  
Benzylation of valine azlactone (Scheme  4.11) 
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General procedure B was followed using 4.29 (15 mg, 0.064 mmol ) and 
Pd(OAc)2 (14.5 mg, 0.064 mmol) in toluene (640 µL). The mixture was allowed to stir at 
95 °C for 45 h and purification by column chromatography provided an inseparable 3.3:1 
mixture 4.30 and 4.31 (15.6 mg) in 81% overall yield.  
 
General procedure B was followed using 4.29 (15 mg, 0.064 mmol) and 
Pd(OAc)2 (14.5 mg, 0.064 mmol) in benzene (640 µL, 0.1 M). The mixture was allowed 
to stir at 95 °C for 45 h and purification by column chromatography provided 4.31 (6.3 
mg) in 43% overall yield as a white solid: 1H NMR (500 MHz, CDCl3) δ 7.99 (d, J = 8.9 
Hz, 2H), 6.97 (d, J = 8.9 Hz, 2H), 3.88 (s, 3H), 2.40 (s, 3H), 2.32 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 165.8, 161.2, 159.2, 131.9, 129.7, 118.6, 114.4, 55.6, 22.9, 19.9; (ESI) 
calcd for C13H14NO2 [M+H]+ m/z = 232.0974; found 232.0973. 
Synthesis of O-acyl phenylglycine azlactone 
 
2-(4-Methoxyphenyl)-4-phenyloxazol-5-yl acetate (4.32). Phenylglycine azlactone 
(4.01) (60 mg, 0.23 mmol) was added to a flame dried 8 mL microwave vial equipped 
with stir bar, under argon and was dissolved in THF (600 uL, 0.38 M). The mixture was 
cooled to 0 °C and NEt3 (47 µL, 0.34 mmol) was added and allowed to stir for 5 minutes. 
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A solution of acyl chloride (0.34 mmol, 325 µL of a 1.0 M solution in THF) was added 
dropwise to the mixture. After 40 min, the white precipitate was removed by filtration 
and the solution was concentrated in vacuo. The resulting residue was dissolved in 
EtOAc (10 mL) and washed with 1 M HCl (5 mL), dried over Na2SO4, filtered and 
concentrated in vacuo. The resulting solid was purified by column chromatography (15% 
EtOAc in hexanes) to afford 4.32 (42 mg) in 61% yield: 1H NMR (500 MHz, CDCl3) δ 
7.98 (d, J = 9.0 Hz, 2H), 7.77 (d, J = 7.3 Hz, 2H), 7.43 (t, J = 7.7 Hz, 2H), 7.31 (t, J = 7.4 
Hz, 1H), 6.97 (d, J = 8.9 Hz, 2H), 3.87 (s, 3H), 2.44 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 167.3, 161.5, 155.6, 144.9, 130.4, 128.8, 127.9, 127.8, 125.9, 123.7, 120.0, 
114.3, 55.5, 20.6; IR (film) 3004, 2932, 2839, 1799, 1645, 1615, 1502, 1256, 1161 cm-1; 
HRMS (ESI) calcd for C18H16NO4 [M+H]+ m/z = 310.1079 ; found 310.1085.   
Benzylation of O-acylazlactone (Scheme  4.12) 
 
Stoichiometric conditions: O-Acyl azlactone (4.32) (4.2 mg, 0.014 mmol) and Pd(OAc)2 
(3.0 mg, 0.014 mmol) were added to a flame dried 8 mL microwave vial equipped with a 
stir bar and brought into the glovebox. Toluene (135 µL, 0.1 M) was added to the 
mixture. The microwave vial was sealed with a Teflon cap, removed from the glovebox 
and placed in a 90 °C oil bath. After 5 h, the reaction mixture was allowed to cool to 
ambient temperature, diluted with CH2Cl2 (1 mL), passed through SiO2 with 30% EtOAc 
in hexanes, and concentrated in vacuo to afford 4.03 (4.5 mg) in 94% yield. See above for 
characterization. 
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Catalytic conditions: O-Acyl azlactone (4.32) (10 mg, 0.032 mmol) and Pd(OAc)2 (1.5 
mg, 0.006 mmol) were added to a flame dried 8 mL microwave vial equipped with a stir 
bar and brought into the glovebox. Toluene (324 µL, 0.1 M) was added to the mixture. 
The microwave vial was sealed with a Teflon cap, removed from the glovebox and 
sparged with an O2 atmosphere  for 5 min. The microwave vial was placed in a 95 °C oil 
bath. After 23 h, the reaction mixture was allowed to cool to ambient temperature, diluted 
with CH2Cl2 (1 mL) and purified directly by column chromatography (7% EtOAc in 
hexanes) to afford 4.03 (6.3 mg) in 53% yield. See above for characterization. 
 
1-Benzyl-1-methyl-3,4-dihydronaphthalen-2(1H)-one (4.34). General procedure B was 
followed using 1-methyl-β-tetralone (5.9 mg, 0.038 mmol ) and Pd(OAc)2 (8.4 mg, 0.038 
mmol) in toluene (750 µL). The mixture was allowed to stir at 90 °C for 5 h and 
purification by column chromatography provided 4.34 (4.1 mg) in 43% yield. Spectral 
data agreed with those reported previously by Miller.184 
 
1,3-Dibenzyl-3-(4-methoxyphenyl)indolin-2-one (4.36). General procedure B was 
followed using oxindole (4.35) (15 mg, 0.046 mmol) and Pd(OAc)2 (10.4 mg, 0.046 
                                                
184) Shi, X.; Miller, B. “Cyclization and Rearrangement Processes Resulting from Bromination of 3-
Benzylcycloalkenes” J. Org. Chem. 1993, 58, 2907-2909.  
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mmol) in toluene (460 µL). The mixture was allowed to stir at 90 °C for 5 h and 
purification by column chromatography (10% EtOAc in hexanes) provided 4.36 (16 mg) 
in 83% yield: 1H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 8.9 Hz, 2H), 7.35-7.31 (m, 1H), 
7.20-7.03 (m, 8H), 6.97-6.87 (m, 4H), 6.67 (d, J = 7.3 Hz, 2H), 6.46-6.41 (m, 1H), 4.90 
(d, J = 16.1 Hz, 1H), 4.53 (d, J = 15.9 Hz, 1H), 3.84-3.77 (m, 4H), 3.51 (d, J = 12.9 Hz, 
1H); 13C NMR (125 MHz, CDCl3) δ 178.1, 159.0, 143.1, 136.0, 135.4, 132.4, 131.5, 
130.6, 128.7, 128.4, 128.2, 127.9, 127.2, 126.8, 126.7, 125.6, 122.3, 114.1, 109.6, 57.8, 
55.4, 44.0, 43.8; IR (film) 2925, 1711, 1610, 1510, 1252, 1182 cm-1; HRMS (ESI) calcd 
for C29H26NO2 [M+H]+ m/z = 420.1964; found 420.1958. 
Chart S4.3 Acidic C−H partners explored in neat toluene solution at 95 °C with 
Pd(OAc)2 (100 mol %) for 7 h. 
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APPENDIX A: SPECTROSCOPIC DATA 
 
Figure A. 1.01c_1 1H NMR spectrum of compound 1.01c (500 MHz, CDCl3) 
 
Figure A. 1.01c_2 13C NMR spectrum of compound 1.01c (125 MHz, CDCl3) 
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Figure A. 1.01d_1 1H NMR spectrum of compound 1.01d (500 MHz, CDCl3) 
 
Figure A. 1.01d_2 13C NMR spectrum of compound 1.01d (125 MHz, CDCl3) 
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Figure A. 1.01s_1 1H NMR spectrum of compound 1.01s (500 MHz, CDCl3) 
 
Figure A. 1.01s_2 13C NMR spectrum of compound 1.01s (125 MHz, CDCl3) 
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Figure A.1.01s_3 IR spectrum of compound 1.01s. 
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Figure A. 1.03a_1 1H NMR spectrum of compound 1.03a (500 MHz, CDCl3) 
 
Figure A. 1.03a_2 13C NMR spectrum of compound 1.03a (125 MHz, CDCl3) 
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Figure A.1.03a_3 IR spectrum of compound 1.03a 
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Figure A. 1.03c_1 1H NMR spectrum of compound 1.03c (500 MHz, CDCl3) 
 
Figure A. 1.03c_2 13C NMR spectrum of compound 1.03c (125 MHz, CDCl3) 
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Figure A.1.03c_3 IR spectrum of compound 1.03c 
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Figure A. 1.03d_1 1H NMR spectrum of compound 1.03d (500 MHz, CDCl3) 
 
Figure A. 1.03d_2 13C NMR spectrum of compound 1.03d (125 MHz, CDCl3) 
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Figure A.1.03d_3 IR spectrum of compound 1.03d 
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Figure A. 1.03e_1 1H NMR spectrum of compound 1.03e (500 MHz, (CD3)2O) 
 
Figure A. 1.03e_2 13C NMR spectrum of compound 1.03e (125 MHz, (CD3)2O) 
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Figure A. 1.03f_1 1H NMR spectrum of compound 1.03f (500 MHz, CDCl3) 
 
Figure A. 1.03f_2 13C NMR spectrum of compound 1.03f (125 MHz, CDCl3) 
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Figure A. 1.03j_1 1H NMR spectrum of compound 1.03j (500 MHz, CDCl3) 
 
Figure A. 1.03j_2 13C NMR spectrum of compound 1.03j (125 MHz, CDCl3) 
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Figure A. 1.03k_1 1H NMR spectrum of compound 1.03k (500 MHz, CDCl3) 
 
Figure A. 1.03k_2 13C NMR spectrum of compound 1.03k (125 MHz, CDCl3) 
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Figure A. 1.03o_1 1H NMR spectrum of compound 1.03o (500 MHz, CDCl3) 
 
Figure A. 1.03o_2 13C NMR spectrum of compound 1.03o (125 MHz, CDCl3) 
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Figure A.1.03o_3 IR spectrum of compound 1.03o 
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Figure A. 1.03p_1 1H NMR spectrum of compound 1.03p (500 MHz, CDCl3) 
 
Figure A. 1.03p_2 13C NMR spectrum of compound 1.03p (125 MHz, CDCl3) 
1.03p
N PMP
O
OMe
Ph
Et
Cl
 
218 
 
Figure A.1.03p_3 IR spectrum of compound 1.03p 
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Figure A. 1.03q_1 1H NMR spectrum of compound 1.03q (500 MHz, CDCl3) 
 
Figure A. 1.03q_2 13C NMR spectrum of compound 1.03q (125 MHz, CDCl3) 
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Figure A.1.03q_3 IR spectrum of compound 1.03q 
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Figure A. 1.03r_1 1H NMR spectrum of compound 1.03r (500 MHz, CDCl3) 
 
Figure A. 1.03r_2 13C NMR spectrum of compound 1.03r (125 MHz, CDCl3) 
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Figure A.1.03r_3 IR spectrum of compound 1.03r 
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Figure A. 1.03t_1 1H NMR spectrum of compound 1.03t (500 MHz, CDCl3) 
 
Figure A. 1.03t_2 13C NMR spectrum of compound 1.03t (125 MHz, CDCl3) 
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Figure A.1.03t_3 IR spectrum of compound 1.03t 
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Figure A. 1.03u_1 1H NMR spectrum of compound 1.03u (500 MHz, CDCl3) 
 
Figure A. 1.03u_2 13C NMR spectrum of compound 1.03u (125 MHz, CDCl3) 
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Figure A.1.03u_3 IR spectrum of compound 1.03qu 
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Figure A. 1.03x_1 1H NMR spectrum of compound 1.03x (500 MHz, CDCl3) 
 
Figure A. 1.03x_2 13C NMR spectrum of compound 1.03x (125 MHz, CDCl3) 
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Figure A.1.03x_3 IR spectrum of compound 1.03x 
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Figure A. 1.03y_1 1H NMR spectrum of compound 1.03y (500 MHz, CDCl3) 
 
Figure A. 1.03y_2 13C NMR spectrum of compound 1.03y (125 MHz, CDCl3) 
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Figure A.1.03y_3 IR spectrum of compound 1.03y 
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Figure A. 1.03z_1 1H NMR spectrum of compound 1.03z (500 MHz, CDCl3) 
 
Figure A. 1.03z_2 13C NMR spectrum of compound 1.03z (125 MHz, CDCl3) 
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Figure A.1.03z_3 IR spectrum of compound 1.03z 
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Figure A. 1.03aa_1 1H NMR spectrum of compound 1.03aa (500 MHz, CDCl3) 
 
Figure A. 1.03aa_2 13C NMR spectrum of compound 1.03aa (125 MHz, CDCl3) 
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Figure A.1.03aa_3 IR spectrum of compound 1.03aa 
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Figure A. 1.03bb_1 1H NMR spectrum of compound 1.03bb (500 MHz, CDCl3) 
 
Figure A. 1.03bb_2 13C NMR spectrum of compound 1.03bb (125 MHz, CDCl3) 
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Figure A.1.03bb_3 IR spectrum of compound 1.03bb 
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Figure A. 1.03cc_1 1H NMR spectrum of compound 1.03cc (500 MHz, CDCl3) 
 
Figure A. 1.03cc_2 13C NMR spectrum of compound 1.03cc (125 MHz, CDCl3) 
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Figure A.1.03cc_3 IR spectrum of compound 1.03cc 
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Figure A. 1.03dd_1 1H NMR spectrum of compound 1.03dd (500 MHz, CDCl3) 
 
Figure A. 1.03dd_2 13C NMR spectrum of compound 1.03dd (125 MHz, CDCl3) 
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Figure A.1.03dd_3 IR spectrum of compound 1.03dd 
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Figure A. 1.03ee_1 1H NMR spectrum of compound 1.03ee (500 MHz, CDCl3) 
 
Figure A. 1.03ee_2 13C NMR spectrum of compound 1.03ee (125 MHz, CDCl3) 
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Figure A.1.03ee_3 IR spectrum of compound 1.03ee 
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Figure A. 2.02h_1 1H NMR spectrum of compound 2.02h (500 MHz, CDCl3) 
 
Figure A. 2.02h _2 13C NMR spectrum of compound 2.02h (125 MHz, CDCl3) 
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Figure A. 2.02h _3 IR spectrum of compound 2.02h 
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Figure A. 2.02i_1 1H NMR spectrum of compound 2.02i (500 MHz, CDCl3) 
 
Figure A. 2.02i _2 13C NMR spectrum of compound 2.02i (125 MHz, CDCl3) 
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Figure A. 2.02i_3 IR spectrum of compound 2.02i 
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Figure A. 2.02j_1 1H NMR spectrum of compound 2.02j (500 MHz, CDCl3) 
 
Figure A. 2.02j_2 13C NMR spectrum of compound 2.02j (125 MHz, CDCl3) 
2.02j
OMe
N
O
PMPEt
Ph
MeO
O
 
248 
 
Figure A. 2.02j _3 IR spectrum of compound 2.02j 
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Figure A. 2.06_1 1H NMR spectrum of compound 2.06 (500 MHz, CDCl3) 
 
Figure A. 2.06_2 13C NMR spectrum of compound 2.06 (125 MHz, CDCl3) 
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Figure A. 2.06_3 IR spectrum of compound 2.06 
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Figure A. 2.07_1 1H NMR spectrum of compound 2.07 (500 MHz, CDCl3) 
 
Figure A. 2.07_2 13C NMR spectrum of compound 2.07 (125 MHz, CDCl3) 
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Figure A. 2.07_3 IR spectrum of compound 2.07 
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Figure A. 2.17a_1 1H NMR spectrum of compound 2.17a (500 MHz, CDCl3) 
 
Figure A. 2.17a_2 13C NMR spectrum of compound 2.17a (125 MHz, CDCl3) 
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Figure A. 2.17a_3 IR spectrum of compound 2.17a 
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Figure A. 2.23_1 1H NMR spectrum of compound 2.23 (500 MHz, CDCl3) 
 
Figure A. 2.23_2 13C NMR spectrum of compound 2.23 (125 MHz, CDCl3) 
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Figure A. 2.23_3 IR spectrum of compound 2.23 
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Figure A. 2.29_1 1H NMR spectrum of compound 2.29 (500 MHz, CDCl3) 
 
 
Figure A. 2.29_2 13C NMR spectrum of compound 2.29 (125 MHz, CDCl3) 
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Figure A. 2.29_3 IR spectrum of compound 2.29 
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Figure A. 2.30_1 1H NMR spectrum of compound 2.30 (500 MHz, CDCl3) 
 
Figure A. 2.30_2 13C NMR spectrum of compound 2.30 (125 MHz, CDCl3) 
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Figure A. 2.30_3 IR spectrum of compound 2.30 
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Figure A. 2.31_1 1H NMR spectrum of compound 2.31 (500 MHz, CDCl3) 
 
Figure A. 2.31_2 13C NMR spectrum of compound 2.31 (125 MHz, CDCl3) 
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Figure A. 2.31_3 IR spectrum of compound 2.31 
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Figure A. 2.32_1 1H NMR spectrum of compound 2.32 (500 MHz, CDCl3) 
 
Figure A. 2.32_2 13C NMR spectrum of compound 2.32 (125 MHz, CDCl3) 
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Figure A. 2.32_3 IR spectrum of compound 2.32 
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Figure A. 2.33_1 1H NMR spectrum of compound 2.33 (500 MHz, CDCl3) 
 
Figure A. 2.33_2 13C NMR spectrum of compound 2.33 (125 MHz, CDCl3) 
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Figure A. 2.33_3 IR spectrum of compound 2.33 
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Figure A. 2.34_1 1H NMR spectrum of compound 2.34 (500 MHz, CDCl3) 
 
Figure A. 2.34_2 13C NMR spectrum of compound 2.34 (125 MHz, CDCl3) 
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Figure A. 2.34_3 IR spectrum of compound 2.34 
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Figure A. 2.35_1 1H NMR spectrum of compound 2.35 (500 MHz, CDCl3) 
 
Figure A. 2.35_2 13C NMR spectrum of compound 2.35 (125 MHz, CDCl3) 
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Figure A. 2.35_3 IR spectrum of compound 2.35 
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Figure A. 3.14_1 1H NMR spectrum of compound 3.14 (500 MHz, CDCl3) 
 
Figure A. 3.14_2 13C NMR spectrum of compound 3.14 (125 MHz, CDCl3) 
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Figure A. 3.14_3 IR spectrum of compound 3.14 
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Figure A. 4.01_1 1H NMR spectrum of compound 4.01 (500 MHz, CDCl3) 
 
Figure A. 4.01_2 13C NMR spectrum of compound 4.01 (125 MHz, CDCl3) 
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Figure A. 4.01_3 IR spectrum of compound 4.01 
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Figure A. 4.03_1 1H NMR spectrum of compound 4.03 (500 MHz, CDCl3) 
 
Figure A. 4.03_2 13C NMR spectrum of compound 4.03 (125 MHz, CDCl3) 
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Figure A. 4.03_3 IR spectrum of compound 4.03 
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Figure A. 4.09_1 1H NMR spectrum of compound 4.09 (500 MHz, CDCl3) 
 
Figure A. 4.09_2 13C NMR spectrum of compound 4.09 (125 MHz, CDCl3) 
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Figure A. 4.09_3 IR spectrum of compound 4.09 
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Figure A. 4.10_1 1H NMR spectrum of compound 4.10 (500 MHz, CDCl3) 
 
Figure A. 4.10_2 13C NMR spectrum of compound 4.10 (125 MHz, CDCl3) 
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Figure A. 4.10_3 IR spectrum of compound 4.10 
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Figure A. 4.11_1 1H NMR spectrum of compound 4.11 (500 MHz, CDCl3) 
 
Figure A. 4.11_2 13C NMR spectrum of compound 4.11 (125 MHz, CDCl3) 
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Figure A. 4.11_3 IR spectrum of compound 4.11 
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Figure A. 4.12_1 1H NMR spectrum of compound 4.12 (500 MHz, CDCl3) 
 
Figure A. 4.12_2 13C NMR spectrum of compound 4.12 (125 MHz, CDCl3) 
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Figure A. 4.13_1 1H NMR spectrum of compound 4.13 (500 MHz, CDCl3) 
 
Figure A. 4.13_2 13C NMR spectrum of compound 4.13 (125 MHz, CDCl3) 
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Figure A. 4.13_3 IR spectrum of compound 4.13 
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Figure A. 4.15_1 1H NMR spectrum of compound 4.15 (500 MHz, CDCl3) 
 
Figure A. 4.15_2 13C NMR spectrum of compound 4.15 (125 MHz, CDCl3) 
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Figure A. 4.15_3 IR spectrum of compound 4.15 
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Figure A. 4.16_1 1H NMR spectrum of compound 4.16 (500 MHz, CDCl3) 
 
Figure A. 4.16_2 13C NMR spectrum of compound 4.16 (125 MHz, CDCl3) 
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Figure A. 4.16_3 IR spectrum of compound 4.16 
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Figure A. 4.17_1 1H NMR spectrum of compound 4.17 (500 MHz, CDCl3) 
 
Figure A. 4.17_2 13C NMR spectrum of compound 4.17 (125 MHz, CDCl3) 
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Figure A. 4.17_3 IR spectrum of compound 4.17 
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Figure A. 4.18_1 1H NMR spectrum of compound 4.18 (500 MHz, CDCl3) 
 
Figure A. 4.18_2 13C NMR spectrum of compound 4.18 (125 MHz, CDCl3) 
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Figure A. 4.18_3 IR spectrum of compound 4.18 
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Figure A. 4.19_1 1H NMR spectrum of compound 4.19 (500 MHz, CDCl3) 
 
Figure A. 4.19_2 13C NMR spectrum of compound 4.19 (125 MHz, CDCl3) 
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Figure A. 4.19_3 IR spectrum of compound 4.19 
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Figure A. 4.20_1 1H NMR spectrum of compound 4.20 (500 MHz, CDCl3) 
 
Figure A. 4.20_2 13C NMR spectrum of compound 4.20 (125 MHz, CDCl3) 
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Figure A. 4.20_3 IR spectrum of compound 4.20 
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Figure A. 4.21a_1 1H NMR spectrum of compound 4.21a (500 MHz, CDCl3) 
 
Figure A. 4.21a_2 13C NMR spectrum of compound 4.21a (125 MHz, CDCl3) 
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Figure A. 4.21a_3 IR spectrum of compound 4.21a 
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Figure A. 4.21b_1 1H NMR spectrum of compound 4.21b (500 MHz, CDCl3) 
 
Figure A. 4.21b_2 13C NMR spectrum of compound 4.21b (125 MHz, CDCl3) 
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Figure A. 4.21b_3 IR spectrum of compound 4.21b 
O
N
PM
P
O
Ph
H
H
H
H
4.
21
b
 
302 
 
Figure A. 4.21c_1 1H NMR spectrum of compound 4.21c (500 MHz, CDCl3) 
 
Figure A. 4.21c_2 13C NMR spectrum of compound 4.21c (125 MHz, CDCl3) 
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Figure A. 4.21c_3 IR spectrum of compound 4.21c 
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Figure A. 4.27_1 1H NMR spectrum of compound 4.27 (500 MHz, CDCl3) 
 
Figure A. 4.27_2 13C NMR spectrum of compound 4.27 (125 MHz, CDCl3) 
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Figure A. 4.27_3 IR spectrum of compound 4.27 
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Figure A. 4.31_1 1H NMR spectrum of compound 4.31 (500 MHz, CDCl3) 
 
Figure A. 4.31_2 13C NMR spectrum of compound 4.31 (125 MHz, CDCl3) 
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Figure A. 4.32_1 1H NMR spectrum of compound 4.32 (500 MHz, CDCl3) 
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Figure A. 4.32_2 13C NMR spectrum of compound 4.32 (125 MHz, CDCl3) 
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Figure A. 4.32_3 IR spectrum of compound 4.32 
 
Figure A. 4.36_1 1H NMR spectrum of compound 4.36 (500 MHz, CDCl3) 
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Figure A. 4.36_2 13C NMR spectrum of compound 4.36 (125 MHz, CDCl3) 
 
Figure A. 4.36_3 IR spectrum of compound 4.36 
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Appendix B: X-Ray Crystallographic Data185 
B.1. X-Ray Structure Determination of Compound 1.03t 
       
Compound 1.03t, C31H31NO3, crystallizes in the orthorhombic space group P212121 
(systematic absences h00:  h=odd, 0k0:  k=odd, and 00l:  l=odd) with a=9.1082(8)Å, 
b=9.9885(8)Å, c=27.957(2)Å, V=2543.5(4)Å3, Z=4, and dcalc=1.216 g/cm3 . X-ray intensity data 
were collected on a Bruker APEXII CCD area detector employing graphite-monochromated Cu-
Kα radiation (λ=1.54178 Å) at a temperature of 143(1)K. Preliminary indexing was performed 
from a series of thirty-six 0.5° rotation frames with exposures of 10 seconds. A total of 3210 
frames were collected with a crystal to detector distance of 37.6 mm, rotation widths of 0.5° and 
exposures of 15 seconds:  
scan type 2θ ω φ χ frames 
φ 92.00 88.66 348.71 -26.26 739 
φ 17.00 30.20 333.95 -55.24 739 
φ 92.00 132.53 152.05 -22.49 415 
φ 17.00 346.55 43.16 65.91 79 
ω -23.00 331.76 256.68 -41.06 211 
φ 87.00 76.65 30.72 62.65 739 
ω 92.00 5.74 317.53 90.29 117 
                                                
185) Dr. Patrick J. Carroll is gratefully acknowledged for solving the crystal structure of each compound. 
N
O
OMe
OMe
 
312 
ω 92.00 152.22 266.47 -93.68 171 
 Rotation frames were integrated using SAINT186, producing a listing of unaveraged F2 
and σ(F2) values which were then passed to the SHELXTL187 program package for further 
processing and structure solution. A total of 15711 reflections were measured over the ranges 
3.16 ≤ θ ≤ 64.73°, -8 ≤ h ≤ 10, -11 ≤ k ≤ 11, -31 ≤ l ≤ 32 yielding 4236 unique reflections (Rint = 
0.0217). The intensity data were corrected for Lorentz and polarization effects and for absorption 
using SADABS188 (minimum and maximum transmission 0.6909, 0.7525). 
The structure was solved by direct methods (SHELXS-97189). Refinement was by full-
matrix least squares based on F2 using SHELXL-97. 190  All reflections were used during 
refinement. The weighting scheme used was w=1/[σ2(Fo2 )+ (0.0344P)2 + 0.3013P] where P = (Fo 
2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined 
isotropically.  Refinement converged to R1=0.0229 and wR2=0.0576 for 4181 observed 
reflections for which F > 4σ(F) and R1=0.0232 and wR2=0.0579 and GOF =0.997 for all 4236 
unique, non-zero reflections and 441 variables.191 The maximum Δ/σ in the final cycle of least 
squares was 0.000 and the two most prominent peaks in the final difference Fourier were +0.108 
and -0.127 e/Å3.  The Hooft absolute structure parameter y192 was calculated using PLATON193. 
The resulting value was y = 0.07(5) indicating that the absolute structure has been assigned 
correctly.  
Table B. 1 lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables B.2 and 3.  Anisotropic 
thermal parameters are in Table B.4.  Tables B.5. and 6. list bond distances and bond angles.  
                                                
186) Bruker (2009) SAINT. Bruker AXS Inc., Madison, Wisconsin, USA. 
187) Bruker (2009) SHELXTL. Bruker AXS Inc., Madison, Wisconsin, USA. 
188) Sheldrick, G.M. (2007) SADABS. University of Gottingen, Germany. 
189) Sheldrick, G.M. (2008) Acta Cryst. A64,112-122. 
190) Sheldrick, G.M. (2008) Acta Cryst. A64,112-122. 
191) R1 = S||Fo| - |Fc|| / S |Fo|; wR2 = [Sw(Fo2 - Fc2)2/Sw(Fo2)2]½; GOF = [Sw(Fo2 - Fc2)2/(n - p)]½; where n = 
the number of reflections and p = the number of parameters refined. 
192) Hooft, R.W.W., Straver, L.H., Spek, A.L. (2008) J. Appl.Cryst., 41, 96-103. 
193) Spek, A.L., Acta Cryst., (2009) D65, 148-155. 
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Figure B.1. is an ORTEP194 representation of the molecule with 30% probability thermal ellipsoids 
displayed. 
 
 
Figure B. 1 ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
Table B. 1 Summary of Structure Determination of 1.03t 
Empirical formula  C31H31NO3 
Formula weight  465.57 
Temperature  143(1) K 
Wavelength  1.54178 Å 
Crystal system  orthorhombic 
Space group  P212121  
                                                
194) “ORTEP-II: A Fortran Thermal Ellipsoid Plot Program for Crystal Structure Illustrations”. C.K. 
Johnson (1976) ORNL-5138. 
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Cell constants:   
a  9.1082(8) Å 
b  9.9885(8) Å 
c  27.957(2) Å 
Volume 2543.5(4) Å3 
Z 4 
Density (calculated) 1.216 Mg/m3 
Absorption coefficient 0.612 mm-1 
F(000) 992 
Crystal size 0.46 x 0.24 x 0.22 mm3 
Theta range for data collection 3.16 to 64.73° 
Index ranges -8 ≤ h ≤ 10, -11 ≤ k ≤ 11, -31 ≤ l ≤ 32 
Reflections collected 15711 
Independent reflections 4236 [R(int) = 0.0217] 
Completeness to theta = 64.73° 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7525 and 0.6909 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4236 / 0 / 441 
Goodness-of-fit on F2 0.997 
Final R indices [I>2sigma(I)] R1 = 0.0229, wR2 = 0.0576 
R indices (all data) R1 = 0.0232, wR2 = 0.0579 
Absolute structure parameter 0.07(13) 
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Largest diff. peak and hole 0.108 and -0.127 e.Å-3 
 
Table B. 2 Refined Positional Parameters for 1.03t 
  Atom x y z Ueq, Å2 
C1 0.70625(11) 0.13558(11) 0.33358(4) 0.0237(2) 
C2 0.58884(12) 0.09598(10) 0.36990(4) 0.0246(2) 
C3 0.60282(13) 0.11924(11) 0.41793(4) 0.0267(2) 
C4 0.48283(13) 0.10002(11) 0.44969(4) 0.0288(2) 
C5 0.49489(16) 0.12586(13) 0.49937(4) 0.0370(3) 
C6 0.37594(17) 0.10776(15) 0.52875(5) 0.0457(3) 
C7 0.24080(16) 0.06406(15) 0.51047(5) 0.0458(3) 
C8 0.22518(15) 0.03806(13) 0.46292(5) 0.0395(3) 
C9 0.34642(13) 0.05417(11) 0.43143(4) 0.0301(2) 
C10 0.33568(13) 0.02671(12) 0.38197(4) 0.0313(3) 
C11 0.45188(12) 0.04807(11) 0.35213(4) 0.0292(2) 
C12 0.65416(13) 0.26935(11) 0.31062(4) 0.0265(2) 
C13 0.62886(12) 0.38211(11) 0.34505(4) 0.0264(2) 
C14 0.49860(13) 0.41081(12) 0.36376(4) 0.0310(2) 
C15 0.46910(12) 0.51849(11) 0.39839(4) 0.0304(2) 
C16 0.54879(15) 0.63732(12) 0.39813(4) 0.0373(3) 
C17 0.52180(19) 0.73625(13) 0.43173(5) 0.0470(4) 
C18 0.41485(19) 0.71749(15) 0.46638(5) 0.0495(4) 
C19 0.33551(17) 0.59990(17) 0.46714(5) 0.0505(4) 
C20 0.36132(15) 0.50159(15) 0.43336(5) 0.0421(3) 
C21 0.86021(12) 0.14710(11) 0.35629(4) 0.0246(2) 
C22 1.07987(15) 0.27307(14) 0.35763(7) 0.0466(3) 
C23 0.80837(12) 0.06319(10) 0.25533(4) 0.0255(2) 
C24 0.74910(13) 0.11831(13) 0.21416(4) 0.0291(2) 
C25 0.83615(14) 0.14806(12) 0.17459(4) 0.0313(3) 
C26 0.98553(13) 0.11816(12) 0.17592(4) 0.0306(2) 
 
316 
C27 1.04568(13) 0.06045(13) 0.21651(4) 0.0326(3) 
C28 0.95878(13) 0.03440(12) 0.25583(4) 0.0298(2) 
C29 1.0300(2) 0.20895(17) 0.09817(5) 0.0493(4) 
C30 0.73005(13) -0.10747(11) 0.31172(4) 0.0283(2) 
C31 0.65707(18) -0.20050(14) 0.27643(5) 0.0407(3) 
N1 0.71376(10) 0.03253(9) 0.29535(3) 0.0251(2) 
O1 0.91847(9) 0.05988(8) 0.37919(3) 0.03344(19) 
O2 0.92711(9) 0.26149(8) 0.34421(3) 0.03284(19) 
O3 1.08149(10) 0.13777(9) 0.13881(3) 0.0396(2) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos 
β+2U23bb*cc*cosα] 
 
Table B. 3 Positional Parameters for Hydrogens in 1.03t 
  Atom x y z Uiso, Å2 
H3 0.6960(14) 0.1502(13) 0.4311(4) 0.027(3) 
H5 0.5925(17) 0.1611(15) 0.5128(5) 0.041(4) 
H6 0.3931(16) 0.1268(16) 0.5627(5) 0.045(4) 
H7 0.1558(19) 0.0523(17) 0.5308(6) 0.058(5) 
H8 0.1297(16) 0.0077(14) 0.4530(5) 0.035(3) 
H10 0.2451(18) -0.0129(15) 0.3690(5) 0.041(4) 
H11 0.4446(15) 0.0278(14) 0.3170(5) 0.037(3) 
H12
a 
0.7228(15) 0.2952(13) 0.2859(5) 0.029(3) 
H12
b 
0.5615(15) 0.2498(12) 0.2939(4) 0.028(3) 
H13 0.7142(16) 0.4341(14) 0.3548(5) 0.037(4) 
H14 0.4149(16) 0.3550(15) 0.3559(5) 0.038(3) 
H16 0.6260(18) 0.6517(16) 0.3743(5) 0.045(4) 
H17 0.578(2) 0.8231(19) 0.4303(6) 0.069(5) 
H18 0.3952(19) 0.7885(16) 0.4899(6) 0.054(4) 
H19 0.2618(19) 0.5831(16) 0.4905(6) 0.055(5) 
H20 0.3056(17) 0.4165(16) 0.4339(5) 0.048(4) 
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H22
a 
1.098(2) 0.2469(18) 0.3912(7) 0.063(5) 
H22
b 
1.109(2) 0.367(2) 0.3494(6) 0.068(5) 
H22
c 
1.138(2) 0.206(2) 0.3366(7) 0.075(6) 
H24 0.6431(15) 0.1362(14) 0.2133(4) 0.031(3) 
H25 0.7922(16) 0.1849(14) 0.1455(5) 0.038(4) 
H27 1.1498(18) 0.0333(16) 0.2170(5) 0.045(4) 
H28 1.0044(16) -0.0038(14) 0.2856(5) 0.037(3) 
H29
a 
0.9533(19) 0.1634(17) 0.0818(6) 0.053(5) 
H29
b 
1.116(2) 0.2173(19) 0.0774(7) 0.067(5) 
H29
c 
0.9913(19) 0.3007(17) 0.1070(6) 0.056(4) 
H30
a 
0.6813(13) -0.1166(13) 0.3441(4) 0.024(3) 
H30
b 
0.8355(15) -0.1330(14) 0.3170(5) 0.035(3) 
H31
a 
0.550(2) -0.1753(17) 0.2735(6) 0.060(5) 
H31
b 
0.6623(17) -0.2953(17) 0.2867(6) 0.048(4) 
H31
c 
0.7007(19) -0.1948(16) 0.2445(6) 0.056(5) 
 
 
Table B. 4 Refined Thermal Parameters (U's) for 1.03t 
  Atom U11 U22 U33 U23 U13 U12 
C1 0.0239(5) 0.0253(5) 0.0218(5) -0.0009(4) -0.0006(4) 0.0009(5) 
C2 0.0251(5) 0.0231(5) 0.0257(5) 0.0008(4) 0.0007(4) 0.0026(4) 
C3 0.0283(6) 0.0246(5) 0.0271(5) 0.0008(4) -0.0004(4) 0.0002(5) 
C4 0.0349(6) 0.0231(5) 0.0283(5) 0.0023(4) 0.0026(5) 0.0052(5) 
C5 0.0456(7) 0.0370(6) 0.0284(6) 0.0001(5) 0.0047(5) 0.0028(6) 
C6 0.0581(9) 0.0476(8) 0.0314(7) 0.0018(6) 0.0127(6) 0.0078(7) 
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C7 0.0465(8) 0.0462(8) 0.0447(7) 0.0084(6) 0.0218(7) 0.0060(6) 
C8 0.0346(7) 0.0348(6) 0.0490(7) 0.0066(6) 0.0125(6) 0.0026(6) 
C9 0.0304(6) 0.0249(5) 0.0350(6) 0.0043(5) 0.0052(5) 0.0040(5) 
C10 0.0247(6) 0.0312(6) 0.0378(6) 0.0012(5) -0.0002(5) -0.0010(5) 
C11 0.0272(6) 0.0321(6) 0.0283(6) -0.0001(5) -0.0019(4) 0.0013(5) 
C12 0.0271(6) 0.0287(6) 0.0237(5) 0.0025(5) -0.0006(5) 0.0023(5) 
C13 0.0279(6) 0.0247(5) 0.0266(5) 0.0030(4) -0.0016(4) 0.0020(5) 
C14 0.0273(6) 0.0335(6) 0.0320(6) -0.0010(5) -0.0023(5) 0.0032(5) 
C15 0.0291(6) 0.0346(6) 0.0276(5) 0.0017(5) -0.0016(5) 0.0105(5) 
C16 0.0497(7) 0.0297(6) 0.0326(6) 0.0038(5) 0.0064(6) 0.0107(6) 
C17 0.0721(10) 0.0302(6) 0.0388(7) 0.0008(5) 0.0023(7) 0.0096(7) 
C18 0.0720(10) 0.0439(7) 0.0327(6) -0.0047(6) 0.0037(7) 0.0223(8) 
C19 0.0481(8) 0.0640(10) 0.0393(7) -0.0049(7) 0.0133(6) 0.0109(7) 
C20 0.0337(7) 0.0523(8) 0.0403(7) -0.0049(6) 0.0063(6) 0.0027(6) 
C21 0.0261(5) 0.0244(5) 0.0233(5) -0.0029(4) 0.0007(4) 0.0006(4) 
C22 0.0250(6) 0.0363(7) 0.0786(11) 0.0103(7) -0.0098(7) -0.0050(6) 
C23 0.0274(6) 0.0251(5) 0.0238(5) -0.0029(4) 0.0023(4) 0.0000(4) 
C24 0.0284(6) 0.0321(6) 0.0269(5) -0.0031(5) 0.0001(4) 0.0026(5) 
C25 0.0390(7) 0.0302(6) 0.0247(5) -0.0006(5) -0.0007(5) 0.0019(5) 
C26 0.0362(6) 0.0284(5) 0.0272(5) -0.0048(5) 0.0072(5) -0.0041(5) 
C27 0.0283(6) 0.0367(6) 0.0327(6) -0.0047(5) 0.0039(5) 0.0004(5) 
C28 0.0299(6) 0.0328(6) 0.0266(5) -0.0013(5) -0.0007(5) 0.0029(5) 
C29 0.0582(9) 0.0605(9) 0.0293(7) 0.0048(6) 0.0074(7) -0.0109(8) 
C30 0.0306(6) 0.0252(5) 0.0290(6) 0.0003(5) 0.0003(5) -0.0009(5) 
C31 0.0504(9) 0.0316(7) 0.0402(7) -0.0059(5) -0.0052(6) -0.0056(6) 
N1 0.0276(5) 0.0254(5) 0.0221(4) -0.0017(4) 0.0013(4) 0.0006(4) 
O1 0.0322(4) 0.0318(4) 0.0364(4) 0.0058(4) -0.0082(4) 0.0008(4) 
O2 0.0238(4) 0.0275(4) 0.0473(5) 0.0043(4) -0.0032(4) -0.0016(3) 
O3 0.0435(5) 0.0453(5) 0.0300(4) 0.0001(4) 0.0121(4) -0.0036(4) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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Table B. 5 Bond Distances in 1.03t, Å 
C1-N1  1.4853(13) C1-C2  1.5268(15) C1-C21  1.5437(15) 
C1-C12  1.5564(15) C2-C3  1.3687(15) C2-C11  1.4254(16) 
C3-C4  1.4212(16) C3-H3  0.975(13) C4-C5  1.4170(16) 
C4-C9  1.4191(17) C5-C6  1.3716(19) C5-H5  1.027(15) 
C6-C7  1.402(2) C6-H6  0.981(15) C7-C8  1.362(2) 
C7-H7  0.968(17) C8-C9  1.4215(17) C8-H8  0.962(15) 
C9-C10  1.4131(17) C10-C11  1.3644(17) C10-H10  0.984(16) 
C11-H11  1.006(14) C12-C13  1.4995(16) C12-H12a  0.967(14) 
C12-H12b  0.983(14) C13-C14  1.3278(17) C13-H13  0.973(15) 
C14-C15  1.4718(16) C14-H14  0.969(15) C15-C16  1.3913(18) 
C15-C20  1.3958(17) C16-C17  1.3855(18) C16-H16  0.980(16) 
C17-C18  1.387(2) C17-H17  1.010(19) C18-C19  1.379(2) 
C18-H18  0.982(17) C19-C20  1.382(2) C19-H19  0.952(17) 
C20-H20  0.990(17) C21-O1  1.2043(13) C21-O2  1.3383(14) 
C22-O2  1.4457(16) C22-H22a  0.988(19) C22-H22b  1.01(2) 
C22-H22c  1.03(2) C23-C24  1.3853(16) C23-C28  1.3999(16) 
C23-N1  1.4451(14) C24-C25  1.3931(17) C24-H24  0.982(14) 
C25-C26  1.3935(18) C25-H25  0.979(15) C26-O3  1.3706(14) 
C26-C27  1.3858(17) C27-C28  1.3792(17) C27-H27  0.986(16) 
C28-H28  1.006(14) C29-O3  1.4197(17) C29-H29a  0.951(18) 
C29-H29b  0.98(2) C29-H29c  1.012(17) C30-N1  1.4789(14) 
C30-C31  1.5096(17) C30-H30a  1.013(12) C30-H30b  1.004(14) 
C31-H31a  1.013(19) C31-H31b  0.991(17) C31-H31c  0.980(17) 
 
Table B. 6 Bond Angles in 1.03t, ° 
N1-C1-C2 109.34(8) N1-C1-C21 107.81(8) C2-C1-C21 112.45(8) 
N1-C1-C12 108.20(8) C2-C1-C12 106.45(8) C21-C1-C12 112.49(9) 
C3-C2-C11 118.70(10) C3-C2-C1 122.91(10) C11-C2-C1 117.92(9) 
C2-C3-C4 121.23(11) C2-C3-H3 120.4(7) C4-C3-H3 118.4(7) 
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C5-C4-C3 121.89(11) C5-C4-C9 118.63(11) C3-C4-C9 119.48(10) 
C6-C5-C4 120.12(13) C6-C5-H5 120.7(8) C4-C5-H5 119.1(8) 
C5-C6-C7 121.06(12) C5-C6-H6 115.4(9) C7-C6-H6 123.6(9) 
C8-C7-C6 120.45(12) C8-C7-H7 117.8(10) C6-C7-H7 121.7(10) 
C7-C8-C9 120.12(13) C7-C8-H8 115.9(8) C9-C8-H8 124.0(8) 
C10-C9-C4 118.38(10) C10-C9-C8 122.03(12) C4-C9-C8 119.60(11) 
C11-C10-
C9 
120.95(11) C11-C10-H10 119.1(8) C9-C10-H10 119.9(8) 
C10-C11-
C2 
121.22(10) C10-C11-H11 121.0(8) C2-C11-H11 117.8(8) 
C13-C12-
C1 
115.28(9) C13-C12-
H12a 
111.0(8) C1-C12-H12a 109.1(8) 
C13-C12-
H12b 
108.8(7) C1-C12-H12b 106.7(7) H12a-C12-
H12b 
105.6(11) 
C14-C13-
C12 
123.52(11) C14-C13-H13 119.3(8) C12-C13-H13 117.2(8) 
C13-C14-
C15 
125.44(11) C13-C14-H14 119.3(8) C15-C14-H14 115.2(8) 
C16-C15-
C20 
118.28(11) C16-C15-C14 121.65(11) C20-C15-C14 120.05(11) 
C17-C16-
C15 
120.82(13) C17-C16-H16 119.0(9) C15-C16-H16 120.2(9) 
C16-C17-
C18 
120.14(14) C16-C17-H17 119.7(11) C18-C17-H17 120.2(11) 
C19-C18-
C17 
119.59(13) C19-C18-H18 120.6(10) C17-C18-H18 119.8(10) 
C18-C19-
C20 
120.36(13) C18-C19-H19 122.0(10) C20-C19-H19 117.6(10) 
C19-C20-
C15 
120.81(14) C19-C20-H20 120.8(9) C15-C20-H20 118.4(9) 
O1-C21-
O2 
123.45(10) O1-C21-C1 124.40(10) O2-C21-C1 111.93(9) 
O2-C22-
H22a 
112.8(11) O2-C22-H22b 105.8(10) H22a-C22-
H22b 
114.9(14) 
O2-C22-
H22c 
107.0(11) H22a-C22-
H22c 
106.5(15) H22b-C22-
H22c 
109.5(15) 
C24-C23-
C28 
118.12(10) C24-C23-N1 119.67(10) C28-C23-N1 122.16(10) 
C23-C24-
C25 
121.51(11) C23-C24-H24 118.4(7) C25-C24-H24 120.1(7) 
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C24-C25-
C26 
119.27(11) C24-C25-H25 120.5(9) C26-C25-H25 120.1(9) 
O3-C26-
C27 
115.30(11) O3-C26-C25 124.88(11) C27-C26-C25 119.79(11) 
C28-C27-
C26 
120.29(11) C28-C27-H27 119.3(9) C26-C27-H27 120.3(9) 
C27-C28-
C23 
120.98(11) C27-C28-H28 119.6(8) C23-C28-H28 119.4(8) 
O3-C29-
H29a 
112.8(10) O3-C29-H29b 104.6(11) H29a-C29-
H29b 
110.2(14) 
O3-C29-
H29c 
111.9(10) H29a-C29-
H29c 
107.1(14) H29b-C29-
H29c 
110.3(14) 
N1-C30-
C31 
109.60(10) N1-C30-H30a 108.5(7) C31-C30-
H30a 
109.6(7) 
N1-C30-
H30b 
112.4(8) C31-C30-
H30b 
111.1(8) H30a-C30-
H30b 
105.5(10) 
C30-C31-
H31a 
108.9(10) C30-C31-
H31b 
112.2(9) H31a-C31-
H31b 
107.9(13) 
C30-C31-
H31c 
112.4(10) H31a-C31-
H31c 
107.7(14) H31b-C31-
H31c 
107.5(13) 
C23-N1-
C30 
112.34(8) C23-N1-C1 115.96(8) C30-N1-C1 115.93(8) 
C21-O2-
C22 
116.17(9) C26-O3-C29 117.83(11)   
 
  
 
322 
B.2. X-Ray Structure Determination of Compound 2.32 
 
Compound 2.32, C21H25NO3, crystallizes in the orthorhombic space group P212121 
(systematic absences h00:  h=odd, 0k0:  k=odd, and 00l:  l=odd) with a=10.1714(10)Å, 
b=10.7715(11)Å, c=16.2870(16)Å, V=1784.4(3)Å3, Z=4, and dcalc=1.263 g/cm3 . X-ray intensity 
data were collected on a Bruker APEXII CCD area detector employing graphite-monochromated 
Mo-Kα radiation (λ=1.54178 Å) at a temperature of 143(1)K. Preliminary indexing was performed 
from a series of thirty-six 0.5° rotation frames with exposures of 10 seconds. A total of 4213 
frames were collected with a crystal to detector distance of 37.617 mm, rotation widths of 0.5° 
and exposures of 20 seconds:  
scan type 2θ ω φ χ frames 
φ 92.00 88.66 348.71 -26.26 739 
φ -33.00 301.93 73.64 23.24 450 
φ -28.00 282.92 258.28 59.32 267 
ω -23.00 8.63 319.72 -61.99 111 
ω -43.00 310.71 275.26 -33.72 128 
φ 82.00 31.51 144.92 52.47 185 
ω -18.00 338.71 192.21 -82.85 119 
φ 92.00 132.53 140.50 -22.49 438 
φ 87.00 76.65 32.32 62.65 724 
ω 92.00 152.22 266.47 -93.68 171 
φ 92.00 198.97 352.62 -82.85 658 
N
O
OMe
OMe
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ω 92.00 9.33 317.53 90.29 109 
φ 7.00 153.70 41.76 -95.28 114 
 Rotation frames were integrated using SAINT186, producing a listing of unaveraged F2 
and σ(F2) values which were then passed to the SHELXTL187 program package for further 
processing and structure solution. A total of 12846 reflections were measured over the ranges 
4.92 ≤ θ ≤ 64.70°, -11 ≤ h ≤ 10, -12 ≤ k ≤ 12, -19 ≤ l ≤ 14 yielding 2947 unique reflections (Rint 
= 0.0245). The intensity data were corrected for Lorentz and polarization effects and for 
absorption using SADABS188 (minimum and maximum transmission 0.6980, 0.7525). 
The structure was solved by direct methods (SHELXS-97189). Refinement was by full-
matrix least squares based on F2 using SHELXL-97.190 All reflections were used during 
refinement. The weighting scheme used was w=1/[σ2(Fo2 )+ (0.0318P)2 + 0.2246P] where P = (Fo 
2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined 
isotropically.  Refinement converged to R1=0.0235 and wR2=0.0589 for 2924 observed 
reflections for which F > 4σ(F) and R1=0.0237 and wR2=0.0591 and GOF =1.110 for all 2947 
unique, non-zero reflections and 328 variables.191 The maximum Δ/σ in the final cycle of least 
squares was 0.000 and the two most prominent peaks in the final difference Fourier were +0.136 
and -0.192 e/Å3.  The absolute structure parameter y192 was calculated using PLATON193. The 
resulting value was y = 0.08(4) indicating that the absolute structure has been assigned correctly. 
Table B.7 lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables B.8 and B.9  
Anisotropic thermal parameters are in Table B.10  Tables B.11 and B.12 list bond distances and 
bond angles.  Figure B.2. is an ORTEP194 representation of the molecule with 30% probability 
thermal ellipsoids displayed. 
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Figure B. 2 ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
Table B. 7 Summary of Structure Determination of Compound 2.32 
Empirical formula  C21H25NO3 
Formula weight  339.42 
Temperature  143(1) K 
Wavelength  1.54178 Å 
Crystal system  orthorhombic 
Space group  P212121 
Cell constants:   
a  10.1714(10) Å 
b  10.7715(11) Å 
c  16.2870(16) Å 
Volume 1784.4(3) Å3 
Z 4 
Density (calculated) 1.263 Mg/m3 
O1
O2
O3
N2
C1
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
C20C21
C22
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Absorption coefficient 0.670 mm-1 
F(000) 728 
Crystal size 0.36 x 0.32 x 0.14 mm3 
Theta range for data collection 4.92 to 64.70° 
Index ranges -11 ≤ h ≤ 10, -12 ≤ k ≤ 12, -19 ≤ l ≤ 14 
Reflections collected 12846 
Independent reflections 2947 [R(int) = 0.0245] 
Completeness to theta = 64.70° 98.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7525 and 0.6980 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2947 / 0 / 328 
Goodness-of-fit on F2 1.110 
Final R indices [I>2sigma(I)] R1 = 0.0235, wR2 = 0.0589 
R indices (all data) R1 = 0.0237, wR2 = 0.0591 
Flack Absolute structure parameter 0.07(14) 
Hooft Absolute structure parameter 0.08(4) 
Largest diff. peak and hole 0.136 and -0.192 e.Å-3 
 
Table B. 8 Refined Positional Parameters for Compound 2.32 
  Atom x y z Ueq, Å2 
C1 0.67393(11) 0.84112(10) 0.18705(7) 0.0221(2) 
C3 0.45621(11) 0.73519(11) 0.19303(7) 0.0236(2) 
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C4 0.36427(12) 0.77281(12) 0.12381(8) 0.0289(3) 
C5 0.37164(12) 0.90932(12) 0.09967(8) 0.0293(3) 
C6 0.51132(13) 0.95541(12) 0.08524(8) 0.0287(3) 
C7 0.59375(12) 0.96054(11) 0.16396(7) 0.0247(3) 
C8 0.78905(11) 0.84253(10) 0.12545(7) 0.0241(2) 
C9 1.01040(14) 0.89110(16) 0.10046(9) 0.0404(3) 
C1
0 
0.71291(11) 0.85258(11) 0.27865(7) 0.0227(2) 
C1
1 
0.77221(12) 0.96008(11) 0.30928(7) 0.0253(3) 
C1
2 
0.79499(13) 0.97437(12) 0.39305(8) 0.0292(3) 
C1
3 
0.75966(13) 0.88166(13) 0.44783(8) 0.0312(3) 
C1
4 
0.70275(13) 0.77416(12) 0.41834(8) 0.0300(3) 
C1
5 
0.67929(11) 0.76025(11) 0.33437(7) 0.0259(3) 
C1
6 
0.65550(11) 0.61440(11) 0.15995(7) 0.0228(2) 
C1
7 
0.78478(12) 0.58977(11) 0.18383(7) 0.0264(3) 
C1
8 
0.84080(12) 0.47234(12) 0.17430(8) 0.0284(3) 
C1
9 
0.76760(12) 0.37642(11) 0.14151(7) 0.0272(3) 
C2
0 
0.64007(12) 0.39951(12) 0.11557(7) 0.0273(3) 
C2
1 
0.58497(12) 0.51561(12) 0.12446(7) 0.0255(2) 
C2
2 
0.93934(15) 0.22968(14) 0.16175(13) 0.0492(4) 
N2 0.59554(9) 0.73100(9) 0.16961(6) 0.0222(2) 
O1 0.77765(9) 0.81587(9) 0.05423(5) 0.0354(2) 
O2 0.90219(8) 0.88333(8) 0.15839(5) 0.0292(2) 
O3 0.81126(9) 0.25561(8) 0.13287(6) 0.0354(2) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos 
β+2U23bb*cc*cosα] 
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Table B. 9 Positional Parameters for Hydrogens in Compound 2.32 
  Atom x y z Uiso, Å2 
H3a 0.4455(13) 0.7913(13) 0.2439(9) 0.028(3) 
H3b 0.4323(13) 0.6511(12) 0.2117(7) 0.020(3) 
H4a 0.2700(16) 0.7530(14) 0.1432(9) 0.036(4) 
H4b 0.3837(15) 0.7208(14) 0.0763(10) 0.035(4) 
H5a 0.3188(16) 0.9212(14) 0.0496(10) 0.037(4) 
H5b 0.3329(14) 0.9638(14) 0.1449(9) 0.032(4) 
H6a 0.5041(14) 1.0417(14) 0.0625(8) 0.030(3) 
H6b 0.5571(14) 0.9008(13) 0.0426(8) 0.025(3) 
H7a 0.5352(14) 0.9783(12) 0.2122(9) 0.025(3) 
H7b 0.6576(14) 1.0307(13) 0.1630(8) 0.027(3) 
H9a 1.0307(17) 0.8075(17) 0.0768(10) 0.049(4) 
H9b 1.0860(17) 0.9260(14) 0.1322(10) 0.041(4) 
H9c 0.9860(18) 0.9499(17) 0.0555(11) 0.051(5) 
H11 0.7966(13) 1.0268(13) 0.2713(8) 0.024(3) 
H12 0.8377(15) 1.0528(15) 0.4134(9) 0.038(4) 
H13 0.7780(15) 0.8918(14) 0.5063(10) 0.039(4) 
H14 0.6773(15) 0.7052(14) 0.4562(9) 0.033(4) 
H15 0.6359(12) 0.6830(13) 0.3149(8) 0.022(3) 
H17 0.8390(14) 0.6554(13) 0.2104(8) 0.026(3) 
H18 0.9295(16) 0.4595(13) 0.1929(8) 0.031(4) 
H20 0.5915(15) 0.3308(15) 0.0933(9) 0.036(4) 
H21 0.4974(14) 0.5299(12) 0.1063(8) 0.021(3) 
H22
a 
1.008(2) 0.2770(19) 0.1285(12) 0.065(5) 
H22
b 
0.9557(18) 0.1411(19) 0.1493(11) 0.060(5) 
H22
c 
0.9512(19) 0.2516(18) 0.2232(12) 0.063(6) 
 
Table B. 10 Refined Thermal Parameters (U's) for Compound 2.32 
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  Atom U11 U22 U33 U23 U13 U12 
C1 0.0211(6) 0.0243(6) 0.0209(5) -0.0011(5) 0.0018(5) -0.0018(5) 
C3 0.0216(6) 0.0256(6) 0.0235(6) -0.0013(5) 0.0027(5) -0.0017(5) 
C4 0.0239(6) 0.0310(6) 0.0318(6) -0.0029(6) -0.0040(5) -0.0001(5) 
C5 0.0240(6) 0.0331(7) 0.0308(7) 0.0012(5) -0.0058(5) 0.0016(5) 
C6 0.0279(7) 0.0321(7) 0.0260(6) 0.0056(6) 0.0003(5) 0.0016(5) 
C7 0.0230(6) 0.0249(6) 0.0262(6) -0.0004(5) 0.0018(5) -0.0008(5) 
C8 0.0232(6) 0.0246(6) 0.0246(6) 0.0010(5) 0.0017(5) 0.0004(5) 
C9 0.0252(7) 0.0532(9) 0.0428(8) -0.0054(8) 0.0113(6) -0.0051(6) 
C1
0 
0.0190(6) 0.0260(6) 0.0230(6) -0.0029(5) 0.0009(5) 0.0022(5) 
C1
1 
0.0231(6) 0.0255(6) 0.0273(6) 0.0000(5) -0.0005(5) -0.0001(5) 
C1
2 
0.0277(6) 0.0298(6) 0.0302(6) -0.0069(5) -0.0057(5) 0.0003(5) 
C1
3 
0.0294(6) 0.0415(7) 0.0227(6) -0.0021(6) -0.0036(5) 0.0018(5) 
C1
4 
0.0291(6) 0.0368(7) 0.0241(6) 0.0039(5) -0.0018(5) -0.0026(5) 
C1
5 
0.0250(6) 0.0273(6) 0.0254(6) -0.0010(5) -0.0012(5) -0.0016(5) 
C1
6 
0.0247(6) 0.0257(6) 0.0180(5) -0.0013(5) 0.0011(5) -0.0004(4) 
C1
7 
0.0235(6) 0.0269(6) 0.0288(6) -0.0043(5) -0.0020(5) -0.0022(5) 
C1
8 
0.0226(6) 0.0299(6) 0.0327(6) -0.0017(5) -0.0017(5) 0.0002(5) 
C1
9 
0.0297(6) 0.0246(6) 0.0273(6) -0.0037(5) 0.0040(5) 0.0000(5) 
C2
0 
0.0288(6) 0.0268(6) 0.0264(6) -0.0047(5) 0.0018(5) -0.0041(5) 
C2
1 
0.0212(6) 0.0310(6) 0.0242(6) -0.0031(5) -0.0001(5) -0.0013(5) 
C2
2 
0.0357(8) 0.0283(7) 0.0837(13) -0.0052(8) -0.0052(8) 0.0061(6) 
N2 0.0198(5) 0.0236(5) 0.0232(5) -0.0026(4) -0.0008(4) -0.0008(4) 
O1 0.0319(5) 0.0510(6) 0.0234(5) -0.0047(4) 0.0052(4) -0.0022(4) 
O2 0.0207(4) 0.0363(5) 0.0305(4) -0.0027(4) 0.0051(4) -0.0033(3) 
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O3 0.0319(4) 0.0255(4) 0.0490(5) -0.0072(4) -0.0011(4) 0.0030(4) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
Table B. 11 Bond Distances in Compound 2.32, Å 
C1-N2  1.4572(14) C1-C8  1.5420(16) C1-C10  1.5486(16) 
C1-C7  1.5688(16) C3-N2  1.4683(15) C3-C4  1.5199(17) 
C3-H3a  1.032(14) C3-H3b  0.986(13) C4-C5  1.5238(18) 
C4-H4a  1.031(16) C4-H4b  0.975(16) C5-C6  1.5232(18) 
C5-H5a  0.985(16) C5-H5b  1.021(15) C6-C7  1.5329(17) 
C6-H6a  1.003(15) C6-H6b  1.022(14) C7-H7a  1.004(14) 
C7-H7b  0.997(14) C8-O1  1.2005(15) C8-O2  1.3437(15) 
C9-O2  1.4521(16) C9-H9a  1.001(19) C9-H9b  1.000(18) 
C9-H9c  1.000(18) C10-C15  1.3891(17) C10-C11  1.3977(16) 
C11-C12  1.3925(17) C11-H11  0.980(14) C12-C13  1.3865(19) 
C12-H12  1.007(16) C13-C14  1.3808(19) C13-H13  0.977(16) 
C14-C15  1.3964(17) C14-H14  1.000(16) C15-H15  0.994(14) 
C16-C17  1.3967(17) C16-N2  1.4050(16) C16-C21  1.4076(17) 
C17-C18  1.3959(17) C17-H17  0.996(15) C18-C19  1.3809(18) 
C18-H18  0.962(15) C19-O3  1.3822(15) C19-C20  1.3868(18) 
C20-C21  1.3781(18) C20-H20  0.961(16) C21-H21  0.951(14) 
C22-O3  1.4129(19) C22-H22a  1.02(2) C22-H22b  0.99(2) 
C22-
H22c  
1.035(19)     
 
Table B. 12 Bond Angles in Compound 2.32, ° 
N2-C1-C8 107.26(9) N2-C1-C10 113.13(9) C8-C1-C10 115.57(9) 
N2-C1-C7 109.65(9) C8-C1-C7 103.34(9) C10-C1-C7 107.38(9) 
N2-C3-C4 114.16(10) N2-C3-H3a 109.2(8) C4-C3-H3a 112.0(7) 
N2-C3-H3b 106.9(7) C4-C3-H3b 108.8(7) H3a-C3-H3b 105.3(10) 
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C3-C4-C5 114.73(10) C3-C4-H4a 106.8(8) C5-C4-H4a 108.9(8) 
C3-C4-H4b 108.1(9) C5-C4-H4b 109.9(9) H4a-C4-H4b 108.2(12) 
C6-C5-C4 113.59(11) C6-C5-H5a 109.8(9) C4-C5-H5a 108.2(9) 
C6-C5-H5b 106.5(8) C4-C5-H5b 110.4(8) H5a-C5-H5b 108.2(12) 
C5-C6-C7 113.13(10) C5-C6-H6a 106.9(8) C7-C6-H6a 108.4(8) 
C5-C6-H6b 110.0(8) C7-C6-H6b 109.9(8) H6a-C6-H6b 108.4(11) 
C6-C7-C1 117.09(10) C6-C7-H7a 109.6(8) C1-C7-H7a 106.1(8) 
C6-C7-H7b 111.7(8) C1-C7-H7b 106.6(8) H7a-C7-H7b 104.8(11) 
O1-C8-O2 123.14(11) O1-C8-C1 123.57(11) O2-C8-C1 113.19(9) 
O2-C9-
H9a 
110.8(10) O2-C9-H9b 105.6(9) H9a-C9-H9b 112.2(13) 
O2-C9-H9c 108.9(11) H9a-C9-H9c 109.8(13) H9b-C9-H9c 109.4(14) 
C15-C10-
C11 
117.79(11) C15-C10-C1 120.62(10) C11-C10-C1 121.36(10) 
C12-C11-
C10 
120.87(12) C12-C11-H11 119.7(8) C10-C11-H11 119.5(8) 
C13-C12-
C11 
120.52(12) C13-C12-H12 120.3(8) C11-C12-H12 119.2(8) 
C14-C13-
C12 
119.26(11) C14-C13-H13 120.9(9) C12-C13-H13 119.9(9) 
C13-C14-
C15 
120.16(12) C13-C14-H14 121.1(8) C15-C14-H14 118.7(8) 
C10-C15-
C14 
121.39(11) C10-C15-H15 120.0(8) C14-C15-H15 118.6(8) 
C17-C16-
N2 
123.18(10) C17-C16-C21 116.79(11) N2-C16-C21 120.03(10) 
C18-C17-
C16 
121.70(11) C18-C17-H17 117.7(8) C16-C17-H17 120.5(8) 
C19-C18-
C17 
120.06(11) C19-C18-H18 121.3(8) C17-C18-H18 118.6(8) 
C18-C19-
O3 
124.79(11) C18-C19-C20 119.21(11) O3-C19-C20 115.99(11) 
C21-C20-
C19 
120.74(12) C21-C20-H20 121.9(9) C19-C20-H20 117.3(9) 
C20-C21-
C16 
121.46(11) C20-C21-H21 119.7(8) C16-C21-H21 118.9(8) 
O3-C22-
H22a 
111.0(11) O3-C22-H22b 106.1(11) H22a-C22-
H22b 
104.9(15) 
O3-C22- 112.6(11) H22a-C22- 108.5(16) H22b-C22- 113.5(15) 
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H22c H22c H22c 
C16-N2-C1 120.79(9) C16-N2-C3 118.40(10) C1-N2-C3 116.90(9) 
C8-O2-C9 114.12(10) C19-O3-C22 116.64(11)   
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B.3. X-Ray Structure Determination of Compound 4.23 
 
Compound 4.23, C32H24N2O6, crystallizes in the triclinic space group P 1
_
 with 
a=6.7034(2)Å, b=10.1139(3)Å, c=19.0350(5)Å, α=87.503(2)°, β=82.219(2)°, γ=76.2860(10)°, 
V=1242.10(6)Å3, Z=2, and dcalc=1.424 g/cm3 . X-ray intensity data were collected on a Bruker 
APEXII CCD area detector employing graphite-monochromated Mo-Kα radiation (λ=0.71073 Å) 
at a temperature of 100(1)K. Preliminary indexing was performed from a series of thirty-six 0.5° 
rotation frames with exposures of 10 seconds. A total of 4619 frames were collected with a crystal 
to detector distance of 37.5 mm, rotation widths of 0.5° and exposures of 10 seconds:  
scan type 2θ ω φ χ frames 
φ -23.00 315.83 12.48 28.88 739 
φ -23.00 334.21 38.95 73.66 739 
φ -15.50 258.48 13.05 19.46 704 
φ 24.50 7.41 12.48 28.88 739 
φ -13.00 335.42 31.84 64.29 739 
φ 19.50 59.55 348.71 -26.26 739 
φ -25.50 323.22 48.36 83.36 220 
 Rotation frames were integrated using SAINT186, producing a listing of unaveraged F2 
and σ(F2) values which were then passed to the SHELXTL187 program package for further 
processing and structure solution. A total of 55649 reflections were measured over the ranges 
2.07 ≤ θ ≤ 27.50°, -8 ≤ h ≤ 8, -13 ≤ k ≤ 13, -24 ≤ l ≤ 24 yielding 5551 unique reflections (Rint = 
0.0314). The intensity data were corrected for Lorentz and polarization effects and for absorption 
N
O
O
N
O
O
O
Ph
Ph
O
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using SADABS188 (minimum and maximum transmission 0.7191, 0.7456). 
The structure was solved by direct methods (SHELXS-97189). Refinement was by full-
matrix least squares based on F2 using SHELXL-97.190 All reflections were used during 
refinement. The weighting scheme used was w=1/[σ2(Fo2 )+ (0.0706P)2 + 0.3765P] where P = (Fo 
2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined 
using a riding model.  Refinement converged to R1=0.0414 and wR2=0.1115 for 4060 observed 
reflections for which F > 4σ(F) and R1=0.0624 and wR2=0.1270 and GOF =1.022 for all 5551 
unique, non-zero reflections and 364 variables.191 The maximum Δ/σ in the final cycle of least 
squares was 0.001 and the two most prominent peaks in the final difference Fourier were +0.417 
and -0.215 e/Å3. 
Table B.13 lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables B.14 and B.15.  
Anisotropic thermal parameters are in Table B.16. Tables B.17 and B.18 list bond distances and 
bond angles. Figures B3. and B4. are ORTEP194 representations of the molecule with 50% 
probability thermal ellipsoids displayed. 
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Figure B. 3 ORTEP drawing of molecule no. 1 of the asymmetric unit with 50% probability 
thermal ellipsoids. 
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Figure B. 4 ORTEP drawing of molecule no. 2 of the asymmetric unit with 50% probability 
thermal ellipsoids. 
Table B. 13 Summary of Structure Determination of Compound 4.23 
Empirical formula  C32H24N2O6 
Formula weight  532.53 
Temperature  100(1) K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group  P1
_
  
Cell constants:   
a  6.7034(2) Å 
b  10.1139(3) Å 
c  19.0350(5) Å 
α 87.503(2)° 
β 82.219(2)° 
γ 76.2860(10)° 
Volume 1242.10(6) Å3 
Z 2 
Density (calculated) 1.424 Mg/m3 
Absorption coefficient 0.099 mm-1 
F(000) 556 
Crystal size 0.35 x 0.08 x 0.02 mm3 
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Theta range for data collection 2.07 to 27.50° 
Index ranges -8 ≤ h ≤ 8, -13 ≤ k ≤ 13, -24 ≤ l ≤ 24 
Reflections collected 55649 
Independent reflections 5551 [R(int) = 0.0314] 
Completeness to theta = 27.50° 97.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.7191 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5551 / 0 / 364 
Goodness-of-fit on F2 1.022 
Final R indices [I>2sigma(I)] R1 = 0.0414, wR2 = 0.1115 
R indices (all data) R1 = 0.0624, wR2 = 0.1270 
Largest diff. peak and hole 0.417 and -0.215 e.Å-3 
 
Table B. 14 Refined Positional Parameters for Compound 4.23 
  Atom x y z Ueq, Å2 
C1 0.0709(2) 0.94160(13) 0.47411(7) 0.0124(3) 
C2 -0.0549(2) 0.83529(14) 0.46534(7) 0.0138(3) 
C3 0.2170(2) 0.74664(14) 0.52120(7) 0.0137(3) 
C4 0.3459(2) 0.63542(14) 0.55799(7) 0.0139(3) 
C5 0.2825(2) 0.51623(14) 0.57875(7) 0.0155(3) 
C6 0.4024(2) 0.41636(15) 0.61775(7) 0.0176(3) 
C7 0.5882(2) 0.43562(15) 0.63579(7) 0.0173(3) 
C8 0.6578(2) 0.55183(15) 0.61219(8) 0.0176(3) 
C9 0.5376(2) 0.65099(14) 0.57367(7) 0.0156(3) 
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C10 0.6163(3) 0.25587(16) 0.72113(8) 0.0240(3) 
C11 0.1438(2) 1.00337(13) 0.40339(7) 0.0136(3) 
C12 0.0142(2) 1.03675(14) 0.35052(7) 0.0167(3) 
C13 0.0811(2) 1.09503(15) 0.28707(8) 0.0199(3) 
C14 0.2771(2) 1.12160(15) 0.27570(8) 0.0203(3) 
C15 0.4060(2) 1.08927(15) 0.32823(8) 0.0194(3) 
C16 0.3410(2) 1.02978(14) 0.39204(7) 0.0156(3) 
N1 0.24400(17) 0.86638(11) 0.50943(6) 0.0132(2) 
O1 0.04303(15) 0.71750(9) 0.49824(5) 0.0152(2) 
O2 -0.20544(16) 0.84061(10) 0.43785(5) 0.0190(2) 
O3 0.71320(17) 0.34628(11) 0.67609(6) 0.0263(3) 
C17 0.9304(2) 0.56097(13) 1.02456(7) 0.0122(3) 
C18 1.0583(2) 0.66748(13) 1.02927(7) 0.0131(3) 
C19 0.7844(2) 0.75204(14) 0.97364(7) 0.0128(3) 
C20 0.6533(2) 0.86282(14) 0.93747(7) 0.0130(3) 
C21 0.4721(2) 0.84233(14) 0.91565(7) 0.0148(3) 
C22 0.3411(2) 0.94588(14) 0.88238(7) 0.0156(3) 
C23 0.3902(2) 1.07284(14) 0.87184(7) 0.0147(3) 
C24 0.5688(2) 1.09492(14) 0.89476(7) 0.0153(3) 
C25 0.6999(2) 0.99072(14) 0.92686(7) 0.0143(3) 
C26 0.1128(3) 1.16178(16) 0.80363(9) 0.0240(3) 
C27 0.8591(2) 0.50644(13) 1.09746(7) 0.0133(3) 
C28 0.6599(2) 0.48413(14) 1.11185(7) 0.0154(3) 
C29 0.5983(2) 0.42854(15) 1.17750(8) 0.0192(3) 
C30 0.7321(2) 0.39702(15) 1.22833(8) 0.0203(3) 
C31 0.9290(2) 0.42171(15) 1.21432(8) 0.0205(3) 
C32 0.9929(2) 0.47566(14) 1.14911(8) 0.0171(3) 
N2 0.75701(17) 0.63322(11) 0.98865(6) 0.0130(2) 
O4 0.96013(15) 0.78285(9) 0.99471(5) 0.0149(2) 
O5 1.21047(15) 0.66466(10) 1.05541(5) 0.0182(2) 
O6 0.27053(16) 1.18325(10) 0.84193(6) 0.0201(2) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
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Table B. 15 Positional Parameters for Hydrogens in Compound 4.23 
  Atom x y z Uiso, Å2 
H5 0.1588 0.5035 0.5664 0.021 
H6 0.3592 0.3373 0.6317 0.023 
H8 0.7849 0.5622 0.6224 0.023 
H9 0.5837 0.7283 0.5581 0.021 
H10a 0.4944 0.3074 0.7487 0.036 
H10b 0.7111 0.2076 0.7522 0.036 
H10c 0.5787 0.1920 0.6926 0.036 
H12 -0.1175 1.0198 0.3579 0.022 
H13 -0.0057 1.1164 0.2520 0.026 
H14 0.3215 1.1608 0.2331 0.027 
H15 0.5370 1.1074 0.3208 0.026 
H16 0.4286 1.0078 0.4269 0.021 
H21 0.4390 0.7582 0.9235 0.020 
H22 0.2220 0.9311 0.8673 0.021 
H24 0.5995 1.1800 0.8884 0.020 
H25 0.8196 1.0055 0.9415 0.019 
H26a 0.1726 1.0948 0.7678 0.036 
H26b 0.0496 1.2457 0.7817 0.036 
H26c 0.0099 1.1303 0.8356 0.036 
H28 0.5688 0.5060 1.0781 0.020 
H29 0.4662 0.4126 1.1871 0.026 
H30 0.6904 0.3594 1.2717 0.027 
H31 1.0183 0.4021 1.2487 0.027 
H32 1.1252 0.4913 1.1398 0.023 
 
 
Table B. 16 Refined Thermal Parameters (U's) for Compound 4.23 
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  Atom U11 U22 U33 U23 U13 U12 
C1 0.0103(6) 0.0119(6) 0.0154(6) 0.0007(5) -0.0032(5) -0.0025(5) 
C2 0.0140(7) 0.0128(7) 0.0140(6) 0.0000(5) -0.0008(5) -0.0025(5) 
C3 0.0110(6) 0.0158(7) 0.0141(6) -0.0015(5) -0.0013(5) -0.0027(5) 
C4 0.0147(7) 0.0127(6) 0.0125(6) -0.0008(5) -0.0009(5) 0.0001(5) 
C5 0.0147(7) 0.0146(7) 0.0173(7) 0.0001(5) -0.0021(5) -0.0037(5) 
C6 0.0211(8) 0.0142(7) 0.0180(7) 0.0017(5) -0.0017(6) -0.0058(6) 
C7 0.0183(7) 0.0163(7) 0.0147(7) 0.0030(5) -0.0017(6) 0.0005(6) 
C8 0.0133(7) 0.0203(7) 0.0190(7) 0.0015(6) -0.0025(6) -0.0035(6) 
C9 0.0161(7) 0.0146(7) 0.0164(7) 0.0014(5) -0.0006(5) -0.0052(5) 
C10 0.0297(9) 0.0192(7) 0.0213(8) 0.0067(6) -0.0054(6) -0.0021(6) 
C11 0.0143(7) 0.0108(6) 0.0149(6) 0.0000(5) -0.0018(5) -0.0014(5) 
C12 0.0157(7) 0.0148(7) 0.0188(7) -0.0004(5) -0.0043(6) -0.0009(5) 
C13 0.0257(8) 0.0162(7) 0.0167(7) 0.0008(6) -0.0066(6) -0.0007(6) 
C14 0.0261(8) 0.0152(7) 0.0164(7) 0.0023(6) 0.0014(6) -0.0014(6) 
C15 0.0162(7) 0.0180(7) 0.0232(7) 0.0009(6) 0.0014(6) -0.0048(6) 
C16 0.0146(7) 0.0147(7) 0.0172(7) -0.0003(5) -0.0032(5) -0.0020(5) 
N1 0.0116(6) 0.0122(5) 0.0147(6) 0.0023(4) -0.0034(5) -0.0003(4) 
O1 0.0145(5) 0.0123(5) 0.0196(5) 0.0020(4) -0.0057(4) -0.0036(4) 
O2 0.0159(5) 0.0182(5) 0.0248(5) 0.0012(4) -0.0082(4) -0.0047(4) 
O3 0.0217(6) 0.0260(6) 0.0288(6) 0.0160(5) -0.0070(5) -0.0016(5) 
C17 0.0107(6) 0.0110(6) 0.0151(6) 0.0004(5) -0.0039(5) -0.0019(5) 
C18 0.0138(7) 0.0105(6) 0.0145(6) -0.0004(5) -0.0009(5) -0.0020(5) 
C19 0.0104(6) 0.0140(7) 0.0134(6) -0.0021(5) -0.0005(5) -0.0022(5) 
C20 0.0130(7) 0.0126(6) 0.0121(6) 0.0001(5) 0.0000(5) -0.0017(5) 
C21 0.0167(7) 0.0121(6) 0.0160(7) -0.0002(5) -0.0021(5) -0.0044(5) 
C22 0.0141(7) 0.0168(7) 0.0169(7) 0.0001(5) -0.0031(5) -0.0048(5) 
C23 0.0158(7) 0.0127(6) 0.0137(6) 0.0012(5) -0.0015(5) -0.0005(5) 
C24 0.0175(7) 0.0126(6) 0.0160(7) 0.0024(5) -0.0016(5) -0.0049(5) 
C25 0.0129(7) 0.0153(7) 0.0151(7) 0.0003(5) -0.0021(5) -0.0040(5) 
C26 0.0251(8) 0.0219(8) 0.0270(8) 0.0042(6) -0.0129(7) -0.0053(6) 
C27 0.0152(7) 0.0086(6) 0.0156(7) -0.0001(5) -0.0032(5) -0.0010(5) 
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C28 0.0155(7) 0.0137(7) 0.0166(7) -0.0012(5) -0.0025(5) -0.0022(5) 
C29 0.0190(7) 0.0166(7) 0.0214(7) -0.0009(6) 0.0013(6) -0.0049(6) 
C30 0.0272(8) 0.0156(7) 0.0146(7) 0.0015(5) 0.0022(6) -0.0011(6) 
C31 0.0237(8) 0.0190(7) 0.0174(7) 0.0017(6) -0.0071(6) -0.0002(6) 
C32 0.0150(7) 0.0158(7) 0.0203(7) -0.0005(6) -0.0045(6) -0.0017(5) 
N2 0.0117(6) 0.0122(5) 0.0142(5) 0.0016(4) -0.0028(4) -0.0007(4) 
O4 0.0138(5) 0.0120(5) 0.0198(5) 0.0025(4) -0.0046(4) -0.0036(4) 
O5 0.0141(5) 0.0166(5) 0.0255(5) 0.0000(4) -0.0072(4) -0.0041(4) 
O6 0.0197(5) 0.0155(5) 0.0260(6) 0.0058(4) -0.0110(4) -0.0025(4) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
Table B. 17 Bond Distances in Compound 4.23, Å 
C1-N1  1.4577(17) C1-C11  1.5280(18) C1-C2  1.5425(19) 
C1-C1#1  1.608(3) C2-O2  1.1873(17) C2-O1  1.3849(16) 
C3-N1  1.2723(18) C3-O1  1.3966(16) C3-C4  1.4617(19) 
C4-C5  1.3951(19) C4-C9  1.403(2) C5-C6  1.389(2) 
C6-C7  1.394(2) C7-O3  1.3645(17) C7-C8  1.399(2) 
C8-C9  1.381(2) C10-O3  1.4336(18) C11-C12  1.3961(19) 
C11-C16  1.396(2) C12-C13  1.387(2) C13-C14  1.389(2) 
C14-C15  1.388(2) C15-C16  1.395(2) C17-N2  1.4562(17) 
C17-C27  1.5287(18) C17-C18  1.5401(18) C17-C17#2  1.608(3) 
C18-O5  1.1877(17) C18-O4  1.3834(16) C19-N2  1.2729(18) 
C19-O4  1.3994(16) C19-C20  1.4599(19) C20-C21  1.3978(19) 
C20-C25  1.4011(19) C21-C22  1.3879(19) C22-C23  1.399(2) 
C23-O6  1.3631(16) C23-C24  1.397(2) C24-C25  1.3808(19) 
C26-O6  1.4240(18) C27-C28  1.395(2) C27-C32  1.3957(19) 
C28-C29  1.399(2) C29-C30  1.384(2) C30-C31  1.389(2) 
C31-C32  1.389(2)     
Symmetry transformations used to generate equivalent atoms:  
#1 -x,-y+2,-z+1    #2 -x+2,-y+1,-z+2      
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Table B. 18 Bond Angles in Compound 4.23, ° 
N1-C1-C11 111.99(11) N1-C1-C2 104.04(11) C11-C1-C2 112.65(11) 
N1-C1-
C1#1 
109.25(13) C11-C1-C1#1 110.52(13) C2-C1-C1#1 108.13(13) 
O2-C2-O1 121.71(12) O2-C2-C1 132.35(13) O1-C2-C1 105.94(11) 
N1-C3-O1 117.23(12) N1-C3-C4 127.19(13) O1-C3-C4 115.57(12) 
C5-C4-C9 119.46(13) C5-C4-C3 122.03(13) C9-C4-C3 118.50(12) 
C6-C5-C4 120.55(13) C5-C6-C7 119.46(13) O3-C7-C6 124.02(13) 
O3-C7-C8 115.68(13) C6-C7-C8 120.30(13) C9-C8-C7 119.93(14) 
C8-C9-C4 120.16(13) C12-C11-C16 119.48(13) C12-C11-C1 120.92(13) 
C16-C11-
C1 
119.58(12) C13-C12-C11 120.30(14) C12-C13-
C14 
120.32(14) 
C15-C14-
C13 
119.60(14) C14-C15-C16 120.57(14) C15-C16-
C11 
119.73(13) 
C3-N1-C1 106.85(11) C2-O1-C3 105.84(10) C7-O3-C10 116.18(12) 
N2-C17-
C27 
112.18(11) N2-C17-C18 103.98(10) C27-C17-
C18 
112.36(11) 
N2-C17-
C17#2 
109.40(13) C27-C17-
C17#2 
110.54(13) C18-C17-
C17#2 
108.11(13) 
O5-C18-O4 121.33(12) O5-C18-C17 132.55(13) O4-C18-C17 106.12(11) 
N2-C19-O4 116.93(12) N2-C19-C20 128.11(13) O4-C19-C20 114.95(11) 
C21-C20-
C25 
119.25(12) C21-C20-C19 119.03(12) C25-C20-
C19 
121.66(12) 
C22-C21-
C20 
120.85(13) C21-C22-C23 119.23(13) O6-C23-C24 115.14(12) 
O6-C23-
C22 
124.56(13) C24-C23-C22 120.26(13) C25-C24-
C23 
120.11(13) 
C24-C25-
C20 
120.28(13) C28-C27-C32 119.73(13) C28-C27-
C17 
119.61(12) 
C32-C27-
C17 
120.64(13) C27-C28-C29 119.46(14) C30-C29-
C28 
120.63(14) 
C29-C30-
C31 
119.74(14) C32-C31-C30 120.24(14) C31-C32-
C27 
120.18(14) 
C19-N2-
C17 
107.07(11) C18-O4-C19 105.82(10) C23-O6-C26 118.05(11) 
Symmetry transformations used to generate equivalent atoms:  
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#1 -x,-y+2,-z+1    #2 -x+2,-y+1,-z+2      
 
B.4. X-Ray Structure Determination of Compound 4.24 
 
Compound 4.24, C36H24N2O10F6Pd, crystallizes in the monoclinic space group P21 
(systematic absences 0k0: k=odd) with a=17.9656(11)Å, b=9.6793(7)Å, c=21.8956(12)Å, 
β=91.748(3)°, V=3805.8(4)Å3, Z=4, and dcalc=1.510 g/cm3 . X-ray intensity data were collected on 
a Bruker APEXII CCD area detector employing graphite-monochromated Mo-Kα radiation 
(λ=0.71073 Å) at a temperature of 100(1)K. Preliminary indexing was performed from a series of 
thirty-six 0.5° rotation frames with exposures of 10 seconds. A total of 36808 frames were 
collected with a crystal to detector distance of 49.9 mm, rotation widths of 0.5° and exposures of 
15 seconds:  
scan type 2θ ω φ χ frames 
φ 24.50 1.93 15.97 36.30 739 
φ 27.00 19.86 76.11 69.08 335 
φ 29.50 126.51 331.87 -58.65 334 
ω 32.00 355.15 337.13 61.00 69 
φ -30.50 251.25 25.81 21.36 416 
φ -30.50 5.08 330.80 -60.33 739 
φ 24.50 68.74 340.76 -42.87 739 
ω 29.50 327.78 183.80 85.83 133 
N
Pd
N
O
O
O
O
Ph
Ph
O
O
CF3
CF3
O
O
OMe
OMe
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ω 32.00 123.10 101.21 -99.65 176 
 Rotation frames were integrated using SAINT186, producing a listing of unaveraged F2 
and σ(F2) values which were then passed to the SHELXTL187 program package for further 
processing and structure solution. A total of 141143 reflections were measured over the ranges 
1.44 ≤ θ ≤ 27.73°, -23 ≤ h ≤ 23, 0 ≤ k ≤ 12, 0 ≤ l ≤ 28 yielding 8803 unique reflections (Rint = 
0.0784). The intensity data were corrected for Lorentz and polarization effects and for absorption 
using SADABS188 (minimum and maximum transmission 0.5019, 0.7456). 
The structure was solved by direct methods (SHELXS-97189). There was a region of 
disordered solvent for which a reliable disorder model could not be devised; the X-ray data were 
corrected for the presence of disordered solvent using SQUEEZE195.  Refinement was by full-
matrix least squares based on F2 using SHELXL-97.189 All reflections were used during 
refinement. The weighting scheme used was w=1/[σ2(Fo2 )+ (0.0367P)2 + 87.6152P] where P = 
(Fo 2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically and hydrogen atoms were 
refined using a riding model.  Refinement converged to R1=0.1089 and wR2=0.2554 for 7923 
observed reflections for which F > 4σ(F) and R1=0.1153 and wR2=0.2578 and GOF =1.235 for all 
8803 unique, non-zero reflections and 535 variables.191 The maximum Δ/σ in the final cycle of 
least squares was 0.007 and the two most prominent peaks in the final difference Fourier were 
+2.856 and -5.121 e/Å3. 
Table B.19 lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables B.20 and B.21  
Anisotropic thermal parameters are in Table B.22  Tables B.23 and B.24 list bond distances and 
bond angles.  Figure B.5 is an ORTEP194 representation of the molecule with 50% probability 
thermal ellipsoids displayed. 
 
                                                
195) v.d. Sluis, P. & A.L. Spek (1990). Acta. Cryst., A46, 194. 
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Figure B. 5 ORTEP drawing of the title compound with 50% probability thermal ellipsoids. 
Table B. 19 Summary of Structure Determination of Compound 4.24 
Empirical formula  C36H24N2O10F6Pd 
Formula weight  864.97 
Temperature  100(1) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P21      
Cell constants:   
a  17.9656(11) Å 
b  9.6793(7) Å 
c  21.8956(12) Å 
Pd1O7
O9
N1 N2
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β 91.748(3)° 
Volume 3805.8(4) Å3 
Z 4 
Density (calculated) 1.510 Mg/m3 
Absorption coefficient 0.574 mm-1 
F(000) 1736 
Crystal size 0.46 x 0.08 x 0.06 mm3 
Theta range for data collection 1.44 to 27.73° 
Index ranges -23 ≤ h ≤ 23, 0 ≤ k ≤ 12, 0 ≤ l ≤ 28 
Reflections collected 141143 
Independent reflections 8803 [R(int) = 0.0784] 
Completeness to theta = 27.73° 98.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.5019 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8803 / 259 / 535 
Goodness-of-fit on F2 1.235 
Final R indices [I>2sigma(I)] R1 = 0.1089, wR2 = 0.2554 
R indices (all data) R1 = 0.1153, wR2 = 0.2578 
Largest diff. peak and hole 2.856 and -5.121 e.Å-3 
 
Table B. 20 Refined Positional Parameters for Compound 4.24 
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  Atom x y z Ueq, Å2 
Pd1 0.50083(3) 0.67733(6) 0.78290(3) 0.01680(17) 
O1 0.6159(3) 0.4903(6) 0.6416(3) 0.0202(12) 
O2 0.5786(4) 0.5921(6) 0.5525(3) 0.0271(14) 
O3 0.7514(4) 0.1523(7) 0.8614(3) 0.0308(15) 
O4 0.3765(3) 0.8586(5) 0.6385(3) 0.0190(12) 
O5 0.4054(4) 0.7509(6) 0.5515(3) 0.0260(13) 
O6 0.2533(4) 1.1953(7) 0.8589(3) 0.0290(14) 
O7 0.5754(3) 0.6283(6) 0.8494(3) 0.0204(12) 
O8 0.6304(4) 0.8381(8) 0.8414(3) 0.0428(19) 
O9 0.4306(3) 0.7261(6) 0.8492(3) 0.0206(12) 
O10 0.3807(4) 0.5119(8) 0.8468(3) 0.0349(16) 
N1 0.5641(4) 0.6236(7) 0.7121(3) 0.0161(13) 
N2 0.4316(4) 0.7283(7) 0.7113(3) 0.0157(13) 
C1 0.5401(4) 0.6845(8) 0.6528(3) 0.0161(14) 
C2 0.5779(5) 0.5897(8) 0.6061(4) 0.0199(16) 
C3 0.6039(4) 0.5131(8) 0.7015(4) 0.0181(16) 
C4 0.6371(5) 0.4150(8) 0.7437(4) 0.0215(17) 
C5 0.7090(5) 0.3645(9) 0.7309(4) 0.0235(17) 
C6 0.7443(5) 0.2760(9) 0.7707(4) 0.0267(18) 
C7 0.7097(5) 0.2344(9) 0.8245(4) 0.0262(18) 
C8 0.6369(5) 0.2771(9) 0.8358(4) 0.0246(18) 
C9 0.6010(5) 0.3676(8) 0.7952(4) 0.0232(17) 
C10 0.7201(7) 0.1096(12) 0.9192(4) 0.039(3) 
C11 0.5621(5) 0.8375(8) 0.6447(4) 0.0234(17) 
C12 0.5609(6) 0.8923(9) 0.5861(4) 0.0282(19) 
C13 0.5764(6) 1.0306(9) 0.5779(4) 0.0272(19) 
C14 0.5929(5) 1.1139(9) 0.6283(5) 0.0294(19) 
C15 0.5941(5) 1.0592(9) 0.6859(4) 0.0280(19) 
C16 0.5793(5) 0.9186(9) 0.6953(4) 0.0238(17) 
C17 0.4526(4) 0.6653(8) 0.6526(3) 0.0175(15) 
C18 0.4101(5) 0.7558(8) 0.6051(4) 0.0216(17) 
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C19 0.3922(5) 0.8391(8) 0.6990(4) 0.0196(16) 
C20 0.3603(4) 0.9379(8) 0.7403(4) 0.0185(16) 
C21 0.2890(5) 0.9846(8) 0.7275(4) 0.0211(17) 
C22 0.2549(5) 1.0730(8) 0.7675(4) 0.0213(17) 
C23 0.2931(5) 1.1142(8) 0.8219(4) 0.0195(16) 
C24 0.3663(5) 1.0722(9) 0.8328(4) 0.0217(17) 
C25 0.4003(5) 0.9850(8) 0.7930(4) 0.0215(17) 
C26 0.2884(6) 1.2364(11) 0.9157(4) 0.032(2) 
C27 0.4289(5) 0.5123(8) 0.6467(4) 0.0205(16) 
C28 0.4239(6) 0.4500(10) 0.5887(4) 0.031(2) 
C29 0.4072(7) 0.3130(11) 0.5839(5) 0.043(3) 
C30 0.3963(7) 0.2315(10) 0.6339(5) 0.038(2) 
C31 0.4005(5) 0.2916(9) 0.6925(4) 0.0276(19) 
C32 0.4179(5) 0.4332(8) 0.6986(4) 0.0192(16) 
C33 0.6236(5) 0.7221(10) 0.8615(4) 0.0251(18) 
C34 0.6864(5) 0.6617(8) 0.9079(4) 0.042(2) 
F1 0.7317(7) 0.5904(13) 0.8744(5) 0.055(3) 
F2 0.7218(10) 0.7685(15) 0.9314(9) 0.055(5) 
F3 0.6625(8) 0.5835(13) 0.9521(6) 0.057(4) 
C35 0.3869(5) 0.6306(10) 0.8641(4) 0.0236(17) 
C36 0.3287(5) 0.6898(8) 0.9111(4) 0.044(2) 
F4 0.2761(6) 0.7498(14) 0.8780(5) 0.062(3) 
F5 0.3574(6) 0.7790(13) 0.9502(5) 0.062(3) 
F6 0.3006(10) 0.5856(14) 0.9408(8) 0.072(5) 
F1' 0.6458(14) 0.648(2) 0.9612(10) 0.066(5) 
F2' 0.7377(15) 0.759(2) 0.9252(16) 0.049(5) 
F3' 0.7141(13) 0.5533(17) 0.8948(9) 0.055(4) 
F4' 0.3760(9) 0.678(2) 0.9680(7) 0.075(4) 
F5' 0.2784(11) 0.5886(15) 0.9260(11) 0.059(4) 
F6' 0.3067(11) 0.7988(13) 0.9075(8) 0.064(4) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
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Table B. 21 Positional Parameters for Hydrogens in Compound 4.24 
  Atom x y z Uiso, Å2 
H5 0.7321 0.3916 0.6954 0.031 
H6 0.7915 0.2430 0.7623 0.036 
H8 0.6128 0.2454 0.8701 0.033 
H9 0.5528 0.3967 0.8025 0.031 
H10a 0.7097 0.1898 0.9433 0.059 
H10b 0.7551 0.0517 0.9411 0.059 
H10c 0.6748 0.0592 0.9113 0.059 
H12 0.5497 0.8362 0.5526 0.038 
H13 0.5757 1.0680 0.5388 0.036 
H14 0.6032 1.2071 0.6227 0.039 
H15 0.6050 1.1159 0.7193 0.037 
H16 0.5809 0.8810 0.7344 0.032 
H21 0.2639 0.9564 0.6920 0.028 
H22 0.2071 1.1054 0.7586 0.028 
H24 0.3924 1.1036 0.8674 0.029 
H25 0.4492 0.9570 0.8005 0.029 
H26a 0.3018 1.1557 0.9390 0.048 
H26b 0.2545 1.2918 0.9382 0.048 
H26c 0.3323 1.2890 0.9078 0.048 
H28 0.4320 0.5020 0.5538 0.041 
H29 0.4030 0.2734 0.5452 0.057 
H30 0.3861 0.1378 0.6293 0.050 
H31 0.3920 0.2383 0.7269 0.037 
H32 0.4220 0.4734 0.7372 0.025 
 
 
Table B. 22 Refined Thermal Parameters (U's) for Compound 4.24 
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  Atom U11 U22 U33 U23 U13 U12 
Pd1 0.0205(3) 0.0113(3) 0.0186(3) -0.0027(2) 0.0017(2) 0.0013(2) 
O1 0.025(3) 0.013(3) 0.023(3) -0.002(2) 0.004(2) 0.002(2) 
O2 0.048(4) 0.021(3) 0.013(3) -0.003(2) 0.007(3) 0.003(3) 
O3 0.035(4) 0.028(3) 0.030(3) 0.007(3) 0.004(3) 0.010(3) 
O4 0.026(3) 0.009(2) 0.022(3) -0.001(2) -0.002(2) 0.001(2) 
O5 0.044(4) 0.020(3) 0.013(3) 0.001(2) -0.001(2) 0.000(3) 
O6 0.035(4) 0.026(3) 0.026(3) -0.010(3) -0.003(3) 0.015(3) 
O7 0.025(3) 0.020(3) 0.017(3) 0.001(2) -0.001(2) 0.004(2) 
O8 0.053(5) 0.040(4) 0.035(4) 0.007(3) -0.006(3) -0.021(4) 
O9 0.028(3) 0.019(3) 0.015(3) -0.001(2) 0.005(2) 0.001(2) 
O10 0.045(4) 0.035(4) 0.024(3) -0.003(3) 0.003(3) -0.009(3) 
N1 0.024(3) 0.010(3) 0.015(3) -0.004(2) 0.001(3) -0.002(3) 
N2 0.018(3) 0.010(3) 0.019(3) -0.006(2) 0.002(2) -0.003(2) 
C1 0.018(4) 0.013(3) 0.018(3) -0.002(3) 0.002(3) -0.001(3) 
C2 0.027(4) 0.016(4) 0.017(4) -0.001(3) 0.006(3) -0.005(3) 
C3 0.019(4) 0.012(3) 0.024(4) -0.002(3) 0.000(3) -0.002(3) 
C4 0.027(4) 0.014(4) 0.024(4) -0.001(3) 0.003(3) 0.001(3) 
C5 0.025(4) 0.016(4) 0.031(4) -0.001(3) 0.008(3) -0.001(3) 
C6 0.026(4) 0.022(4) 0.032(5) 0.000(4) 0.006(4) 0.001(3) 
C7 0.031(5) 0.021(4) 0.027(4) -0.002(4) 0.003(4) 0.004(4) 
C8 0.034(5) 0.017(4) 0.024(4) -0.002(3) 0.009(4) 0.002(3) 
C9 0.025(4) 0.014(4) 0.031(4) -0.006(3) 0.007(3) 0.002(3) 
C10 0.061(7) 0.037(6) 0.020(5) 0.002(4) 0.001(4) 0.008(5) 
C11 0.030(4) 0.011(3) 0.029(4) 0.003(3) 0.004(3) -0.006(3) 
C12 0.040(5) 0.017(4) 0.028(4) -0.004(3) 0.007(4) -0.006(4) 
C13 0.051(6) 0.021(4) 0.010(3) 0.004(3) 0.006(3) 0.003(4) 
C14 0.036(5) 0.013(4) 0.040(5) -0.004(3) 0.001(4) -0.012(4) 
C15 0.035(5) 0.015(4) 0.034(4) -0.006(3) 0.000(4) -0.008(4) 
C16 0.033(5) 0.017(4) 0.023(4) -0.005(3) 0.008(3) -0.001(3) 
C17 0.020(4) 0.015(4) 0.018(4) 0.005(3) 0.003(3) -0.006(3) 
C18 0.031(5) 0.015(4) 0.020(4) 0.000(3) 0.009(3) -0.003(3) 
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C19 0.024(4) 0.013(4) 0.022(4) 0.000(3) -0.003(3) -0.005(3) 
C20 0.019(4) 0.014(4) 0.023(4) -0.001(3) 0.002(3) 0.002(3) 
C21 0.021(4) 0.016(4) 0.026(4) -0.002(3) -0.003(3) 0.001(3) 
C22 0.025(4) 0.017(4) 0.021(4) -0.002(3) -0.008(3) 0.006(3) 
C23 0.025(4) 0.015(4) 0.019(4) -0.003(3) 0.002(3) 0.004(3) 
C24 0.029(4) 0.021(4) 0.015(4) -0.008(3) -0.006(3) -0.003(3) 
C25 0.028(4) 0.013(4) 0.024(4) -0.003(3) 0.002(3) 0.007(3) 
C26 0.041(6) 0.033(5) 0.022(4) -0.015(4) -0.002(4) 0.005(4) 
C27 0.023(4) 0.014(4) 0.025(4) -0.005(3) 0.002(3) 0.001(3) 
C28 0.043(6) 0.021(4) 0.029(5) 0.003(4) 0.004(4) -0.009(4) 
C29 0.076(8) 0.024(5) 0.029(5) -0.014(4) 0.010(5) -0.009(5) 
C30 0.063(7) 0.016(4) 0.034(5) -0.007(4) 0.008(5) -0.014(4) 
C31 0.038(5) 0.013(4) 0.032(5) -0.001(3) 0.002(4) -0.005(3) 
C32 0.027(4) 0.013(4) 0.018(4) -0.003(3) 0.003(3) -0.005(3) 
C33 0.032(5) 0.032(5) 0.011(4) -0.005(3) 0.002(3) 0.001(4) 
C34 0.044(6) 0.052(5) 0.030(4) -0.002(4) -0.011(4) -0.007(4) 
F1 0.041(7) 0.068(9) 0.055(8) -0.003(6) -0.004(5) 0.008(6) 
F2 0.044(11) 0.073(9) 0.048(9) -0.015(7) -0.017(7) -0.015(8) 
F3 0.054(8) 0.073(9) 0.043(7) 0.026(7) -0.015(5) -0.001(7) 
C35 0.028(4) 0.030(4) 0.013(3) 0.002(3) -0.002(3) 0.003(3) 
C36 0.053(6) 0.042(5) 0.038(5) -0.005(4) 0.021(4) 0.003(4) 
F4 0.048(7) 0.077(9) 0.063(8) -0.004(6) 0.015(5) 0.026(7) 
F5 0.064(8) 0.080(8) 0.045(7) -0.038(6) 0.031(5) -0.002(6) 
F6 0.080(13) 0.068(8) 0.070(11) 0.017(7) 0.044(7) -0.005(8) 
F1' 0.072(13) 0.090(14) 0.034(8) 0.010(11) -0.005(7) -0.010(11) 
F2' 0.024(9) 0.049(8) 0.072(17) 0.005(8) -0.028(7) 0.008(6) 
F3' 0.065(8) 0.049(6) 0.051(7) 0.013(6) -0.021(5) 0.012(6) 
F4' 0.095(10) 0.100(11) 0.031(6) -0.027(8) 0.011(6) 0.016(9) 
F5' 0.048(9) 0.050(7) 0.081(13) -0.002(7) 0.048(7) 0.011(6) 
F6' 0.082(12) 0.041(6) 0.070(10) -0.012(6) 0.034(6) 0.015(6) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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Table B. 23 Bond Distances in Compound 4.24, Å 
Pd1-O7  2.005(6) Pd1-O9  2.009(6) Pd1-N1  2.018(7) 
Pd1-N2  2.031(7) O1-C3  1.353(10) O1-C2  1.403(10) 
O2-C2  1.172(10) O3-C7  1.346(11) O3-C10  1.460(12) 
O4-C19  1.358(10) O4-C18  1.384(10) O5-C18  1.176(10) 
O6-C23  1.349(10) O6-C26  1.433(10) O7-C33  1.277(11) 
O8-C33  1.215(12) O9-C35  1.262(11) O10-C35  1.214(11) 
N1-C3  1.311(10) N1-C1  1.477(10) N2-C19  1.309(10) 
N2-C17  1.481(10) C1-C11  1.545(11) C1-C2  1.547(11) 
C1-C17  1.584(10) C3-C4  1.441(11) C4-C9  1.397(12) 
C4-C5  1.417(12) C5-C6  1.365(13) C6-C7  1.406(13) 
C7-C8  1.401(13) C8-C9  1.392(13) C11-C16  1.385(12) 
C11-C12  1.387(12) C12-C13  1.380(12) C13-C14  1.391(12) 
C14-C15  1.368(14) C15-C16  1.403(12) C17-C18  1.544(11) 
C17-C27  1.545(11) C19-C20  1.446(11) C20-C21  1.379(11) 
C20-C25  1.416(12) C21-C22  1.380(12) C22-C23  1.413(11) 
C23-C24  1.389(12) C24-C25  1.370(11) C27-C32  1.390(12) 
C27-C28  1.407(12) C28-C29  1.363(13) C29-C30  1.370(15) 
C30-C31  1.407(13) C31-C32  1.412(11) C33-C34  1.604(12) 
C34-F3'  1.20(2) C34-F2  1.3100 C34-F1  1.3100 
C34-F3  1.3101 C34-F2'  1.36(2) C34-F1'  1.40(2) 
F1-F3'  0.66(2) F3-F1'  0.73(2) F3-F3'  1.609(19) 
C35-C36  1.596(11) C36-F6'  1.128(15) C36-F5  1.3098 
C36-F4  1.3100 C36-F6  1.3100 C36-F5'  1.379(19) 
C36-F4'  1.491(16) F4-F6'  0.960(18) F5-F4'  1.101(19) 
F5-F6'  1.300(17) F6-F5'  0.51(3) F6-F4'  1.71(2) 
 
Table B. 24  Bond Angles in Compound 4.24, ° 
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O7-Pd1-O9 87.2(2) O7-Pd1-N1 96.7(3) O9-Pd1-N1 175.4(3) 
O7-Pd1-N2 175.8(3) O9-Pd1-N2 96.7(3) N1-Pd1-N2 79.4(3) 
C3-O1-C2 109.6(6) C7-O3-C10 117.8(8) C19-O4-C18 109.6(6) 
C23-O6-C26 117.1(7) C33-O7-Pd1 114.7(5) C35-O9-Pd1 115.0(5) 
C3-N1-C1 108.4(6) C3-N1-Pd1 132.0(6) C1-N1-Pd1 114.6(5) 
C19-N2-C17 108.0(7) C19-N2-Pd1 132.3(5) C17-N2-Pd1 113.8(5) 
N1-C1-C11 114.5(6) N1-C1-C2 102.9(6) C11-C1-C2 111.9(6) 
N1-C1-C17 102.6(6) C11-C1-C17 111.7(6) C2-C1-C17 112.5(6) 
O2-C2-O1 123.2(8) O2-C2-C1 132.0(8) O1-C2-C1 104.8(6) 
N1-C3-O1 114.2(7) N1-C3-C4 129.8(8) O1-C3-C4 116.0(7) 
C9-C4-C5 119.7(8) C9-C4-C3 122.8(8) C5-C4-C3 117.6(8) 
C6-C5-C4 119.9(8) C5-C6-C7 120.4(9) O3-C7-C8 125.0(8) 
O3-C7-C6 114.8(8) C8-C7-C6 120.2(8) C9-C8-C7 119.2(8) 
C8-C9-C4 120.4(8) C16-C11-C12 121.3(8) C16-C11-C1 120.2(8) 
C12-C11-C1 118.4(8) C13-C12-C11 119.6(8) C12-C13-C14 119.8(8) 
C15-C14-
C13 
120.3(8) C14-C15-C16 120.9(8) C11-C16-C15 118.1(8) 
N2-C17-C18 102.5(6) N2-C17-C27 113.1(6) C18-C17-C27 111.0(7) 
N2-C17-C1 103.1(6) C18-C17-C1 113.9(6) C27-C17-C1 112.5(7) 
O5-C18-O4 122.6(8) O5-C18-C17 132.0(8) O4-C18-C17 105.4(6) 
N2-C19-O4 114.2(7) N2-C19-C20 129.4(7) O4-C19-C20 116.3(7) 
C21-C20-
C25 
120.3(7) C21-C20-C19 118.2(8) C25-C20-C19 121.5(7) 
C20-C21-
C22 
120.2(8) C21-C22-C23 119.7(8) O6-C23-C24 125.6(7) 
O6-C23-C22 114.7(7) C24-C23-C22 119.7(7) C25-C24-C23 120.6(8) 
C24-C25-
C20 
119.5(8) C32-C27-C28 119.8(8) C32-C27-C17 120.3(7) 
C28-C27-
C17 
119.8(8) C29-C28-C27 119.6(9) C28-C29-C30 122.3(9) 
C29-C30-
C31 
119.1(9) C30-C31-C32 119.6(9) C27-C32-C31 119.5(8) 
O8-C33-O7 131.0(9) O8-C33-C34 119.4(8) O7-C33-C34 109.4(7) 
F3'-C34-F2 125.7(15) F3'-C34-F1 30.2(10) F2-C34-F1 109.4 
F3'-C34-F3 79.6(10) F2-C34-F3 109.4 F1-C34-F3 109.4 
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F3'-C34-F2' 112.8(18) F2-C34-F2' 14.1(17) F1-C34-F2' 95.3(17) 
F3-C34-F2' 115(2) F3'-C34-F1' 110.4(13) F2-C34-F1' 90.3(15) 
F1-C34-F1' 140.1(10) F3-C34-F1' 30.9(10) F2'-C34-F1' 101.4(15) 
F3'-C34-C33 117.2(13) F2-C34-C33 106.5(11) F1-C34-C33 105.9(8) 
F3-C34-C33 115.9(9) F2'-C34-C33 112.3(17) F1'-C34-C33 100.8(13) 
F3'-F1-C34 65.7(17) F1'-F3-C34 81(2) F1'-F3-F3' 129(2) 
C34-F3-F3' 47.2(7) O10-C35-O9 131.7(9) O10-C35-C36 119.1(8) 
O9-C35-C36 109.1(7) F6'-C36-F5 63.9(9) F6'-C36-F4 45.6(9) 
F5-C36-F4 109.4 F6'-C36-F6 127.9(12) F5-C36-F6 109.4 
F4-C36-F6 109.4 F6'-C36-F5' 116.7(15) F5-C36-F5' 124.2(17) 
F4-C36-F5' 88.7(12) F6-C36-F5' 21.6(12) F6'-C36-F4' 108.7(10) 
F5-C36-F4' 45.7(9) F4-C36-F4' 151.7(8) F6-C36-F4' 75.2(10) 
F5'-C36-F4' 96.3(11) F6'-C36-C35 121.7(12) F5-C36-C35 113.9(8) 
F4-C36-C35 106.2(8) F6-C36-C35 108.3(10) F5'-C36-C35 110.1(12) 
F4'-C36-C35 98.2(8) F6'-F4-C36 57.1(9) F4'-F5-F6' 125.7(14) 
F4'-F5-C36 75.8(11) F6'-F5-C36 51.2(7) F5'-F6-C36 87(2) 
F5'-F6-F4' 142(2) C36-F6-F4' 57.2(7) F3-F1'-C34 67.7(15) 
F1-F3'-C34 84.1(19) F1-F3'-F3 137(2) C34-F3'-F3 53.2(7) 
F5-F4'-C36 58.4(7) F5-F4'-F6 96.4(12) C36-F4'-F6 47.6(6) 
F6-F5'-C36 71(2) F4-F6'-C36 77.2(11) F4-F6'-F5 141.8(15) 
C36-F6'-F5 64.8(8)     
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Appendix C: Computational Studies on compound 2.35 
Calculated Structures. Structures were calculated using MM2* as implemented in 
MacroModel 6.5.1961 Monte Carlo conformational searches were performed of all ground 
states using a minimum of 1000-5000 steps.1972 Structures are provided in pdb file 
format.  
MM2* Calculated distances (Å) and coupling constants (Hz) for Pyrrolizidine Products 
2.35a-d.  
 
 
 
 
 
 
 
 
  
                                                
196) MacroModel 6.5; W.C. Still, Columbia Univ. 
197) Mohamdi, F.; Richards, N.G.; Guida, W.C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, C.; 
Hendrickson, T.; Still, W.C. J. Comput. Chem. 1990, 11, 440-467. 
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Hb
Hb
C1-H C8-H
C1-H C2-Ha
C1-H C2-Hb
o-H-Ph C2-Ha
o-H-Ph C2-Hb
o-H-Ph C1-H
o-H-Ph C5-Ha
o-H-Ph C5-Hb
o-H-Ph C8-H
3.109
2.436
3.647
2.764
4.048
4.649
2.886
3.098
2.495
J Value
10.3
Distance
5.3
11.8
C1-H C8-H
C1-H C2-Ha
C1-H C2-Hb
o-H-Ph C2-Ha
o-H-Ph C2-Hb
o-H-Ph C1-H
o-H-Ph C5-Ha
o-H-Ph C5-Hb
o-H-Ph C8-H
3.112
2.730
4.779
3.118
2.668
2.244
2.211
2.520
3.090
J Value
10.4
Distance
11.8
5.2
C1-H C8-H
C1-H C2-Ha
C1-H C2-Hb
o-H-Ph C2-Ha
o-H-Ph C2-Hb
o-H-Ph C1-H
o-H-Ph C5-Ha
o-H-Ph C5-Hb
o-H-Ph C8-H
2.330
3.722
2.586
3.907
4.582
3.110
2.385
2.469
3.088
J Value
7.4
Distance
12.0
5.2
C1-H C8-H
C1-H C2-Ha
C1-H C2-Hb
o-H-Ph C2-Ha
o-H-Ph C2-Hb
o-H-Ph C1-H
o-H-Ph C5-Ha
o-H-Ph C5-Hb
o-H-Ph C8-H
2.332
2.244
4.671
3.263
2.626
4.711
2.571
3.083
2.471
J Value
7.4
Distance
5.2
11.9
 
355 
 
 
Ground state 36.44 kcal/mol 
 
Ground State (S,S,R) 2.35a 
 
COMPND    John1_PDB                                                    
REMARK   1  PDB:    37    38    39    40   
REMARK   1 MMOD:    39    40    34    35 / 
HETATM    1  C01 UNK     0      -1.049  -1.970   1.004  0.01  0.01   0 
HETATM    2  C02 UNK     0      -2.284  -1.902   1.918  0.00  0.00   0 
HETATM    3  C03 UNK     0      -1.860   0.215   0.976  0.01  0.01   0 
(S,S,R) 2.35a
2
356
7 8
N
Ph
IH
1
O
OMe
H
Ha
Hb
Ha
Ha
Ha
Hb
Hb
Hb
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HETATM    4  N04 UNK     0      -0.955  -0.698   0.303  0.19  0.19   0 
HETATM    5  C05 UNK     0       0.449  -0.312   0.147  0.09  0.09   0 
HETATM    6  C06 UNK     0       0.303  -2.158   1.694  0.13  0.13   0 
HETATM    7  C07 UNK     0       1.230  -1.565   0.627  0.00  0.00   0 
HETATM    8  C08 UNK     0       0.824  -0.031  -1.305 -0.04 -0.04   0 
HETATM    9  C09 UNK     0      -0.135   0.132  -2.309  0.00  0.00   0 
HETATM   10  C10 UNK     0       0.241   0.401  -3.624  0.00  0.00   0 
HETATM   11  C11 UNK     0       1.588   0.519  -3.958  0.00  0.00   0 
HETATM   12  C12 UNK     0       2.555   0.370  -2.967  0.00  0.00   0 
HETATM   13  C13 UNK     0       2.172   0.100  -1.655  0.00  0.00   0 
HETATM   14  C14 UNK     0       0.829   0.900   1.000  0.38  0.38   0 
HETATM   15  O15 UNK     0       1.320   0.823   2.109 -0.45 -0.45   0 
HETATM   16  O16 UNK     0       0.530   2.052   0.334  0.59  0.59   0 
HETATM   17  C17 UNK     0       0.798   3.242   1.045  0.07  0.07   0 
HETATM   18  C18 UNK     0      -3.041  -0.686   1.364  0.00  0.00   0 
HETATM   19  H19 UNK     0      -1.200  -2.761   0.229  0.00  0.00   0 
HETATM   20  H20 UNK     0      -2.897  -2.832   1.893  0.00  0.00   0 
HETATM   21  H21 UNK     0      -1.977  -1.695   2.970  0.00  0.00   0 
HETATM   22  H22 UNK     0      -1.417   0.618   1.916  0.00  0.00   0 
HETATM   23  H23 UNK     0      -2.164   1.055   0.307  0.00  0.00   0 
HETATM   24  LP4 UNK     0      -1.174  -0.785  -0.247 -0.21 -0.21   0 
HETATM   25  I26 UNK     0       0.749  -4.198   2.208 -0.13 -0.13   0 
HETATM   26  H25 UNK     0       0.362  -1.568   2.638  0.00  0.00   0 
HETATM   27  H27 UNK     0       1.327  -2.290  -0.216  0.00  0.00   0 
HETATM   28  H28 UNK     0       2.249  -1.342   1.021  0.00  0.00   0 
HETATM   29  H29 UNK     0      -1.211   0.056  -2.087  0.00  0.00   0 
HETATM   30  H30 UNK     0      -0.530   0.525  -4.402  0.00  0.00   0 
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HETATM   31  H31 UNK     0       1.886   0.733  -4.997  0.00  0.00   0 
HETATM   32  H32 UNK     0       3.623   0.467  -3.221  0.00  0.00   0 
HETATM   33  H33 UNK     0       2.957  -0.006  -0.889  0.00  0.00   0 
HETATM   34  H36 UNK     0       0.505   4.102   0.400  0.00  0.00   0 
HETATM   35  H37 UNK     0       0.193   3.263   1.982  0.00  0.00   0 
HETATM   36  H38 UNK     0       1.889   3.307   1.272  0.00  0.00   0 
HETATM   37  H39 UNK     0      -3.619  -0.971   0.453  0.00  0.00   0 
HETATM   38  H40 UNK     0      -3.722  -0.219   2.114  0.00  0.00   0 
HETATM   39  LP4 UNK     0       0.922   2.073  -0.127 -0.31 -0.31   0 
HETATM   40  LP5 UNK     0      -0.073   2.047   0.281 -0.31 -0.31   0 
CONECT    1    2    4    6   19 
CONECT    2    1   18   20   21 
CONECT    3    4   18   22   23 
CONECT    4    3    1    5   24 
CONECT    5    4    7    8   14 
CONECT    6    1    7   26   25 
CONECT    7    5    6   27   28 
CONECT    8   13    5 
CONECT    8    9 
CONECT    8    9 
CONECT    9   10   29 
CONECT    9    8 
CONECT    9    8 
CONECT   10    9   30 
CONECT   10   11 
CONECT   10   11 
CONECT   11   12   31 
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CONECT   11   10 
CONECT   11   10 
CONECT   12   11   32 
CONECT   12   13 
CONECT   12   13 
CONECT   13    8   33 
CONECT   13   12 
CONECT   13   12 
CONECT   14    5   16 
CONECT   14   15 
CONECT   14   15 
CONECT   15   14 
CONECT   15   14 
CONECT   16   14   17   39   40 
CONECT   17   16   34   35   36 
CONECT   18    2    3   37   38 
CONECT   19    1 
CONECT   20    2 
CONECT   21    2 
CONECT   22    3 
CONECT   23    3 
CONECT   24    4 
CONECT   25    6 
CONECT   26    6 
CONECT   27    7 
CONECT   28    7 
CONECT   29    9 
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CONECT   30   10 
CONECT   31   11 
CONECT   32   12 
CONECT   33   13 
CONECT   34   17 
CONECT   35   17 
CONECT   36   17 
CONECT   37   18 
CONECT   38   18 
CONECT   39   16 
CONECT   40   16 
END 
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Ground State 38.21 kcal/mol 
 
Ground State (R,S,S) 2.35b 
 
 
COMPND    John2_PDB                                                    
REMARK   1  PDB:    37    38    39    40   
REMARK   1 MMOD:    39    40    34    35 / 
HETATM    1  C01 UNK     0      -1.007  -1.993  -0.864  0.01  0.01   0 
HETATM    2  C02 UNK     0      -2.215  -2.173  -1.801  0.00  0.00   0 
HETATM    3  C03 UNK     0      -1.885   0.110  -1.302  0.01  0.01   0 
(R,S,S) 2.35b
2
356
7 8
N
Ph
IH
1
O
OMe
H
Ha
Hb
Ha
Ha
Ha
Hb
Hb
Hb
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HETATM    4  N04 UNK     0      -1.024  -0.618  -0.388  0.19  0.19   0 
HETATM    5  C05 UNK     0       0.349  -0.142  -0.198  0.09  0.09   0 
HETATM    6  C06 UNK     0       0.370  -2.173  -1.508  0.13  0.13   0 
HETATM    7  C07 UNK     0       1.230  -1.379  -0.518  0.00  0.00   0 
HETATM    8  C08 UNK     0       0.664   1.100  -1.029 -0.04 -0.04   0 
HETATM    9  C09 UNK     0       1.358   1.055  -2.242  0.00  0.00   0 
HETATM   10  C10 UNK     0       1.618   2.214  -2.971  0.00  0.00   0 
HETATM   11  C11 UNK     0       1.186   3.451  -2.501  0.00  0.00   0 
HETATM   12  C12 UNK     0       0.489   3.517  -1.298  0.00  0.00   0 
HETATM   13  C13 UNK     0       0.233   2.353  -0.576  0.00  0.00   0 
HETATM   14  C14 UNK     0       0.596   0.189   1.277  0.38  0.38   0 
HETATM   15  O15 UNK     0      -0.248   0.133   2.150 -0.45 -0.45   0 
HETATM   16  O16 UNK     0       1.896   0.569   1.443  0.59  0.59   0 
HETATM   17  C17 UNK     0       2.250   0.931   2.762  0.07  0.07   0 
HETATM   18  C18 UNK     0      -3.021  -0.886  -1.575  0.00  0.00   0 
HETATM   19  H19 UNK     0      -1.110  -2.659   0.027  0.00  0.00   0 
HETATM   20  H20 UNK     0      -2.809  -3.088  -1.573  0.00  0.00   0 
HETATM   21  H21 UNK     0      -1.878  -2.214  -2.863  0.00  0.00   0 
HETATM   22  H22 UNK     0      -1.369   0.322  -2.268  0.00  0.00   0 
HETATM   23  H23 UNK     0      -2.258   1.057  -0.848  0.00  0.00   0 
HETATM   24  LP4 UNK     0      -1.290  -0.615   0.148 -0.21 -0.21   0 
HETATM   25  I26 UNK     0       0.972  -4.224  -1.741 -0.13 -0.13   0 
HETATM   26  H25 UNK     0       0.403  -1.711  -2.522  0.00  0.00   0 
HETATM   27  H27 UNK     0       1.362  -1.996   0.402  0.00  0.00   0 
HETATM   28  H28 UNK     0       2.246  -1.131  -0.904  0.00  0.00   0 
HETATM   29  H29 UNK     0       1.716   0.103  -2.661  0.00  0.00   0 
HETATM   30  H30 UNK     0       2.167   2.153  -3.925  0.00  0.00   0 
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HETATM   31  H31 UNK     0       1.390   4.368  -3.077  0.00  0.00   0 
HETATM   32  H32 UNK     0       0.138   4.490  -0.918  0.00  0.00   0 
HETATM   33  H33 UNK     0      -0.328   2.441   0.368  0.00  0.00   0 
HETATM   34  H36 UNK     0       3.327   1.219   2.762  0.00  0.00   0 
HETATM   35  H37 UNK     0       2.102   0.059   3.443  0.00  0.00   0 
HETATM   36  H38 UNK     0       1.636   1.803   3.089  0.00  0.00   0 
HETATM   37  H39 UNK     0      -3.661  -0.987  -0.667  0.00  0.00   0 
HETATM   38  H40 UNK     0      -3.649  -0.607  -2.452  0.00  0.00   0 
HETATM   39  LP4 UNK     0       1.949   1.087   1.134 -0.31 -0.31   0 
HETATM   40  LP5 UNK     0       2.219   0.067   1.339 -0.31 -0.31   0 
CONECT    1    2    4    6   19 
CONECT    2    1   18   20   21 
CONECT    3    4   18   22   23 
CONECT    4    3    1    5   24 
CONECT    5    4    7    8   14 
CONECT    6    1    7   26   25 
CONECT    7    5    6   27   28 
CONECT    8   13    5 
CONECT    8    9 
CONECT    8    9 
CONECT    9   10   29 
CONECT    9    8 
CONECT    9    8 
CONECT   10    9   30 
CONECT   10   11 
CONECT   10   11 
CONECT   11   12   31 
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CONECT   11   10 
CONECT   11   10 
CONECT   12   11   32 
CONECT   12   13 
CONECT   12   13 
CONECT   13    8   33 
CONECT   13   12 
CONECT   13   12 
CONECT   14    5   16 
CONECT   14   15 
CONECT   14   15 
CONECT   15   14 
CONECT   15   14 
CONECT   16   14   17   39   40 
CONECT   17   16   34   35   36 
CONECT   18    2    3   37   38 
CONECT   19    1 
CONECT   20    2 
CONECT   21    2 
CONECT   22    3 
CONECT   23    3 
CONECT   24    4 
CONECT   25    6 
CONECT   26    6 
CONECT   27    7 
CONECT   28    7 
CONECT   29    9 
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CONECT   30   10 
CONECT   31   11 
CONECT   32   12 
CONECT   33   13 
CONECT   34   17 
CONECT   35   17 
CONECT   36   17 
CONECT   37   18 
CONECT   38   18 
CONECT   39   16 
CONECT   40   16 
END 
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Ground State 39.36 kcal/mol 
 
Ground State (S,S,S) 2.35c 
 
COMPND    John3_PDB                                                    
REMARK   1  PDB:    37    38    39    40   
REMARK   1 MMOD:    39    40    32    33 / 
HETATM    1  C01 UNK     0      -1.361  -1.902  -0.630  0.01  0.01   0 
HETATM    2  C02 UNK     0      -2.280  -2.210  -1.827  0.00  0.00   0 
HETATM    3  C03 UNK     0      -1.970   0.088  -1.712  0.01  0.01   0 
HETATM    4  N04 UNK     0      -1.207  -0.445  -0.593  0.19  0.19   0 
(S,S,S) 2.35c
2
356
7 8
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Ph
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HETATM    5  C05 UNK     0       0.220  -0.119  -0.584  0.09  0.09   0 
HETATM    6  C06 UNK     0       0.058  -2.491  -0.644  0.13  0.13   0 
HETATM    7  C07 UNK     0       0.527   1.231  -1.219 -0.04 -0.04   0 
HETATM    8  C08 UNK     0       1.391   1.382  -2.307  0.00  0.00   0 
HETATM    9  C09 UNK     0       1.651   2.640  -2.847  0.00  0.00   0 
HETATM   10  C10 UNK     0       1.054   3.774  -2.301  0.00  0.00   0 
HETATM   11  C11 UNK     0       0.199   3.641  -1.210  0.00  0.00   0 
HETATM   12  C12 UNK     0      -0.056   2.380  -0.676  0.00  0.00   0 
HETATM   13  C13 UNK     0       0.734  -0.049   0.859  0.38  0.38   0 
HETATM   14  O14 UNK     0       0.060  -0.291   1.841 -0.45 -0.45   0 
HETATM   15  O15 UNK     0       2.046   0.325   0.861  0.59  0.59   0 
HETATM   16  C16 UNK     0       2.638   0.423   2.140  0.07  0.07   0 
HETATM   17  C17 UNK     0      -3.101  -0.921  -1.937  0.00  0.00   0 
HETATM   18  C18 UNK     0       0.862  -1.347  -1.273  0.00  0.00   0 
HETATM   19  H19 UNK     0      -1.889  -2.226   0.299  0.00  0.00   0 
HETATM   20  H20 UNK     0      -1.690  -2.337  -2.764  0.00  0.00   0 
HETATM   21  H21 UNK     0      -2.919  -3.108  -1.666  0.00  0.00   0 
HETATM   22  H22 UNK     0      -2.364   1.107  -1.489  0.00  0.00   0 
HETATM   23  H23 UNK     0      -1.349   0.127  -2.638  0.00  0.00   0 
HETATM   24  LP4 UNK     0      -1.450  -0.238  -0.086 -0.21 -0.21   0 
HETATM   25  I26 UNK     0       0.334  -4.407  -1.583 -0.13 -0.13   0 
HETATM   26  H25 UNK     0       0.403  -2.641   0.405  0.00  0.00   0 
HETATM   27  H27 UNK     0       1.889   0.513  -2.763  0.00  0.00   0 
HETATM   28  H28 UNK     0       2.333   2.740  -3.707  0.00  0.00   0 
HETATM   29  H29 UNK     0       1.260   4.769  -2.727  0.00  0.00   0 
HETATM   30  H30 UNK     0      -0.274   4.534  -0.769  0.00  0.00   0 
HETATM   31  H31 UNK     0      -0.734   2.299   0.190  0.00  0.00   0 
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HETATM   32  H34 UNK     0       3.702   0.728   2.004  0.00  0.00   0 
HETATM   33  H35 UNK     0       2.107   1.199   2.741  0.00  0.00   0 
HETATM   34  H36 UNK     0       2.602  -0.570   2.648  0.00  0.00   0 
HETATM   35  H37 UNK     0      -3.601  -0.806  -2.926  0.00  0.00   0 
HETATM   36  H38 UNK     0      -3.853  -0.858  -1.116  0.00  0.00   0 
HETATM   37  H39 UNK     0       1.958  -1.444  -1.097  0.00  0.00   0 
HETATM   38  H40 UNK     0       0.666  -1.327  -2.371  0.00  0.00   0 
HETATM   39  LP2 UNK     0       2.338  -0.139   0.603 -0.31 -0.31   0 
HETATM   40  LP3 UNK     0       2.049   0.895   0.659 -0.31 -0.31   0 
CONECT    1    2    4    6   19 
CONECT    2    1   17   20   21 
CONECT    3    4   17   22   23 
CONECT    4    3    1    5   24 
CONECT    5    4   18    7   13 
CONECT    6    1   18   26   25 
CONECT    7   12    5 
CONECT    7    8 
CONECT    7    8 
CONECT    8    9   27 
CONECT    8    7 
CONECT    8    7 
CONECT    9    8   28 
CONECT    9   10 
CONECT    9   10 
CONECT   10   11   29 
CONECT   10    9 
CONECT   10    9 
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CONECT   11   10   30 
CONECT   11   12 
CONECT   11   12 
CONECT   12    7   31 
CONECT   12   11 
CONECT   12   11 
CONECT   13    5   15 
CONECT   13   14 
CONECT   13   14 
CONECT   14   13 
CONECT   14   13 
CONECT   15   13   16   39   40 
CONECT   16   15   32   33   34 
CONECT   17    2    3   35   36 
CONECT   18    6    5   37   38 
CONECT   19    1 
CONECT   20    2 
CONECT   21    2 
CONECT   22    3 
CONECT   23    3 
CONECT   24    4 
CONECT   25    6 
CONECT   26    6 
CONECT   27    8 
CONECT   28    9 
CONECT   29   10 
CONECT   30   11 
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CONECT   31   12 
CONECT   32   16 
CONECT   33   16 
CONECT   34   16 
CONECT   35   17 
CONECT   36   17 
CONECT   37   18 
CONECT   38   18 
CONECT   39   15 
CONECT   40   15 
END 
 
  
 
370 
 
Ground State 38.05 kcal/mol 
 
Ground State (R,S,R) 2.35d 
 
COMPND    John4_PDB                                                    
REMARK   1  PDB:    37    38    39    40   
REMARK   1 MMOD:    39    40    32    33 / 
HETATM    1  C01 UNK     0      -1.391  -1.778   0.671  0.01  0.01   0 
HETATM    2  C02 UNK     0      -2.334  -1.951   1.876  0.00  0.00   0 
HETATM    3  C03 UNK     0      -1.877   0.311   1.623  0.01  0.01   0 
HETATM    4  N04 UNK     0      -1.145  -0.339   0.545  0.19  0.19   0 
(R,S,R) 2.35d
2
356
7 8
N
Ph
IH
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HETATM    5  C05 UNK     0       0.301  -0.110   0.516  0.09  0.09   0 
HETATM    6  C06 UNK     0      -0.012  -2.451   0.729  0.13  0.13   0 
HETATM    7  C07 UNK     0       0.863  -0.115  -0.906 -0.04 -0.04   0 
HETATM    8  C08 UNK     0       0.060  -0.277  -2.040  0.00  0.00   0 
HETATM    9  C09 UNK     0       0.613  -0.269  -3.320  0.00  0.00   0 
HETATM   10  C10 UNK     0       1.984  -0.095  -3.491  0.00  0.00   0 
HETATM   11  C11 UNK     0       2.796   0.074  -2.373  0.00  0.00   0 
HETATM   12  C12 UNK     0       2.237   0.064  -1.097  0.00  0.00   0 
HETATM   13  C13 UNK     0       0.702   1.213   1.161  0.38  0.38   0 
HETATM   14  O14 UNK     0       1.326   1.304   2.201 -0.45 -0.45   0 
HETATM   15  O15 UNK     0       0.257   2.247   0.393  0.59  0.59   0 
HETATM   16  C16 UNK     0       0.555   3.534   0.894  0.07  0.07   0 
HETATM   17  C17 UNK     0      -3.072  -0.609   1.897  0.00  0.00   0 
HETATM   18  C18 UNK     0       0.862  -1.326   1.294  0.00  0.00   0 
HETATM   19  H19 UNK     0      -1.937  -2.125  -0.240  0.00  0.00   0 
HETATM   20  H20 UNK     0      -3.028  -2.816   1.766  0.00  0.00   0 
HETATM   21  H21 UNK     0      -1.757  -2.057   2.825  0.00  0.00   0 
HETATM   22  H22 UNK     0      -1.264   0.362   2.554  0.00  0.00   0 
HETATM   23  H23 UNK     0      -2.198   1.338   1.334  0.00  0.00   0 
HETATM   24  LP4 UNK     0      -1.375  -0.148   0.027 -0.21 -0.21   0 
HETATM   25  I25 UNK     0       0.138  -4.323   1.777 -0.13 -0.13   0 
HETATM   26  H26 UNK     0       0.325  -2.681  -0.309  0.00  0.00   0 
HETATM   27  H27 UNK     0      -1.028  -0.416  -1.955  0.00  0.00   0 
HETATM   28  H28 UNK     0      -0.037  -0.401  -4.201  0.00  0.00   0 
HETATM   29  H29 UNK     0       2.421  -0.088  -4.502  0.00  0.00   0 
HETATM   30  H30 UNK     0       3.882   0.215  -2.498  0.00  0.00   0 
HETATM   31  H31 UNK     0       2.904   0.204  -0.231  0.00  0.00   0 
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HETATM   32  H34 UNK     0       0.139   4.285   0.183  0.00  0.00   0 
HETATM   33  H35 UNK     0       0.075   3.668   1.892  0.00  0.00   0 
HETATM   34  H36 UNK     0       1.661   3.664   0.961  0.00  0.00   0 
HETATM   35  H37 UNK     0      -3.813  -0.550   1.064  0.00  0.00   0 
HETATM   36  H38 UNK     0      -3.572  -0.401   2.871  0.00  0.00   0 
HETATM   37  H39 UNK     0       0.671  -1.216   2.387  0.00  0.00   0 
HETATM   38  H40 UNK     0       1.950  -1.505   1.132  0.00  0.00   0 
HETATM   39  LP2 UNK     0       0.582   2.215  -0.117 -0.31 -0.31   0 
HETATM   40  LP3 UNK     0      -0.346   2.217   0.426 -0.31 -0.31   0 
CONECT    1    2    4    6   19 
CONECT    2    1   17   20   21 
CONECT    3    4   17   22   23 
CONECT    4    3    1    5   24 
CONECT    5    4    7   13   18 
CONECT    6    1   18   25   26 
CONECT    7   12    5 
CONECT    7    8 
CONECT    7    8 
CONECT    8    9   27 
CONECT    8    7 
CONECT    8    7 
CONECT    9    8   28 
CONECT    9   10 
CONECT    9   10 
CONECT   10   11   29 
CONECT   10    9 
CONECT   10    9 
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CONECT   11   10   30 
CONECT   11   12 
CONECT   11   12 
CONECT   12    7   31 
CONECT   12   11 
CONECT   12   11 
CONECT   13    5   15 
CONECT   13   14 
CONECT   13   14 
CONECT   14   13 
CONECT   14   13 
CONECT   15   13   16   39   40 
CONECT   16   15   32   33   34 
CONECT   17    2    3   35   36 
CONECT   18    6    5   37   38 
CONECT   19    1 
CONECT   20    2 
CONECT   21    2 
CONECT   22    3 
CONECT   23    3 
CONECT   24    4 
CONECT   25    6 
CONECT   26    6 
CONECT   27    8 
CONECT   28    9 
CONECT   29   10 
CONECT   30   11 
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CONECT   31   12 
CONECT   32   16 
CONECT   33   16 
CONECT   34   16 
CONECT   35   17 
CONECT   36   17 
CONECT   37   18 
CONECT   38   18 
CONECT   39   15 
CONECT   40   15 
END 
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